data_1n27_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n27 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -132.59 153.95 50.52 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.707 1.203 . . . . 0.0 109.799 -169.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.14 52.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.5 -12.0 68.24 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.748 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.28 166.58 21.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.609 1.705 . . . . 0.0 109.589 166.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.44 148.81 47.4 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.66 170.46 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 C-N-CA 123.363 0.665 . . . . 0.0 111.083 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.69 138.23 40.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.64 120.73 39.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 108.158 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 18.2 tptp -104.99 106.53 17.07 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -87.91 158.05 18.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -64.5 93.46 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 111.404 -172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -18.78 42.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.631 1.11 . . . . 0.0 112.593 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -72.63 162.11 75.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.646 1.223 . . . . 0.0 108.753 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -61.78 178.73 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.645 2.23 . . . . 0.0 112.284 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.421 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 55.6 m80 -64.96 92.33 0.1 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 158.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -76.37 141.06 69.44 Favored Pre-proline 0 C--O 1.234 0.266 0 C-N-CA 123.979 0.911 . . . . 0.0 109.414 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.96 121.06 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.617 2.211 . . . . 0.0 109.187 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 163.47 32.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.5 0.667 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 13.2 ptt180 -119.93 152.33 37.58 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.2 mm -78.46 121.87 32.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 163.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -102.5 -174.39 2.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 168.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.26 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -83.16 166.99 18.17 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.501 1.046 . . . . 0.0 111.352 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -130.26 149.4 73.21 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.426 1.09 . . . . 0.0 109.225 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 92.26 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.723 2.949 . . . . 0.0 108.976 163.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.47 122.93 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -102.12 117.43 34.76 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.151 1.38 . . . . 0.0 107.476 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -84.1 105.17 14.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.69 1.596 . . . . 0.0 107.658 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 11.5 m-85 -60.69 156.77 16.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.107 0.479 . . . . 0.0 110.731 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.16 -23.42 0.91 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.448 1.975 . . . . 0.0 115.616 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -113.55 -18.46 11.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.931 1.366 . . . . 0.0 110.604 170.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.6 m170 61.85 18.43 9.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.06 2.544 . . . . 0.0 111.578 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.19 160.2 32.32 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.753 0.821 . . . . 0.0 110.005 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.3 p -125.71 131.01 52.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.734 1.214 . . . . 0.0 108.157 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.78 170.22 16.29 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.653 166.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.16 118.06 35.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.49 154.23 40.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.45 167.05 19.94 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -61.56 -32.76 87.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.982 2.455 . . . . 0.0 112.86 -163.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -63.25 -28.8 70.28 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.763 0.825 . . . . 0.0 112.799 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.78 -1.16 50.88 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 111.716 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -126.85 160.75 30.03 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.957 1.703 . . . . 0.0 109.34 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -140.39 136.38 16.72 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.31 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.62 128.69 21.73 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.785 2.323 . . . . 0.0 110.128 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -51.15 -59.48 4.15 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.355 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -61.31 -23.54 65.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.629 1.559 . . . . 0.0 113.26 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -29.71 41.55 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.189 1.358 . . . . 0.0 111.507 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -114.55 6.19 15.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.742 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -57.08 -44.49 83.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.073 1.749 . . . . 0.0 109.854 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -89.87 -27.99 19.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -68.54 -44.05 75.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.741 1.616 . . . . 0.0 112.55 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -114.19 -27.25 7.71 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.938 2.095 . . . . 0.0 111.017 -172.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 63.5 3.86 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.814 1.197 . . . . 0.0 110.894 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -142.67 157.65 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.614 1.165 . . . . 0.0 109.158 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m -73.38 71.41 1.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.218 1.807 . . . . 0.0 115.34 -151.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.99 -11.12 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.563 1.545 . . . . 0.0 113.031 -170.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.6 tttt 53.69 29.14 8.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.078 2.151 . . . . 0.0 115.865 165.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -71.73 11.28 0.53 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 61.98 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.333 2.253 . . . . 0.0 109.393 -152.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.64 -40.91 0.65 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.441 -1.412 . . . . 0.0 112.632 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -30.43 68.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.917 1.687 . . . . 0.0 114.277 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -33.16 32.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 120.967 -1.083 . . . . 0.0 110.483 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.2 -58.22 9.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.79 1.636 . . . . 0.0 106.866 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.69 -33.69 87.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 118.998 0.817 . . . . 0.0 113.288 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.7 -29.61 69.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.689 1.245 . . . . 0.0 111.842 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -75.48 -43.38 49.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.929 0.786 . . . . 0.0 109.28 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.75 -38.21 90.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.028 1.331 . . . . 0.0 110.143 -171.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 tt -73.46 -45.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.341 1.057 . . . . 0.0 111.281 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.45 -55.91 26.27 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 . . . . . 0 CA--C 1.532 0.271 0 C-N-CA 125.112 1.365 . . . . 0.0 112.773 -177.547 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 . . . . . 0 C--O 1.234 0.271 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -142.58 161.81 37.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.518 1.527 . . . . 0.0 107.774 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 133.66 56.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.85 -12.73 68.84 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.614 -1.103 . . . . 0.0 112.915 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 128.07 34.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.349 1.575 . . . . 0.0 107.576 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -85.65 147.7 26.25 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.85 168.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.655 0.74 . . . . 0.0 111.781 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.52 125.5 50.11 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 160.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.82 154.17 18.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -130.19 105.89 8.23 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mtm -73.14 168.96 18.04 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 110.042 171.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.75 55.01 2.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 110.768 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.5 -28.22 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.946 0.784 . . . . 0.0 112.494 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -70.5 160.43 81.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.882 -0.775 . . . . 0.0 110.258 167.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.11 177.84 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.965 3.11 . . . . 0.0 111.749 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -62.65 112.57 2.56 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -114.56 143.56 30.15 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 124.91 1.284 . . . . 0.0 108.037 -166.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.77 123.85 11.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 110.973 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.48 159.38 42.52 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.274 0.559 . . . . 0.0 110.153 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 138.84 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -75.53 92.49 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 163.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -78.21 -164.08 0.5 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.239 0.529 0 O-C-N 120.77 -1.206 . . . . 0.0 108.318 165.123 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m120 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -125.58 160.98 28.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.715 1.143 . . . . 0.0 111.985 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -123.31 152.81 64.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.03 1.732 . . . . 0.0 109.015 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.59 93.39 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 124.506 3.47 . . . . 0.0 111.358 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mm -86.03 108.4 17.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.031 0.933 . . . . 0.0 108.577 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -94.5 119.16 32.78 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 111.64 18.55 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 107.85 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -61.04 157.18 16.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.745 0.783 . . . . 0.0 110.377 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.92 -70.68 1.75 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.745 1.164 . . . . 0.0 111.894 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 p -69.02 -22.29 64.07 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.948 -1.325 . . . . 0.0 112.275 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 66.45 10.17 7.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.1 2.16 . . . . 0.0 113.679 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.14 159.17 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.914 -1.116 . . . . 0.0 110.262 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.25 130.38 40.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.24 -176.15 5.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.82 1.248 . . . . 0.0 109.952 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.95 125.99 40.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 171.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.2 mt -128.85 155.93 44.45 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 108.247 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.87 171.83 22.12 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.744 1.164 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.85 -26.36 32.18 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.483 2.122 . . . . 0.0 113.07 -160.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.86 -14.16 61.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.061 0.846 . . . . 0.0 112.494 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -94.38 -4.59 48.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.761 0.709 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -127.84 153.66 46.36 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.277 1.831 . . . . 0.0 109.927 -163.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -136.29 147.1 58.9 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 109.72 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -63.1 140.41 78.22 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.595 2.197 . . . . 0.0 109.456 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -59.1 -65.69 0.63 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -24.96 67.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -162.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -68.44 -58.77 3.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.552 0.741 . . . . 0.0 109.937 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.48 16.46 7.61 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.968 1.707 . . . . 0.0 111.055 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -60.42 -40.17 90.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.698 1.199 . . . . 0.0 109.518 -164.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.408 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 t70 -80.19 -53.39 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.579 170.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -51.06 -39.94 57.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.676 1.59 . . . . 0.0 113.84 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -110.23 -24.33 10.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.164 1.385 . . . . 0.0 110.643 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.16 71.07 2.89 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 70' ' ' ASP . 9.3 mmpt? -121.66 145.03 48.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 107.659 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -58.04 99.03 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.867 1.667 . . . . 0.0 109.053 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -77.75 173.27 12.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.506 0.669 . . . . 0.0 110.058 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -73.44 -39.34 65.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.694 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.57 141.18 56.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.452 0.569 . . . . 0.0 110.606 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -64.5 163.22 13.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.782 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -47.29 0.83 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.946 1.736 . . . . 0.0 112.167 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -49.58 -49.01 48.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.16 1.384 . . . . 0.0 111.404 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.69 -29.15 69.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.52 -46.93 71.39 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -28.7 73.79 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.24 -0.755 . . . . 0.0 112.895 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.97 -49.8 59.57 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.604 1.202 . . . . 0.0 110.593 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -59.68 -39.01 83.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.891 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.03 -63.11 1.32 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.671 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.85 -32.58 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 119.747 1.158 . . . . 0.0 112.247 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.15 -53.73 40.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.503 0.321 . . . . 0.0 110.141 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 . . . . . 0 C--N 1.332 -0.153 0 O-C-N 121.869 -0.519 . . . . 0.0 111.204 -174.595 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -143.36 167.96 20.93 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.673 1.589 . . . . 0.0 108.269 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.6 26.61 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.61 32.96 4.61 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.785 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.48 168.85 16.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.202 1.001 . . . . 0.0 108.636 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.1 mt -123.08 147.89 46.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.839 1.656 . . . . 0.0 106.665 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.09 171.52 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.333 0.653 . . . . 0.0 110.26 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.36 149.54 27.73 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.17 144.46 50.43 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.944 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -128.53 105.83 8.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.023 0.829 . . . . 0.0 110.369 -174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.9 mtp -90.18 170.8 9.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.56 1.144 . . . . 0.0 109.527 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -60.01 138.89 57.75 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.644 -0.66 . . . . 0.0 109.375 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 -36.25 0.74 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.704 1.145 . . . . 0.0 114.738 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.44 160.72 81.73 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.75 2.02 . . . . 0.0 112.277 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.34 -177.6 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.89 1 C-N-CA 125.574 4.182 . . . . 0.0 110.454 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -71.79 90.39 1.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -77.74 141.74 64.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.821 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.0 127.56 17.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.411 2.074 . . . . 0.0 110.564 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.17 166.03 26.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.114 0.566 . . . . 0.0 110.596 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -128.02 162.91 25.73 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 120.929 -1.107 . . . . 0.0 111.584 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -94.87 101.93 13.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.7 -177.09 6.5 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.161 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 N--CA 1.451 -0.389 0 C-N-CA 125.186 1.394 . . . . 0.0 108.141 -178.603 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.4 p30 . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.621 0.724 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -141.56 171.74 13.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.786 2.835 . . . . 0.0 107.999 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -131.74 152.34 80.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.182 1.393 . . . . 0.0 108.894 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.13 91.32 1.21 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.863 3.708 . . . . 0.0 110.684 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.9 mm -89.18 110.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -169.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -88.87 132.18 34.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 108.304 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -103.08 94.56 5.61 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.103 1.361 . . . . 0.0 108.552 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -47.53 147.81 1.63 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.82 1.648 . . . . 0.0 112.365 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 -39.16 0.75 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.977 1.751 . . . . 0.0 114.241 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -22.65 24.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.467 1.507 . . . . 0.0 112.429 173.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.4 m80 58.72 11.91 2.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.676 2.39 . . . . 0.0 114.749 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -74.13 169.62 17.18 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.629 0.649 . . . . 0.0 110.225 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -127.97 166.14 18.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.39 166.1 34.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.148 1.379 . . . . 0.0 108.165 163.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -105.96 114.32 28.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 166.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.07 150.51 52.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.508 0.723 . . . . 0.0 109.307 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.33 25.62 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.14 -10.62 29.23 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.933 3.089 . . . . 0.0 113.314 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -76.75 -5.66 49.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.869 1.268 . . . . 0.0 113.744 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -122.17 12.05 10.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.0 110.723 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 mt -135.2 162.26 33.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.514 1.526 . . . . 0.0 110.574 -170.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.36 148.17 52.77 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.981 1.313 . . . . 0.0 111.703 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.77 142.83 95.14 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -67.49 -56.07 11.03 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.436 -0.79 . . . . 0.0 109.961 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.61 -9.3 53.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.86 -77.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 155.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -72.48 10.39 0.83 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.766 2.826 . . . . 0.0 114.523 -164.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -59.99 -35.23 74.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.073 1.349 . . . . 0.0 109.009 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.55 -45.45 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.115 1.325 . . . . 0.0 111.551 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -60.52 -55.01 38.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.406 0.682 . . . . 0.0 111.065 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -97.77 -16.23 19.96 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.795 1.238 . . . . 0.0 111.965 -171.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.3 37.75 1.58 Allowed Glycine 0 CA--C 1.541 1.658 0 O-C-N 120.985 -1.072 . . . . 0.0 114.564 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -115.15 135.51 54.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.837 1.318 . . . . 0.0 109.302 -164.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.8 p -57.52 107.45 0.44 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.567 1.147 . . . . 0.0 109.594 -171.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -94.21 163.88 13.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.307 -173.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -92.88 -7.66 45.58 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -66.06 136.84 56.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 158.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -66.73 168.45 9.49 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.471 0.708 . . . . 0.0 109.181 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.96 -32.0 1.07 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.983 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -55.33 -42.04 73.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.925 1.29 . . . . 0.0 110.571 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -45.94 81.87 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.213 0.605 . . . . 0.0 111.348 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.96 -49.05 74.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.5 -38.37 96.22 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.329 -0.706 . . . . 0.0 112.777 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.46 -30.13 71.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.413 1.106 . . . . 0.0 111.832 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -73.7 -48.18 33.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.926 0.784 . . . . 0.0 109.017 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.76 -49.26 73.59 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.104 0.962 . . . . 0.0 111.19 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 tt -67.42 -37.52 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.585 0.354 . . . . 0.0 111.07 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.34 -41.05 96.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.609 -0.682 . . . . 0.0 109.96 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 125.653 1.581 . . . . 0.0 110.678 -179.866 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -141.74 161.21 38.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.633 1.173 . . . . 0.0 109.315 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 141.2 46.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 110.956 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.37 54.65 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.221 -1.321 . . . . 0.0 113.036 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 169.0 18.93 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 119.61 1.705 . . . . 0.0 110.69 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.09 142.85 50.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.943 1.297 . . . . 0.0 108.082 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 175.78 2.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 123.377 0.671 . . . . 0.0 110.701 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.39 131.6 54.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 156.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.97 164.4 13.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.868 2.867 . . . . 0.0 108.324 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -149.48 106.04 3.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.4 mtm -90.15 -179.76 5.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.324 1.049 . . . . 0.0 109.751 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.89 61.41 6.81 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.12 -0.988 . . . . 0.0 112.859 -164.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.54 -27.55 2.6 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 124.451 1.024 . . . . 0.0 110.614 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -60.62 150.86 73.59 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 122.264 -0.55 . . . . 0.0 109.525 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.47 174.03 5.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.388 3.392 . . . . 0.0 110.724 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.25 96.93 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -88.75 131.67 40.91 Favored Pre-proline 0 N--CA 1.456 -0.128 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.43 136.0 38.36 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.261 1.307 . . . . 0.0 109.1 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.27 163.88 34.1 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.973 0.909 . . . . 0.0 109.554 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.61 146.18 50.93 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.462 -0.774 . . . . 0.0 110.26 -178.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mm -80.9 103.14 7.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -78.79 -175.53 4.49 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.326 -0.427 0 C-N-CA 124.573 1.149 . . . . 0.0 108.504 -170.237 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -140.99 163.67 32.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.418 1.087 . . . . 0.0 109.295 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.88 153.55 67.29 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 124.872 1.269 . . . . 0.0 109.239 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -67.26 95.31 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.734 2.956 . . . . 0.0 110.066 167.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.41 113.21 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -85.16 150.8 24.57 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.46 93.26 3.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.8 m-85 -47.58 150.25 1.03 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.826 2.051 . . . . 0.0 111.257 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.18 -49.88 3.62 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.28 1.419 . . . . 0.0 111.774 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -91.61 -16.08 27.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 113.603 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.7 m170 53.11 16.53 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.261 2.624 . . . . 0.0 114.77 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -71.97 164.39 26.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.898 -1.126 . . . . 0.0 110.194 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -139.72 137.89 35.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.032 1.333 . . . . 0.0 108.091 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.68 163.87 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.391 0.615 . . . . 0.0 109.42 169.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -101.99 109.69 21.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -127.83 151.35 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.014 0.926 . . . . 0.0 108.554 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.72 173.74 29.82 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.702 1.144 . . . . 0.0 110.479 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.74 -21.67 58.14 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.259 2.64 . . . . 0.0 112.366 -165.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -64.59 -18.48 64.93 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.293 -0.879 . . . . 0.0 113.055 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -109.07 10.96 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.915 1.286 . . . . 0.0 110.345 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.84 162.24 30.03 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.458 1.903 . . . . 0.0 109.364 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -148.17 143.11 17.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.422 1.089 . . . . 0.0 109.545 176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -63.27 126.38 17.68 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.592 2.861 . . . . 0.0 112.196 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.46 -51.89 67.62 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 121.337 -0.852 . . . . 0.0 111.252 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -59.79 -24.03 63.78 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.39 -72.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -82.25 9.9 7.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.298 1.439 . . . . 0.0 113.461 -164.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -54.89 -34.69 63.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.655 1.582 . . . . 0.0 110.91 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.28 -59.36 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.741 1.216 . . . . 0.0 110.179 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -55.92 -43.13 77.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.501 1.52 . . . . 0.0 113.335 -167.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.85 -26.79 9.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.63 1.972 . . . . 0.0 111.592 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.48 84.04 1.6 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -147.12 166.36 27.16 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 123.503 0.721 . . . . 0.0 110.108 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.8 m -73.57 124.94 26.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -117.13 146.48 43.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.297 1.439 . . . . 0.0 109.63 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -67.98 -14.66 63.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 127.46 32.69 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 120.671 1.578 . . . . 0.0 108.39 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -61.2 162.51 7.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -36.82 1.83 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 112.126 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.007 1.403 . . . . 0.0 110.804 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -67.05 -42.75 84.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 111.694 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.05 -42.38 76.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.06 21.87 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.1 -20.93 57.97 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.352 1.076 . . . . 0.0 113.548 -174.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -68.67 -42.04 78.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.499 1.045 . . . . 0.0 111.442 170.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -55.24 14.44 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 110.535 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.9 tt -55.33 -27.32 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.052 0.842 . . . . 0.0 112.802 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -78.18 -51.91 9.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.315 1.446 . . . . 0.0 111.044 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 . . . . . 0 C--O 1.234 0.246 0 C-N-CA 123.111 0.565 . . . . 0.0 112.239 -177.913 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--O 1.232 0.158 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -142.46 173.16 11.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.994 1.717 . . . . 0.0 109.383 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.64 15.12 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.621 0.768 . . . . 0.0 111.433 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 -22.24 30.37 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 124.561 1.077 . . . . 0.0 112.533 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.35 167.91 20.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 122.572 1.177 . . . . 0.0 111.572 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.32 150.78 38.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.424 1.89 . . . . 0.0 107.731 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 m -152.23 177.33 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.797 1.239 . . . . 0.0 110.105 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.86 127.03 53.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 159.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.77 137.58 32.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.0 108.758 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 15.0 tptp -108.11 105.11 14.71 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.7 mtm -76.9 166.66 23.04 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.14 58.33 3.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.485 0.714 . . . . 0.0 112.098 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -46.54 0.44 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.468 1.509 . . . . 0.0 110.907 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -60.19 159.4 22.13 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.696 1.199 . . . . 0.0 110.286 170.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.97 -176.34 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.498 2.799 . . . . 0.0 110.883 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.417 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 26.3 m80 -55.19 107.16 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 107.36 163.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -106.15 128.39 26.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 124.92 1.288 . . . . 0.0 108.115 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.54 129.76 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.14 1.893 . . . . 0.0 109.422 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.98 167.51 22.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -123.55 153.43 40.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.8 mm -84.47 105.4 13.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.87 -172.88 2.85 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 N--CA 1.445 -0.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.986 164.636 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -129.92 168.42 16.67 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.657 1.117 . . . . 0.0 111.657 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -131.17 153.46 81.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.473 2.309 . . . . 0.0 109.898 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -68.98 104.53 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 124.352 3.368 . . . . 0.0 110.045 169.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -97.19 140.28 17.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -123.89 113.29 18.3 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.086 1.755 . . . . 0.0 106.65 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -85.88 101.22 12.66 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.447 1.099 . . . . 0.0 108.482 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -53.37 152.7 4.49 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.757 1.623 . . . . 0.0 112.192 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.26 -60.25 2.74 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.83 1.205 . . . . 0.0 110.38 -167.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -21.32 59.62 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.0 m170 55.27 11.56 0.58 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.994 1.717 . . . . 0.0 114.092 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.48 161.56 30.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.195 0.997 . . . . 0.0 110.044 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 p -141.56 138.42 32.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.911 2.084 . . . . 0.0 107.255 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.51 154.37 28.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.45 122.75 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.42 156.54 36.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.83 161.76 21.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.99 1.281 . . . . 0.0 111.391 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.65 -34.85 72.89 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.681 2.921 . . . . 0.0 112.119 -166.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mppt? -75.74 -7.41 54.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.11 -20.79 16.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.309 0.958 . . . . 0.0 110.557 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.11 170.23 14.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.523 1.529 . . . . 0.0 109.189 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -139.17 149.4 60.9 Favored Pre-proline 0 C--O 1.236 0.395 0 C-N-CA 123.909 0.884 . . . . 0.0 109.358 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.31 152.57 75.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.813 2.342 . . . . 0.0 112.273 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -71.5 -59.72 2.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.969 -0.457 . . . . 0.0 111.336 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.62 -25.82 68.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.393 0.542 . . . . 0.0 111.853 -163.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.71 -39.83 69.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.635 1.174 . . . . 0.0 110.879 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.41 9.63 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 0.0 112.673 -166.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -54.94 -30.65 59.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.89 1.276 . . . . 0.0 111.248 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -98.79 -34.74 10.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.773 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -68.68 -65.97 0.63 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.478 1.035 . . . . 0.0 109.57 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -84.91 -29.56 25.09 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.872 1.269 . . . . 0.0 111.694 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.19 62.53 3.36 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.11 173.48 11.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.903 -1.351 . . . . 0.0 110.558 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -66.53 153.15 43.71 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.415 1.102 . . . . 0.0 109.483 168.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -135.27 -96.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 159.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 -20.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 146.46 54.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 120.9 1.682 . . . . 0.0 110.759 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -60.17 156.05 16.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.242 1.417 . . . . 0.0 108.039 158.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 -43.82 1.19 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 125.663 1.602 . . . . 0.0 113.406 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -48.04 -54.01 14.44 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 125.626 1.571 . . . . 0.0 109.792 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -57.97 -34.47 69.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.37 0.668 . . . . 0.0 111.729 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.98 -49.29 53.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.356 1.062 . . . . 0.0 110.653 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.64 84.98 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.683 0.674 . . . . 0.0 112.576 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.52 -35.97 76.0 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.407 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -66.12 -39.07 89.63 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.214 0.915 . . . . 0.0 110.19 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.12 -47.96 75.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.848 0.859 . . . . 0.0 110.525 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.9 tt -67.28 -26.81 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 118.887 0.767 . . . . 0.0 111.729 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.48 -15.5 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 0.0 111.959 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 N--CA 1.456 -0.159 0 C-N-CA 124.862 1.265 . . . . 0.0 108.067 -179.645 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.556 0.217 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -149.44 156.68 42.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.133 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 103.25 0.14 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.931 1.693 . . . . 0.0 110.143 -173.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.06 -24.41 2.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.136 1.827 . . . . 0.0 111.637 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.57 162.28 27.22 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.634 1.217 . . . . 0.0 112.334 -173.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.67 134.87 54.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 106.206 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -147.92 176.54 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.983 0.913 . . . . 0.0 111.445 -166.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.4 150.96 30.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 156.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.47 168.18 14.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.067 2.147 . . . . 0.0 109.01 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -141.36 107.11 5.11 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.9 mtp -83.81 160.6 21.17 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 165.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.16 112.21 1.3 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.207 1.003 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.56 -11.59 55.39 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.882 1.229 . . . . 0.0 114.652 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -74.86 158.03 85.04 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 118.347 1.073 . . . . 0.0 109.188 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.79 169.75 16.93 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.581 2.187 . . . . 0.0 108.793 163.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -59.57 103.31 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -87.22 143.5 34.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 108.035 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.69 136.82 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.967 1.778 . . . . 0.0 110.484 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.99 168.3 21.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.333 0.653 . . . . 0.0 109.39 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -132.84 156.64 46.8 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.573 -0.705 . . . . 0.0 109.517 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -89.28 136.22 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.37 169.74 15.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--O 1.237 0.44 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 168.498 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -144.14 171.46 14.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.155 1.382 . . . . 0.0 109.388 -167.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -131.37 152.53 80.69 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.355 1.862 . . . . 0.0 107.519 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.1 90.99 1.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.728 2.952 . . . . 0.0 109.131 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.8 mm -83.93 114.54 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -85.13 142.34 29.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.55 118.39 36.47 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -65.05 152.69 42.82 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.028 0.918 . . . . 0.0 110.213 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.31 -68.24 2.4 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 125.002 1.286 . . . . 0.0 110.663 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.5 p -68.11 -25.02 65.1 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.839 -0.8 . . . . 0.0 111.5 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 m170 58.12 14.59 2.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.665 1.986 . . . . 0.0 112.977 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.88 168.57 13.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.995 0.902 . . . . 0.0 110.138 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.13 151.43 48.66 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.313 1.445 . . . . 0.0 108.564 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.92 148.48 27.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.988 0.915 . . . . 0.0 108.536 163.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.41 111.77 21.46 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -124.89 151.41 45.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.001 1.32 . . . . 0.0 108.238 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.58 168.2 31.7 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.347 0.975 . . . . 0.0 110.732 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.49 -40.16 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.628 2.218 . . . . 0.0 110.46 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -8.87 16.55 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.5 -17.13 24.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.272 1.396 . . . . 0.0 111.383 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.69 170.2 8.02 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 127.833 2.453 . . . . 0.0 110.647 -168.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -144.71 142.85 19.56 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.002 0.921 . . . . 0.0 109.845 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 129.51 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.573 2.182 . . . . 0.0 110.718 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -53.15 -54.91 28.92 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 121.582 -0.699 . . . . 0.0 111.272 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -66.64 -13.6 61.39 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.14 -26.0 19.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.99 1.316 . . . . 0.0 111.711 175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.42 12.3 13.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.725 1.61 . . . . 0.0 113.112 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.01 -20.37 16.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 128.456 2.702 . . . . 0.0 113.136 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -117.6 -34.68 4.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 119.322 0.965 . . . . 0.0 110.227 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -61.57 -37.91 85.58 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.631 -0.668 . . . . 0.0 111.072 -177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.72 -35.73 4.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 109.514 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.33 85.84 0.33 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -151.1 -173.93 4.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.885 2.074 . . . . 0.0 107.006 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.08 146.2 28.83 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 122.543 1.163 . . . . 0.0 108.421 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -147.38 134.92 20.89 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.785 1.634 . . . . 0.0 107.088 170.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.26 20.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -59.35 155.57 14.4 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.682 2.037 . . . . 0.0 108.784 162.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.76 161.47 30.83 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 160.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -31.05 0.55 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.422 1.963 . . . . 0.0 115.629 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -56.58 -60.78 3.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.437 1.895 . . . . 0.0 110.587 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -32.87 72.08 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.524 -0.735 . . . . 0.0 112.163 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -56.07 26.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.435 1.494 . . . . 0.0 110.016 169.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.3 77.02 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.672 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.24 -45.1 74.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 118.328 1.064 . . . . 0.0 111.637 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -56.98 -42.02 79.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.044 0.838 . . . . 0.0 108.803 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.22 -48.33 80.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.45 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.72 -35.9 71.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 119.375 0.989 . . . . 0.0 110.757 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.04 -49.6 77.01 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 113.216 178.238 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.616 0.722 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -132.66 177.66 7.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.13 140.78 24.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.679 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.27 -31.96 6.91 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.329 -1.262 . . . . 0.0 111.862 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.81 100.27 4.0 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 119.275 1.537 . . . . 0.0 108.002 -173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.04 149.92 49.5 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.54 169.42 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -105.7 142.91 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 157.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.65 110.28 13.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 109.792 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -91.55 106.29 18.38 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.052 1.741 . . . . 0.0 107.69 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.83 19.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 174.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 128.65 36.7 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.04 15.59 63.03 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.298 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -128.51 162.05 53.34 Favored Pre-proline 0 C--O 1.232 0.149 0 CA-C-N 118.897 1.349 . . . . 0.0 109.044 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.25 -179.7 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.519 3.479 . . . . 0.0 110.831 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -72.7 88.37 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -71.98 136.72 82.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.291 -169.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.35 124.56 13.08 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.059 1.839 . . . . 0.0 108.789 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.86 168.1 20.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.024 0.916 . . . . 0.0 110.634 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm85 -128.8 148.48 50.88 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 mm -86.08 121.07 36.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 170.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.89 179.11 7.63 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.206 0.527 . . . . 0.0 112.202 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 126.094 1.757 . . . . 0.0 107.891 -178.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -102.72 173.64 6.24 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.401 1.08 . . . . 0.0 109.216 160.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -132.32 152.58 80.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.362 1.065 . . . . 0.0 108.799 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 106.95 1.96 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.907 3.071 . . . . 0.0 110.317 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -98.12 115.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.741 1.216 . . . . 0.0 107.943 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -97.37 119.05 35.19 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -78.65 117.35 19.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -66.78 156.03 36.59 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.218 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 -46.48 1.74 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.35 1.453 . . . . 0.0 113.584 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 -29.48 22.26 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.98 1.39 . . . . 0.0 111.501 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.4 m80 69.82 14.23 8.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.036 2.134 . . . . 0.0 112.565 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.16 159.24 35.04 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.532 -0.73 . . . . 0.0 110.047 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.1 p -129.76 128.8 43.16 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.779 1.232 . . . . 0.0 108.441 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.94 172.49 14.12 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.908 0.883 . . . . 0.0 110.083 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -119.65 112.12 18.91 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.0 mt -121.81 150.49 41.81 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.53 166.34 31.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -65.61 -31.37 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.408 2.739 . . . . 0.0 112.108 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -70.28 -11.31 60.81 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.523 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.1 -10.77 34.82 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.078 1.308 . . . . 0.0 110.851 170.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.38 159.83 19.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.566 1.546 . . . . 0.0 109.19 -166.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -138.79 145.69 46.99 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.99 126.53 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.538 2.158 . . . . 0.0 109.932 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -53.86 -62.49 1.62 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -56.37 -40.81 75.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.928 0.786 . . . . 0.0 111.587 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 -34.9 79.54 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 119.141 0.882 . . . . 0.0 112.354 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.85 10.66 38.25 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.855 1.662 . . . . 0.0 111.119 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.21 -47.53 84.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.686 1.195 . . . . 0.0 110.179 -171.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -23.52 55.89 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.242 0.928 . . . . 0.0 112.006 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -77.52 -44.55 28.33 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.224 -0.923 . . . . 0.0 111.386 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -118.7 -23.46 7.03 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.69 1.996 . . . . 0.0 111.235 -165.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.28 58.2 3.66 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -133.25 135.54 45.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.451 1.9 . . . . 0.0 106.568 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.9 97.77 0.03 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.816 1.647 . . . . 0.0 110.938 -170.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -71.87 158.79 35.41 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.11 -0.994 . . . . 0.0 108.986 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -71.7 -27.63 63.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.111 0.964 . . . . 0.0 113.06 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -64.28 142.78 58.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.523 1.056 . . . . 0.0 110.399 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -65.33 164.6 13.27 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 160.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.83 -41.85 2.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.498 1.523 . . . . 0.0 110.223 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -58.48 -46.99 85.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.088 0.955 . . . . 0.0 110.966 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -62.16 -44.8 95.82 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.049 -0.407 . . . . 0.0 110.12 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -69.47 -27.74 65.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.009 0.818 . . . . 0.0 111.68 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 -23.07 35.23 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.125 -0.984 . . . . 0.0 112.83 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.3 -32.13 71.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.99 1.395 . . . . 0.0 110.563 168.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -66.61 -47.9 71.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.557 -0.714 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.63 -48.57 80.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.388 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.3 -41.39 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.222 0.326 . . . . 0.0 110.238 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.67 -37.12 85.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.292 0.637 . . . . 0.0 110.498 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 . . . . . 0 CA--C 1.536 0.416 0 O-C-N 121.421 -0.799 . . . . 0.0 112.384 177.945 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -135.89 178.24 7.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.076 0.853 . . . . 0.0 111.483 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.93 132.54 32.26 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.903 0.881 . . . . 0.0 111.33 -167.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.6 -17.39 58.65 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.096 -0.835 . . . . 0.0 111.775 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.18 161.28 19.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.044 1.402 . . . . 0.0 109.312 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -124.74 156.37 37.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.817 1.647 . . . . 0.0 106.682 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.71 171.88 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.916 0.886 . . . . 0.0 108.861 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -105.85 122.24 45.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 159.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.06 134.87 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.762 1.225 . . . . 0.0 109.39 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -106.79 108.59 20.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.5 mtp -86.39 167.17 14.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.1 150.0 22.25 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 163.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.86 -68.29 1.05 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.226 0.917 . . . . 0.0 111.999 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -56.02 156.05 10.96 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.301 2.24 . . . . 0.0 112.547 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.33 173.44 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.752 2.968 . . . . 0.0 109.88 163.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -62.9 108.04 1.11 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -91.17 140.26 25.77 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 123.934 0.894 . . . . 0.0 108.792 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.01 126.62 16.83 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.216 1.944 . . . . 0.0 110.482 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.22 157.16 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.262 0.553 . . . . 0.0 111.113 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -103.8 152.42 21.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.14 99.95 8.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -74.18 -177.32 2.92 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.955 0.407 . . . . 0.0 109.966 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--N 1.325 -0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 107.712 176.265 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 . . . . . 0 CA--C 1.516 -0.334 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -140.27 145.65 37.59 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -114.46 153.61 46.6 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.332 1.853 . . . . 0.0 110.176 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 91.63 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.399 3.399 . . . . 0.0 111.107 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.24 121.5 43.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -113.21 116.54 29.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -87.55 97.22 10.73 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.104 1.762 . . . . 0.0 108.52 -169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 10.7 m-85 -52.21 150.55 4.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.495 1.118 . . . . 0.0 112.085 -175.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.11 4.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.638 1.59 . . . . 0.0 111.976 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.58 -31.51 68.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.92 0.888 . . . . 0.0 110.849 167.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.1 m80 53.52 25.98 5.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.61 1.964 . . . . 0.0 112.043 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.31 165.73 23.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.975 2.11 . . . . 0.0 109.475 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -127.76 151.61 48.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.849 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.19 155.74 23.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 154.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -86.51 123.95 32.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.71 149.94 50.0 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.191 1.396 . . . . 0.0 108.341 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.21 165.08 27.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.37 -24.12 43.56 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.867 2.378 . . . . 0.0 112.118 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -54.14 -15.22 1.38 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.502 1.521 . . . . 0.0 114.151 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -118.1 7.39 12.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.515 1.526 . . . . 0.0 110.712 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.28 168.67 9.75 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.673 1.589 . . . . 0.0 109.388 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -144.53 146.14 31.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 127.214 2.206 . . . . 0.0 107.124 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.69 152.71 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.652 2.235 . . . . 0.0 111.74 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.0 -62.69 1.37 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.193 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -46.99 -46.4 21.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.861 1.21 . . . . 0.0 111.308 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -18.12 65.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -172.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -130.31 13.6 5.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.502 1.121 . . . . 0.0 111.39 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -55.33 -36.85 66.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.799 1.639 . . . . 0.0 112.225 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -104.83 -15.96 15.04 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.667 0.787 . . . . 0.0 109.723 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -85.66 -57.36 3.08 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 120.918 -1.114 . . . . 0.0 110.079 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -89.6 -36.14 15.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 109.726 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.89 71.11 0.57 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.782 1.658 . . . . 0.0 111.681 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.8 150.09 48.14 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 126.069 1.748 . . . . 0.0 107.465 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.0 p -59.58 105.35 0.35 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.971 0.508 . . . . 0.0 110.015 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -93.82 152.57 18.81 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -89.89 54.5 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 109.355 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -115.54 123.61 48.93 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -67.97 103.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.42 -25.96 4.2 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.551 1.548 . . . . 0.0 111.269 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -65.02 -51.79 59.66 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.404 1.102 . . . . 0.0 111.146 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -73.27 -23.04 60.26 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.409 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -65.04 -48.13 74.92 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 124.34 1.056 . . . . 0.0 108.888 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.92 -31.22 78.92 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.309 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.35 -46.7 85.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.376 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -57.16 -41.26 78.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.594 1.543 . . . . 0.0 111.043 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.09 -51.11 65.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.774 0.715 . . . . 0.0 111.511 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.5 tt -70.35 -38.89 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.432 0.693 . . . . 0.0 110.382 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.56 -27.63 69.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.835 0.854 . . . . 0.0 110.032 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 125.721 1.609 . . . . 0.0 113.019 176.504 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 120.658 0.266 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -147.74 168.16 22.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 108.867 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.27 135.81 57.77 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 123.288 0.367 . . . . 0.0 111.034 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.5 35.58 5.4 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 117.878 -1.512 . . . . 0.0 112.233 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.18 172.8 12.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.238 1.519 . . . . 0.0 111.151 172.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -117.43 142.27 47.34 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.257 1.423 . . . . 0.0 108.414 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.9 m -154.46 171.08 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.029 0.931 . . . . 0.0 111.95 -165.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.07 117.41 30.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.244 1.018 . . . . 0.0 111.652 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.07 163.96 13.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.607 1.163 . . . . 0.0 110.469 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -147.67 106.97 3.88 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.261 -0.899 . . . . 0.0 110.452 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.5 mtm -83.76 168.05 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.026 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -81.15 83.61 6.75 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.967 1.307 . . . . 0.0 109.155 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.42 -56.74 0.67 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -61.66 159.22 35.39 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.445 1.498 . . . . 0.0 113.222 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.07 176.0 10.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.284 3.989 . . . . 0.0 111.153 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -64.02 97.04 0.16 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.982 1.313 . . . . 0.0 108.166 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -89.6 134.9 31.51 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.181 -165.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.74 121.01 8.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.579 2.186 . . . . 0.0 109.658 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.5 19.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 110.236 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -124.58 148.27 47.95 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.1 mm -78.59 99.96 3.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.278 -2.489 . . . . 0.0 104.278 163.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -65.77 173.34 2.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.095 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--N 1.322 -0.618 0 C-N-CA 125.153 1.381 . . . . 0.0 108.972 179.619 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -112.89 160.29 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.014 1.279 . . . . 0.0 111.384 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -115.26 149.85 43.42 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 126.713 2.005 . . . . 0.0 108.161 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.009 3.139 . . . . 0.0 108.919 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.0 mm -102.61 112.89 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -99.3 124.05 44.08 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.3 98.02 11.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -50.43 148.38 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.033 0.933 . . . . 0.0 110.89 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.47 -15.2 1.6 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.963 1.268 . . . . 0.0 115.862 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -115.68 -17.27 11.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.26 1.53 . . . . 0.0 111.596 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.37 16.17 7.2 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.808 2.043 . . . . 0.0 112.749 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -83.55 165.65 18.9 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.428 -0.795 . . . . 0.0 110.219 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -127.5 150.61 49.6 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.176 0.99 . . . . 0.0 110.648 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.3 29.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.155 1.382 . . . . 0.0 109.369 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.53 107.38 16.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.7 mt -123.54 143.69 50.03 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 162.55 28.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.48 -20.5 47.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 113.676 -160.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -52.86 -32.2 43.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.82 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -94.96 9.23 40.17 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 111.506 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 mt -135.28 157.38 47.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.568 1.147 . . . . 0.0 111.144 -161.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -141.64 155.81 66.57 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.016 1.326 . . . . 0.0 110.726 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -68.89 134.11 28.97 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.126 2.55 . . . . 0.0 112.273 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -65.1 -48.1 74.86 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.864 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -62.19 -27.54 69.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.853 1.206 . . . . 0.0 112.361 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.47 -51.08 11.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 111.023 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -97.23 8.85 43.71 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.014 -1.054 . . . . 0.0 113.816 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -53.3 -49.45 66.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.646 1.178 . . . . 0.0 108.684 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.59 -53.09 38.17 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.39 0.431 . . . . 0.0 110.743 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -64.64 -33.87 76.96 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 113.713 -169.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -118.36 -29.21 5.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 112.518 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.58 70.86 3.07 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 153.81 51.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.615 1.566 . . . . 0.0 109.317 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.0 p -74.93 99.9 3.96 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -80.92 168.61 18.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.937 -1.102 . . . . 0.0 111.404 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -89.04 -5.33 57.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -73.15 141.96 47.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.277 1.853 . . . . 0.0 109.023 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HE3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.29 164.29 16.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.17 -40.95 1.27 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.355 0.979 . . . . 0.0 111.564 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.02 -37.94 84.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.185 1.493 . . . . 0.0 111.154 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -48.76 78.32 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.433 0.693 . . . . 0.0 110.167 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.95 -38.42 86.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.856 1.662 . . . . 0.0 110.438 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -72.45 -32.9 61.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.56 1.076 . . . . 0.0 111.944 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.612 1.206 . . . . 0.0 111.16 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -66.31 -44.06 84.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.629 0.649 . . . . 0.0 109.557 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -60.96 -55.38 33.57 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.102 0.961 . . . . 0.0 111.248 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 tt -62.07 -28.36 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.079 0.854 . . . . 0.0 111.187 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -60.05 3.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.013 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 C--O 1.235 0.329 0 C-N-CA 125.399 1.48 . . . . 0.0 112.04 -176.072 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -137.25 176.14 8.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.672 1.589 . . . . 0.0 110.684 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.71 135.2 41.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.42 -28.39 15.8 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.609 1.576 . . . . 0.0 112.31 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -75.74 123.86 26.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.479 1.14 . . . . 0.0 109.325 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.97 145.03 28.76 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.29 168.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.587 0.708 . . . . 0.0 112.699 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -112.85 121.79 45.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.643 1.177 . . . . 0.0 108.189 161.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.34 121.82 35.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.72 1.208 . . . . 0.0 109.147 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -91.49 107.24 19.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mtm -74.01 169.42 17.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.376 0.534 . . . . 0.0 110.433 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -61.69 127.51 31.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.81 -60.48 3.38 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.657 1.122 . . . . 0.0 113.343 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -51.43 155.85 2.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.786 1.635 . . . . 0.0 111.488 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.45 -175.55 2.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.454 3.436 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -62.53 89.75 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.89 2.476 . . . . 0.0 108.251 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -86.45 135.33 36.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -67.47 130.8 23.1 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.298 1.332 . . . . 0.0 108.669 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.65 151.66 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 12.7 ptm180 -103.06 160.63 14.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.437 1.017 . . . . 0.0 109.162 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.6 124.89 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 151.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.91 -156.42 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 O-C-N 119.501 -2.0 . . . . 0.0 109.189 147.443 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.52 0.676 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -138.35 134.18 33.9 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.41 2.284 . . . . 0.0 110.046 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -102.27 147.45 33.98 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.809 2.444 . . . . 0.0 111.241 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.03 100.38 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.053 2.502 . . . . 0.0 111.464 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 mm -83.07 155.5 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -142.08 106.78 4.86 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.22 1.808 . . . . 0.0 107.286 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.93 98.7 3.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.83 1.252 . . . . 0.0 109.107 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m-85 -49.27 139.04 11.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 127.222 2.209 . . . . 0.0 111.999 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.98 -37.55 1.5 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.638 1.589 . . . . 0.0 113.552 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.4 -28.14 52.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.418 1.109 . . . . 0.0 111.753 171.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.9 m80 48.98 60.02 4.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 110.081 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.0 147.84 32.77 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 108.215 163.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 p -121.41 142.99 49.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.421 1.089 . . . . 0.0 109.027 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.05 169.76 21.02 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.596 1.559 . . . . 0.0 108.082 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.65 107.44 18.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.58 133.79 50.71 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.077 1.751 . . . . 0.0 110.586 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.28 167.73 54.12 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.02 -32.07 94.47 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.465 2.776 . . . . 0.0 114.421 -175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.32 -15.79 18.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.39 0.995 . . . . 0.0 113.4 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -103.03 4.0 36.77 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.024 1.284 . . . . 0.0 111.225 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -135.27 134.78 40.3 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.684 1.594 . . . . 0.0 109.767 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.05 145.48 43.94 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 110.851 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.8 116.1 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.104 3.202 . . . . 0.0 109.615 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -49.14 -52.23 27.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.472 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -55.99 -35.96 67.35 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.114 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -41.79 66.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.839 1.199 . . . . 0.0 111.208 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.71 16.16 24.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.741 1.216 . . . . 0.0 110.756 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -61.51 -40.58 95.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.332 0.969 . . . . 0.0 110.471 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.53 -49.95 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.059 -1.026 . . . . 0.0 108.999 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -60.05 -33.82 72.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.245 1.418 . . . . 0.0 113.604 -169.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -125.66 -18.58 5.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.277 1.831 . . . . 0.0 112.649 -173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.97 30.62 1.8 Allowed Glycine 0 N--CA 1.474 1.194 0 CA-C-N 121.32 1.873 . . . . 0.0 113.472 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -115.47 158.65 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.201 2.2 . . . . 0.0 109.062 -167.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -75.44 164.08 26.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.345 1.545 . . . . 0.0 112.302 -163.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -153.85 155.68 36.21 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 128.715 2.806 . . . . 0.0 107.778 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.46 2.27 33.54 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.582 1.153 . . . . 0.0 113.52 -171.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.66 133.78 55.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.895 1.278 . . . . 0.0 108.785 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -62.09 162.27 9.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.38 -46.32 2.76 Favored Glycine 0 N--CA 1.461 0.335 0 O-C-N 120.969 -1.082 . . . . 0.0 111.052 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -54.89 -54.84 37.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.729 0.812 . . . . 0.0 111.202 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.02 -39.72 66.39 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.269 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.33 -43.52 98.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 110.303 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.97 -32.94 82.33 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.648 -0.658 . . . . 0.0 112.386 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.19 -24.59 54.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.007 0.904 . . . . 0.0 112.08 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -68.64 -52.62 29.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -56.59 -54.56 44.51 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.322 0.649 . . . . 0.0 111.187 -174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.2 tt -58.56 -36.37 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.37 0.532 . . . . 0.0 111.759 -172.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.22 -48.53 64.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 125.213 1.405 . . . . 0.0 112.66 -173.281 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -147.33 169.82 18.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.978 0.808 . . . . 0.0 111.284 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.69 124.87 14.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.81 0.844 . . . . 0.0 109.816 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.16 -9.16 61.2 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.777 -1.013 . . . . 0.0 112.836 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.78 159.6 32.69 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 119.285 1.543 . . . . 0.0 108.88 163.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.2 150.14 39.23 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.74 173.85 3.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.856 0.836 . . . . 0.0 111.296 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.29 133.71 52.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 157.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.69 125.86 53.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.228 1.411 . . . . 0.0 108.449 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -105.18 105.89 16.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mtm -77.58 170.21 16.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.122 0.963 . . . . 0.0 109.398 164.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -64.91 130.85 44.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.77 -48.24 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.853 0.739 . . . . 0.0 113.257 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -54.31 152.07 12.31 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 169.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.73 175.26 9.15 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.719 2.946 . . . . 0.0 109.713 171.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -63.07 97.61 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -79.27 140.26 56.57 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.817 1.647 . . . . 0.0 109.22 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.19 128.93 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.771 1.647 . . . . 0.0 109.069 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.84 165.64 27.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.112 0.958 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -116.4 147.67 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.76 108.82 14.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 161.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.61 -174.54 4.34 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 110.129 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 124.858 1.263 . . . . 0.0 109.627 169.011 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -131.37 147.48 52.57 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 124.437 1.095 . . . . 0.0 108.368 167.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.79 153.06 43.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 124.609 1.163 . . . . 0.0 110.146 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.18 94.57 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.441 2.761 . . . . 0.0 108.808 167.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.3 mm -85.07 141.18 14.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CE1' ' HA ' ' A' ' 52' ' ' HIS . 56.0 t80 -125.95 122.46 36.03 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -87.15 99.8 12.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.05 1.34 . . . . 0.0 108.743 -174.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 7.1 m-85 -53.14 144.88 14.58 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.506 1.122 . . . . 0.0 111.163 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 -33.15 0.9 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.248 1.404 . . . . 0.0 114.342 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 p -95.63 -11.96 26.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.295 1.548 . . . . 0.0 112.723 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.9 m170 56.4 26.23 10.49 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.648 1.979 . . . . 0.0 113.542 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -92.01 161.7 14.68 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.726 0.81 . . . . 0.0 109.874 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -127.68 142.92 51.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.652 1.181 . . . . 0.0 109.449 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.52 174.11 13.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 110.16 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.88 107.5 15.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.7 mt -117.93 150.5 39.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.33 164.96 28.57 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.44 -28.03 86.49 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.129 2.553 . . . . 0.0 111.878 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -61.28 -10.72 7.49 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.61 10.35 9.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 110.645 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.2 mt -129.4 153.82 47.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 109.346 -172.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -132.61 148.16 68.45 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.664 0.785 . . . . 0.0 111.356 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.53 125.23 13.03 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.326 3.351 . . . . 0.0 111.049 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.6 -58.04 9.78 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.076 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -55.44 -27.94 51.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.36 -173.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -60.44 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.091 0.86 . . . . 0.0 109.039 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.55 13.13 14.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.928 1.691 . . . . 0.0 112.947 -170.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -57.0 -24.21 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.15 1.78 . . . . 0.0 112.162 -172.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.13 -35.51 5.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.522 1.129 . . . . 0.0 108.472 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.46 81.9 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.818 -1.176 . . . . 0.0 113.035 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -106.7 -27.17 10.97 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.837 1.655 . . . . 0.0 109.273 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.94 73.78 2.58 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 133.77 16.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.042 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.2 p -65.15 137.0 57.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.706 1.603 . . . . 0.0 107.677 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -142.12 -6.01 0.97 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -154.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 tttt 121.64 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 131.402 3.881 . . . . 0.0 111.495 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 133.49 53.16 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.938 0.79 . . . . 0.0 110.076 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -60.25 167.43 2.44 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 125.182 1.551 . . . . 0.0 109.831 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.75 -54.61 0.73 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.897 1.713 . . . . 0.0 111.685 -172.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -46.51 -43.73 17.13 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 126.678 1.991 . . . . 0.0 113.398 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -68.45 -47.6 66.74 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.488 0.715 . . . . 0.0 111.928 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -52.96 -38.93 62.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.994 1.317 . . . . 0.0 109.958 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.17 -28.61 65.97 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.542 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.58 -47.32 70.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.903 1.352 . . . . 0.0 109.659 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -53.79 -45.46 70.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.59 0.556 . . . . 0.0 109.545 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.06 -52.18 60.58 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.86 -30.28 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.484 1.038 . . . . 0.0 111.249 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.91 -31.71 68.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.546 0.612 . . . . 0.0 111.881 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 . . . . . 0 C--O 1.231 0.102 0 C-N-CA 123.633 0.773 . . . . 0.0 112.582 -178.248 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 121.265 0.555 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -160.33 162.77 33.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 109.194 -173.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.02 112.72 0.91 Allowed 'General case' 0 C--O 1.236 0.348 0 O-C-N 124.157 0.911 . . . . 0.0 109.167 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.61 -33.89 2.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.008 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.2 134.66 45.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.819 1.809 . . . . 0.0 108.616 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.86 147.94 25.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 162.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 m -147.92 167.78 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -108.4 148.34 30.28 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 156.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.98 127.8 45.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.278 1.831 . . . . 0.0 108.327 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.17 104.94 16.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.9 mtm -76.26 159.57 30.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 161.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -67.36 142.69 56.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.72 -41.31 0.83 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.717 1.627 . . . . 0.0 113.343 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.72 161.79 68.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 126.898 2.079 . . . . 0.0 112.266 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.6 179.97 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.106 3.204 . . . . 0.0 109.835 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -67.09 98.42 0.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -81.7 139.04 47.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.407 1.083 . . . . 0.0 108.289 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.04 140.74 61.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.266 1.311 . . . . 0.0 110.222 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.56 168.37 22.15 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.11 0.964 . . . . 0.0 109.493 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.0 mm -71.0 115.3 10.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 162.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.31 176.43 8.73 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.712 0.767 . . . . 0.0 109.644 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.457 0 C-N-CA 124.71 1.204 . . . . 0.0 107.941 157.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 . . . . . 0 C--O 1.237 0.395 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -129.79 157.57 41.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 160.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.98 153.54 47.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 126.004 1.722 . . . . 0.0 107.182 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.16 104.47 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.773 2.315 . . . . 0.0 109.641 167.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.8 mm -103.49 111.66 34.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.14 124.29 34.7 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.875 1.27 . . . . 0.0 108.275 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -90.7 101.88 14.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.143 0.977 . . . . 0.0 109.283 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -52.92 145.2 13.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.593 1.157 . . . . 0.0 111.904 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.17 -46.31 2.43 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.363 1.458 . . . . 0.0 111.883 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 p -80.89 -22.32 39.88 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.149 -1.207 . . . . 0.0 112.321 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 m170 55.27 20.35 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.908 2.483 . . . . 0.0 113.822 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -78.43 166.65 22.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 p -125.42 152.64 44.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.35 161.03 39.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 154.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -88.06 123.3 32.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 166.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.3 mt -130.17 152.6 49.43 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.046 0.938 . . . . 0.0 108.525 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.41 169.19 18.24 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.022 0.82 . . . . 0.0 111.682 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.81 5.71 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.371 1 C-N-CA 125.503 4.135 . . . . 0.0 115.838 -166.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -102.14 -6.67 22.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -110.03 7.57 23.68 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.91 -1.119 . . . . 0.0 111.013 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.59 134.95 31.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.69 1.596 . . . . 0.0 108.717 -157.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -126.64 160.5 58.18 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.63 1.172 . . . . 0.0 109.649 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.14 131.67 27.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.742 2.295 . . . . 0.0 110.454 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.96 -57.63 12.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.994 1.27 . . . . 0.0 110.803 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -49.11 -40.61 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.171 0.988 . . . . 0.0 112.402 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -40.95 89.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.806 1.643 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -104.86 6.36 33.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.495 1.518 . . . . 0.0 112.603 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -61.41 -17.18 53.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.277 1.831 . . . . 0.0 111.51 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -115.19 -33.84 5.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.366 1.466 . . . . 0.0 111.856 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -64.1 -55.99 18.08 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.207 1.003 . . . . 0.0 109.937 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -92.66 -39.51 11.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.909 1.284 . . . . 0.0 110.146 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.6 77.94 0.75 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -122.97 179.0 4.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.611 1.564 . . . . 0.0 107.548 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 p -80.82 150.21 29.26 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -153.03 144.04 22.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.074 172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -81.68 68.49 8.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.492 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -128.26 119.25 24.78 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.807 2.043 . . . . 0.0 106.333 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -72.87 116.54 13.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -171.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.12 14.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.991 0.805 . . . . 0.0 111.783 -171.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -62.07 -60.59 3.38 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.949 1.375 . . . . 0.0 108.48 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -56.98 -21.81 33.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.98 -39.53 42.09 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.464 0.706 . . . . 0.0 109.552 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.81 97.22 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.382 -0.824 . . . . 0.0 111.945 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.74 -14.46 63.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.08 0.94 . . . . 0.0 112.613 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -79.76 -48.56 13.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.189 0.904 . . . . 0.0 108.742 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.31 -52.49 65.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.703 0.683 . . . . 0.0 110.446 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.64 -43.69 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.598 0.635 . . . . 0.0 111.622 -170.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.07 -46.63 89.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.356 1.062 . . . . 0.0 109.661 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.337 1.055 . . . . 0.0 112.931 -173.921 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -138.11 170.53 15.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.121 0.968 . . . . 0.0 110.053 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 149.6 18.66 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.615 0.572 . . . . 0.0 110.629 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 -1.63 88.09 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.973 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -101.27 173.62 6.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.022 1.411 . . . . 0.0 109.464 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -131.38 149.31 52.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.757 1.223 . . . . 0.0 109.859 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.42 164.72 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 109.914 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.81 126.59 50.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 158.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.94 165.8 12.7 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -140.07 105.67 5.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.8 mtm -73.65 168.8 18.61 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 168.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -59.44 129.63 42.96 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 162.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.92 -30.03 2.07 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.627 2.061 . . . . 0.0 115.823 168.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.89 163.66 66.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 118.793 1.297 . . . . 0.0 111.576 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.64 175.67 10.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.573 3.515 . . . . 0.0 110.993 168.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -62.59 88.09 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.227 2.211 . . . . 0.0 109.786 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -86.75 137.88 33.56 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 120.904 -1.122 . . . . 0.0 109.252 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.07 137.79 63.84 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 111.665 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.04 167.44 22.67 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.159 0.98 . . . . 0.0 111.09 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 ptm180 -112.45 156.06 23.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.1 mm -82.45 107.48 14.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 159.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.74 -174.55 4.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 CA--C 1.532 0.252 0 O-C-N 120.647 -1.283 . . . . 0.0 109.296 176.662 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -132.85 168.1 19.0 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.913 -1.117 . . . . 0.0 112.916 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -125.2 152.87 71.53 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 130.232 3.413 . . . . 0.0 110.206 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.44 102.03 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.99 3.126 . . . . 0.0 109.543 166.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -87.86 116.31 25.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.626 1.97 . . . . 0.0 107.623 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.83 99.61 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.801 2.041 . . . . 0.0 109.435 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 3.3 m-85 -49.28 143.73 5.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.484 1.514 . . . . 0.0 113.141 -172.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.46 -58.26 2.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.175 1.369 . . . . 0.0 111.394 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -21.35 64.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.327 -1.102 . . . . 0.0 113.056 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 m170 58.09 3.15 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.08 2.152 . . . . 0.0 114.398 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.82 164.63 11.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.297 1.046 . . . . 0.0 109.407 172.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 p -141.24 136.22 31.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -166.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.28 151.09 36.04 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -89.08 107.34 18.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 mt -128.79 150.77 50.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 169.13 21.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.87 1.224 . . . . 0.0 112.762 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -68.42 -23.65 37.6 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.331 2.687 . . . . 0.0 113.924 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -57.25 -19.12 19.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.796 1.18 . . . . 0.0 113.31 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.0 7.05 23.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 109.507 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.3 166.22 11.89 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.389 1.875 . . . . 0.0 110.187 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -148.36 154.28 41.69 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.317 1.847 . . . . 0.0 106.847 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -69.97 127.4 14.38 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.135 2.557 . . . . 0.0 111.148 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -55.35 -53.73 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.456 1.102 . . . . 0.0 111.271 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.01 -21.91 59.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.761 0.824 . . . . 0.0 111.881 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -71.21 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.25 1.42 . . . . 0.0 109.031 167.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.26 15.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.379 1.472 . . . . 0.0 113.575 -166.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -52.93 -28.93 25.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.886 1.674 . . . . 0.0 112.019 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -34.86 6.9 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.123 0.874 . . . . 0.0 111.635 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -60.87 -60.9 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.258 1.023 . . . . 0.0 109.011 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -85.19 -52.02 6.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.695 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.33 88.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 126.187 1.851 . . . . 0.0 111.856 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -151.48 158.83 44.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.418 1.887 . . . . 0.0 108.899 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -60.0 150.89 27.75 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.886 1.327 . . . . 0.0 108.966 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.14 149.86 44.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.615 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -86.0 -14.1 45.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.171 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mmt-85 -58.31 123.9 17.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 164.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -64.78 164.17 12.75 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 -40.69 2.28 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.043 0.83 . . . . 0.0 111.719 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -52.43 -34.96 50.88 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.49 1.145 . . . . 0.0 112.168 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -46.43 76.43 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 121.34 -0.85 . . . . 0.0 112.794 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.04 -43.76 86.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.771 1.229 . . . . 0.0 109.294 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.36 -36.45 93.1 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.421 -0.8 . . . . 0.0 113.02 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.04 -16.91 61.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.289 1.036 . . . . 0.0 112.661 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -77.97 -52.73 8.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.02 -46.09 92.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 112.331 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.8 tt -63.58 -33.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.201 0.909 . . . . 0.0 111.806 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.49 -53.38 19.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.624 -0.672 . . . . 0.0 109.272 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 . . . . . 0 CA--C 1.529 0.172 0 O-C-N 123.803 0.689 . . . . 0.0 112.106 -170.844 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -136.97 169.95 16.91 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.527 1.531 . . . . 0.0 108.759 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 144.08 44.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.491 0.662 . . . . 0.0 110.863 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.18 5.9 59.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.418 -1.212 . . . . 0.0 113.328 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.84 140.98 51.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.28 2.04 . . . . 0.0 108.251 166.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.5 mt -88.42 136.38 33.01 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.05 162.38 13.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 123.478 0.711 . . . . 0.0 109.593 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -102.1 126.6 49.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 164.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.9 168.8 10.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.707 0.803 . . . . 0.0 109.507 173.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -133.44 150.2 51.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.472 0.709 . . . . 0.0 109.569 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 55.4 mtm -132.62 172.89 11.93 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.127 1.771 . . . . 0.0 109.463 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -80.55 71.23 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.143 1.377 . . . . 0.0 109.981 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.36 -41.38 1.2 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.414 1.483 . . . . 0.0 111.276 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -60.65 150.6 74.76 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.505 1.122 . . . . 0.0 110.946 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.52 165.44 29.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.549 3.499 . . . . 0.0 111.333 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -55.36 116.57 2.92 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -118.33 132.1 23.93 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.33 137.44 36.71 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.969 1.78 . . . . 0.0 110.751 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.03 167.34 23.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.674 1.19 . . . . 0.0 110.249 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.41 139.5 53.6 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.69 112.5 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -73.97 171.04 14.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.582 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.239 0.525 0 CA-C-O 122.43 1.109 . . . . 0.0 111.147 -172.082 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -128.19 166.7 18.02 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.349 1.06 . . . . 0.0 108.146 162.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -129.71 153.34 80.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 126.491 1.916 . . . . 0.0 107.283 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.12 115.68 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.397 2.065 . . . . 0.0 108.929 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.5 113.47 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -85.98 131.77 34.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -98.44 115.47 28.58 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -54.8 144.75 21.51 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.055 1.342 . . . . 0.0 110.718 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.86 -58.0 4.04 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.76 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 p -83.48 -24.64 31.68 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.849 2.324 . . . . 0.0 111.273 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.0 m170 70.01 17.43 7.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.349 1.459 . . . . 0.0 112.113 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.59 155.41 33.25 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 130.26 32.52 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.991 1.316 . . . . 0.0 108.0 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.02 159.02 42.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.79 121.63 32.11 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.7 mt -126.79 158.56 36.25 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 109.062 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.86 16.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.701 1.143 . . . . 0.0 112.658 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -67.84 -15.73 44.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.33 2.687 . . . . 0.0 115.188 -160.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -63.53 -26.37 68.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.393 1.451 . . . . 0.0 111.664 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.1 10.66 33.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.485 1.514 . . . . 0.0 111.533 -173.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.3 mt -133.35 127.09 32.76 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.927 1.291 . . . . 0.0 109.408 -169.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.33 142.68 37.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.424 1.089 . . . . 0.0 110.745 -167.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.49 121.04 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.821 3.014 . . . . 0.0 111.411 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -56.28 -50.08 72.41 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.8 -0.562 . . . . 0.0 111.064 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -57.87 -31.97 67.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 112.267 -173.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.19 -68.06 0.5 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.013 0.925 . . . . 0.0 108.823 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.4 -2.57 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.374 1.07 . . . . 0.0 113.265 -160.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.49 -46.46 57.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.935 1.694 . . . . 0.0 110.713 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.67 -17.36 53.88 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -97.76 -62.48 1.24 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.683 1.593 . . . . 0.0 109.786 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -86.22 -30.82 22.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.822 1.649 . . . . 0.0 111.782 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.21 73.41 2.0 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -132.38 128.94 38.67 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.504 1.122 . . . . 0.0 108.556 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -41.89 130.74 3.39 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 126.371 1.868 . . . . 0.0 109.208 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -138.85 134.72 33.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -78.1 72.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -120.09 133.96 55.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -68.32 147.74 51.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -58.69 5.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -48.77 -61.1 2.22 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 124.83 1.252 . . . . 0.0 110.67 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.1 -33.41 70.8 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.785 1.234 . . . . 0.0 114.073 -169.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.14 -39.97 68.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.645 0.778 . . . . 0.0 110.732 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -34.69 80.14 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.567 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.94 -24.78 64.31 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.371 1.085 . . . . 0.0 111.832 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -70.69 -50.06 40.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.79 -46.51 87.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.308 1.043 . . . . 0.0 111.545 -172.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 tt -66.69 -42.36 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.409 0.284 . . . . 0.0 110.864 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.02 -20.32 64.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.013 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 126.77 2.028 . . . . 0.0 110.74 177.062 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -128.94 158.67 38.17 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.089 0.859 . . . . 0.0 110.306 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.09 3.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 109.778 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.09 -37.75 2.23 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -69.8 160.7 31.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.716 1.246 . . . . 0.0 110.778 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -117.82 143.63 46.1 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 107.846 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.31 167.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.554 0.742 . . . . 0.0 111.479 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.43 128.34 50.6 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 158.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.1 165.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE2' ' CE1' ' A' ' 24' ' ' HIS . 6.8 tptp -143.92 106.32 4.41 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.9 mtm -78.28 161.7 27.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 166.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.02 139.34 58.76 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.61 -44.43 2.5 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.078 1.323 . . . . 0.0 113.796 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.67 160.03 78.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.61 1.205 . . . . 0.0 112.384 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 178.46 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.979 3.786 . . . . 0.0 111.482 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.431 ' CE1' ' HE2' ' A' ' 18' ' ' LYS . 55.1 m80 -71.28 89.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.495 1.118 . . . . 0.0 109.234 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -80.69 136.31 51.79 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 110.161 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.43 124.51 12.56 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.895 2.397 . . . . 0.0 110.506 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.82 166.66 24.6 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.717 -0.615 . . . . 0.0 110.28 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.8 ptm85 -125.89 159.62 32.08 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.512 -0.743 . . . . 0.0 109.882 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.5 mm -86.27 108.88 18.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -73.28 174.98 7.28 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 164.191 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -114.1 159.33 20.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.003 0.82 . . . . 0.0 110.2 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -122.84 153.11 63.5 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.282 1.833 . . . . 0.0 108.416 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.13 105.24 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.606 2.87 . . . . 0.0 110.487 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.7 mm -92.89 123.36 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.128 0.571 . . . . 0.0 109.527 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -101.87 115.99 31.74 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 107.091 170.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -80.44 115.84 20.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -65.86 149.04 50.83 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.402 0.62 . . . . 0.0 110.737 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 -34.45 0.34 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.884 2.183 . . . . 0.0 114.059 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -85.68 -28.48 24.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.68 2.24 . . . . 0.0 110.88 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 66.36 13.83 9.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.31 2.244 . . . . 0.0 113.701 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.68 160.07 30.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.2 1.0 . . . . 0.0 109.288 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -122.65 149.55 43.86 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 109.476 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.39 177.65 9.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.762 0.825 . . . . 0.0 109.287 167.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -117.33 122.82 44.94 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.83 156.94 32.18 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.73 0.3 . . . . 0.0 110.5 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.16 161.4 35.88 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.13 -20.97 63.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.957 2.438 . . . . 0.0 111.765 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -60.25 -23.73 64.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.87 0.868 . . . . 0.0 112.386 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.79 -9.94 50.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.489 1.04 . . . . 0.0 111.53 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.9 mt -116.48 160.58 20.39 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.23 1.412 . . . . 0.0 110.795 -162.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.55 146.95 47.14 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.066 0.946 . . . . 0.0 110.767 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -67.12 126.72 15.56 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.426 2.751 . . . . 0.0 110.508 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -52.8 -52.06 58.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.793 0.437 . . . . 0.0 110.841 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -66.66 -6.34 15.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -64.49 1.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.725 -0.609 . . . . 0.0 110.532 164.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -79.96 9.76 5.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.488 1.915 . . . . 0.0 113.525 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -53.71 -20.45 5.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.748 2.019 . . . . 0.0 112.464 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -33.13 4.62 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 119.972 1.26 . . . . 0.0 113.229 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -61.26 -51.56 68.41 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.615 1.098 . . . . 0.0 109.024 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -92.4 -35.06 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.108 0.963 . . . . 0.0 110.112 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.97 80.25 0.59 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.64 -1.089 . . . . 0.0 110.993 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -141.86 142.59 33.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.095 1.758 . . . . 0.0 107.648 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -54.4 103.54 0.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.853 2.461 . . . . 0.0 111.7 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.71 150.5 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.344 -0.848 . . . . 0.0 112.268 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.62 -49.39 14.29 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.8 1.64 . . . . 0.0 113.232 168.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -58.49 139.39 55.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.83 0.741 . . . . 0.0 110.598 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HD3' ' H ' ' A' ' 80' ' ' GLY . 2.7 mmtt -71.27 172.5 9.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 162.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.412 ' H ' ' HD3' ' A' ' 79' ' ' LYS . . . 65.34 -88.01 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 104.611 -3.396 . . . . 0.0 104.611 -143.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -32.24 -53.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.535 2.734 . . . . 0.0 115.547 -151.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -23.7 62.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.39 -57.29 4.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.633 2.373 . . . . 0.0 108.501 170.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.42 -27.75 61.19 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.332 -0.705 . . . . 0.0 112.563 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.48 -48.85 73.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.14 0.97 . . . . 0.0 111.384 170.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -60.89 -40.58 93.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.666 1.121 . . . . 0.0 110.178 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.58 -51.64 67.71 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.356 0.663 . . . . 0.0 111.678 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.2 tt -66.57 -29.4 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 118.892 0.769 . . . . 0.0 110.945 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.69 -30.99 69.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.214 -0.929 . . . . 0.0 110.905 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 . . . . . 0 C--O 1.236 0.388 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 179.476 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -134.5 167.95 19.84 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.974 1.31 . . . . 0.0 108.83 169.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.23 139.57 8.38 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.16 25.12 49.76 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.08 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -109.76 167.42 10.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.548 1.674 . . . . 0.0 109.693 164.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.45 138.25 46.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.766 2.026 . . . . 0.0 106.751 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -140.63 175.3 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 108.901 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -109.38 151.9 26.03 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 157.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.13 147.09 49.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.461 1.505 . . . . 0.0 109.056 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -134.63 104.81 6.21 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -164.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.8 mtm -88.95 167.2 13.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.302 0.573 . . . . 0.0 110.349 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -51.06 113.32 0.9 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.892 1.677 . . . . 0.0 109.154 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.77 -36.13 3.16 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.781 1.658 . . . . 0.0 114.26 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.54 163.65 19.2 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.54 1.536 . . . . 0.0 112.515 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -85.55 -179.04 3.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 125.126 3.884 . . . . 0.0 110.68 168.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -67.18 92.66 0.27 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.269 1.028 . . . . 0.0 108.655 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -78.13 139.1 60.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.986 1.314 . . . . 0.0 108.089 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.4 137.22 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.352 2.034 . . . . 0.0 108.914 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.77 156.86 43.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 141.72 49.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mm -78.12 105.37 7.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.27 170.87 6.5 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.655 0.782 . . . . 0.0 108.896 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 121.179 -0.951 . . . . 0.0 108.584 162.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.631 0.253 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -141.02 164.19 30.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.927 1.291 . . . . 0.0 108.187 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.67 152.67 59.03 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 124.412 1.085 . . . . 0.0 110.158 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.03 91.06 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.637 2.891 . . . . 0.0 109.476 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.6 mm -82.36 118.1 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -85.09 149.51 25.5 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 163.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -111.86 113.34 25.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -64.8 160.4 20.34 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.933 0.873 . . . . 0.0 110.455 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.49 -47.31 2.38 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.92 2.2 . . . . 0.0 113.201 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -96.77 -21.64 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.485 1.143 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.0 m80 66.79 21.71 10.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.454 1.902 . . . . 0.0 112.065 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -71.66 163.37 27.9 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.219 1.009 . . . . 0.0 109.845 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -142.79 142.85 31.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 109.254 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.52 -175.81 5.53 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.986 2.514 . . . . 0.0 107.055 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.82 125.29 48.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 109.386 165.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 mt -130.48 150.89 51.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.518 1.927 . . . . 0.0 108.769 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.81 165.54 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.34 0.971 . . . . 0.0 111.687 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.66 -22.33 50.63 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.937 3.091 . . . . 0.0 113.385 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -60.96 -13.33 15.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.127 -0.939 . . . . 0.0 112.142 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.44 -5.26 21.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 113.734 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.2 mt -122.39 146.96 46.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.565 1.075 . . . . 0.0 109.911 -157.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.15 143.28 46.48 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.579 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -65.02 114.88 2.99 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.619 2.213 . . . . 0.0 108.664 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -46.98 -54.26 10.55 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 123.929 0.892 . . . . 0.0 109.471 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -60.11 -25.24 65.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.502 0.502 . . . . 0.0 112.299 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -57.03 4.18 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -83.42 17.06 2.27 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 112.434 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -66.65 -31.36 71.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.278 1.431 . . . . 0.0 108.968 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.62 -57.07 3.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.414 0.552 . . . . 0.0 111.253 162.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.92 -41.85 83.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.115 0.87 . . . . 0.0 110.843 -162.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -102.73 -14.78 16.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.027 1.731 . . . . 0.0 112.541 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.64 75.17 2.14 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 119.719 1.145 . . . . 0.0 110.268 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -133.3 132.67 41.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.251 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 p -61.62 79.79 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.833 2.053 . . . . 0.0 112.867 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -95.41 147.11 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 110.181 -168.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -91.97 41.96 1.09 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -149.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -105.09 147.14 28.22 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.21 155.37 37.26 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.2 1.64 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.973 1.273 . . . . 0.0 112.197 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.28 -49.61 63.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.905 1.353 . . . . 0.0 112.932 -164.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -66.82 -22.64 66.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.625 0.77 . . . . 0.0 110.754 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -75.53 -47.52 26.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 108.39 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.66 -26.79 72.99 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 120.11 -0.272 . . . . 0.0 113.366 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 mt -72.23 -29.72 64.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.65 1.225 . . . . 0.0 111.584 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -70.72 -42.59 70.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.33 -0.856 . . . . 0.0 109.161 171.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.84 -55.22 37.2 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.156 0.582 . . . . 0.0 110.409 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.02 -34.12 64.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.989 0.813 . . . . 0.0 111.316 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.38 -29.94 65.54 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.496 -0.752 . . . . 0.0 111.631 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 125.071 1.348 . . . . 0.0 112.795 175.539 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.73 156.52 46.74 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.794 -1.191 . . . . 0.0 110.058 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 141.8 50.44 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.63 40.41 10.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -136.55 173.08 12.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.248 1.024 . . . . 0.0 110.588 159.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -119.25 147.2 44.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.877 2.471 . . . . 0.0 106.801 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.73 171.33 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.381 1.073 . . . . 0.0 108.759 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.76 125.56 52.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.03 151.55 20.81 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.041 0.936 . . . . 0.0 110.796 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -126.9 106.32 9.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.2 mtp -83.99 167.78 16.58 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 162.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.18 119.79 11.51 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.05 -16.53 2.0 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.038 -1.423 . . . . 0.0 116.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -67.16 159.19 78.35 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 119.741 1.77 . . . . 0.0 110.907 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.13 164.28 34.52 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.61 2.873 . . . . 0.0 110.037 168.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -65.47 103.15 0.79 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -95.28 138.44 21.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.389 -164.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.56 124.49 14.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.695 2.264 . . . . 0.0 110.345 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.83 164.16 30.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.047 0.539 . . . . 0.0 110.324 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -128.85 146.13 51.01 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.037 -0.414 . . . . 0.0 110.612 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.24 98.63 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 172.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -85.68 -175.88 5.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.754 1.622 . . . . 0.0 109.252 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 126.576 1.951 . . . . 0.0 108.907 167.135 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -136.9 -177.04 4.57 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.924 1.29 . . . . 0.0 109.679 -163.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -140.65 152.44 66.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.36 1.464 . . . . 0.0 109.084 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.81 92.01 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.424 3.416 . . . . 0.0 110.867 170.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.84 141.15 14.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -118.59 133.02 56.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.018 1.727 . . . . 0.0 108.2 172.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -89.85 112.53 23.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.242 1.417 . . . . 0.0 108.357 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 17.1 m-85 -62.39 154.56 27.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 171.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.49 -21.53 0.9 Allowed Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.725 -1.597 . . . . 0.0 115.951 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.96 -14.05 7.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 121.079 2.439 . . . . 0.0 113.879 178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.65 16.3 7.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.569 2.348 . . . . 0.0 112.832 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.1 170.4 10.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.373 1.082 . . . . 0.0 109.954 170.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -141.79 147.73 37.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 108.198 -172.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.42 24.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.318 0.508 . . . . 0.0 109.695 167.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -110.28 112.34 24.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 mt -125.13 142.0 51.76 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.55 164.17 37.68 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -64.4 -32.61 60.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.27 2.647 . . . . 0.0 112.363 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -58.95 -32.95 70.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.856 0.862 . . . . 0.0 112.788 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -82.72 -10.36 58.94 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.236 0.925 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.1 mt -108.15 154.7 21.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.614 1.965 . . . . 0.0 109.687 -171.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -134.01 140.89 37.66 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.797 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.76 126.12 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.442 2.761 . . . . 0.0 109.591 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.42 -48.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.706 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.56 -43.63 72.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.72 1.145 . . . . 0.0 112.731 -172.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -54.11 36.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.403 0.681 . . . . 0.0 110.61 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -85.47 2.85 42.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -55.76 -49.87 71.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.144 1.777 . . . . 0.0 108.991 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.27 -16.99 44.18 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -82.17 -64.76 1.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.885 1.221 . . . . 0.0 112.085 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -88.68 -31.48 18.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.818 2.447 . . . . 0.0 113.712 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.62 63.87 1.14 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.463 1.506 . . . . 0.0 113.367 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -128.99 142.6 50.87 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 p -56.75 150.13 16.71 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.382 1.087 . . . . 0.0 109.801 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.97 167.11 17.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.732 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -83.47 -16.83 44.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.155 0.889 . . . . 0.0 112.846 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -58.85 138.59 57.2 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.558 1.072 . . . . 0.0 109.768 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -67.29 154.69 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.356 0.663 . . . . 0.0 109.411 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.14 -31.97 1.11 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.389 0.995 . . . . 0.0 112.642 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.35 -26.23 66.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.922 1.861 . . . . 0.0 112.487 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -49.9 21.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.135 -0.978 . . . . 0.0 109.742 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -55.45 -47.69 75.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.131 1.372 . . . . 0.0 108.572 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.97 -34.75 88.02 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.425 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.57 -20.38 64.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.581 1.691 . . . . 0.0 111.872 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -83.62 -42.69 16.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 120.765 1.621 . . . . 0.0 110.334 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -55.1 -49.93 70.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.045 0.538 . . . . 0.0 109.884 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.69 -31.79 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.527 -0.733 . . . . 0.0 111.94 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.66 -21.56 65.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.617 1.167 . . . . 0.0 111.769 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 . . . . . 0 C--O 1.234 0.267 0 C-N-CA 123.562 0.745 . . . . 0.0 112.058 -168.24 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.065 -0.017 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -143.07 167.63 21.64 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.409 1.084 . . . . 0.0 110.214 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.21 132.37 23.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.065 0.946 . . . . 0.0 110.659 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.71 76.77 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.26 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.93 144.29 57.38 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.371 1.585 . . . . 0.0 107.926 165.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -101.25 144.1 30.52 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 171.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.87 173.98 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.327 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -114.35 138.07 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 154.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.87 172.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.156 1.383 . . . . 0.0 107.92 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -141.89 106.32 4.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.78 172.8 12.88 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.297 1.046 . . . . 0.0 110.628 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -80.74 44.28 0.72 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.864 2.066 . . . . 0.0 112.956 -165.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.83 -43.11 0.68 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.536 1.541 . . . . 0.0 109.758 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -55.95 155.61 11.55 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 117.284 0.542 . . . . 0.0 110.41 170.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.57 -178.2 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.187 3.258 . . . . 0.0 109.894 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -74.54 79.29 1.96 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.441 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -63.31 134.31 95.79 Favored Pre-proline 0 CA--C 1.539 0.549 0 O-C-N 120.855 -1.153 . . . . 0.0 111.27 -170.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.95 131.38 23.78 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.587 2.191 . . . . 0.0 110.032 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.99 168.65 22.53 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.078 0.466 . . . . 0.0 109.843 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 7.5 ptm180 -134.67 160.29 38.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.692 -0.63 . . . . 0.0 110.878 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.2 mm -84.13 117.13 29.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -82.64 -179.4 7.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.382 1.473 . . . . 0.0 108.587 166.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 108.04 172.857 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -115.26 143.96 44.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.725 1.602 . . . . 0.0 110.972 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -103.81 150.74 38.5 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.32 104.49 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.663 2.242 . . . . 0.0 108.555 159.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.55 140.83 16.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -112.97 121.16 43.81 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.563 2.345 . . . . 0.0 107.513 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -78.11 115.71 18.04 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.6 m-85 -67.79 155.77 38.54 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.906 0.384 . . . . 0.0 110.653 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.47 -58.8 4.1 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.979 0.8 . . . . 0.0 111.548 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -81.82 -21.16 37.8 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 112.152 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.4 m170 55.56 18.01 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.012 2.125 . . . . 0.0 112.619 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.86 166.56 19.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 109.095 173.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 p -142.56 148.11 37.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.229 1.011 . . . . 0.0 108.523 -171.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.52 179.47 7.65 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.521 1.128 . . . . 0.0 109.002 173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -123.01 107.39 11.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.4 146.54 47.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.454 1.901 . . . . 0.0 107.96 -176.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.46 162.13 23.37 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.91 -24.07 61.22 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.846 3.031 . . . . 0.0 113.961 -165.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -67.06 -9.1 35.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.239 1.381 . . . . 0.0 112.457 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.62 4.86 36.06 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.782 1.174 . . . . 0.0 111.501 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.51 153.93 50.44 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.298 1.439 . . . . 0.0 109.601 -166.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.13 143.93 26.7 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.901 0.88 . . . . 0.0 110.362 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.26 129.31 21.28 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.841 2.361 . . . . 0.0 110.568 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.54 -48.05 75.35 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 121.926 -0.484 . . . . 0.0 110.137 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.82 -24.74 66.08 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.75 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -43.28 18.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.523 1.129 . . . . 0.0 110.203 174.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.428 ' CD1' ' CE2' ' A' ' 72' ' ' PHE . 54.3 m-85 -100.84 6.29 43.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.538 1.535 . . . . 0.0 114.047 -164.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -58.81 -33.72 70.7 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 127.249 2.219 . . . . 0.0 112.78 -167.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -98.85 -21.36 16.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.027 0.83 . . . . 0.0 110.346 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -76.13 -68.77 0.55 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.685 1.194 . . . . 0.0 108.576 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 68' ' ' TYR . 22.1 m-30 -81.0 -44.36 18.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.938 1.695 . . . . 0.0 108.975 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.36 96.0 0.05 OUTLIER Glycine 0 C--N 1.339 0.723 0 C-N-CA 125.862 1.696 . . . . 0.0 109.081 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -140.27 133.13 29.16 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.675 1.99 . . . . 0.0 106.245 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 122.57 21.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -145.06 171.76 14.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.256 1.823 . . . . 0.0 108.988 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -88.24 -60.05 2.07 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.083 0.856 . . . . 0.0 112.262 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.304 0.3 OUTLIER 44.5 -126.1 1.02 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.824 0.85 . . . . 0.0 109.876 -173.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -136.99 105.64 5.84 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 127.706 2.402 . . . . 0.0 105.975 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.1 89.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 119.927 1.239 . . . . 0.0 114.207 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -76.55 -52.91 8.84 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.243 1.522 . . . . 0.0 110.816 -170.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -40.97 69.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.882 1.219 . . . . 0.0 110.561 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -61.7 -52.0 66.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.059 1.344 . . . . 0.0 110.591 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.62 92.21 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 123.39 0.519 . . . . 0.0 112.676 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.53 -49.48 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -57.58 -35.86 70.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.469 0.577 . . . . 0.0 110.935 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.58 -47.63 69.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.924 0.784 . . . . 0.0 110.681 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -67.76 -34.65 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.867 0.758 . . . . 0.0 109.79 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.52 -17.83 60.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.789 1.235 . . . . 0.0 111.648 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 . . . . . 0 N--CA 1.463 0.194 0 C-N-CA 125.541 1.536 . . . . 0.0 112.658 -169.592 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -139.83 172.25 13.05 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.899 -1.125 . . . . 0.0 108.557 168.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.1 55.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.6 73.79 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.767 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -97.74 157.69 15.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.753 1.276 . . . . 0.0 108.697 161.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -118.14 134.45 54.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.56 1.944 . . . . 0.0 106.328 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.98 171.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 118.942 0.792 . . . . 0.0 110.414 -167.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.36 142.11 34.78 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.499 -1.376 . . . . 0.0 107.791 162.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.58 161.47 15.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.433 1.493 . . . . 0.0 109.118 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -143.79 107.17 4.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.6 171.5 8.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.69 0.757 . . . . 0.0 109.816 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -53.08 119.13 4.33 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.025 1.73 . . . . 0.0 108.7 173.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.08 -48.36 3.54 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.397 0.999 . . . . 0.0 112.801 172.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -54.45 158.14 4.34 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.908 1.683 . . . . 0.0 112.297 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.36 179.58 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.031 3.154 . . . . 0.0 110.698 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.86 94.12 0.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -85.62 134.91 38.95 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.809 1.243 . . . . 0.0 109.495 -170.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.81 126.18 17.6 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.052 2.501 . . . . 0.0 110.225 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.69 168.11 20.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.764 1.226 . . . . 0.0 109.493 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.23 52.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -80.18 105.15 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 168.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -89.61 -172.39 3.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 121.987 0.899 . . . . 0.0 111.258 -173.112 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -136.01 153.58 51.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.387 1.075 . . . . 0.0 110.068 -171.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -106.11 148.18 36.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 125.121 1.368 . . . . 0.0 107.719 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.3 122.16 10.24 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.124 1.883 . . . . 0.0 107.625 155.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.88 111.38 32.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.656 1.582 . . . . 0.0 107.589 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -85.47 129.14 34.88 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.121 0.969 . . . . 0.0 108.656 171.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -93.62 93.84 8.27 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 108.149 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.18 151.01 1.48 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.637 1.175 . . . . 0.0 110.572 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.57 -74.07 2.3 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -68.34 -20.89 64.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m170 46.35 50.56 12.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.511 1.925 . . . . 0.0 111.001 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -97.09 162.06 13.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 161.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.0 p -134.76 130.81 36.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 157.6 43.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.636 0.653 . . . . 0.0 111.189 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -94.98 108.44 20.5 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.8 mt -126.06 146.71 49.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.069 0.548 . . . . 0.0 110.305 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.4 161.9 23.35 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.09 0.852 . . . . 0.0 111.506 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.2 -20.81 42.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.734 2.956 . . . . 0.0 113.857 -164.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -70.54 -14.57 62.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.655 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.64 0.39 44.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.005 1.322 . . . . 0.0 111.047 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -115.62 160.73 19.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.387 1.449 . . . . 0.0 110.482 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.8 145.63 28.61 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.14 130.91 26.88 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -51.25 -58.05 7.21 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.183 0.993 . . . . 0.0 110.853 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.5 -34.26 72.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.964 1.305 . . . . 0.0 111.508 -168.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -56.38 6.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -86.16 6.38 29.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.831 1.253 . . . . 0.0 113.57 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -57.33 -40.83 78.8 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.271 1.828 . . . . 0.0 110.739 -172.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.58 -45.19 39.15 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.899 0.772 . . . . 0.0 111.475 172.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -66.24 -41.25 90.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.58 0.752 . . . . 0.0 111.767 -169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -114.83 -31.01 6.26 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.844 1.658 . . . . 0.0 110.969 -167.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.19 70.68 2.55 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -140.67 139.2 34.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.498 1.119 . . . . 0.0 108.256 -167.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 p -54.54 140.51 34.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.27 1.428 . . . . 0.0 109.993 -176.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.22 154.92 50.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.232 174.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -77.99 66.97 3.74 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 109.739 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 mmt-85 -133.94 112.68 11.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.167 1.787 . . . . 0.0 106.529 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -57.93 150.13 21.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.36 -18.26 0.56 Allowed Glycine 0 CA--C 1.537 1.457 0 CA-C-O 118.477 -1.18 . . . . 0.0 115.031 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -73.47 -55.93 5.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 121.426 2.613 . . . . 0.0 110.527 -174.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -66.06 -27.92 68.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.703 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -65.25 -41.02 94.72 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.775 2.03 . . . . 0.0 110.594 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.37 -35.24 81.74 Favored Glycine 0 CA--C 1.523 0.543 0 O-C-N 121.399 -0.813 . . . . 0.0 111.697 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.65 -32.82 74.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.901 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -59.77 -47.58 85.12 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.92 1.236 . . . . 0.0 110.435 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.39 -57.69 8.59 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.077 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 tt -59.24 -32.5 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 118.688 0.676 . . . . 0.0 111.732 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.98 -52.31 56.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.432 1.093 . . . . 0.0 109.799 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.816 0.846 . . . . 0.0 112.807 -178.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -135.43 157.89 45.76 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.962 1.705 . . . . 0.0 110.099 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.75 134.42 56.73 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.711 0.632 . . . . 0.0 109.981 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.98 47.33 5.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.54 174.59 10.45 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.021 0.529 . . . . 0.0 110.275 161.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.1 mt -125.08 140.31 53.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.805 2.042 . . . . 0.0 106.262 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.91 172.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -105.7 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 152.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.42 154.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.181 1.392 . . . . 0.0 108.216 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -128.92 106.32 8.82 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mtm -86.21 167.59 14.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 167.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.26 125.43 20.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.719 1.207 . . . . 0.0 108.532 177.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.77 -33.58 1.22 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.371 1.462 . . . . 0.0 115.132 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.13 158.69 62.22 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 118.887 1.344 . . . . 0.0 112.072 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 178.21 6.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.55 3.5 . . . . 0.0 110.247 168.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.7 96.31 0.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.565 0.746 . . . . 0.0 109.093 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -78.81 135.22 59.67 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.109 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.04 122.5 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.537 2.158 . . . . 0.0 108.914 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.15 165.91 25.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 109.908 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -129.86 164.11 24.85 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.101 -1.0 . . . . 0.0 110.621 -178.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.17 96.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -86.4 -169.12 2.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.69 2.396 . . . . 0.0 110.834 -166.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.535 0.367 0 O-C-N 120.23 -1.544 . . . . 0.0 112.281 -175.772 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -132.36 145.3 51.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.768 1.227 . . . . 0.0 108.972 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -107.75 148.6 37.64 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 124.002 0.921 . . . . 0.0 108.629 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.83 105.2 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.446 2.764 . . . . 0.0 109.19 162.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.64 156.77 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -133.13 124.96 28.48 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.338 1.855 . . . . 0.0 107.299 166.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -89.62 94.65 9.94 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 16.5 m-85 -46.68 148.13 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.493 1.117 . . . . 0.0 111.069 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.99 -35.87 1.06 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.093 0.854 . . . . 0.0 113.869 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.8 p -87.07 -26.81 23.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.586 1.693 . . . . 0.0 110.864 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.8 m80 62.01 24.46 14.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.496 2.318 . . . . 0.0 112.194 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -97.03 149.87 21.44 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.544 1.138 . . . . 0.0 108.994 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -123.74 147.42 47.51 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 -172.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.96 165.27 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.681 1.193 . . . . 0.0 109.122 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.95 106.94 17.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.19 156.58 19.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 161.25 22.54 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 166.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -63.32 -16.71 56.21 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.085 3.19 . . . . 0.0 115.076 -166.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -69.3 -17.79 63.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.446 1.476 . . . . 0.0 111.606 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -89.23 1.84 55.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.619 1.168 . . . . 0.0 110.905 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.7 mt -117.58 167.77 11.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.751 1.62 . . . . 0.0 111.463 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -143.69 152.31 55.77 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.025 1.73 . . . . 0.0 109.169 162.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.58 118.27 5.4 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 0.0 111.034 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -44.33 -62.27 1.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 125.075 1.35 . . . . 0.0 112.324 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -42.52 62.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.473 1.033 . . . . 0.0 112.055 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.41 -33.09 74.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.908 0.883 . . . . 0.0 111.426 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.31 8.82 18.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.198 -1.564 . . . . 0.0 112.787 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -56.77 -42.57 79.62 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.347 1.859 . . . . 0.0 111.144 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -74.54 -37.17 63.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.877 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -82.26 -49.37 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.895 1.278 . . . . 0.0 111.48 -162.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -94.75 -33.34 12.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.752 2.021 . . . . 0.0 110.363 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.29 61.76 3.47 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.278 1.418 . . . . 0.0 111.366 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 11.1 mmpt? -131.24 136.95 48.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.566 1.947 . . . . 0.0 107.799 -172.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.6 m -40.34 110.31 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.435 2.294 . . . . 0.0 110.824 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.65 176.6 7.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.046 0.45 . . . . 0.0 109.829 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -83.83 -38.8 20.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.537 -1.221 . . . . 0.0 110.047 164.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 125.81 16.63 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.669 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.23 163.65 8.01 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 0.0 109.675 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.08 -42.32 1.86 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -56.91 -44.74 82.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.455 1.102 . . . . 0.0 111.861 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.52 -36.81 71.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.24 0.927 . . . . 0.0 110.445 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -63.11 -31.71 72.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.608 0.763 . . . . 0.0 110.39 172.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.19 -32.69 42.73 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.566 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.6 -41.81 99.2 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.387 1.094 . . . . 0.0 110.137 172.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -54.87 -43.77 73.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.191 0.45 . . . . 0.0 111.101 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.62 -53.06 57.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.849 0.295 . . . . 0.0 111.357 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.4 tt -67.45 -33.97 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.785 0.266 . . . . 0.0 110.589 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -62.87 -38.06 89.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.7 0.8 . . . . 0.0 110.06 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 . . . . . 0 N--CA 1.463 0.201 0 O-C-N 121.538 -0.726 . . . . 0.0 110.473 177.697 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -144.93 95.6 2.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.836 0.855 . . . . 0.0 108.748 -155.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m -57.54 149.51 21.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.438 1.095 . . . . 0.0 111.369 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.74 127.31 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 -171.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -65.68 -33.2 75.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.434 1.117 . . . . 0.0 110.892 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 t 44.71 41.12 4.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.522 1.929 . . . . 0.0 112.296 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.37 81.63 1.07 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.58 109.22 0.42 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.34 2.656 . . . . 0.0 106.403 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -75.56 155.3 36.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -155.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -132.59 153.95 50.52 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.707 1.203 . . . . 0.0 109.799 -169.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.14 52.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.5 -12.0 68.24 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.748 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.28 166.58 21.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.609 1.705 . . . . 0.0 109.589 166.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.44 148.81 47.4 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.66 170.46 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 C-N-CA 123.363 0.665 . . . . 0.0 111.083 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.69 138.23 40.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.64 120.73 39.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 108.158 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 18.2 tptp -104.99 106.53 17.07 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -87.91 158.05 18.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -64.5 93.46 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 111.404 -172.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -18.78 42.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.631 1.11 . . . . 0.0 112.593 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -72.63 162.11 75.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.646 1.223 . . . . 0.0 108.753 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -61.78 178.73 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.645 2.23 . . . . 0.0 112.284 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.421 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 55.6 m80 -64.96 92.33 0.1 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 158.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -76.37 141.06 69.44 Favored Pre-proline 0 C--O 1.234 0.266 0 C-N-CA 123.979 0.911 . . . . 0.0 109.414 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.96 121.06 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.617 2.211 . . . . 0.0 109.187 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 163.47 32.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.5 0.667 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 13.2 ptt180 -119.93 152.33 37.58 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.2 mm -78.46 121.87 32.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 163.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -102.5 -174.39 2.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 168.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.72 -171.48 1.88 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -113.74 136.84 22.07 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.53 164.23 33.7 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.944 1.762 . . . . 0.0 109.927 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -78.45 51.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.881 1.672 . . . . 0.0 109.439 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.88 10.08 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 118.783 2.273 . . . . 0.0 118.783 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.9 -159.74 0.76 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.81 2.805 . . . . 0.0 111.512 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.14 142.05 16.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 109.483 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 113.41 54.26 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.048 0.939 . . . . 0.0 109.709 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.24 170.13 17.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.82 2.347 . . . . 0.0 112.401 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.47 153.94 31.15 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.196 1.264 . . . . 0.0 111.342 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.0 136.36 57.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 97.92 -26.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 1 C-N-CA 132.424 4.29 . . . . 0.0 110.946 -175.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -83.16 166.99 18.17 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.501 1.046 . . . . 0.0 111.352 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -130.26 149.4 73.21 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.426 1.09 . . . . 0.0 109.225 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 92.26 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.723 2.949 . . . . 0.0 108.976 163.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.47 122.93 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -102.12 117.43 34.76 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.151 1.38 . . . . 0.0 107.476 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -84.1 105.17 14.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.69 1.596 . . . . 0.0 107.658 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 11.5 m-85 -60.69 156.77 16.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.107 0.479 . . . . 0.0 110.731 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.16 -23.42 0.91 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.448 1.975 . . . . 0.0 115.616 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -113.55 -18.46 11.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.931 1.366 . . . . 0.0 110.604 170.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.6 m170 61.85 18.43 9.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.06 2.544 . . . . 0.0 111.578 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.19 160.2 32.32 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.753 0.821 . . . . 0.0 110.005 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.3 p -125.71 131.01 52.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.734 1.214 . . . . 0.0 108.157 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.78 170.22 16.29 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.653 166.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.16 118.06 35.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.49 154.23 40.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.45 167.05 19.94 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -61.56 -32.76 87.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.982 2.455 . . . . 0.0 112.86 -163.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -63.25 -28.8 70.28 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.763 0.825 . . . . 0.0 112.799 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.78 -1.16 50.88 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 111.716 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -126.85 160.75 30.03 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.957 1.703 . . . . 0.0 109.34 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -140.39 136.38 16.72 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.31 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.62 128.69 21.73 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.785 2.323 . . . . 0.0 110.128 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -51.15 -59.48 4.15 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.355 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -61.31 -23.54 65.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.629 1.559 . . . . 0.0 113.26 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -29.71 41.55 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.189 1.358 . . . . 0.0 111.507 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -114.55 6.19 15.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.742 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -57.08 -44.49 83.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.073 1.749 . . . . 0.0 109.854 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -89.87 -27.99 19.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -68.54 -44.05 75.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.741 1.616 . . . . 0.0 112.55 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -114.19 -27.25 7.71 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.938 2.095 . . . . 0.0 111.017 -172.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 63.5 3.86 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.814 1.197 . . . . 0.0 110.894 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -142.67 157.65 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.614 1.165 . . . . 0.0 109.158 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m -73.38 71.41 1.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.218 1.807 . . . . 0.0 115.34 -151.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.99 -11.12 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.563 1.545 . . . . 0.0 113.031 -170.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.6 tttt 53.69 29.14 8.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.078 2.151 . . . . 0.0 115.865 165.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -71.73 11.28 0.53 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 61.98 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.333 2.253 . . . . 0.0 109.393 -152.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.64 -40.91 0.65 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.441 -1.412 . . . . 0.0 112.632 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -30.43 68.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.917 1.687 . . . . 0.0 114.277 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -33.16 32.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 120.967 -1.083 . . . . 0.0 110.483 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.2 -58.22 9.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.79 1.636 . . . . 0.0 106.866 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.69 -33.69 87.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 118.998 0.817 . . . . 0.0 113.288 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.7 -29.61 69.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.689 1.245 . . . . 0.0 111.842 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -75.48 -43.38 49.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.929 0.786 . . . . 0.0 109.28 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.75 -38.21 90.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.028 1.331 . . . . 0.0 110.143 -171.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 tt -73.46 -45.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.341 1.057 . . . . 0.0 111.281 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.45 -55.91 26.27 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -75.56 -3.46 34.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.112 1.365 . . . . 0.0 112.773 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 t -83.74 -36.76 23.41 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.298 1.408 . . . . 0.0 110.199 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.61 170.32 36.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.81 112.0 1.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.791 2.327 . . . . 0.0 107.756 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.4 t -137.38 149.0 46.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.358 2.263 . . . . 0.0 104.919 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.1 m 57.65 2.26 0.15 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.719 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -177.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.406 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -140.95 -51.79 0.46 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.36 1.064 . . . . 0.0 110.271 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t 57.68 58.39 3.74 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.844 0.858 . . . . 0.0 110.612 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.26 67.88 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.22 120.34 40.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.232 1.013 . . . . 0.0 109.815 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.4 m -67.82 -25.17 65.44 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.892 0.877 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.67 108.09 2.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 -153.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -138.21 175.5 9.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.13 2.572 . . . . 0.0 105.118 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.13 156.6 44.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -142.58 161.81 37.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.518 1.527 . . . . 0.0 107.774 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 133.66 56.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.85 -12.73 68.84 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.614 -1.103 . . . . 0.0 112.915 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 128.07 34.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.349 1.575 . . . . 0.0 107.576 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -85.65 147.7 26.25 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.85 168.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.655 0.74 . . . . 0.0 111.781 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.52 125.5 50.11 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 160.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.82 154.17 18.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -130.19 105.89 8.23 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mtm -73.14 168.96 18.04 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 110.042 171.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.75 55.01 2.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 110.768 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.5 -28.22 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.946 0.784 . . . . 0.0 112.494 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -70.5 160.43 81.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.882 -0.775 . . . . 0.0 110.258 167.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.11 177.84 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.965 3.11 . . . . 0.0 111.749 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -62.65 112.57 2.56 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -114.56 143.56 30.15 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 124.91 1.284 . . . . 0.0 108.037 -166.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.77 123.85 11.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 110.973 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.48 159.38 42.52 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.274 0.559 . . . . 0.0 110.153 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 138.84 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -75.53 92.49 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 163.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -78.21 -164.08 0.5 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -125.74 -167.75 1.74 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.77 -1.206 . . . . 0.0 108.318 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.72 124.51 18.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.166 -166.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.32 168.71 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.811 2.341 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.23 73.83 0.96 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.02 1.728 . . . . 0.0 109.738 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 84.73 1.7 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -166.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 -172.02 2.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 150.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.06 151.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 163.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.21 147.02 39.37 Favored Pre-proline 0 C--O 1.237 0.415 0 O-C-N 121.553 -0.717 . . . . 0.0 109.182 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.98 150.27 26.49 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.646 2.231 . . . . 0.0 110.317 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.63 170.69 17.99 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.597 1.531 . . . . 0.0 112.054 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.97 125.87 22.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.019 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m120 77.71 17.32 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.55 2.34 . . . . 0.0 112.494 171.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -125.58 160.98 28.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.715 1.143 . . . . 0.0 111.985 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -123.31 152.81 64.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.03 1.732 . . . . 0.0 109.015 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.59 93.39 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 124.506 3.47 . . . . 0.0 111.358 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mm -86.03 108.4 17.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.031 0.933 . . . . 0.0 108.577 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -94.5 119.16 32.78 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 111.64 18.55 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 107.85 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -61.04 157.18 16.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.745 0.783 . . . . 0.0 110.377 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.92 -70.68 1.75 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.745 1.164 . . . . 0.0 111.894 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 p -69.02 -22.29 64.07 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.948 -1.325 . . . . 0.0 112.275 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 66.45 10.17 7.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.1 2.16 . . . . 0.0 113.679 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.14 159.17 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.914 -1.116 . . . . 0.0 110.262 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.25 130.38 40.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.24 -176.15 5.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.82 1.248 . . . . 0.0 109.952 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.95 125.99 40.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 171.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.2 mt -128.85 155.93 44.45 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 108.247 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.87 171.83 22.12 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.744 1.164 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.85 -26.36 32.18 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.483 2.122 . . . . 0.0 113.07 -160.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.86 -14.16 61.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.061 0.846 . . . . 0.0 112.494 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -94.38 -4.59 48.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.761 0.709 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -127.84 153.66 46.36 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.277 1.831 . . . . 0.0 109.927 -163.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -136.29 147.1 58.9 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 109.72 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -63.1 140.41 78.22 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.595 2.197 . . . . 0.0 109.456 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -59.1 -65.69 0.63 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -24.96 67.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -162.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -68.44 -58.77 3.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.552 0.741 . . . . 0.0 109.937 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.48 16.46 7.61 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.968 1.707 . . . . 0.0 111.055 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -60.42 -40.17 90.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.698 1.199 . . . . 0.0 109.518 -164.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.408 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 t70 -80.19 -53.39 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.579 170.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -51.06 -39.94 57.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.676 1.59 . . . . 0.0 113.84 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -110.23 -24.33 10.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.164 1.385 . . . . 0.0 110.643 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.16 71.07 2.89 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 70' ' ' ASP . 9.3 mmpt? -121.66 145.03 48.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 107.659 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -58.04 99.03 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.867 1.667 . . . . 0.0 109.053 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -77.75 173.27 12.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.506 0.669 . . . . 0.0 110.058 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -73.44 -39.34 65.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.694 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.57 141.18 56.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.452 0.569 . . . . 0.0 110.606 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -64.5 163.22 13.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.782 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -47.29 0.83 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.946 1.736 . . . . 0.0 112.167 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -49.58 -49.01 48.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.16 1.384 . . . . 0.0 111.404 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.69 -29.15 69.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.52 -46.93 71.39 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -28.7 73.79 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.24 -0.755 . . . . 0.0 112.895 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.97 -49.8 59.57 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.604 1.202 . . . . 0.0 110.593 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -59.68 -39.01 83.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.891 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.03 -63.11 1.32 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.671 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.85 -32.58 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 119.747 1.158 . . . . 0.0 112.247 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.15 -53.73 40.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.503 0.321 . . . . 0.0 110.141 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -68.35 -38.31 81.33 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 121.869 -0.519 . . . . 0.0 111.204 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.9 m -73.59 -0.16 14.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.661 1.584 . . . . 0.0 112.404 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.86 82.66 0.34 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.919 -1.49 . . . . 0.0 111.458 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.94 64.87 4.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.671 3.581 . . . . 0.0 112.111 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -66.63 149.21 50.82 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.662 -1.274 . . . . 0.0 110.248 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 p -73.75 117.81 15.96 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 -179.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.7 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m 37.6 43.96 0.49 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.751 2.02 . . . . 0.0 115.36 162.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.9 m -99.89 146.43 26.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 169.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.97 -149.65 46.91 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 p -145.39 79.18 1.57 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.07 1.748 . . . . 0.0 109.851 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 m -65.44 169.93 5.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.368 -0.833 . . . . 0.0 110.387 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.12 -128.7 2.91 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 56.0 94.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.523 1.929 . . . . 0.0 113.794 170.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -67.66 158.54 31.97 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.757 1.223 . . . . 0.0 110.475 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -143.36 167.96 20.93 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.673 1.589 . . . . 0.0 108.269 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.6 26.61 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.61 32.96 4.61 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.785 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.48 168.85 16.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.202 1.001 . . . . 0.0 108.636 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.1 mt -123.08 147.89 46.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.839 1.656 . . . . 0.0 106.665 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.09 171.52 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.333 0.653 . . . . 0.0 110.26 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.36 149.54 27.73 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.17 144.46 50.43 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.944 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -128.53 105.83 8.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.023 0.829 . . . . 0.0 110.369 -174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.9 mtp -90.18 170.8 9.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.56 1.144 . . . . 0.0 109.527 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -60.01 138.89 57.75 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.644 -0.66 . . . . 0.0 109.375 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 -36.25 0.74 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.704 1.145 . . . . 0.0 114.738 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.44 160.72 81.73 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.75 2.02 . . . . 0.0 112.277 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.34 -177.6 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.89 1 C-N-CA 125.574 4.182 . . . . 0.0 110.454 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -71.79 90.39 1.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -77.74 141.74 64.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.821 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.0 127.56 17.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.411 2.074 . . . . 0.0 110.564 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.17 166.03 26.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.114 0.566 . . . . 0.0 110.596 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -128.02 162.91 25.73 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 120.929 -1.107 . . . . 0.0 111.584 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -94.87 101.93 13.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.7 -177.09 6.5 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.161 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -122.81 140.52 52.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.186 1.394 . . . . 0.0 108.141 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 mt -76.69 119.03 75.66 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.14 158.07 26.63 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.093 2.529 . . . . 0.0 111.35 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.65 103.77 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.68 2.392 . . . . 0.0 112.498 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.28 7.68 51.56 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.029 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.5 -168.79 0.13 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.089 1.356 . . . . 0.0 111.855 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -65.07 162.55 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.016 0.926 . . . . 0.0 108.698 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.7 97.77 49.56 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 110.333 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.37 163.29 38.16 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.587 2.192 . . . . 0.0 111.937 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.48 156.93 64.08 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.899 1.733 . . . . 0.0 110.859 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.44 27.4 0.43 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.772 1.229 . . . . 0.0 114.151 -163.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -153.79 21.35 0.52 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.827 2.451 . . . . 0.0 109.51 -161.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -141.56 171.74 13.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.786 2.835 . . . . 0.0 107.999 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -131.74 152.34 80.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.182 1.393 . . . . 0.0 108.894 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.13 91.32 1.21 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.863 3.708 . . . . 0.0 110.684 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.9 mm -89.18 110.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -169.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -88.87 132.18 34.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 108.304 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -103.08 94.56 5.61 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.103 1.361 . . . . 0.0 108.552 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -47.53 147.81 1.63 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.82 1.648 . . . . 0.0 112.365 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 -39.16 0.75 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.977 1.751 . . . . 0.0 114.241 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -22.65 24.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.467 1.507 . . . . 0.0 112.429 173.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.4 m80 58.72 11.91 2.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.676 2.39 . . . . 0.0 114.749 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -74.13 169.62 17.18 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.629 0.649 . . . . 0.0 110.225 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -127.97 166.14 18.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.39 166.1 34.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.148 1.379 . . . . 0.0 108.165 163.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -105.96 114.32 28.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 166.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.07 150.51 52.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.508 0.723 . . . . 0.0 109.307 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.33 25.62 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.14 -10.62 29.23 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.933 3.089 . . . . 0.0 113.314 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -76.75 -5.66 49.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.869 1.268 . . . . 0.0 113.744 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -122.17 12.05 10.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.0 110.723 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 mt -135.2 162.26 33.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.514 1.526 . . . . 0.0 110.574 -170.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.36 148.17 52.77 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.981 1.313 . . . . 0.0 111.703 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.77 142.83 95.14 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -67.49 -56.07 11.03 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.436 -0.79 . . . . 0.0 109.961 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.61 -9.3 53.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.86 -77.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 155.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -72.48 10.39 0.83 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.766 2.826 . . . . 0.0 114.523 -164.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -59.99 -35.23 74.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.073 1.349 . . . . 0.0 109.009 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.55 -45.45 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.115 1.325 . . . . 0.0 111.551 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -60.52 -55.01 38.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.406 0.682 . . . . 0.0 111.065 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -97.77 -16.23 19.96 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.795 1.238 . . . . 0.0 111.965 -171.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.3 37.75 1.58 Allowed Glycine 0 CA--C 1.541 1.658 0 O-C-N 120.985 -1.072 . . . . 0.0 114.564 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -115.15 135.51 54.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.837 1.318 . . . . 0.0 109.302 -164.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.8 p -57.52 107.45 0.44 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.567 1.147 . . . . 0.0 109.594 -171.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -94.21 163.88 13.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.307 -173.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -92.88 -7.66 45.58 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -66.06 136.84 56.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 158.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -66.73 168.45 9.49 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.471 0.708 . . . . 0.0 109.181 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.96 -32.0 1.07 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.983 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -55.33 -42.04 73.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.925 1.29 . . . . 0.0 110.571 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -45.94 81.87 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.213 0.605 . . . . 0.0 111.348 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.96 -49.05 74.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.5 -38.37 96.22 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.329 -0.706 . . . . 0.0 112.777 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.46 -30.13 71.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.413 1.106 . . . . 0.0 111.832 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -73.7 -48.18 33.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.926 0.784 . . . . 0.0 109.017 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.76 -49.26 73.59 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.104 0.962 . . . . 0.0 111.19 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 tt -67.42 -37.52 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.585 0.354 . . . . 0.0 111.07 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.34 -41.05 96.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.609 -0.682 . . . . 0.0 109.96 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -83.32 25.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.653 1.581 . . . . 0.0 110.678 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 m -130.55 145.7 51.92 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 128.433 2.693 . . . . 0.0 103.748 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.62 175.7 16.48 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.791 2.138 . . . . 0.0 110.496 -166.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.18 167.59 8.98 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.895 3.063 . . . . 0.0 113.225 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -84.37 67.02 9.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.464 0.706 . . . . 0.0 109.247 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m -156.11 -174.17 4.83 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 127.236 2.214 . . . . 0.0 107.951 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.01 0.814 . . . . 0.0 113.572 169.499 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.777 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -150.84 -52.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 117.909 0.854 . . . . 0.0 110.975 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.1 t -58.17 107.54 0.49 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.301 1.04 . . . . 0.0 110.823 -172.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.74 113.41 3.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -169.85 114.57 0.52 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.851 1.261 . . . . 0.0 108.226 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.9 m -155.89 140.59 17.02 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 53.11 55.53 23.62 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.74 158.05 41.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 166.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -144.71 153.7 41.98 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.899 1.679 . . . . 0.0 107.17 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -141.74 161.21 38.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.633 1.173 . . . . 0.0 109.315 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 141.2 46.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 110.956 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.37 54.65 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.221 -1.321 . . . . 0.0 113.036 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 169.0 18.93 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 119.61 1.705 . . . . 0.0 110.69 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.6 mt -123.09 142.85 50.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.943 1.297 . . . . 0.0 108.082 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 175.78 2.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 123.377 0.671 . . . . 0.0 110.701 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.39 131.6 54.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 156.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.97 164.4 13.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.868 2.867 . . . . 0.0 108.324 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -149.48 106.04 3.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.4 mtm -90.15 -179.76 5.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.324 1.049 . . . . 0.0 109.751 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.89 61.41 6.81 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.12 -0.988 . . . . 0.0 112.859 -164.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.54 -27.55 2.6 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 124.451 1.024 . . . . 0.0 110.614 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -60.62 150.86 73.59 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 122.264 -0.55 . . . . 0.0 109.525 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.47 174.03 5.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.388 3.392 . . . . 0.0 110.724 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.25 96.93 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -88.75 131.67 40.91 Favored Pre-proline 0 N--CA 1.456 -0.128 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.43 136.0 38.36 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.261 1.307 . . . . 0.0 109.1 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.27 163.88 34.1 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.973 0.909 . . . . 0.0 109.554 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.61 146.18 50.93 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.462 -0.774 . . . . 0.0 110.26 -178.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mm -80.9 103.14 7.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -78.79 -175.53 4.49 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -130.61 136.73 49.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.573 1.149 . . . . 0.0 108.504 -170.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.5 mt -83.13 120.34 75.74 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.127 -161.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.59 166.1 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.397 2.731 . . . . 0.0 112.277 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.21 53.73 0.52 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.965 1.306 . . . . 0.0 110.191 162.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.37 68.13 0.01 OUTLIER Glycine 0 C--N 1.333 0.412 0 O-C-N 121.15 -0.969 . . . . 0.0 111.269 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.91 179.88 7.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.163 1.385 . . . . 0.0 108.634 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.03 165.7 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.25 -0.907 . . . . 0.0 109.595 170.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 127.88 29.58 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.04 166.13 28.5 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.972 2.448 . . . . 0.0 112.51 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.85 149.58 72.7 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 120.737 0.958 . . . . 0.0 109.779 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.42 53.0 1.45 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.269 0.627 . . . . 0.0 111.836 -168.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.33 9.83 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.346 1.858 . . . . 0.0 111.76 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -140.99 163.67 32.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.418 1.087 . . . . 0.0 109.295 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.88 153.55 67.29 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 124.872 1.269 . . . . 0.0 109.239 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -67.26 95.31 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.734 2.956 . . . . 0.0 110.066 167.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.41 113.21 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -85.16 150.8 24.57 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.46 93.26 3.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.8 m-85 -47.58 150.25 1.03 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.826 2.051 . . . . 0.0 111.257 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.18 -49.88 3.62 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.28 1.419 . . . . 0.0 111.774 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -91.61 -16.08 27.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 113.603 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.7 m170 53.11 16.53 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.261 2.624 . . . . 0.0 114.77 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -71.97 164.39 26.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.898 -1.126 . . . . 0.0 110.194 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -139.72 137.89 35.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.032 1.333 . . . . 0.0 108.091 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.68 163.87 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.391 0.615 . . . . 0.0 109.42 169.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -101.99 109.69 21.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -127.83 151.35 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.014 0.926 . . . . 0.0 108.554 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.72 173.74 29.82 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.702 1.144 . . . . 0.0 110.479 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.74 -21.67 58.14 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.259 2.64 . . . . 0.0 112.366 -165.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -64.59 -18.48 64.93 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.293 -0.879 . . . . 0.0 113.055 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -109.07 10.96 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.915 1.286 . . . . 0.0 110.345 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.84 162.24 30.03 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.458 1.903 . . . . 0.0 109.364 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -148.17 143.11 17.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.422 1.089 . . . . 0.0 109.545 176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -63.27 126.38 17.68 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.592 2.861 . . . . 0.0 112.196 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.46 -51.89 67.62 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 121.337 -0.852 . . . . 0.0 111.252 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -59.79 -24.03 63.78 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.39 -72.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -82.25 9.9 7.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.298 1.439 . . . . 0.0 113.461 -164.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -54.89 -34.69 63.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.655 1.582 . . . . 0.0 110.91 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.28 -59.36 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.741 1.216 . . . . 0.0 110.179 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -55.92 -43.13 77.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.501 1.52 . . . . 0.0 113.335 -167.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.85 -26.79 9.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.63 1.972 . . . . 0.0 111.592 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.48 84.04 1.6 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -147.12 166.36 27.16 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 123.503 0.721 . . . . 0.0 110.108 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.8 m -73.57 124.94 26.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -117.13 146.48 43.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.297 1.439 . . . . 0.0 109.63 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -67.98 -14.66 63.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 127.46 32.69 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 120.671 1.578 . . . . 0.0 108.39 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -61.2 162.51 7.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -36.82 1.83 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 112.126 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.007 1.403 . . . . 0.0 110.804 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -67.05 -42.75 84.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 111.694 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.05 -42.38 76.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.06 21.87 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.1 -20.93 57.97 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.352 1.076 . . . . 0.0 113.548 -174.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -68.67 -42.04 78.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.499 1.045 . . . . 0.0 111.442 170.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -55.24 14.44 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 110.535 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.9 tt -55.33 -27.32 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.052 0.842 . . . . 0.0 112.802 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -78.18 -51.91 9.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.315 1.446 . . . . 0.0 111.044 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -73.69 -12.59 60.77 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.111 0.565 . . . . 0.0 112.239 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 t -73.9 82.43 1.68 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.545 1.538 . . . . 0.0 108.644 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.5 136.9 3.23 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 161.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.4 140.2 62.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 106.829 -2.027 . . . . 0.0 106.829 152.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.97 126.97 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.053 1.741 . . . . 0.0 108.227 -166.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.1 p -160.2 147.75 16.39 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.945 -0.472 . . . . 0.0 110.217 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.361 0 C-N-CA 125.849 1.69 . . . . 0.0 109.652 177.266 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.949 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -157.15 156.28 32.43 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.271 -1.135 . . . . 0.0 109.963 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.42 177.95 4.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.27 1.828 . . . . 0.0 108.941 171.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.48 -144.64 8.27 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 159.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 t -140.81 -51.5 0.46 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.963 1.305 . . . . 0.0 109.842 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.7 m 63.36 170.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.019 1.728 . . . . 0.0 114.195 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.44 -67.1 2.87 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 126.007 1.765 . . . . 0.0 113.552 169.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -142.25 -149.05 0.26 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.882 2.073 . . . . 0.0 107.276 -171.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.65 148.69 49.06 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.922 1.689 . . . . 0.0 107.932 172.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -142.46 173.16 11.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.994 1.717 . . . . 0.0 109.383 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.64 15.12 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.621 0.768 . . . . 0.0 111.433 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 -22.24 30.37 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 124.561 1.077 . . . . 0.0 112.533 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.35 167.91 20.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 122.572 1.177 . . . . 0.0 111.572 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.32 150.78 38.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.424 1.89 . . . . 0.0 107.731 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 m -152.23 177.33 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.797 1.239 . . . . 0.0 110.105 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.86 127.03 53.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 159.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.77 137.58 32.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.0 108.758 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 15.0 tptp -108.11 105.11 14.71 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.7 mtm -76.9 166.66 23.04 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.14 58.33 3.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.485 0.714 . . . . 0.0 112.098 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -46.54 0.44 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.468 1.509 . . . . 0.0 110.907 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -60.19 159.4 22.13 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.696 1.199 . . . . 0.0 110.286 170.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.97 -176.34 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.498 2.799 . . . . 0.0 110.883 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.417 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 26.3 m80 -55.19 107.16 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 107.36 163.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -106.15 128.39 26.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 124.92 1.288 . . . . 0.0 108.115 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.54 129.76 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.14 1.893 . . . . 0.0 109.422 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.98 167.51 22.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -123.55 153.43 40.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.8 mm -84.47 105.4 13.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 169.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.87 -172.88 2.85 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -126.68 -161.65 1.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.986 164.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -138.93 148.17 56.85 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 127.132 2.173 . . . . 0.0 106.785 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -77.16 179.79 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.945 2.43 . . . . 0.0 109.597 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.75 158.79 33.96 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.896 -1.128 . . . . 0.0 110.094 165.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.15 61.22 5.54 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.586 1.565 . . . . 0.0 112.881 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.24 -171.69 3.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.089 1.356 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.67 144.37 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 155.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -141.3 157.9 65.17 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.743 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 154.56 55.87 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.617 2.211 . . . . 0.0 111.063 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.15 173.6 12.7 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.662 1.575 . . . . 0.0 110.677 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.13 41.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 122.341 1.067 . . . . 0.0 108.569 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 m120 62.15 17.4 9.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 127.571 2.348 . . . . 0.0 113.007 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -129.92 168.42 16.67 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.657 1.117 . . . . 0.0 111.657 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -131.17 153.46 81.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.473 2.309 . . . . 0.0 109.898 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -68.98 104.53 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 124.352 3.368 . . . . 0.0 110.045 169.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -97.19 140.28 17.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -123.89 113.29 18.3 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.086 1.755 . . . . 0.0 106.65 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -85.88 101.22 12.66 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.447 1.099 . . . . 0.0 108.482 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -53.37 152.7 4.49 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.757 1.623 . . . . 0.0 112.192 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.26 -60.25 2.74 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.83 1.205 . . . . 0.0 110.38 -167.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -21.32 59.62 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.0 m170 55.27 11.56 0.58 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.994 1.717 . . . . 0.0 114.092 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.48 161.56 30.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.195 0.997 . . . . 0.0 110.044 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 p -141.56 138.42 32.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.911 2.084 . . . . 0.0 107.255 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.51 154.37 28.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.45 122.75 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.42 156.54 36.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.83 161.76 21.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.99 1.281 . . . . 0.0 111.391 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.65 -34.85 72.89 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.681 2.921 . . . . 0.0 112.119 -166.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mppt? -75.74 -7.41 54.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.11 -20.79 16.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.309 0.958 . . . . 0.0 110.557 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.11 170.23 14.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.523 1.529 . . . . 0.0 109.189 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -139.17 149.4 60.9 Favored Pre-proline 0 C--O 1.236 0.395 0 C-N-CA 123.909 0.884 . . . . 0.0 109.358 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.31 152.57 75.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.813 2.342 . . . . 0.0 112.273 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -71.5 -59.72 2.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.969 -0.457 . . . . 0.0 111.336 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.62 -25.82 68.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.393 0.542 . . . . 0.0 111.853 -163.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.71 -39.83 69.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.635 1.174 . . . . 0.0 110.879 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.41 9.63 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 0.0 112.673 -166.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -54.94 -30.65 59.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.89 1.276 . . . . 0.0 111.248 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -98.79 -34.74 10.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.773 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -68.68 -65.97 0.63 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.478 1.035 . . . . 0.0 109.57 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -84.91 -29.56 25.09 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.872 1.269 . . . . 0.0 111.694 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.19 62.53 3.36 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.11 173.48 11.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.903 -1.351 . . . . 0.0 110.558 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -66.53 153.15 43.71 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.415 1.102 . . . . 0.0 109.483 168.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -135.27 -96.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 159.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 -20.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 146.46 54.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 120.9 1.682 . . . . 0.0 110.759 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -60.17 156.05 16.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.242 1.417 . . . . 0.0 108.039 158.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 -43.82 1.19 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 125.663 1.602 . . . . 0.0 113.406 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -48.04 -54.01 14.44 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 125.626 1.571 . . . . 0.0 109.792 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -57.97 -34.47 69.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.37 0.668 . . . . 0.0 111.729 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.98 -49.29 53.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.356 1.062 . . . . 0.0 110.653 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.64 84.98 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.683 0.674 . . . . 0.0 112.576 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.52 -35.97 76.0 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.407 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -66.12 -39.07 89.63 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.214 0.915 . . . . 0.0 110.19 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.12 -47.96 75.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.848 0.859 . . . . 0.0 110.525 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.9 tt -67.28 -26.81 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 118.887 0.767 . . . . 0.0 111.729 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.48 -15.5 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 0.0 111.959 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -103.96 -71.34 0.74 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.862 1.265 . . . . 0.0 108.067 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.4 t 46.42 55.5 7.39 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.157 1.783 . . . . 0.0 109.71 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.13 170.31 40.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.133 0.873 . . . . 0.0 111.931 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.65 177.44 8.83 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.675 2.917 . . . . 0.0 110.883 166.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.74 168.96 20.78 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.592 0.757 . . . . 0.0 109.967 167.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 p -153.02 122.87 6.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.465 1.506 . . . . 0.0 108.016 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.738 0 C-N-CA 126.271 1.891 . . . . 0.0 108.572 -171.353 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 p -139.57 175.04 9.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -149.65 159.29 44.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.57 173.93 49.87 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 p -90.66 -51.35 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.487 1.115 . . . . 0.0 109.97 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 m 49.16 66.64 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -159.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.77 -122.47 2.09 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.971 1.272 . . . . 0.0 109.933 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -77.53 103.52 7.51 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.638 0.733 . . . . 0.0 110.166 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -48.34 155.86 0.46 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.779 2.032 . . . . 0.0 111.409 166.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -149.44 156.68 42.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.133 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 103.25 0.14 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.931 1.693 . . . . 0.0 110.143 -173.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.06 -24.41 2.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.136 1.827 . . . . 0.0 111.637 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.57 162.28 27.22 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.634 1.217 . . . . 0.0 112.334 -173.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.67 134.87 54.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 106.206 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -147.92 176.54 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.983 0.913 . . . . 0.0 111.445 -166.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.4 150.96 30.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 156.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.47 168.18 14.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.067 2.147 . . . . 0.0 109.01 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -141.36 107.11 5.11 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.9 mtp -83.81 160.6 21.17 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 165.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.16 112.21 1.3 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.207 1.003 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.56 -11.59 55.39 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.882 1.229 . . . . 0.0 114.652 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -74.86 158.03 85.04 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 118.347 1.073 . . . . 0.0 109.188 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.79 169.75 16.93 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.581 2.187 . . . . 0.0 108.793 163.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -59.57 103.31 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -87.22 143.5 34.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 108.035 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.69 136.82 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.967 1.778 . . . . 0.0 110.484 173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.99 168.3 21.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.333 0.653 . . . . 0.0 109.39 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -132.84 156.64 46.8 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.573 -0.705 . . . . 0.0 109.517 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -89.28 136.22 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.37 169.74 15.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.44 160.39 29.57 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 168.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -76.37 136.57 68.35 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-O 117.553 -1.213 . . . . 0.0 107.922 163.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.97 158.96 44.6 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.992 1.795 . . . . 0.0 109.865 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.0 82.97 1.24 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.894 0.854 . . . . 0.0 110.338 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.84 83.92 0.96 Allowed Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.25 169.08 18.02 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.964 1.705 . . . . 0.0 107.946 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.01 127.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.55 125.08 91.79 Favored Pre-proline 0 C--O 1.238 0.453 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.302 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.8 164.69 18.06 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.894 3.063 . . . . 0.0 112.949 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.67 155.04 65.6 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 121.577 1.518 . . . . 0.0 111.986 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.94 69.52 5.12 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.282 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.92 0.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.911 1.284 . . . . 0.0 113.382 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -144.14 171.46 14.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.155 1.382 . . . . 0.0 109.388 -167.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -131.37 152.53 80.69 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.355 1.862 . . . . 0.0 107.519 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.1 90.99 1.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.728 2.952 . . . . 0.0 109.131 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.8 mm -83.93 114.54 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -85.13 142.34 29.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.55 118.39 36.47 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -65.05 152.69 42.82 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.028 0.918 . . . . 0.0 110.213 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.31 -68.24 2.4 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 125.002 1.286 . . . . 0.0 110.663 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.5 p -68.11 -25.02 65.1 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.839 -0.8 . . . . 0.0 111.5 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 m170 58.12 14.59 2.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.665 1.986 . . . . 0.0 112.977 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.88 168.57 13.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.995 0.902 . . . . 0.0 110.138 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.13 151.43 48.66 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.313 1.445 . . . . 0.0 108.564 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.92 148.48 27.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.988 0.915 . . . . 0.0 108.536 163.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.41 111.77 21.46 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -124.89 151.41 45.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.001 1.32 . . . . 0.0 108.238 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.58 168.2 31.7 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.347 0.975 . . . . 0.0 110.732 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.49 -40.16 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.628 2.218 . . . . 0.0 110.46 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -8.87 16.55 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.5 -17.13 24.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.272 1.396 . . . . 0.0 111.383 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.69 170.2 8.02 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 127.833 2.453 . . . . 0.0 110.647 -168.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -144.71 142.85 19.56 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.002 0.921 . . . . 0.0 109.845 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 129.51 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.573 2.182 . . . . 0.0 110.718 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -53.15 -54.91 28.92 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 121.582 -0.699 . . . . 0.0 111.272 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -66.64 -13.6 61.39 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.14 -26.0 19.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.99 1.316 . . . . 0.0 111.711 175.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.42 12.3 13.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.725 1.61 . . . . 0.0 113.112 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.01 -20.37 16.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 128.456 2.702 . . . . 0.0 113.136 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -117.6 -34.68 4.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 119.322 0.965 . . . . 0.0 110.227 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -61.57 -37.91 85.58 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.631 -0.668 . . . . 0.0 111.072 -177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.72 -35.73 4.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 109.514 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.33 85.84 0.33 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -151.1 -173.93 4.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.885 2.074 . . . . 0.0 107.006 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.08 146.2 28.83 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 122.543 1.163 . . . . 0.0 108.421 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -147.38 134.92 20.89 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.785 1.634 . . . . 0.0 107.088 170.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.26 20.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -59.35 155.57 14.4 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.682 2.037 . . . . 0.0 108.784 162.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.76 161.47 30.83 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 160.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -31.05 0.55 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.422 1.963 . . . . 0.0 115.629 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -56.58 -60.78 3.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.437 1.895 . . . . 0.0 110.587 -177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -32.87 72.08 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.524 -0.735 . . . . 0.0 112.163 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -56.07 26.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.435 1.494 . . . . 0.0 110.016 169.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.3 77.02 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.672 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.24 -45.1 74.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 118.328 1.064 . . . . 0.0 111.637 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -56.98 -42.02 79.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.044 0.838 . . . . 0.0 108.803 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.22 -48.33 80.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.45 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.72 -35.9 71.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 119.375 0.989 . . . . 0.0 110.757 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.04 -49.6 77.01 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -73.33 -8.23 54.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 113.216 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 t -76.31 6.81 5.0 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.451 -1.405 . . . . 0.0 112.93 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.47 177.32 19.72 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.719 1.145 . . . . 0.0 111.191 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.0 56.58 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.719 3.612 . . . . 0.0 108.991 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 m -77.05 136.76 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.201 1.4 . . . . 0.0 108.686 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.94 3.19 43.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.419 1.087 . . . . 0.0 113.081 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 174.577 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 p -170.99 109.66 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.246 1.818 . . . . 0.0 107.889 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.59 48.4 0.55 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.203 1.401 . . . . 0.0 110.39 172.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.89 -112.6 1.09 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.597 2.046 . . . . 0.0 108.472 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m 59.59 92.75 0.04 OUTLIER 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.233 1.813 . . . . 0.0 110.777 -167.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m 59.22 166.57 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.916 2.086 . . . . 0.0 112.274 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.45 107.12 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -171.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.54 140.91 24.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.788 1.235 . . . . 0.0 107.808 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -85.8 133.46 33.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.616 0.722 . . . . 0.0 110.274 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -132.66 177.66 7.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.13 140.78 24.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.679 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.27 -31.96 6.91 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.329 -1.262 . . . . 0.0 111.862 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.81 100.27 4.0 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 119.275 1.537 . . . . 0.0 108.002 -173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.04 149.92 49.5 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.54 169.42 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -105.7 142.91 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 157.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.65 110.28 13.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 109.792 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -91.55 106.29 18.38 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.052 1.741 . . . . 0.0 107.69 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.83 19.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 174.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 128.65 36.7 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.04 15.59 63.03 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.298 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -128.51 162.05 53.34 Favored Pre-proline 0 C--O 1.232 0.149 0 CA-C-N 118.897 1.349 . . . . 0.0 109.044 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.25 -179.7 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.519 3.479 . . . . 0.0 110.831 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -72.7 88.37 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -71.98 136.72 82.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.291 -169.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.35 124.56 13.08 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.059 1.839 . . . . 0.0 108.789 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.86 168.1 20.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.024 0.916 . . . . 0.0 110.634 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm85 -128.8 148.48 50.88 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 mm -86.08 121.07 36.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 170.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.89 179.11 7.63 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.206 0.527 . . . . 0.0 112.202 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.97 112.07 15.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.094 1.757 . . . . 0.0 107.891 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.44 137.81 83.71 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.081 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.77 163.1 39.98 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.351 2.034 . . . . 0.0 111.844 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.9 131.69 47.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.844 0.858 . . . . 0.0 109.224 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 61.83 5.04 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.69 174.23 10.83 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.92 1.288 . . . . 0.0 109.316 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 p -52.74 159.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.225 1.01 . . . . 0.0 111.102 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -130.44 149.96 74.91 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.206 1.802 . . . . 0.0 108.417 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 162.22 43.05 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.586 2.191 . . . . 0.0 112.795 -166.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.72 -179.48 5.19 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 122.346 2.031 . . . . 0.0 109.445 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -43.74 91.96 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.694 1.998 . . . . 0.0 115.626 -164.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 33.64 58.19 0.55 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.038 2.535 . . . . 0.0 111.432 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -102.72 173.64 6.24 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.401 1.08 . . . . 0.0 109.216 160.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -132.32 152.58 80.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.362 1.065 . . . . 0.0 108.799 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 106.95 1.96 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.907 3.071 . . . . 0.0 110.317 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -98.12 115.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.741 1.216 . . . . 0.0 107.943 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -97.37 119.05 35.19 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -78.65 117.35 19.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -66.78 156.03 36.59 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.218 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 -46.48 1.74 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.35 1.453 . . . . 0.0 113.584 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 -29.48 22.26 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.98 1.39 . . . . 0.0 111.501 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.4 m80 69.82 14.23 8.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.036 2.134 . . . . 0.0 112.565 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.16 159.24 35.04 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.532 -0.73 . . . . 0.0 110.047 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.1 p -129.76 128.8 43.16 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.779 1.232 . . . . 0.0 108.441 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.94 172.49 14.12 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.908 0.883 . . . . 0.0 110.083 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -119.65 112.12 18.91 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.0 mt -121.81 150.49 41.81 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.53 166.34 31.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -65.61 -31.37 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.408 2.739 . . . . 0.0 112.108 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -70.28 -11.31 60.81 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.523 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.1 -10.77 34.82 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.078 1.308 . . . . 0.0 110.851 170.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.38 159.83 19.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.566 1.546 . . . . 0.0 109.19 -166.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -138.79 145.69 46.99 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.99 126.53 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.538 2.158 . . . . 0.0 109.932 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -53.86 -62.49 1.62 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -56.37 -40.81 75.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.928 0.786 . . . . 0.0 111.587 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 -34.9 79.54 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 119.141 0.882 . . . . 0.0 112.354 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.85 10.66 38.25 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.855 1.662 . . . . 0.0 111.119 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.21 -47.53 84.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.686 1.195 . . . . 0.0 110.179 -171.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -23.52 55.89 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.242 0.928 . . . . 0.0 112.006 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -77.52 -44.55 28.33 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.224 -0.923 . . . . 0.0 111.386 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -118.7 -23.46 7.03 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.69 1.996 . . . . 0.0 111.235 -165.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.28 58.2 3.66 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -133.25 135.54 45.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.451 1.9 . . . . 0.0 106.568 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.9 97.77 0.03 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.816 1.647 . . . . 0.0 110.938 -170.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -71.87 158.79 35.41 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.11 -0.994 . . . . 0.0 108.986 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -71.7 -27.63 63.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.111 0.964 . . . . 0.0 113.06 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -64.28 142.78 58.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.523 1.056 . . . . 0.0 110.399 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -65.33 164.6 13.27 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 160.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.83 -41.85 2.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.498 1.523 . . . . 0.0 110.223 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -58.48 -46.99 85.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.088 0.955 . . . . 0.0 110.966 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -62.16 -44.8 95.82 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.049 -0.407 . . . . 0.0 110.12 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -69.47 -27.74 65.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.009 0.818 . . . . 0.0 111.68 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 -23.07 35.23 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.125 -0.984 . . . . 0.0 112.83 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.3 -32.13 71.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.99 1.395 . . . . 0.0 110.563 168.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -66.61 -47.9 71.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.557 -0.714 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.63 -48.57 80.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.388 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.3 -41.39 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.222 0.326 . . . . 0.0 110.238 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.67 -37.12 85.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.292 0.637 . . . . 0.0 110.498 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -72.76 -10.66 60.05 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.421 -0.799 . . . . 0.0 112.384 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.27 22.74 1.18 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 113.524 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.59 159.24 24.42 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.57 -1.331 . . . . 0.0 110.57 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.13 13.83 1.46 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.455 3.437 . . . . 0.0 113.001 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 152.13 45.95 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.688 -1.258 . . . . 0.0 109.111 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.8 m -155.01 -53.57 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 N-CA-C 106.659 -2.577 . . . . 0.0 106.659 135.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.831 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 57.19 157.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.858 2.463 . . . . 0.0 112.114 -158.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.2 m 50.48 -154.81 0.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.168 0.587 . . . . 0.0 110.829 -164.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.4 -162.69 28.21 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.45 105.28 4.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 p -160.83 -87.4 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.37 93.72 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.1 177.06 9.05 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.076 1.35 . . . . 0.0 107.865 168.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.38 131.35 29.79 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.717 2.007 . . . . 0.0 105.992 170.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -135.89 178.24 7.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.076 0.853 . . . . 0.0 111.483 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.93 132.54 32.26 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.903 0.881 . . . . 0.0 111.33 -167.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.6 -17.39 58.65 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.096 -0.835 . . . . 0.0 111.775 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.18 161.28 19.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.044 1.402 . . . . 0.0 109.312 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -124.74 156.37 37.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.817 1.647 . . . . 0.0 106.682 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.71 171.88 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.916 0.886 . . . . 0.0 108.861 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -105.85 122.24 45.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 159.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.06 134.87 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.762 1.225 . . . . 0.0 109.39 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -106.79 108.59 20.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.5 mtp -86.39 167.17 14.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.1 150.0 22.25 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 163.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.86 -68.29 1.05 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.226 0.917 . . . . 0.0 111.999 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -56.02 156.05 10.96 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.301 2.24 . . . . 0.0 112.547 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.33 173.44 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.752 2.968 . . . . 0.0 109.88 163.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -62.9 108.04 1.11 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -91.17 140.26 25.77 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 123.934 0.894 . . . . 0.0 108.792 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.01 126.62 16.83 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.216 1.944 . . . . 0.0 110.482 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.22 157.16 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.262 0.553 . . . . 0.0 111.113 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -103.8 152.42 21.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.14 99.95 8.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -74.18 -177.32 2.92 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.955 0.407 . . . . 0.0 109.966 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -114.71 -171.08 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 107.712 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.6 mt -140.63 116.82 7.68 Favored Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 153.63 72.56 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 121.3 1.333 . . . . 0.0 109.808 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.97 21.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.869 3.268 . . . . 0.0 113.852 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.4 47.5 0.2 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.21 1.386 . . . . 0.0 110.255 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.24 -173.88 2.97 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.239 1.816 . . . . 0.0 109.335 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.6 150.69 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.383 1.073 . . . . 0.0 109.789 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -118.72 139.33 26.97 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.823 1.249 . . . . 0.0 108.833 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.85 160.22 14.0 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.781 2.321 . . . . 0.0 110.656 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.16 170.32 19.35 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.182 1.255 . . . . 0.0 111.149 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.35 58.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.069 0.938 . . . . 0.0 108.796 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 47.18 50.12 14.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.501 -2.136 . . . . 0.0 109.896 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -140.27 145.65 37.59 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -114.46 153.61 46.6 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.332 1.853 . . . . 0.0 110.176 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 91.63 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.399 3.399 . . . . 0.0 111.107 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.24 121.5 43.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -113.21 116.54 29.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -87.55 97.22 10.73 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.104 1.762 . . . . 0.0 108.52 -169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 10.7 m-85 -52.21 150.55 4.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.495 1.118 . . . . 0.0 112.085 -175.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.11 4.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.638 1.59 . . . . 0.0 111.976 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.58 -31.51 68.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.92 0.888 . . . . 0.0 110.849 167.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.1 m80 53.52 25.98 5.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.61 1.964 . . . . 0.0 112.043 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.31 165.73 23.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.975 2.11 . . . . 0.0 109.475 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -127.76 151.61 48.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.849 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.19 155.74 23.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 154.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -86.51 123.95 32.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.71 149.94 50.0 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.191 1.396 . . . . 0.0 108.341 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.21 165.08 27.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.37 -24.12 43.56 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.867 2.378 . . . . 0.0 112.118 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -54.14 -15.22 1.38 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.502 1.521 . . . . 0.0 114.151 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -118.1 7.39 12.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.515 1.526 . . . . 0.0 110.712 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.28 168.67 9.75 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.673 1.589 . . . . 0.0 109.388 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -144.53 146.14 31.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 127.214 2.206 . . . . 0.0 107.124 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.69 152.71 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.652 2.235 . . . . 0.0 111.74 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.0 -62.69 1.37 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.193 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -46.99 -46.4 21.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.861 1.21 . . . . 0.0 111.308 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -18.12 65.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -172.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -130.31 13.6 5.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.502 1.121 . . . . 0.0 111.39 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -55.33 -36.85 66.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.799 1.639 . . . . 0.0 112.225 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -104.83 -15.96 15.04 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.667 0.787 . . . . 0.0 109.723 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -85.66 -57.36 3.08 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 120.918 -1.114 . . . . 0.0 110.079 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -89.6 -36.14 15.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 109.726 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.89 71.11 0.57 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.782 1.658 . . . . 0.0 111.681 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.8 150.09 48.14 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 126.069 1.748 . . . . 0.0 107.465 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.0 p -59.58 105.35 0.35 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.971 0.508 . . . . 0.0 110.015 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -93.82 152.57 18.81 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -89.89 54.5 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 109.355 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -115.54 123.61 48.93 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -67.97 103.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.42 -25.96 4.2 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.551 1.548 . . . . 0.0 111.269 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -65.02 -51.79 59.66 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.404 1.102 . . . . 0.0 111.146 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -73.27 -23.04 60.26 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.409 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -65.04 -48.13 74.92 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 124.34 1.056 . . . . 0.0 108.888 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.92 -31.22 78.92 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.309 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.35 -46.7 85.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.376 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -57.16 -41.26 78.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.594 1.543 . . . . 0.0 111.043 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.09 -51.11 65.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.774 0.715 . . . . 0.0 111.511 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.5 tt -70.35 -38.89 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.432 0.693 . . . . 0.0 110.382 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.56 -27.63 69.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.835 0.854 . . . . 0.0 110.032 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -93.47 -8.96 40.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.721 1.609 . . . . 0.0 113.019 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 m -78.38 71.65 4.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 109.609 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.21 151.54 23.52 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.98 25.84 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 115.098 -161.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -77.67 155.46 31.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.213 1.369 . . . . 0.0 107.841 157.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -62.61 -43.55 98.54 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.128 -0.982 . . . . 0.0 110.328 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.266 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 -171.253 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.667 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 62.5 164.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.577 1.951 . . . . 0.0 110.6 -164.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -169.06 -53.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.984 2.113 . . . . 0.0 108.263 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.64 -98.07 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 m 56.78 52.01 10.1 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.989 0.899 . . . . 0.0 109.568 -168.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -72.82 123.0 22.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.11 94.42 1.88 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 -161.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 74.14 88.07 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.936 2.494 . . . . 0.0 112.576 167.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -53.76 166.57 0.32 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.375 1.87 . . . . 0.0 111.47 167.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -147.74 168.16 22.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 108.867 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.27 135.81 57.77 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 123.288 0.367 . . . . 0.0 111.034 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.5 35.58 5.4 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 117.878 -1.512 . . . . 0.0 112.233 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.18 172.8 12.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.238 1.519 . . . . 0.0 111.151 172.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -117.43 142.27 47.34 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.257 1.423 . . . . 0.0 108.414 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.9 m -154.46 171.08 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.029 0.931 . . . . 0.0 111.95 -165.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.07 117.41 30.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.244 1.018 . . . . 0.0 111.652 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.07 163.96 13.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.607 1.163 . . . . 0.0 110.469 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -147.67 106.97 3.88 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.261 -0.899 . . . . 0.0 110.452 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.5 mtm -83.76 168.05 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.026 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -81.15 83.61 6.75 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.967 1.307 . . . . 0.0 109.155 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.42 -56.74 0.67 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -61.66 159.22 35.39 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.445 1.498 . . . . 0.0 113.222 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.07 176.0 10.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.284 3.989 . . . . 0.0 111.153 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -64.02 97.04 0.16 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.982 1.313 . . . . 0.0 108.166 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -89.6 134.9 31.51 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.181 -165.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.74 121.01 8.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.579 2.186 . . . . 0.0 109.658 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.5 19.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 110.236 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -124.58 148.27 47.95 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.1 mm -78.59 99.96 3.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.278 -2.489 . . . . 0.0 104.278 163.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -65.77 173.34 2.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.095 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -124.79 161.04 27.32 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.153 1.381 . . . . 0.0 108.972 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.98 101.52 12.61 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -156.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -46.4 139.36 12.83 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.964 3.776 . . . . 0.0 111.45 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.59 110.38 1.69 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.49 -9.56 22.06 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.596 1.57 . . . . 0.0 112.2 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.6 15.69 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 119.173 1.486 . . . . 0.0 111.349 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.24 146.32 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.355 157.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.59 158.61 56.0 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 118.415 0.552 . . . . 0.0 110.557 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.58 161.33 28.51 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.179 2.586 . . . . 0.0 112.214 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.13 168.32 25.06 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 121.835 1.69 . . . . 0.0 111.294 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.24 127.04 27.43 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.04 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 83.55 1.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.892 2.477 . . . . 0.0 112.239 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -112.89 160.29 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.014 1.279 . . . . 0.0 111.384 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -115.26 149.85 43.42 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 126.713 2.005 . . . . 0.0 108.161 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.009 3.139 . . . . 0.0 108.919 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.0 mm -102.61 112.89 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -99.3 124.05 44.08 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.3 98.02 11.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -50.43 148.38 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.033 0.933 . . . . 0.0 110.89 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.47 -15.2 1.6 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.963 1.268 . . . . 0.0 115.862 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -115.68 -17.27 11.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.26 1.53 . . . . 0.0 111.596 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.37 16.17 7.2 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.808 2.043 . . . . 0.0 112.749 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -83.55 165.65 18.9 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.428 -0.795 . . . . 0.0 110.219 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -127.5 150.61 49.6 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.176 0.99 . . . . 0.0 110.648 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.3 29.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.155 1.382 . . . . 0.0 109.369 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.53 107.38 16.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.7 mt -123.54 143.69 50.03 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 162.55 28.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.48 -20.5 47.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 113.676 -160.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -52.86 -32.2 43.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.82 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -94.96 9.23 40.17 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 111.506 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 mt -135.28 157.38 47.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.568 1.147 . . . . 0.0 111.144 -161.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -141.64 155.81 66.57 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.016 1.326 . . . . 0.0 110.726 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -68.89 134.11 28.97 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.126 2.55 . . . . 0.0 112.273 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -65.1 -48.1 74.86 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.864 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -62.19 -27.54 69.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.853 1.206 . . . . 0.0 112.361 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.47 -51.08 11.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 111.023 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -97.23 8.85 43.71 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.014 -1.054 . . . . 0.0 113.816 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -53.3 -49.45 66.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.646 1.178 . . . . 0.0 108.684 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.59 -53.09 38.17 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.39 0.431 . . . . 0.0 110.743 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -64.64 -33.87 76.96 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 113.713 -169.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -118.36 -29.21 5.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 112.518 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.58 70.86 3.07 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 153.81 51.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.615 1.566 . . . . 0.0 109.317 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.0 p -74.93 99.9 3.96 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -80.92 168.61 18.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.937 -1.102 . . . . 0.0 111.404 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -89.04 -5.33 57.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -73.15 141.96 47.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.277 1.853 . . . . 0.0 109.023 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HE3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.29 164.29 16.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.17 -40.95 1.27 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.355 0.979 . . . . 0.0 111.564 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.02 -37.94 84.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.185 1.493 . . . . 0.0 111.154 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -48.76 78.32 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.433 0.693 . . . . 0.0 110.167 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.95 -38.42 86.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.856 1.662 . . . . 0.0 110.438 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -72.45 -32.9 61.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.56 1.076 . . . . 0.0 111.944 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.612 1.206 . . . . 0.0 111.16 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -66.31 -44.06 84.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.629 0.649 . . . . 0.0 109.557 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -60.96 -55.38 33.57 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.102 0.961 . . . . 0.0 111.248 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 tt -62.07 -28.36 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.079 0.854 . . . . 0.0 111.187 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -60.05 3.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.013 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -81.69 43.17 0.74 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.399 1.48 . . . . 0.0 112.04 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.5 t -128.28 -19.3 3.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.649 1.98 . . . . 0.0 109.62 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.01 -161.88 11.52 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.882 1.706 . . . . 0.0 109.393 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.29 137.2 36.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.436 2.09 . . . . 0.0 109.59 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t -152.53 159.07 43.32 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.223 0.535 . . . . 0.0 109.91 165.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.4 m -146.0 -21.26 0.45 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 112.87 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.259 179.768 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.453 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.33 107.15 1.19 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.616 1.166 . . . . 0.0 108.192 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -151.41 173.66 14.28 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 108.427 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.88 163.68 14.53 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 p -68.14 174.09 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.023 -0.692 . . . . 0.0 110.772 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.2 m -140.55 136.79 33.21 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 160.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.31 40.03 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.334 1.921 . . . . 0.0 109.221 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -134.32 -174.4 3.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.426 2.29 . . . . 0.0 107.581 -175.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -131.54 155.82 46.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.924 1.289 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -137.25 176.14 8.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.672 1.589 . . . . 0.0 110.684 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.71 135.2 41.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.42 -28.39 15.8 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.609 1.576 . . . . 0.0 112.31 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -75.74 123.86 26.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.479 1.14 . . . . 0.0 109.325 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.97 145.03 28.76 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.29 168.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.587 0.708 . . . . 0.0 112.699 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -112.85 121.79 45.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.643 1.177 . . . . 0.0 108.189 161.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.34 121.82 35.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.72 1.208 . . . . 0.0 109.147 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -91.49 107.24 19.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mtm -74.01 169.42 17.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.376 0.534 . . . . 0.0 110.433 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -61.69 127.51 31.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.81 -60.48 3.38 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.657 1.122 . . . . 0.0 113.343 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -51.43 155.85 2.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.786 1.635 . . . . 0.0 111.488 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.45 -175.55 2.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.454 3.436 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -62.53 89.75 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.89 2.476 . . . . 0.0 108.251 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -86.45 135.33 36.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -67.47 130.8 23.1 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.298 1.332 . . . . 0.0 108.669 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.65 151.66 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 12.7 ptm180 -103.06 160.63 14.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.437 1.017 . . . . 0.0 109.162 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.6 124.89 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 151.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.91 -156.42 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -132.86 149.31 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.501 -2.0 . . . . 0.0 109.189 147.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.94 136.57 66.34 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.52 151.19 80.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.652 1.568 . . . . 0.0 110.062 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.77 92.75 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.89 31.57 0.39 Allowed Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.037 -1.424 . . . . 0.0 112.357 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.06 161.84 36.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.76 1.78 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.7 111.99 5.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.856 0.836 . . . . 0.0 109.41 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -57.23 158.4 10.17 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 111.021 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.17 164.84 23.86 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.618 2.212 . . . . 0.0 111.243 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.19 179.52 2.83 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.117 1.211 . . . . 0.0 110.722 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 134.79 57.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.358 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 60.12 42.29 15.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.745 2.418 . . . . 0.0 111.421 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -138.35 134.18 33.9 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.41 2.284 . . . . 0.0 110.046 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -102.27 147.45 33.98 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.809 2.444 . . . . 0.0 111.241 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.03 100.38 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.053 2.502 . . . . 0.0 111.464 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 mm -83.07 155.5 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -142.08 106.78 4.86 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.22 1.808 . . . . 0.0 107.286 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.93 98.7 3.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.83 1.252 . . . . 0.0 109.107 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m-85 -49.27 139.04 11.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 127.222 2.209 . . . . 0.0 111.999 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.98 -37.55 1.5 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.638 1.589 . . . . 0.0 113.552 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.4 -28.14 52.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.418 1.109 . . . . 0.0 111.753 171.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.9 m80 48.98 60.02 4.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 110.081 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.0 147.84 32.77 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 108.215 163.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 p -121.41 142.99 49.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.421 1.089 . . . . 0.0 109.027 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.05 169.76 21.02 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.596 1.559 . . . . 0.0 108.082 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.65 107.44 18.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.58 133.79 50.71 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.077 1.751 . . . . 0.0 110.586 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.28 167.73 54.12 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.02 -32.07 94.47 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.465 2.776 . . . . 0.0 114.421 -175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.32 -15.79 18.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.39 0.995 . . . . 0.0 113.4 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -103.03 4.0 36.77 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.024 1.284 . . . . 0.0 111.225 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -135.27 134.78 40.3 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.684 1.594 . . . . 0.0 109.767 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.05 145.48 43.94 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 110.851 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.8 116.1 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.104 3.202 . . . . 0.0 109.615 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -49.14 -52.23 27.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.472 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -55.99 -35.96 67.35 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.114 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -41.79 66.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.839 1.199 . . . . 0.0 111.208 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.71 16.16 24.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.741 1.216 . . . . 0.0 110.756 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -61.51 -40.58 95.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.332 0.969 . . . . 0.0 110.471 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.53 -49.95 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.059 -1.026 . . . . 0.0 108.999 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -60.05 -33.82 72.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.245 1.418 . . . . 0.0 113.604 -169.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -125.66 -18.58 5.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.277 1.831 . . . . 0.0 112.649 -173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.97 30.62 1.8 Allowed Glycine 0 N--CA 1.474 1.194 0 CA-C-N 121.32 1.873 . . . . 0.0 113.472 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -115.47 158.65 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.201 2.2 . . . . 0.0 109.062 -167.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -75.44 164.08 26.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.345 1.545 . . . . 0.0 112.302 -163.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -153.85 155.68 36.21 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 128.715 2.806 . . . . 0.0 107.778 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.46 2.27 33.54 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.582 1.153 . . . . 0.0 113.52 -171.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.66 133.78 55.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.895 1.278 . . . . 0.0 108.785 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -62.09 162.27 9.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.38 -46.32 2.76 Favored Glycine 0 N--CA 1.461 0.335 0 O-C-N 120.969 -1.082 . . . . 0.0 111.052 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -54.89 -54.84 37.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.729 0.812 . . . . 0.0 111.202 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.02 -39.72 66.39 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.269 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.33 -43.52 98.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 110.303 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.97 -32.94 82.33 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.648 -0.658 . . . . 0.0 112.386 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.19 -24.59 54.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.007 0.904 . . . . 0.0 112.08 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -68.64 -52.62 29.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -56.59 -54.56 44.51 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.322 0.649 . . . . 0.0 111.187 -174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.2 tt -58.56 -36.37 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.37 0.532 . . . . 0.0 111.759 -172.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.22 -48.53 64.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.72 -0.09 45.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.213 1.405 . . . . 0.0 112.66 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.3 t -62.16 -58.25 8.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.29 1.836 . . . . 0.0 110.346 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.06 68.38 0.45 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.4 113.32 3.28 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.745 2.297 . . . . 0.0 108.433 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 t 67.9 -41.53 0.44 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.443 2.697 . . . . 0.0 112.698 -167.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.43 18.57 0.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.924 1.69 . . . . 0.0 112.713 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 O-C-N 120.666 -1.271 . . . . 0.0 110.253 -178.586 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t -158.34 171.13 20.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.829 1.252 . . . . 0.0 108.116 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -141.01 174.59 10.37 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.382 1.873 . . . . 0.0 109.302 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.59 -116.1 4.17 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 m -122.67 74.13 1.17 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.9 t -63.09 152.9 35.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.21 -102.86 0.18 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 -173.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 68.25 165.65 0.24 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.76 2.424 . . . . 0.0 109.721 -165.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -119.02 158.76 25.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -147.33 169.82 18.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.978 0.808 . . . . 0.0 111.284 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.69 124.87 14.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.81 0.844 . . . . 0.0 109.816 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.16 -9.16 61.2 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.777 -1.013 . . . . 0.0 112.836 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.78 159.6 32.69 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 119.285 1.543 . . . . 0.0 108.88 163.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.2 150.14 39.23 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.74 173.85 3.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.856 0.836 . . . . 0.0 111.296 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.29 133.71 52.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 157.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.69 125.86 53.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.228 1.411 . . . . 0.0 108.449 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -105.18 105.89 16.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mtm -77.58 170.21 16.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.122 0.963 . . . . 0.0 109.398 164.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -64.91 130.85 44.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.77 -48.24 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.853 0.739 . . . . 0.0 113.257 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -54.31 152.07 12.31 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 169.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.73 175.26 9.15 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.719 2.946 . . . . 0.0 109.713 171.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -63.07 97.61 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -79.27 140.26 56.57 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.817 1.647 . . . . 0.0 109.22 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.19 128.93 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.771 1.647 . . . . 0.0 109.069 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.84 165.64 27.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.112 0.958 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -116.4 147.67 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.76 108.82 14.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 161.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.61 -174.54 4.34 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 110.129 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -115.58 178.1 4.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.858 1.263 . . . . 0.0 109.627 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -135.55 112.17 10.77 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.27 152.6 79.01 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.066 2.511 . . . . 0.0 111.194 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.1 91.72 0.71 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.76 -20.67 1.01 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 125.944 1.735 . . . . 0.0 111.121 -169.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.17 178.67 7.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.526 1.163 . . . . 0.0 111.895 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.463 ' CG2' ' H ' ' A' ' 38' ' ' LYS . 9.6 p -68.27 -173.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 126.523 1.929 . . . . 0.0 110.019 160.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' H ' ' CG2' ' A' ' 37' ' ' VAL . 6.5 pttt -131.84 146.78 63.26 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.67 1.988 . . . . 0.0 109.246 177.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.27 164.38 32.97 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.242 1.961 . . . . 0.0 110.126 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.67 155.95 58.12 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 167.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.51 146.05 49.89 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.608 1.194 . . . . 0.0 110.913 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 55.48 32.19 18.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.235 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -131.37 147.48 52.57 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 124.437 1.095 . . . . 0.0 108.368 167.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.79 153.06 43.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 124.609 1.163 . . . . 0.0 110.146 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.18 94.57 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.441 2.761 . . . . 0.0 108.808 167.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.3 mm -85.07 141.18 14.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' CE1' ' HA ' ' A' ' 52' ' ' HIS . 56.0 t80 -125.95 122.46 36.03 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -87.15 99.8 12.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.05 1.34 . . . . 0.0 108.743 -174.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 7.1 m-85 -53.14 144.88 14.58 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.506 1.122 . . . . 0.0 111.163 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 -33.15 0.9 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.248 1.404 . . . . 0.0 114.342 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 p -95.63 -11.96 26.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.295 1.548 . . . . 0.0 112.723 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.408 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.9 m170 56.4 26.23 10.49 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.648 1.979 . . . . 0.0 113.542 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -92.01 161.7 14.68 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.726 0.81 . . . . 0.0 109.874 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -127.68 142.92 51.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.652 1.181 . . . . 0.0 109.449 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.52 174.11 13.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 110.16 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.88 107.5 15.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.7 mt -117.93 150.5 39.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.33 164.96 28.57 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.44 -28.03 86.49 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.129 2.553 . . . . 0.0 111.878 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -61.28 -10.72 7.49 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.61 10.35 9.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 110.645 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.2 mt -129.4 153.82 47.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 109.346 -172.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -132.61 148.16 68.45 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.664 0.785 . . . . 0.0 111.356 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.53 125.23 13.03 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.326 3.351 . . . . 0.0 111.049 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.6 -58.04 9.78 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.076 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -55.44 -27.94 51.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.36 -173.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -60.44 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.091 0.86 . . . . 0.0 109.039 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.55 13.13 14.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.928 1.691 . . . . 0.0 112.947 -170.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -57.0 -24.21 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.15 1.78 . . . . 0.0 112.162 -172.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.13 -35.51 5.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.522 1.129 . . . . 0.0 108.472 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.46 81.9 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.818 -1.176 . . . . 0.0 113.035 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -106.7 -27.17 10.97 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.837 1.655 . . . . 0.0 109.273 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.94 73.78 2.58 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 133.77 16.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.042 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.2 p -65.15 137.0 57.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.706 1.603 . . . . 0.0 107.677 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -142.12 -6.01 0.97 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -154.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 tttt 121.64 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 131.402 3.881 . . . . 0.0 111.495 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 133.49 53.16 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.938 0.79 . . . . 0.0 110.076 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -60.25 167.43 2.44 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 125.182 1.551 . . . . 0.0 109.831 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.75 -54.61 0.73 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.897 1.713 . . . . 0.0 111.685 -172.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -46.51 -43.73 17.13 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 126.678 1.991 . . . . 0.0 113.398 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -68.45 -47.6 66.74 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.488 0.715 . . . . 0.0 111.928 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -52.96 -38.93 62.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.994 1.317 . . . . 0.0 109.958 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.17 -28.61 65.97 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.542 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.58 -47.32 70.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.903 1.352 . . . . 0.0 109.659 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -53.79 -45.46 70.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.59 0.556 . . . . 0.0 109.545 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.06 -52.18 60.58 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.86 -30.28 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.484 1.038 . . . . 0.0 111.249 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.91 -31.71 68.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.546 0.612 . . . . 0.0 111.881 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -98.09 4.06 49.18 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.633 0.773 . . . . 0.0 112.582 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -68.92 74.6 0.29 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.352 1.861 . . . . 0.0 110.707 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.03 163.38 34.88 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.715 2.102 . . . . 0.0 112.92 175.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' C ' ' H ' ' A' ' 95' ' ' SER . 65.8 Cg_endo -81.81 77.86 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.727 1 C-N-CA 125.483 4.122 . . . . 0.0 110.793 -173.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.81 -25.83 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.826 2.05 . . . . 0.0 113.748 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.445 ' H ' ' C ' ' A' ' 93' ' ' PRO . 50.3 m 45.79 29.06 0.64 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 128.187 2.595 . . . . 0.0 114.119 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.764 0 CA-C-O 116.598 -2.223 . . . . 0.0 110.812 179.798 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t 63.87 -175.55 0.16 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.79 0.836 . . . . 0.0 109.485 -156.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.59 -174.04 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.858 0.863 . . . . 0.0 109.799 -154.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.21 -171.39 36.18 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.347 -0.845 . . . . 0.0 112.499 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 p -69.9 157.56 37.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.411 1.084 . . . . 0.0 111.334 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -65.18 -34.61 78.8 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.539 -0.726 . . . . 0.0 111.939 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.46 -173.86 54.88 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 107.866 -2.093 . . . . 0.0 107.866 -156.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 112.46 0.92 Allowed 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.392 1.877 . . . . 0.0 109.055 167.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.55 154.49 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.642 1.977 . . . . 0.0 111.18 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -160.33 162.77 33.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 109.194 -173.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.02 112.72 0.91 Allowed 'General case' 0 C--O 1.236 0.348 0 O-C-N 124.157 0.911 . . . . 0.0 109.167 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.61 -33.89 2.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.008 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.2 134.66 45.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.819 1.809 . . . . 0.0 108.616 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.86 147.94 25.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 162.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 m -147.92 167.78 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -108.4 148.34 30.28 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 156.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.98 127.8 45.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.278 1.831 . . . . 0.0 108.327 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.17 104.94 16.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.9 mtm -76.26 159.57 30.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 161.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -67.36 142.69 56.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.72 -41.31 0.83 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.717 1.627 . . . . 0.0 113.343 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.72 161.79 68.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 126.898 2.079 . . . . 0.0 112.266 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.6 179.97 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.106 3.204 . . . . 0.0 109.835 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -67.09 98.42 0.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -81.7 139.04 47.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.407 1.083 . . . . 0.0 108.289 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.04 140.74 61.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.266 1.311 . . . . 0.0 110.222 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.56 168.37 22.15 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.11 0.964 . . . . 0.0 109.493 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.0 mm -71.0 115.3 10.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 162.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.31 176.43 8.73 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.712 0.767 . . . . 0.0 109.644 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -169.71 1.67 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.71 1.204 . . . . 0.0 107.941 157.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mt -127.41 122.46 22.84 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.53 158.27 46.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.85 1.7 . . . . 0.0 109.633 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.0 76.73 5.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.148 0.499 . . . . 0.0 111.264 -167.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.92 -20.03 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.384 -1.231 . . . . 0.0 111.32 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.84 169.53 12.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 119.223 1.511 . . . . 0.0 112.841 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 p -75.26 107.88 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.447 2.299 . . . . 0.0 110.571 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -60.29 141.19 91.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.421 -0.799 . . . . 0.0 112.217 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.41 158.8 53.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.203 3.269 . . . . 0.0 112.384 -174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.19 173.51 14.38 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.78 132.27 52.82 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.939 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 40.41 50.14 2.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.501 2.721 . . . . 0.0 110.166 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -129.79 157.57 41.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 160.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.98 153.54 47.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 126.004 1.722 . . . . 0.0 107.182 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.16 104.47 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.773 2.315 . . . . 0.0 109.641 167.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.8 mm -103.49 111.66 34.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.14 124.29 34.7 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.875 1.27 . . . . 0.0 108.275 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -90.7 101.88 14.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.143 0.977 . . . . 0.0 109.283 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -52.92 145.2 13.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.593 1.157 . . . . 0.0 111.904 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.17 -46.31 2.43 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.363 1.458 . . . . 0.0 111.883 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 p -80.89 -22.32 39.88 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.149 -1.207 . . . . 0.0 112.321 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 m170 55.27 20.35 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.908 2.483 . . . . 0.0 113.822 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -78.43 166.65 22.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 p -125.42 152.64 44.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.35 161.03 39.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 154.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -88.06 123.3 32.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 166.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.3 mt -130.17 152.6 49.43 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.046 0.938 . . . . 0.0 108.525 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.41 169.19 18.24 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.022 0.82 . . . . 0.0 111.682 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.81 5.71 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.371 1 C-N-CA 125.503 4.135 . . . . 0.0 115.838 -166.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -102.14 -6.67 22.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -110.03 7.57 23.68 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.91 -1.119 . . . . 0.0 111.013 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.59 134.95 31.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.69 1.596 . . . . 0.0 108.717 -157.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -126.64 160.5 58.18 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.63 1.172 . . . . 0.0 109.649 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.14 131.67 27.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.742 2.295 . . . . 0.0 110.454 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.96 -57.63 12.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.994 1.27 . . . . 0.0 110.803 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -49.11 -40.61 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.171 0.988 . . . . 0.0 112.402 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -40.95 89.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.806 1.643 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -104.86 6.36 33.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.495 1.518 . . . . 0.0 112.603 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -61.41 -17.18 53.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.277 1.831 . . . . 0.0 111.51 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -115.19 -33.84 5.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.366 1.466 . . . . 0.0 111.856 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -64.1 -55.99 18.08 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.207 1.003 . . . . 0.0 109.937 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -92.66 -39.51 11.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.909 1.284 . . . . 0.0 110.146 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.6 77.94 0.75 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -122.97 179.0 4.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.611 1.564 . . . . 0.0 107.548 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 p -80.82 150.21 29.26 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -153.03 144.04 22.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.074 172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -81.68 68.49 8.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.492 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -128.26 119.25 24.78 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.807 2.043 . . . . 0.0 106.333 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -72.87 116.54 13.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -171.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.12 14.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.991 0.805 . . . . 0.0 111.783 -171.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -62.07 -60.59 3.38 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.949 1.375 . . . . 0.0 108.48 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -56.98 -21.81 33.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.98 -39.53 42.09 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.464 0.706 . . . . 0.0 109.552 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.81 97.22 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.382 -0.824 . . . . 0.0 111.945 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.74 -14.46 63.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.08 0.94 . . . . 0.0 112.613 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -79.76 -48.56 13.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.189 0.904 . . . . 0.0 108.742 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.31 -52.49 65.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.703 0.683 . . . . 0.0 110.446 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.64 -43.69 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.598 0.635 . . . . 0.0 111.622 -170.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.07 -46.63 89.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.356 1.062 . . . . 0.0 109.661 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -85.29 -6.81 59.23 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.337 1.055 . . . . 0.0 112.931 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -60.32 -29.93 69.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.538 1.935 . . . . 0.0 111.886 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.9 172.97 30.52 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.96 1.743 . . . . 0.0 109.321 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.84 169.92 20.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.452 3.435 . . . . 0.0 110.143 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -171.75 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.31 0.644 . . . . 0.0 110.148 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 m -77.52 -7.72 56.7 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.9 -1.125 . . . . 0.0 111.66 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 104.826 -3.31 . . . . 0.0 104.826 175.639 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.24 133.34 52.44 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.412 1.106 . . . . 0.0 108.087 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 p -66.43 161.65 22.23 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 122.778 0.431 . . . . 0.0 109.924 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.38 163.23 11.27 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.505 1.05 . . . . 0.0 111.22 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 m 63.72 -70.93 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.824 2.049 . . . . 0.0 112.028 -173.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.6 m -135.48 157.87 45.79 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.487 1.494 . . . . 0.0 109.491 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.86 176.47 39.03 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 124.395 0.998 . . . . 0.0 111.386 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.23 102.86 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 163.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -55.95 151.55 11.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.929 1.292 . . . . 0.0 110.366 172.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -138.11 170.53 15.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.121 0.968 . . . . 0.0 110.053 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 149.6 18.66 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.615 0.572 . . . . 0.0 110.629 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 -1.63 88.09 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.973 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -101.27 173.62 6.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.022 1.411 . . . . 0.0 109.464 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -131.38 149.31 52.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.757 1.223 . . . . 0.0 109.859 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.42 164.72 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 109.914 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.81 126.59 50.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 158.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.94 165.8 12.7 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -140.07 105.67 5.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.8 mtm -73.65 168.8 18.61 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 168.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -59.44 129.63 42.96 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 162.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.92 -30.03 2.07 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.627 2.061 . . . . 0.0 115.823 168.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.89 163.66 66.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 118.793 1.297 . . . . 0.0 111.576 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.64 175.67 10.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.573 3.515 . . . . 0.0 110.993 168.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -62.59 88.09 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.227 2.211 . . . . 0.0 109.786 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -86.75 137.88 33.56 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 120.904 -1.122 . . . . 0.0 109.252 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.07 137.79 63.84 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 111.665 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.04 167.44 22.67 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.159 0.98 . . . . 0.0 111.09 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 ptm180 -112.45 156.06 23.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.1 mm -82.45 107.48 14.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 159.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.74 -174.55 4.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 32' ' ' LEU . 4.7 tt0 -128.56 -177.22 4.09 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.647 -1.283 . . . . 0.0 109.296 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.48 ' H ' ' HG2' ' A' ' 31' ' ' GLU . 6.2 mt -142.36 116.39 6.52 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -166.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.9 151.38 56.64 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.462 2.108 . . . . 0.0 109.867 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.75 24.13 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.383 2.273 . . . . 0.0 114.77 -169.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.8 -0.76 1.24 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.479 -1.179 . . . . 0.0 113.3 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.29 175.05 6.41 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.524 1.662 . . . . 0.0 113.053 -167.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -35.19 131.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.766 2.426 . . . . 0.0 109.045 162.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -117.08 141.83 29.03 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.338 0.655 . . . . 0.0 111.336 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.65 161.84 14.44 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 123.628 2.885 . . . . 0.0 112.493 -162.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.26 167.58 17.49 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.668 2.245 . . . . 0.0 111.426 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.58 135.18 57.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 121.304 -0.872 . . . . 0.0 109.641 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 64.13 32.48 12.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.71 2.404 . . . . 0.0 113.039 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -132.85 168.1 19.0 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.913 -1.117 . . . . 0.0 112.916 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -125.2 152.87 71.53 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 130.232 3.413 . . . . 0.0 110.206 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.44 102.03 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.99 3.126 . . . . 0.0 109.543 166.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -87.86 116.31 25.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.626 1.97 . . . . 0.0 107.623 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.83 99.61 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.801 2.041 . . . . 0.0 109.435 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 3.3 m-85 -49.28 143.73 5.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.484 1.514 . . . . 0.0 113.141 -172.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.46 -58.26 2.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.175 1.369 . . . . 0.0 111.394 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -21.35 64.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.327 -1.102 . . . . 0.0 113.056 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 m170 58.09 3.15 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.08 2.152 . . . . 0.0 114.398 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.82 164.63 11.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.297 1.046 . . . . 0.0 109.407 172.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 p -141.24 136.22 31.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -166.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.28 151.09 36.04 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -89.08 107.34 18.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 mt -128.79 150.77 50.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 169.13 21.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.87 1.224 . . . . 0.0 112.762 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -68.42 -23.65 37.6 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.331 2.687 . . . . 0.0 113.924 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -57.25 -19.12 19.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.796 1.18 . . . . 0.0 113.31 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.0 7.05 23.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 109.507 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.3 166.22 11.89 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.389 1.875 . . . . 0.0 110.187 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -148.36 154.28 41.69 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.317 1.847 . . . . 0.0 106.847 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -69.97 127.4 14.38 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.135 2.557 . . . . 0.0 111.148 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -55.35 -53.73 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.456 1.102 . . . . 0.0 111.271 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.01 -21.91 59.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.761 0.824 . . . . 0.0 111.881 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -71.21 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.25 1.42 . . . . 0.0 109.031 167.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.26 15.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.379 1.472 . . . . 0.0 113.575 -166.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -52.93 -28.93 25.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.886 1.674 . . . . 0.0 112.019 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -34.86 6.9 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.123 0.874 . . . . 0.0 111.635 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -60.87 -60.9 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.258 1.023 . . . . 0.0 109.011 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -85.19 -52.02 6.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.695 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.33 88.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 126.187 1.851 . . . . 0.0 111.856 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -151.48 158.83 44.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.418 1.887 . . . . 0.0 108.899 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -60.0 150.89 27.75 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.886 1.327 . . . . 0.0 108.966 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.14 149.86 44.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.615 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -86.0 -14.1 45.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.171 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mmt-85 -58.31 123.9 17.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 164.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -64.78 164.17 12.75 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 -40.69 2.28 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.043 0.83 . . . . 0.0 111.719 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -52.43 -34.96 50.88 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.49 1.145 . . . . 0.0 112.168 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -46.43 76.43 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 121.34 -0.85 . . . . 0.0 112.794 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.04 -43.76 86.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.771 1.229 . . . . 0.0 109.294 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.36 -36.45 93.1 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.421 -0.8 . . . . 0.0 113.02 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.04 -16.91 61.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.289 1.036 . . . . 0.0 112.661 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -77.97 -52.73 8.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.02 -46.09 92.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 112.331 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.8 tt -63.58 -33.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.201 0.909 . . . . 0.0 111.806 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.49 -53.38 19.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.624 -0.672 . . . . 0.0 109.272 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -71.59 -21.94 61.79 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.803 0.689 . . . . 0.0 112.106 -170.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -55.63 -60.82 2.9 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.139 0.976 . . . . 0.0 110.219 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.82 -176.56 42.63 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 121.842 0.69 . . . . 0.0 113.631 -164.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.21 128.75 21.16 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.886 3.057 . . . . 0.0 109.829 -167.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 p -154.77 166.66 32.75 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 108.199 -165.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.57 22.95 13.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.974 0.91 . . . . 0.0 113.393 173.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.716 0 N-CA-C 107.579 -2.209 . . . . 0.0 107.579 178.247 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -131.44 161.65 31.99 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.182 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 125.35 2.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.91 -95.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.208 1.385 . . . . 0.0 110.893 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 p -169.34 -62.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -49.7 128.48 18.0 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.922 1.289 . . . . 0.0 109.978 162.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.57 -157.68 2.25 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 159.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -143.83 156.93 44.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -78.34 169.51 18.14 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -136.97 169.95 16.91 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.527 1.531 . . . . 0.0 108.759 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 144.08 44.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.491 0.662 . . . . 0.0 110.863 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.18 5.9 59.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.418 -1.212 . . . . 0.0 113.328 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.84 140.98 51.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.28 2.04 . . . . 0.0 108.251 166.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.5 mt -88.42 136.38 33.01 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.05 162.38 13.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 123.478 0.711 . . . . 0.0 109.593 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -102.1 126.6 49.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 164.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.9 168.8 10.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.707 0.803 . . . . 0.0 109.507 173.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -133.44 150.2 51.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.472 0.709 . . . . 0.0 109.569 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 55.4 mtm -132.62 172.89 11.93 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.127 1.771 . . . . 0.0 109.463 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -80.55 71.23 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.143 1.377 . . . . 0.0 109.981 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.36 -41.38 1.2 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.414 1.483 . . . . 0.0 111.276 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -60.65 150.6 74.76 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.505 1.122 . . . . 0.0 110.946 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.52 165.44 29.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.549 3.499 . . . . 0.0 111.333 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -55.36 116.57 2.92 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -118.33 132.1 23.93 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.33 137.44 36.71 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.969 1.78 . . . . 0.0 110.751 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.03 167.34 23.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.674 1.19 . . . . 0.0 110.249 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.41 139.5 53.6 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.69 112.5 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -73.97 171.04 14.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.582 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.2 154.31 37.66 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.43 1.109 . . . . 0.0 111.147 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.5 mt -134.37 112.33 11.95 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.589 -1.641 . . . . 0.0 108.068 -161.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.69 166.02 19.1 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 124.477 3.452 . . . . 0.0 110.495 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.72 82.91 7.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.127 -0.983 . . . . 0.0 108.658 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 68.85 0.28 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.49 1.519 . . . . 0.0 110.525 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.94 -171.77 3.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.532 1.533 . . . . 0.0 107.621 160.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.58 140.48 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.096 0.862 . . . . 0.0 108.684 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -121.72 141.71 34.37 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 123.5 0.72 . . . . 0.0 111.668 -168.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -70.79 156.61 60.32 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.702 2.268 . . . . 0.0 110.357 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.69 156.41 35.58 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 C-N-CA 120.823 1.015 . . . . 0.0 109.594 168.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.4 46.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.82 1.295 . . . . 0.0 110.142 -174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.27 27.2 2.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.363 -169.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -128.19 166.7 18.02 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.349 1.06 . . . . 0.0 108.146 162.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -129.71 153.34 80.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 126.491 1.916 . . . . 0.0 107.283 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.12 115.68 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.397 2.065 . . . . 0.0 108.929 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.5 113.47 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -85.98 131.77 34.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -98.44 115.47 28.58 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -54.8 144.75 21.51 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.055 1.342 . . . . 0.0 110.718 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.86 -58.0 4.04 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.76 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 p -83.48 -24.64 31.68 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.849 2.324 . . . . 0.0 111.273 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.0 m170 70.01 17.43 7.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.349 1.459 . . . . 0.0 112.113 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.59 155.41 33.25 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 130.26 32.52 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.991 1.316 . . . . 0.0 108.0 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.02 159.02 42.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.79 121.63 32.11 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.7 mt -126.79 158.56 36.25 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 109.062 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.86 16.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.701 1.143 . . . . 0.0 112.658 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -67.84 -15.73 44.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.33 2.687 . . . . 0.0 115.188 -160.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -63.53 -26.37 68.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.393 1.451 . . . . 0.0 111.664 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.1 10.66 33.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.485 1.514 . . . . 0.0 111.533 -173.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.3 mt -133.35 127.09 32.76 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.927 1.291 . . . . 0.0 109.408 -169.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.33 142.68 37.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.424 1.089 . . . . 0.0 110.745 -167.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.49 121.04 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.821 3.014 . . . . 0.0 111.411 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -56.28 -50.08 72.41 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.8 -0.562 . . . . 0.0 111.064 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -57.87 -31.97 67.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 112.267 -173.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.19 -68.06 0.5 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.013 0.925 . . . . 0.0 108.823 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.4 -2.57 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.374 1.07 . . . . 0.0 113.265 -160.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.49 -46.46 57.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.935 1.694 . . . . 0.0 110.713 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.67 -17.36 53.88 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -97.76 -62.48 1.24 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.683 1.593 . . . . 0.0 109.786 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -86.22 -30.82 22.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.822 1.649 . . . . 0.0 111.782 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.21 73.41 2.0 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -132.38 128.94 38.67 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.504 1.122 . . . . 0.0 108.556 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -41.89 130.74 3.39 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 126.371 1.868 . . . . 0.0 109.208 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -138.85 134.72 33.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -78.1 72.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -120.09 133.96 55.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -68.32 147.74 51.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -58.69 5.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -48.77 -61.1 2.22 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 124.83 1.252 . . . . 0.0 110.67 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.1 -33.41 70.8 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.785 1.234 . . . . 0.0 114.073 -169.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.14 -39.97 68.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.645 0.778 . . . . 0.0 110.732 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -34.69 80.14 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.567 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.94 -24.78 64.31 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.371 1.085 . . . . 0.0 111.832 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -70.69 -50.06 40.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.79 -46.51 87.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.308 1.043 . . . . 0.0 111.545 -172.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 tt -66.69 -42.36 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.409 0.284 . . . . 0.0 110.864 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.02 -20.32 64.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.013 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -109.53 28.99 7.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.77 2.028 . . . . 0.0 110.74 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 p -61.9 -17.82 57.99 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.12 -177.73 21.01 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.161 1.362 . . . . 0.0 109.926 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.7 154.73 67.61 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.478 2.785 . . . . 0.0 110.929 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 m -103.75 120.03 40.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.211 1.004 . . . . 0.0 110.044 -163.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -137.85 -79.3 0.37 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.9 0.773 . . . . 0.0 111.69 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 104.488 -3.445 . . . . 0.0 104.488 -159.048 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 t -134.97 159.37 41.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.748 1.619 . . . . 0.0 107.902 168.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.99 50.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.748 1.219 . . . . 0.0 108.88 174.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.32 78.6 1.32 Allowed Glycine 0 C--N 1.338 0.64 0 C-N-CA 123.65 0.643 . . . . 0.0 112.448 166.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.5 m -116.85 175.66 5.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.948 1.699 . . . . 0.0 107.766 161.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.8 m -57.96 126.4 27.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 162.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.87 -91.4 0.17 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -138.02 96.49 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -62.48 135.17 57.29 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -128.94 158.67 38.17 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.089 0.859 . . . . 0.0 110.306 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.09 3.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 109.778 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.09 -37.75 2.23 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -69.8 160.7 31.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.716 1.246 . . . . 0.0 110.778 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -117.82 143.63 46.1 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 107.846 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.31 167.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.554 0.742 . . . . 0.0 111.479 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.43 128.34 50.6 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 158.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.1 165.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HE2' ' CE1' ' A' ' 24' ' ' HIS . 6.8 tptp -143.92 106.32 4.41 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.9 mtm -78.28 161.7 27.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 166.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.02 139.34 58.76 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.61 -44.43 2.5 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.078 1.323 . . . . 0.0 113.796 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.67 160.03 78.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.61 1.205 . . . . 0.0 112.384 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 178.46 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.979 3.786 . . . . 0.0 111.482 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.431 ' CE1' ' HE2' ' A' ' 18' ' ' LYS . 55.1 m80 -71.28 89.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.495 1.118 . . . . 0.0 109.234 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -80.69 136.31 51.79 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 110.161 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.43 124.51 12.56 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.895 2.397 . . . . 0.0 110.506 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.82 166.66 24.6 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.717 -0.615 . . . . 0.0 110.28 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.8 ptm85 -125.89 159.62 32.08 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.512 -0.743 . . . . 0.0 109.882 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.5 mm -86.27 108.88 18.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -73.28 174.98 7.28 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 32' ' ' LEU . 13.8 tt0 -101.74 -163.91 1.05 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 164.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' H ' ' HG2' ' A' ' 31' ' ' GLU . 1.8 mp -132.12 144.18 52.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.04 161.87 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.205 2.603 . . . . 0.0 112.2 171.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -76.89 18.4 0.36 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.299 -0.876 . . . . 0.0 112.019 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.05 92.82 0.09 OUTLIER Glycine 0 CA--C 1.524 0.606 0 C-N-CA 128.146 2.784 . . . . 0.0 108.025 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -157.64 -169.76 2.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.359 1.079 . . . . 0.0 110.184 -175.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.17 162.75 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 155.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 146.93 63.69 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 120.93 -1.107 . . . . 0.0 110.375 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.37 167.5 9.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.476 3.451 . . . . 0.0 115.719 -168.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -67.39 158.46 56.95 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 121.1 1.2 . . . . 0.0 111.647 160.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 131.07 46.54 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 63.04 16.39 9.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.23 2.612 . . . . 0.0 113.851 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -114.1 159.33 20.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.003 0.82 . . . . 0.0 110.2 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -122.84 153.11 63.5 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.282 1.833 . . . . 0.0 108.416 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.13 105.24 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.606 2.87 . . . . 0.0 110.487 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.7 mm -92.89 123.36 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.128 0.571 . . . . 0.0 109.527 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -101.87 115.99 31.74 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 107.091 170.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -80.44 115.84 20.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -65.86 149.04 50.83 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.402 0.62 . . . . 0.0 110.737 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 -34.45 0.34 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.884 2.183 . . . . 0.0 114.059 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -85.68 -28.48 24.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.68 2.24 . . . . 0.0 110.88 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 66.36 13.83 9.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.31 2.244 . . . . 0.0 113.701 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.68 160.07 30.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.2 1.0 . . . . 0.0 109.288 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -122.65 149.55 43.86 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 109.476 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.39 177.65 9.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.762 0.825 . . . . 0.0 109.287 167.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -117.33 122.82 44.94 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.83 156.94 32.18 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.73 0.3 . . . . 0.0 110.5 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.16 161.4 35.88 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.13 -20.97 63.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.957 2.438 . . . . 0.0 111.765 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -60.25 -23.73 64.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.87 0.868 . . . . 0.0 112.386 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.79 -9.94 50.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.489 1.04 . . . . 0.0 111.53 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.9 mt -116.48 160.58 20.39 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.23 1.412 . . . . 0.0 110.795 -162.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.55 146.95 47.14 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.066 0.946 . . . . 0.0 110.767 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -67.12 126.72 15.56 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.426 2.751 . . . . 0.0 110.508 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -52.8 -52.06 58.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.793 0.437 . . . . 0.0 110.841 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -66.66 -6.34 15.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -64.49 1.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.725 -0.609 . . . . 0.0 110.532 164.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -79.96 9.76 5.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.488 1.915 . . . . 0.0 113.525 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -53.71 -20.45 5.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.748 2.019 . . . . 0.0 112.464 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -33.13 4.62 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 119.972 1.26 . . . . 0.0 113.229 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -61.26 -51.56 68.41 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.615 1.098 . . . . 0.0 109.024 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -92.4 -35.06 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.108 0.963 . . . . 0.0 110.112 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.97 80.25 0.59 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.64 -1.089 . . . . 0.0 110.993 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -141.86 142.59 33.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.095 1.758 . . . . 0.0 107.648 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -54.4 103.54 0.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.853 2.461 . . . . 0.0 111.7 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.71 150.5 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.344 -0.848 . . . . 0.0 112.268 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.62 -49.39 14.29 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.8 1.64 . . . . 0.0 113.232 168.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -58.49 139.39 55.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.83 0.741 . . . . 0.0 110.598 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.412 ' HD3' ' H ' ' A' ' 80' ' ' GLY . 2.7 mmtt -71.27 172.5 9.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 162.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.412 ' H ' ' HD3' ' A' ' 79' ' ' LYS . . . 65.34 -88.01 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 104.611 -3.396 . . . . 0.0 104.611 -143.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -32.24 -53.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.535 2.734 . . . . 0.0 115.547 -151.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -23.7 62.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.39 -57.29 4.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.633 2.373 . . . . 0.0 108.501 170.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.42 -27.75 61.19 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.332 -0.705 . . . . 0.0 112.563 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.48 -48.85 73.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.14 0.97 . . . . 0.0 111.384 170.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -60.89 -40.58 93.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.666 1.121 . . . . 0.0 110.178 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.58 -51.64 67.71 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.356 0.663 . . . . 0.0 111.678 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.2 tt -66.57 -29.4 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 118.892 0.769 . . . . 0.0 110.945 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.69 -30.99 69.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.214 -0.929 . . . . 0.0 110.905 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -96.04 39.18 1.15 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.3 m -142.67 125.31 15.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.628 2.771 . . . . 0.0 106.631 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.29 -124.17 5.97 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.433 1.968 . . . . 0.0 110.233 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -63.55 100.85 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.183 2.589 . . . . 0.0 109.233 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -77.54 100.39 6.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 169.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m 56.21 30.84 17.3 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -176.644 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 m 55.0 -91.79 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.889 1.676 . . . . 0.0 112.295 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.6 171.56 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.264 1.393 . . . . 0.0 111.181 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.78 100.46 2.66 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -44.58 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.445 1.498 . . . . 0.0 111.344 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -171.65 -174.57 1.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.535 1.934 . . . . 0.0 108.119 -166.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.13 163.31 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.048 1.308 . . . . 0.0 111.141 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 10.19 98.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 131.811 4.045 . . . . 0.0 115.183 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.73 136.32 57.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.188 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -134.5 167.95 19.84 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.974 1.31 . . . . 0.0 108.83 169.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.23 139.57 8.38 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.16 25.12 49.76 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.08 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -109.76 167.42 10.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.548 1.674 . . . . 0.0 109.693 164.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.45 138.25 46.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.766 2.026 . . . . 0.0 106.751 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -140.63 175.3 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 108.901 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -109.38 151.9 26.03 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 157.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.13 147.09 49.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.461 1.505 . . . . 0.0 109.056 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -134.63 104.81 6.21 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -164.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.8 mtm -88.95 167.2 13.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.302 0.573 . . . . 0.0 110.349 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -51.06 113.32 0.9 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.892 1.677 . . . . 0.0 109.154 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.77 -36.13 3.16 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.781 1.658 . . . . 0.0 114.26 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.54 163.65 19.2 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.54 1.536 . . . . 0.0 112.515 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -85.55 -179.04 3.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 125.126 3.884 . . . . 0.0 110.68 168.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -67.18 92.66 0.27 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.269 1.028 . . . . 0.0 108.655 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -78.13 139.1 60.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.986 1.314 . . . . 0.0 108.089 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.4 137.22 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.352 2.034 . . . . 0.0 108.914 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.77 156.86 43.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 141.72 49.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mm -78.12 105.37 7.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.27 170.87 6.5 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.655 0.782 . . . . 0.0 108.896 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -90.08 167.94 12.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.179 -0.951 . . . . 0.0 108.584 162.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.11 107.71 57.47 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 164.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.72 174.43 5.53 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.557 2.171 . . . . 0.0 109.872 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.1 163.07 6.44 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.576 -0.703 . . . . 0.0 110.138 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.72 -9.56 0.27 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.919 1.247 . . . . 0.0 115.698 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.97 177.64 3.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.284 1.834 . . . . 0.0 111.008 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.89 147.97 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.766 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -108.03 105.39 56.3 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 125.007 1.323 . . . . 0.0 107.84 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.96 169.07 20.05 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.789 2.326 . . . . 0.0 111.187 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 42' ' ' ASN . 71.8 Cg_endo -68.95 160.08 51.31 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 N-CA-C 110.137 -0.755 . . . . 0.0 110.137 169.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.06 13.66 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 40' ' ' PRO . 1.0 OUTLIER -142.98 8.57 1.67 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.38 2.272 . . . . 0.0 111.278 -159.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -141.02 164.19 30.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.927 1.291 . . . . 0.0 108.187 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.67 152.67 59.03 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 124.412 1.085 . . . . 0.0 110.158 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.03 91.06 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.637 2.891 . . . . 0.0 109.476 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.6 mm -82.36 118.1 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -85.09 149.51 25.5 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 163.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -111.86 113.34 25.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -64.8 160.4 20.34 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.933 0.873 . . . . 0.0 110.455 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.49 -47.31 2.38 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.92 2.2 . . . . 0.0 113.201 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -96.77 -21.64 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.485 1.143 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.0 m80 66.79 21.71 10.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.454 1.902 . . . . 0.0 112.065 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -71.66 163.37 27.9 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.219 1.009 . . . . 0.0 109.845 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -142.79 142.85 31.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 109.254 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.52 -175.81 5.53 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.986 2.514 . . . . 0.0 107.055 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.82 125.29 48.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 109.386 165.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 mt -130.48 150.89 51.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.518 1.927 . . . . 0.0 108.769 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.81 165.54 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.34 0.971 . . . . 0.0 111.687 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.66 -22.33 50.63 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.937 3.091 . . . . 0.0 113.385 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -60.96 -13.33 15.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.127 -0.939 . . . . 0.0 112.142 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.44 -5.26 21.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 113.734 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.2 mt -122.39 146.96 46.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.565 1.075 . . . . 0.0 109.911 -157.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.15 143.28 46.48 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.579 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -65.02 114.88 2.99 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.619 2.213 . . . . 0.0 108.664 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -46.98 -54.26 10.55 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 123.929 0.892 . . . . 0.0 109.471 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -60.11 -25.24 65.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.502 0.502 . . . . 0.0 112.299 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -57.03 4.18 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -83.42 17.06 2.27 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 112.434 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -66.65 -31.36 71.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.278 1.431 . . . . 0.0 108.968 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.62 -57.07 3.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.414 0.552 . . . . 0.0 111.253 162.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.92 -41.85 83.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.115 0.87 . . . . 0.0 110.843 -162.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -102.73 -14.78 16.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.027 1.731 . . . . 0.0 112.541 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.64 75.17 2.14 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 119.719 1.145 . . . . 0.0 110.268 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -133.3 132.67 41.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.251 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 p -61.62 79.79 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.833 2.053 . . . . 0.0 112.867 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -95.41 147.11 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 110.181 -168.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -91.97 41.96 1.09 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -149.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -105.09 147.14 28.22 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.21 155.37 37.26 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.2 1.64 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.973 1.273 . . . . 0.0 112.197 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.28 -49.61 63.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.905 1.353 . . . . 0.0 112.932 -164.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -66.82 -22.64 66.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.625 0.77 . . . . 0.0 110.754 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -75.53 -47.52 26.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 108.39 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.66 -26.79 72.99 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 120.11 -0.272 . . . . 0.0 113.366 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 mt -72.23 -29.72 64.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.65 1.225 . . . . 0.0 111.584 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -70.72 -42.59 70.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.33 -0.856 . . . . 0.0 109.161 171.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.84 -55.22 37.2 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.156 0.582 . . . . 0.0 110.409 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.02 -34.12 64.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.989 0.813 . . . . 0.0 111.316 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.38 -29.94 65.54 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.496 -0.752 . . . . 0.0 111.631 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -83.96 -7.86 59.31 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.071 1.348 . . . . 0.0 112.795 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -82.13 77.4 8.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.464 1.506 . . . . 0.0 109.616 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.09 -169.99 39.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.38 157.38 41.22 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.304 3.336 . . . . 0.0 110.421 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.4 m -110.31 112.73 24.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.013 0.925 . . . . 0.0 109.214 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.1 m -152.93 141.59 20.93 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.571 1.948 . . . . 0.0 106.453 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 106.071 -2.812 . . . . 0.0 106.071 -170.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m 50.08 82.22 0.05 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.4 1.48 . . . . 0.0 112.95 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 p -72.75 164.18 26.96 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 150.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.3 65.5 0.43 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -77.06 -83.2 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 163.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p -82.76 170.37 15.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.533 0.733 . . . . 0.0 109.988 169.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.75 -83.71 0.31 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 165.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -141.76 135.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -85.07 155.6 21.45 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.73 156.52 46.74 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.794 -1.191 . . . . 0.0 110.058 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 141.8 50.44 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.63 40.41 10.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -136.55 173.08 12.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.248 1.024 . . . . 0.0 110.588 159.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -119.25 147.2 44.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.877 2.471 . . . . 0.0 106.801 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.73 171.33 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.381 1.073 . . . . 0.0 108.759 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.76 125.56 52.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.03 151.55 20.81 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.041 0.936 . . . . 0.0 110.796 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -126.9 106.32 9.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.2 mtp -83.99 167.78 16.58 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 162.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.18 119.79 11.51 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.05 -16.53 2.0 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.038 -1.423 . . . . 0.0 116.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -67.16 159.19 78.35 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 119.741 1.77 . . . . 0.0 110.907 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.13 164.28 34.52 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.61 2.873 . . . . 0.0 110.037 168.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -65.47 103.15 0.79 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -95.28 138.44 21.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.389 -164.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.56 124.49 14.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.695 2.264 . . . . 0.0 110.345 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.83 164.16 30.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.047 0.539 . . . . 0.0 110.324 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -128.85 146.13 51.01 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.037 -0.414 . . . . 0.0 110.612 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.24 98.63 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 172.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -85.68 -175.88 5.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.754 1.622 . . . . 0.0 109.252 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -107.65 168.45 9.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.576 1.951 . . . . 0.0 108.907 167.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -81.08 151.62 70.31 Favored Pre-proline 0 N--CA 1.467 0.423 0 O-C-N 121.307 -0.871 . . . . 0.0 110.325 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -83.04 -167.49 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 124.721 3.614 . . . . 0.0 109.652 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -112.47 31.38 6.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.671 1.589 . . . . 0.0 112.163 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.23 46.45 0.17 Allowed Glycine 0 C--N 1.338 0.647 0 O-C-N 120.71 -1.244 . . . . 0.0 113.815 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.32 168.55 14.64 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.292 1.037 . . . . 0.0 110.998 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -66.11 119.2 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 143.04 96.0 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.931 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -85.7 161.63 10.7 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.156 2.571 . . . . 0.0 114.591 -173.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.5 143.79 27.93 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.137 1.891 . . . . 0.0 111.11 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.81 75.32 3.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.091 -171.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -175.08 6.42 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.181 2.192 . . . . 0.0 110.622 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -136.9 -177.04 4.57 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.924 1.29 . . . . 0.0 109.679 -163.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -140.65 152.44 66.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.36 1.464 . . . . 0.0 109.084 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.81 92.01 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.424 3.416 . . . . 0.0 110.867 170.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.84 141.15 14.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -118.59 133.02 56.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.018 1.727 . . . . 0.0 108.2 172.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -89.85 112.53 23.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.242 1.417 . . . . 0.0 108.357 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 17.1 m-85 -62.39 154.56 27.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 171.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.49 -21.53 0.9 Allowed Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.725 -1.597 . . . . 0.0 115.951 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.96 -14.05 7.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 121.079 2.439 . . . . 0.0 113.879 178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.65 16.3 7.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.569 2.348 . . . . 0.0 112.832 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.1 170.4 10.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.373 1.082 . . . . 0.0 109.954 170.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -141.79 147.73 37.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 108.198 -172.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.42 24.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.318 0.508 . . . . 0.0 109.695 167.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -110.28 112.34 24.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 mt -125.13 142.0 51.76 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.55 164.17 37.68 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -64.4 -32.61 60.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.27 2.647 . . . . 0.0 112.363 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -58.95 -32.95 70.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.856 0.862 . . . . 0.0 112.788 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -82.72 -10.36 58.94 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.236 0.925 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.1 mt -108.15 154.7 21.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.614 1.965 . . . . 0.0 109.687 -171.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -134.01 140.89 37.66 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.797 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.76 126.12 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.442 2.761 . . . . 0.0 109.591 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.42 -48.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.706 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.56 -43.63 72.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.72 1.145 . . . . 0.0 112.731 -172.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -54.11 36.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.403 0.681 . . . . 0.0 110.61 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -85.47 2.85 42.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -55.76 -49.87 71.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.144 1.777 . . . . 0.0 108.991 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.27 -16.99 44.18 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -82.17 -64.76 1.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.885 1.221 . . . . 0.0 112.085 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -88.68 -31.48 18.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.818 2.447 . . . . 0.0 113.712 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.62 63.87 1.14 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.463 1.506 . . . . 0.0 113.367 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -128.99 142.6 50.87 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 p -56.75 150.13 16.71 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.382 1.087 . . . . 0.0 109.801 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.97 167.11 17.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.732 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -83.47 -16.83 44.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.155 0.889 . . . . 0.0 112.846 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -58.85 138.59 57.2 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.558 1.072 . . . . 0.0 109.768 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -67.29 154.69 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.356 0.663 . . . . 0.0 109.411 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.14 -31.97 1.11 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.389 0.995 . . . . 0.0 112.642 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.35 -26.23 66.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.922 1.861 . . . . 0.0 112.487 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -49.9 21.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.135 -0.978 . . . . 0.0 109.742 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -55.45 -47.69 75.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.131 1.372 . . . . 0.0 108.572 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.97 -34.75 88.02 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.425 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.57 -20.38 64.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.581 1.691 . . . . 0.0 111.872 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -83.62 -42.69 16.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 120.765 1.621 . . . . 0.0 110.334 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -55.1 -49.93 70.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.045 0.538 . . . . 0.0 109.884 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.69 -31.79 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.527 -0.733 . . . . 0.0 111.94 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.66 -21.56 65.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.617 1.167 . . . . 0.0 111.769 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -117.09 -16.87 10.42 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.562 0.745 . . . . 0.0 112.058 -168.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -53.01 45.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.212 1.405 . . . . 0.0 111.402 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.73 41.71 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 117.95 0.341 . . . . 0.0 113.16 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.19 81.63 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.433 3.422 . . . . 0.0 110.433 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.2 m -147.3 109.44 4.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.72 1.208 . . . . 0.0 108.437 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.0 t -50.61 111.06 0.48 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.385 1.474 . . . . 0.0 108.842 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 C-N-CA 127.715 2.579 . . . . 0.0 107.353 -178.05 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.42 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.4 p -75.11 -161.75 0.15 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.697 0.799 . . . . 0.0 108.925 166.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -142.5 159.95 41.24 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.779 1.632 . . . . 0.0 107.767 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.89 143.84 13.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -71.95 -4.39 28.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.722 0.809 . . . . 0.0 111.496 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t -154.95 -164.78 1.87 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.112 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 38.69 14.74 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.208 175.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 109.48 141.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 1 C-N-CA 132.163 4.185 . . . . 0.0 108.041 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.78 157.78 15.98 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.705 0.802 . . . . 0.0 110.984 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -143.07 167.63 21.64 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.409 1.084 . . . . 0.0 110.214 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.21 132.37 23.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.065 0.946 . . . . 0.0 110.659 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.71 76.77 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.26 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.93 144.29 57.38 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.371 1.585 . . . . 0.0 107.926 165.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -101.25 144.1 30.52 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 171.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.87 173.98 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.327 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -114.35 138.07 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 154.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.87 172.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.156 1.383 . . . . 0.0 107.92 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -141.89 106.32 4.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.78 172.8 12.88 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.297 1.046 . . . . 0.0 110.628 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -80.74 44.28 0.72 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.864 2.066 . . . . 0.0 112.956 -165.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.83 -43.11 0.68 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.536 1.541 . . . . 0.0 109.758 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -55.95 155.61 11.55 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 117.284 0.542 . . . . 0.0 110.41 170.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.57 -178.2 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.187 3.258 . . . . 0.0 109.894 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -74.54 79.29 1.96 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.441 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -63.31 134.31 95.79 Favored Pre-proline 0 CA--C 1.539 0.549 0 O-C-N 120.855 -1.153 . . . . 0.0 111.27 -170.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.95 131.38 23.78 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.587 2.191 . . . . 0.0 110.032 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.99 168.65 22.53 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.078 0.466 . . . . 0.0 109.843 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 7.5 ptm180 -134.67 160.29 38.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.692 -0.63 . . . . 0.0 110.878 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.2 mm -84.13 117.13 29.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -82.64 -179.4 7.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.382 1.473 . . . . 0.0 108.587 166.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -129.01 149.05 51.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 108.04 172.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -80.89 120.71 79.63 Favored Pre-proline 0 C--O 1.239 0.509 0 CA-C-O 117.537 -1.221 . . . . 0.0 109.083 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.37 166.8 8.84 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.738 1.625 . . . . 0.0 109.632 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -76.23 -4.49 42.16 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -160.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.64 51.01 0.83 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 128.396 2.903 . . . . 0.0 109.782 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 -179.7 4.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 122.199 1.0 . . . . 0.0 112.198 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 t -92.66 74.32 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 122.136 0.97 . . . . 0.0 108.95 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -28.22 108.94 0.23 Allowed Pre-proline 0 C--O 1.24 0.6 0 C-N-CA 128.169 2.588 . . . . 0.0 113.695 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.74 162.92 37.34 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.393 2.062 . . . . 0.0 112.012 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.34 138.74 39.91 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 N-CA-C 109.303 -1.076 . . . . 0.0 109.303 160.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.9 111.44 3.78 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 131.67 -4.48 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 131.428 3.891 . . . . 0.0 111.085 -170.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -115.26 143.96 44.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.725 1.602 . . . . 0.0 110.972 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -103.81 150.74 38.5 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.32 104.49 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.663 2.242 . . . . 0.0 108.555 159.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.55 140.83 16.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -112.97 121.16 43.81 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.563 2.345 . . . . 0.0 107.513 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -78.11 115.71 18.04 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.6 m-85 -67.79 155.77 38.54 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.906 0.384 . . . . 0.0 110.653 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.47 -58.8 4.1 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.979 0.8 . . . . 0.0 111.548 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -81.82 -21.16 37.8 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 112.152 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.4 m170 55.56 18.01 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.012 2.125 . . . . 0.0 112.619 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.86 166.56 19.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 109.095 173.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 p -142.56 148.11 37.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.229 1.011 . . . . 0.0 108.523 -171.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.52 179.47 7.65 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.521 1.128 . . . . 0.0 109.002 173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -123.01 107.39 11.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.4 146.54 47.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.454 1.901 . . . . 0.0 107.96 -176.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.46 162.13 23.37 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.91 -24.07 61.22 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.846 3.031 . . . . 0.0 113.961 -165.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -67.06 -9.1 35.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.239 1.381 . . . . 0.0 112.457 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.62 4.86 36.06 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.782 1.174 . . . . 0.0 111.501 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.51 153.93 50.44 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.298 1.439 . . . . 0.0 109.601 -166.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.13 143.93 26.7 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.901 0.88 . . . . 0.0 110.362 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.26 129.31 21.28 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.841 2.361 . . . . 0.0 110.568 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.54 -48.05 75.35 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 121.926 -0.484 . . . . 0.0 110.137 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.82 -24.74 66.08 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.75 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -43.28 18.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.523 1.129 . . . . 0.0 110.203 174.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.428 ' CD1' ' CE2' ' A' ' 72' ' ' PHE . 54.3 m-85 -100.84 6.29 43.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.538 1.535 . . . . 0.0 114.047 -164.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -58.81 -33.72 70.7 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 127.249 2.219 . . . . 0.0 112.78 -167.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -98.85 -21.36 16.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.027 0.83 . . . . 0.0 110.346 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -76.13 -68.77 0.55 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.685 1.194 . . . . 0.0 108.576 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 68' ' ' TYR . 22.1 m-30 -81.0 -44.36 18.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.938 1.695 . . . . 0.0 108.975 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.36 96.0 0.05 OUTLIER Glycine 0 C--N 1.339 0.723 0 C-N-CA 125.862 1.696 . . . . 0.0 109.081 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -140.27 133.13 29.16 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.675 1.99 . . . . 0.0 106.245 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 122.57 21.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -145.06 171.76 14.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.256 1.823 . . . . 0.0 108.988 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -88.24 -60.05 2.07 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.083 0.856 . . . . 0.0 112.262 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.304 0.3 OUTLIER 44.5 -126.1 1.02 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.824 0.85 . . . . 0.0 109.876 -173.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -136.99 105.64 5.84 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 127.706 2.402 . . . . 0.0 105.975 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.1 89.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 119.927 1.239 . . . . 0.0 114.207 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -76.55 -52.91 8.84 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.243 1.522 . . . . 0.0 110.816 -170.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -40.97 69.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.882 1.219 . . . . 0.0 110.561 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -61.7 -52.0 66.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.059 1.344 . . . . 0.0 110.591 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.62 92.21 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 123.39 0.519 . . . . 0.0 112.676 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.53 -49.48 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -57.58 -35.86 70.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.469 0.577 . . . . 0.0 110.935 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.58 -47.63 69.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.924 0.784 . . . . 0.0 110.681 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -67.76 -34.65 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.867 0.758 . . . . 0.0 109.79 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.52 -17.83 60.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.789 1.235 . . . . 0.0 111.648 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -130.88 10.2 5.02 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.541 1.536 . . . . 0.0 112.658 -169.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -15.4 62.93 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -167.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.24 87.94 0.06 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.872 -1.515 . . . . 0.0 109.46 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.94 108.67 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.374 2.716 . . . . 0.0 110.783 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -60.01 156.06 15.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.062 0.545 . . . . 0.0 110.699 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 77.7 p -113.72 168.94 9.35 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.251 1.02 . . . . 0.0 110.164 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.255 -1.303 . . . . 0.0 112.39 171.799 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 p 54.14 34.57 20.4 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.608 -1.524 . . . . 0.0 112.453 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 m -54.2 114.46 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.03 80.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 104.47 -3.452 . . . . 0.0 104.47 -168.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 m -138.57 95.54 3.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.206 1.002 . . . . 0.0 108.371 -154.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 m -133.15 100.11 4.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.985 1.714 . . . . 0.0 110.24 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.47 46.62 0.91 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-O 119.92 -0.378 . . . . 0.0 113.575 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -130.49 157.0 43.84 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 143.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -87.25 177.38 7.18 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -139.83 172.25 13.05 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.899 -1.125 . . . . 0.0 108.557 168.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.1 55.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.6 73.79 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.767 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -97.74 157.69 15.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.753 1.276 . . . . 0.0 108.697 161.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -118.14 134.45 54.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.56 1.944 . . . . 0.0 106.328 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.98 171.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 118.942 0.792 . . . . 0.0 110.414 -167.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.36 142.11 34.78 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.499 -1.376 . . . . 0.0 107.791 162.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.58 161.47 15.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.433 1.493 . . . . 0.0 109.118 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -143.79 107.17 4.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.6 171.5 8.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.69 0.757 . . . . 0.0 109.816 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -53.08 119.13 4.33 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.025 1.73 . . . . 0.0 108.7 173.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.08 -48.36 3.54 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.397 0.999 . . . . 0.0 112.801 172.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -54.45 158.14 4.34 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.908 1.683 . . . . 0.0 112.297 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.36 179.58 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.031 3.154 . . . . 0.0 110.698 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.86 94.12 0.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -85.62 134.91 38.95 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.809 1.243 . . . . 0.0 109.495 -170.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.81 126.18 17.6 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.052 2.501 . . . . 0.0 110.225 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.69 168.11 20.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.764 1.226 . . . . 0.0 109.493 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.23 52.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -80.18 105.15 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 168.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -89.61 -172.39 3.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -126.04 157.33 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.987 0.899 . . . . 0.0 111.258 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 mt -78.7 134.3 61.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 109.336 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.22 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 124.489 3.459 . . . . 0.0 111.262 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' CG ' ' H ' ' A' ' 35' ' ' GLY . 1.1 tt0 -66.78 -138.45 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.858 2.863 . . . . 0.0 112.197 175.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' H ' ' CG ' ' A' ' 34' ' ' GLU . . . -62.8 21.39 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 129.144 3.259 . . . . 0.0 116.48 -171.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -179.83 0.18 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.389 1.876 . . . . 0.0 111.735 166.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.69 164.22 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.903 1.681 . . . . 0.0 109.509 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -112.07 136.78 21.28 Favored Pre-proline 0 C--O 1.242 0.708 0 O-C-N 120.545 -1.347 . . . . 0.0 109.736 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.14 163.61 38.18 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.06 2.507 . . . . 0.0 112.052 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.01 151.36 73.37 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.21 66.17 4.59 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.82 -8.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.582 1.953 . . . . 0.0 111.233 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -136.01 153.58 51.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.387 1.075 . . . . 0.0 110.068 -171.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -106.11 148.18 36.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 125.121 1.368 . . . . 0.0 107.719 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.3 122.16 10.24 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.124 1.883 . . . . 0.0 107.625 155.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.88 111.38 32.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.656 1.582 . . . . 0.0 107.589 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -85.47 129.14 34.88 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.121 0.969 . . . . 0.0 108.656 171.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -93.62 93.84 8.27 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 108.149 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.18 151.01 1.48 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.637 1.175 . . . . 0.0 110.572 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.57 -74.07 2.3 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -68.34 -20.89 64.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m170 46.35 50.56 12.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.511 1.925 . . . . 0.0 111.001 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -97.09 162.06 13.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 161.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.0 p -134.76 130.81 36.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 157.6 43.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.636 0.653 . . . . 0.0 111.189 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -94.98 108.44 20.5 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.8 mt -126.06 146.71 49.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.069 0.548 . . . . 0.0 110.305 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.4 161.9 23.35 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.09 0.852 . . . . 0.0 111.506 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.2 -20.81 42.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.734 2.956 . . . . 0.0 113.857 -164.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -70.54 -14.57 62.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.655 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.64 0.39 44.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.005 1.322 . . . . 0.0 111.047 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -115.62 160.73 19.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.387 1.449 . . . . 0.0 110.482 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.8 145.63 28.61 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.14 130.91 26.88 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -51.25 -58.05 7.21 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.183 0.993 . . . . 0.0 110.853 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.5 -34.26 72.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.964 1.305 . . . . 0.0 111.508 -168.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -56.38 6.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -86.16 6.38 29.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.831 1.253 . . . . 0.0 113.57 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -57.33 -40.83 78.8 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.271 1.828 . . . . 0.0 110.739 -172.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.58 -45.19 39.15 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.899 0.772 . . . . 0.0 111.475 172.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -66.24 -41.25 90.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.58 0.752 . . . . 0.0 111.767 -169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -114.83 -31.01 6.26 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.844 1.658 . . . . 0.0 110.969 -167.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.19 70.68 2.55 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -140.67 139.2 34.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.498 1.119 . . . . 0.0 108.256 -167.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 p -54.54 140.51 34.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.27 1.428 . . . . 0.0 109.993 -176.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.22 154.92 50.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.232 174.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -77.99 66.97 3.74 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 109.739 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 mmt-85 -133.94 112.68 11.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.167 1.787 . . . . 0.0 106.529 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -57.93 150.13 21.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.36 -18.26 0.56 Allowed Glycine 0 CA--C 1.537 1.457 0 CA-C-O 118.477 -1.18 . . . . 0.0 115.031 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -73.47 -55.93 5.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 121.426 2.613 . . . . 0.0 110.527 -174.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -66.06 -27.92 68.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.703 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -65.25 -41.02 94.72 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.775 2.03 . . . . 0.0 110.594 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.37 -35.24 81.74 Favored Glycine 0 CA--C 1.523 0.543 0 O-C-N 121.399 -0.813 . . . . 0.0 111.697 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.65 -32.82 74.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.901 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -59.77 -47.58 85.12 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.92 1.236 . . . . 0.0 110.435 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.39 -57.69 8.59 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.077 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 tt -59.24 -32.5 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 118.688 0.676 . . . . 0.0 111.732 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.98 -52.31 56.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.432 1.093 . . . . 0.0 109.799 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -73.91 -19.27 60.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.816 0.846 . . . . 0.0 112.807 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.0 m -85.35 2.29 44.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.705 2.002 . . . . 0.0 113.044 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.2 -163.02 9.58 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.637 -1.29 . . . . 0.0 110.181 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.63 94.19 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.207 2.605 . . . . 0.0 108.784 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.0 t -65.68 -40.32 92.22 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m 53.25 -151.9 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.886 0.874 . . . . 0.0 110.558 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.374 0 N-CA-C 106.456 -2.658 . . . . 0.0 106.456 -170.45 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.15 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 p -132.72 137.54 46.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.775 1.23 . . . . 0.0 109.364 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -135.45 -37.57 0.76 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.114 1.365 . . . . 0.0 109.534 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.78 -179.37 51.28 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 124.683 1.135 . . . . 0.0 110.953 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.64 107.48 2.38 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -68.59 113.13 5.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.55 97.55 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.52 159.26 0.07 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.472 2.709 . . . . 0.0 111.283 -167.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -117.5 148.43 41.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.945 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -135.43 157.89 45.76 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.962 1.705 . . . . 0.0 110.099 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.75 134.42 56.73 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.711 0.632 . . . . 0.0 109.981 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.98 47.33 5.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.54 174.59 10.45 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.021 0.529 . . . . 0.0 110.275 161.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.1 mt -125.08 140.31 53.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.805 2.042 . . . . 0.0 106.262 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.91 172.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -105.7 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 152.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.42 154.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.181 1.392 . . . . 0.0 108.216 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -128.92 106.32 8.82 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mtm -86.21 167.59 14.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 167.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.26 125.43 20.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.719 1.207 . . . . 0.0 108.532 177.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.77 -33.58 1.22 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.371 1.462 . . . . 0.0 115.132 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.13 158.69 62.22 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 118.887 1.344 . . . . 0.0 112.072 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 178.21 6.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.55 3.5 . . . . 0.0 110.247 168.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.7 96.31 0.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.565 0.746 . . . . 0.0 109.093 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -78.81 135.22 59.67 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.109 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.04 122.5 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.537 2.158 . . . . 0.0 108.914 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.15 165.91 25.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 109.908 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -129.86 164.11 24.85 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.101 -1.0 . . . . 0.0 110.621 -178.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.17 96.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -86.4 -169.12 2.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.69 2.396 . . . . 0.0 110.834 -166.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.16 170.26 14.79 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.23 -1.544 . . . . 0.0 112.281 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.4 mt -148.27 135.95 10.89 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.461 1.904 . . . . 0.0 106.31 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.93 127.99 7.26 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.64 2.227 . . . . 0.0 110.2 164.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.4 125.81 24.88 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.256 0.622 . . . . 0.0 109.696 171.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.56 -38.78 2.45 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.341 1.448 . . . . 0.0 110.012 -172.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -167.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.65 1.18 . . . . 0.0 110.667 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -48.24 143.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.601 1.16 . . . . 0.0 110.802 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -129.01 115.16 18.85 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.814 1.246 . . . . 0.0 109.989 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.79 163.6 37.96 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.76 2.306 . . . . 0.0 111.704 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.22 153.58 74.24 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 121.278 1.318 . . . . 0.0 110.137 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.84 52.19 1.44 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 124.192 0.932 . . . . 0.0 110.949 -172.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.47 7.52 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.748 2.419 . . . . 0.0 110.429 174.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -132.36 145.3 51.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.768 1.227 . . . . 0.0 108.972 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -107.75 148.6 37.64 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 124.002 0.921 . . . . 0.0 108.629 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.83 105.2 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.446 2.764 . . . . 0.0 109.19 162.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.64 156.77 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -133.13 124.96 28.48 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.338 1.855 . . . . 0.0 107.299 166.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -89.62 94.65 9.94 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 16.5 m-85 -46.68 148.13 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.493 1.117 . . . . 0.0 111.069 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.99 -35.87 1.06 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.093 0.854 . . . . 0.0 113.869 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.8 p -87.07 -26.81 23.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.586 1.693 . . . . 0.0 110.864 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.8 m80 62.01 24.46 14.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.496 2.318 . . . . 0.0 112.194 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -97.03 149.87 21.44 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.544 1.138 . . . . 0.0 108.994 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -123.74 147.42 47.51 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 -172.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.96 165.27 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.681 1.193 . . . . 0.0 109.122 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.95 106.94 17.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.19 156.58 19.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 161.25 22.54 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 166.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -63.32 -16.71 56.21 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.085 3.19 . . . . 0.0 115.076 -166.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -69.3 -17.79 63.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.446 1.476 . . . . 0.0 111.606 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -89.23 1.84 55.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.619 1.168 . . . . 0.0 110.905 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.7 mt -117.58 167.77 11.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.751 1.62 . . . . 0.0 111.463 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -143.69 152.31 55.77 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.025 1.73 . . . . 0.0 109.169 162.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.58 118.27 5.4 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 0.0 111.034 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -44.33 -62.27 1.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 125.075 1.35 . . . . 0.0 112.324 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -42.52 62.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.473 1.033 . . . . 0.0 112.055 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.41 -33.09 74.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.908 0.883 . . . . 0.0 111.426 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.31 8.82 18.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.198 -1.564 . . . . 0.0 112.787 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -56.77 -42.57 79.62 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.347 1.859 . . . . 0.0 111.144 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -74.54 -37.17 63.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.877 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -82.26 -49.37 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.895 1.278 . . . . 0.0 111.48 -162.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -94.75 -33.34 12.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.752 2.021 . . . . 0.0 110.363 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.29 61.76 3.47 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.278 1.418 . . . . 0.0 111.366 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 11.1 mmpt? -131.24 136.95 48.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.566 1.947 . . . . 0.0 107.799 -172.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.6 m -40.34 110.31 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.435 2.294 . . . . 0.0 110.824 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.65 176.6 7.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.046 0.45 . . . . 0.0 109.829 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -83.83 -38.8 20.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.537 -1.221 . . . . 0.0 110.047 164.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 125.81 16.63 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.669 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.23 163.65 8.01 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 0.0 109.675 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.08 -42.32 1.86 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -56.91 -44.74 82.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.455 1.102 . . . . 0.0 111.861 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.52 -36.81 71.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.24 0.927 . . . . 0.0 110.445 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -63.11 -31.71 72.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.608 0.763 . . . . 0.0 110.39 172.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.19 -32.69 42.73 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.566 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.6 -41.81 99.2 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.387 1.094 . . . . 0.0 110.137 172.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -54.87 -43.77 73.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.191 0.45 . . . . 0.0 111.101 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.62 -53.06 57.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.849 0.295 . . . . 0.0 111.357 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.4 tt -67.45 -33.97 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.785 0.266 . . . . 0.0 110.589 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -62.87 -38.06 89.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.7 0.8 . . . . 0.0 110.06 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -76.03 -74.28 0.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.538 -0.726 . . . . 0.0 110.473 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.9 p 48.36 73.2 0.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.203 2.201 . . . . 0.0 112.135 -167.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.07 100.87 0.17 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.905 -0.941 . . . . 0.0 111.54 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.38 156.0 28.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.213 1.942 . . . . 0.0 108.454 164.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 46.2 55.34 7.36 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.45 1.1 . . . . 0.0 112.011 -174.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 103.76 135.72 0.01 OUTLIER 'General case' 0 C--O 1.236 0.375 0 C-N-CA 131.545 3.938 . . . . 0.0 108.311 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.14 0 N-CA-C 103.92 -3.672 . . . . 0.0 103.92 -146.657 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -132.59 153.95 50.52 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.707 1.203 . . . . 0.0 109.799 -169.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.14 52.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.5 -12.0 68.24 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.748 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.28 166.58 21.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.609 1.705 . . . . 0.0 109.589 166.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.44 148.81 47.4 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 29' ' ' ILE . 28.9 m -148.66 170.46 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 C-N-CA 123.363 0.665 . . . . 0.0 111.083 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.69 138.23 40.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.64 120.73 39.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 108.158 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 18.2 tptp -104.99 106.53 17.07 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -87.91 158.05 18.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -64.5 93.46 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 111.404 -172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -18.78 42.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.631 1.11 . . . . 0.0 112.593 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -72.63 162.11 75.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.646 1.223 . . . . 0.0 108.753 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -61.78 178.73 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.645 2.23 . . . . 0.0 112.284 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.426 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 55.6 m80 -64.96 92.33 0.1 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 158.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -76.37 141.06 69.44 Favored Pre-proline 0 C--O 1.234 0.266 0 C-N-CA 123.979 0.911 . . . . 0.0 109.414 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.96 121.06 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.617 2.211 . . . . 0.0 109.187 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 163.47 32.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.5 0.667 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 13.2 ptt180 -119.93 152.33 37.58 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.42 HD11 HG11 ' A' ' 15' ' ' VAL . 11.2 mm -78.46 121.87 32.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 163.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -102.5 -174.39 2.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 168.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.26 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -83.16 166.99 18.17 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.501 1.046 . . . . 0.0 111.352 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -130.26 149.4 73.21 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.426 1.09 . . . . 0.0 109.225 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 92.26 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.723 2.949 . . . . 0.0 108.976 163.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.47 122.93 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -102.12 117.43 34.76 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.151 1.38 . . . . 0.0 107.476 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -84.1 105.17 14.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.69 1.596 . . . . 0.0 107.658 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 11.5 m-85 -60.69 156.77 16.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.107 0.479 . . . . 0.0 110.731 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.16 -23.42 0.91 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.448 1.975 . . . . 0.0 115.616 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -113.55 -18.46 11.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.931 1.366 . . . . 0.0 110.604 170.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.6 m170 61.85 18.43 9.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.06 2.544 . . . . 0.0 111.578 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.19 160.2 32.32 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.753 0.821 . . . . 0.0 110.005 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.3 p -125.71 131.01 52.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.734 1.214 . . . . 0.0 108.157 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.78 170.22 16.29 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.653 166.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.16 118.06 35.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.49 154.23 40.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.45 167.05 19.94 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -61.56 -32.76 87.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.982 2.455 . . . . 0.0 112.86 -163.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -63.25 -28.8 70.28 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.763 0.825 . . . . 0.0 112.799 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.78 -1.16 50.88 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 111.716 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -126.85 160.75 30.03 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.957 1.703 . . . . 0.0 109.34 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -140.39 136.38 16.72 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.31 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.62 128.69 21.73 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.785 2.323 . . . . 0.0 110.128 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -51.15 -59.48 4.15 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.355 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -61.31 -23.54 65.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.629 1.559 . . . . 0.0 113.26 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -29.71 41.55 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.189 1.358 . . . . 0.0 111.507 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -114.55 6.19 15.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.742 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -57.08 -44.49 83.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.073 1.749 . . . . 0.0 109.854 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -89.87 -27.99 19.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -68.54 -44.05 75.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.741 1.616 . . . . 0.0 112.55 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -114.19 -27.25 7.71 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.938 2.095 . . . . 0.0 111.017 -172.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 63.5 3.86 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.814 1.197 . . . . 0.0 110.894 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -142.67 157.65 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.614 1.165 . . . . 0.0 109.158 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m -73.38 71.41 1.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.218 1.807 . . . . 0.0 115.34 -151.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.99 -11.12 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.563 1.545 . . . . 0.0 113.031 -170.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.6 tttt 53.69 29.14 8.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.078 2.151 . . . . 0.0 115.865 165.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -71.73 11.28 0.53 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 61.98 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.333 2.253 . . . . 0.0 109.393 -152.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.64 -40.91 0.65 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.441 -1.412 . . . . 0.0 112.632 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -30.43 68.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.917 1.687 . . . . 0.0 114.277 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -33.16 32.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 120.967 -1.083 . . . . 0.0 110.483 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.2 -58.22 9.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.79 1.636 . . . . 0.0 106.866 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.69 -33.69 87.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 118.998 0.817 . . . . 0.0 113.288 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.7 -29.61 69.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.689 1.245 . . . . 0.0 111.842 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -75.48 -43.38 49.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.929 0.786 . . . . 0.0 109.28 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.75 -38.21 90.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.028 1.331 . . . . 0.0 110.143 -171.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 tt -73.46 -45.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.341 1.057 . . . . 0.0 111.281 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.45 -55.91 26.27 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 . . . . . 0 CA--C 1.532 0.271 0 C-N-CA 125.112 1.365 . . . . 0.0 112.773 -177.547 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 . . . . . 0 C--O 1.234 0.271 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -142.58 161.81 37.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.518 1.527 . . . . 0.0 107.774 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 133.66 56.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.85 -12.73 68.84 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.614 -1.103 . . . . 0.0 112.915 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 128.07 34.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.349 1.575 . . . . 0.0 107.576 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -85.65 147.7 26.25 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.85 168.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.655 0.74 . . . . 0.0 111.781 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.52 125.5 50.11 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 160.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.402 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -92.82 154.17 18.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -130.19 105.89 8.23 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mtm -73.14 168.96 18.04 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 110.042 171.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.75 55.01 2.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 110.768 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.5 -28.22 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.946 0.784 . . . . 0.0 112.494 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -70.5 160.43 81.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.882 -0.775 . . . . 0.0 110.258 167.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.11 177.84 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.965 3.11 . . . . 0.0 111.749 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -62.65 112.57 2.56 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -114.56 143.56 30.15 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 124.91 1.284 . . . . 0.0 108.037 -166.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.77 123.85 11.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 110.973 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.48 159.38 42.52 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.274 0.559 . . . . 0.0 110.153 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 138.84 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -75.53 92.49 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 163.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -78.21 -164.08 0.5 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.239 0.529 0 O-C-N 120.77 -1.206 . . . . 0.0 108.318 165.123 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m120 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -125.58 160.98 28.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.715 1.143 . . . . 0.0 111.985 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -123.31 152.81 64.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.03 1.732 . . . . 0.0 109.015 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.59 93.39 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 124.506 3.47 . . . . 0.0 111.358 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mm -86.03 108.4 17.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.031 0.933 . . . . 0.0 108.577 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -94.5 119.16 32.78 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 111.64 18.55 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 107.85 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -61.04 157.18 16.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.745 0.783 . . . . 0.0 110.377 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.92 -70.68 1.75 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.745 1.164 . . . . 0.0 111.894 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 p -69.02 -22.29 64.07 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.948 -1.325 . . . . 0.0 112.275 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 66.45 10.17 7.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.1 2.16 . . . . 0.0 113.679 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.14 159.17 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.914 -1.116 . . . . 0.0 110.262 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.25 130.38 40.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.24 -176.15 5.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.82 1.248 . . . . 0.0 109.952 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.95 125.99 40.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 171.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.2 mt -128.85 155.93 44.45 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 108.247 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.87 171.83 22.12 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.744 1.164 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.85 -26.36 32.18 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.483 2.122 . . . . 0.0 113.07 -160.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.86 -14.16 61.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.061 0.846 . . . . 0.0 112.494 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -94.38 -4.59 48.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.761 0.709 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 17' ' ' ALA . 90.1 mt -127.84 153.66 46.36 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.277 1.831 . . . . 0.0 109.927 -163.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -136.29 147.1 58.9 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 109.72 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -63.1 140.41 78.22 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.595 2.197 . . . . 0.0 109.456 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -59.1 -65.69 0.63 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -24.96 67.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -162.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -68.44 -58.77 3.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.552 0.741 . . . . 0.0 109.937 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.48 16.46 7.61 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.968 1.707 . . . . 0.0 111.055 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -60.42 -40.17 90.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.698 1.199 . . . . 0.0 109.518 -164.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.421 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 t70 -80.19 -53.39 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.579 170.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -51.06 -39.94 57.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.676 1.59 . . . . 0.0 113.84 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -110.23 -24.33 10.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.164 1.385 . . . . 0.0 110.643 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.16 71.07 2.89 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 70' ' ' ASP . 9.3 mmpt? -121.66 145.03 48.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 107.659 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -58.04 99.03 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.867 1.667 . . . . 0.0 109.053 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -77.75 173.27 12.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.506 0.669 . . . . 0.0 110.058 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -73.44 -39.34 65.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.694 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.57 141.18 56.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.452 0.569 . . . . 0.0 110.606 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -64.5 163.22 13.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.782 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -47.29 0.83 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.946 1.736 . . . . 0.0 112.167 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -49.58 -49.01 48.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.16 1.384 . . . . 0.0 111.404 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.69 -29.15 69.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.52 -46.93 71.39 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -28.7 73.79 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.24 -0.755 . . . . 0.0 112.895 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.97 -49.8 59.57 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.604 1.202 . . . . 0.0 110.593 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -59.68 -39.01 83.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.891 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.03 -63.11 1.32 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.671 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.85 -32.58 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 119.747 1.158 . . . . 0.0 112.247 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.15 -53.73 40.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.503 0.321 . . . . 0.0 110.141 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 . . . . . 0 C--N 1.332 -0.153 0 O-C-N 121.869 -0.519 . . . . 0.0 111.204 -174.595 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -143.36 167.96 20.93 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.673 1.589 . . . . 0.0 108.269 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.6 26.61 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.61 32.96 4.61 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.785 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.48 168.85 16.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.202 1.001 . . . . 0.0 108.636 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.1 mt -123.08 147.89 46.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.839 1.656 . . . . 0.0 106.665 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.09 171.52 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.333 0.653 . . . . 0.0 110.26 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.36 149.54 27.73 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.17 144.46 50.43 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.944 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE2' ' NE2' ' A' ' 24' ' ' HIS . 5.0 tptp -128.53 105.83 8.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.023 0.829 . . . . 0.0 110.369 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.9 mtp -90.18 170.8 9.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.56 1.144 . . . . 0.0 109.527 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -60.01 138.89 57.75 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.644 -0.66 . . . . 0.0 109.375 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 -36.25 0.74 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.704 1.145 . . . . 0.0 114.738 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.44 160.72 81.73 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.75 2.02 . . . . 0.0 112.277 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.34 -177.6 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.89 1 C-N-CA 125.574 4.182 . . . . 0.0 110.454 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.415 ' NE2' ' HE2' ' A' ' 18' ' ' LYS . 16.4 m80 -71.79 90.39 1.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -77.74 141.74 64.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.821 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.0 127.56 17.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.411 2.074 . . . . 0.0 110.564 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.17 166.03 26.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.114 0.566 . . . . 0.0 110.596 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -128.02 162.91 25.73 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 120.929 -1.107 . . . . 0.0 111.584 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -94.87 101.93 13.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.7 -177.09 6.5 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.161 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 N--CA 1.451 -0.389 0 C-N-CA 125.186 1.394 . . . . 0.0 108.141 -178.603 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.4 p30 . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.621 0.724 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -141.56 171.74 13.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.786 2.835 . . . . 0.0 107.999 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -131.74 152.34 80.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.182 1.393 . . . . 0.0 108.894 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.13 91.32 1.21 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.863 3.708 . . . . 0.0 110.684 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.9 mm -89.18 110.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -169.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -88.87 132.18 34.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 108.304 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -103.08 94.56 5.61 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.103 1.361 . . . . 0.0 108.552 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -47.53 147.81 1.63 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.82 1.648 . . . . 0.0 112.365 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 -39.16 0.75 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.977 1.751 . . . . 0.0 114.241 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -22.65 24.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.467 1.507 . . . . 0.0 112.429 173.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.4 m80 58.72 11.91 2.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.676 2.39 . . . . 0.0 114.749 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -74.13 169.62 17.18 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.629 0.649 . . . . 0.0 110.225 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -127.97 166.14 18.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.39 166.1 34.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.148 1.379 . . . . 0.0 108.165 163.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -105.96 114.32 28.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 166.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.07 150.51 52.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.508 0.723 . . . . 0.0 109.307 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.33 25.62 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.14 -10.62 29.23 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.933 3.089 . . . . 0.0 113.314 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -76.75 -5.66 49.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.869 1.268 . . . . 0.0 113.744 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -122.17 12.05 10.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.0 110.723 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 mt -135.2 162.26 33.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.514 1.526 . . . . 0.0 110.574 -170.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.36 148.17 52.77 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.981 1.313 . . . . 0.0 111.703 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.77 142.83 95.14 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -67.49 -56.07 11.03 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.436 -0.79 . . . . 0.0 109.961 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.61 -9.3 53.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.86 -77.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 155.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -72.48 10.39 0.83 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.766 2.826 . . . . 0.0 114.523 -164.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -59.99 -35.23 74.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.073 1.349 . . . . 0.0 109.009 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.55 -45.45 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.115 1.325 . . . . 0.0 111.551 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -60.52 -55.01 38.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.406 0.682 . . . . 0.0 111.065 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -97.77 -16.23 19.96 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.795 1.238 . . . . 0.0 111.965 -171.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.3 37.75 1.58 Allowed Glycine 0 CA--C 1.541 1.658 0 O-C-N 120.985 -1.072 . . . . 0.0 114.564 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -115.15 135.51 54.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.837 1.318 . . . . 0.0 109.302 -164.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.8 p -57.52 107.45 0.44 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.567 1.147 . . . . 0.0 109.594 -171.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -94.21 163.88 13.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.307 -173.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -92.88 -7.66 45.58 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -66.06 136.84 56.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 158.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -66.73 168.45 9.49 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.471 0.708 . . . . 0.0 109.181 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.96 -32.0 1.07 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.983 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -55.33 -42.04 73.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.925 1.29 . . . . 0.0 110.571 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -65.43 -45.94 81.87 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.213 0.605 . . . . 0.0 111.348 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.96 -49.05 74.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.5 -38.37 96.22 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.329 -0.706 . . . . 0.0 112.777 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.46 -30.13 71.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.413 1.106 . . . . 0.0 111.832 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -73.7 -48.18 33.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.926 0.784 . . . . 0.0 109.017 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.76 -49.26 73.59 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.104 0.962 . . . . 0.0 111.19 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 tt -67.42 -37.52 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.585 0.354 . . . . 0.0 111.07 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.34 -41.05 96.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.609 -0.682 . . . . 0.0 109.96 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 125.653 1.581 . . . . 0.0 110.678 -179.866 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -141.74 161.21 38.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.633 1.173 . . . . 0.0 109.315 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 141.2 46.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 110.956 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.37 54.65 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.221 -1.321 . . . . 0.0 113.036 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 169.0 18.93 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 119.61 1.705 . . . . 0.0 110.69 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 88' ' ' ILE . 93.6 mt -123.09 142.85 50.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.943 1.297 . . . . 0.0 108.082 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 175.78 2.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 123.377 0.671 . . . . 0.0 110.701 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.39 131.6 54.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 156.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.97 164.4 13.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.868 2.867 . . . . 0.0 108.324 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -149.48 106.04 3.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.4 mtm -90.15 -179.76 5.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.324 1.049 . . . . 0.0 109.751 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.89 61.41 6.81 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.12 -0.988 . . . . 0.0 112.859 -164.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.54 -27.55 2.6 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 124.451 1.024 . . . . 0.0 110.614 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -60.62 150.86 73.59 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 122.264 -0.55 . . . . 0.0 109.525 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.47 174.03 5.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.388 3.392 . . . . 0.0 110.724 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.25 96.93 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -88.75 131.67 40.91 Favored Pre-proline 0 N--CA 1.456 -0.128 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.43 136.0 38.36 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.261 1.307 . . . . 0.0 109.1 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.27 163.88 34.1 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.973 0.909 . . . . 0.0 109.554 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.61 146.18 50.93 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.462 -0.774 . . . . 0.0 110.26 -178.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mm -80.9 103.14 7.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -78.79 -175.53 4.49 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.326 -0.427 0 C-N-CA 124.573 1.149 . . . . 0.0 108.504 -170.237 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -140.99 163.67 32.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.418 1.087 . . . . 0.0 109.295 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.88 153.55 67.29 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 124.872 1.269 . . . . 0.0 109.239 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -67.26 95.31 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.734 2.956 . . . . 0.0 110.066 167.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.41 113.21 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -85.16 150.8 24.57 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.46 93.26 3.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.8 m-85 -47.58 150.25 1.03 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.826 2.051 . . . . 0.0 111.257 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.18 -49.88 3.62 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.28 1.419 . . . . 0.0 111.774 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -91.61 -16.08 27.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 113.603 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.7 m170 53.11 16.53 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.261 2.624 . . . . 0.0 114.77 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -71.97 164.39 26.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.898 -1.126 . . . . 0.0 110.194 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -139.72 137.89 35.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.032 1.333 . . . . 0.0 108.091 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.68 163.87 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.391 0.615 . . . . 0.0 109.42 169.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -101.99 109.69 21.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -127.83 151.35 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.014 0.926 . . . . 0.0 108.554 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.72 173.74 29.82 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.702 1.144 . . . . 0.0 110.479 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.74 -21.67 58.14 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.259 2.64 . . . . 0.0 112.366 -165.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -64.59 -18.48 64.93 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.293 -0.879 . . . . 0.0 113.055 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -109.07 10.96 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.915 1.286 . . . . 0.0 110.345 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.84 162.24 30.03 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.458 1.903 . . . . 0.0 109.364 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -148.17 143.11 17.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.422 1.089 . . . . 0.0 109.545 176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -63.27 126.38 17.68 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.592 2.861 . . . . 0.0 112.196 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.46 -51.89 67.62 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 121.337 -0.852 . . . . 0.0 111.252 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -59.79 -24.03 63.78 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.39 -72.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -82.25 9.9 7.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.298 1.439 . . . . 0.0 113.461 -164.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -54.89 -34.69 63.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.655 1.582 . . . . 0.0 110.91 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.28 -59.36 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.741 1.216 . . . . 0.0 110.179 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -55.92 -43.13 77.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.501 1.52 . . . . 0.0 113.335 -167.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.85 -26.79 9.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.63 1.972 . . . . 0.0 111.592 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.48 84.04 1.6 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -147.12 166.36 27.16 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 123.503 0.721 . . . . 0.0 110.108 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.8 m -73.57 124.94 26.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -117.13 146.48 43.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.297 1.439 . . . . 0.0 109.63 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -67.98 -14.66 63.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 127.46 32.69 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 120.671 1.578 . . . . 0.0 108.39 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -61.2 162.51 7.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -36.82 1.83 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 112.126 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.007 1.403 . . . . 0.0 110.804 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -67.05 -42.75 84.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 111.694 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.05 -42.38 76.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.06 21.87 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.1 -20.93 57.97 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.352 1.076 . . . . 0.0 113.548 -174.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -68.67 -42.04 78.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.499 1.045 . . . . 0.0 111.442 170.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -55.24 14.44 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 110.535 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 HD22 ' A' ' 14' ' ' LEU . 16.9 tt -55.33 -27.32 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.052 0.842 . . . . 0.0 112.802 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -78.18 -51.91 9.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.315 1.446 . . . . 0.0 111.044 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 . . . . . 0 C--O 1.234 0.246 0 C-N-CA 123.111 0.565 . . . . 0.0 112.239 -177.913 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--O 1.232 0.158 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -142.46 173.16 11.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.994 1.717 . . . . 0.0 109.383 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.64 15.12 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.621 0.768 . . . . 0.0 111.433 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 -22.24 30.37 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 124.561 1.077 . . . . 0.0 112.533 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.35 167.91 20.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 122.572 1.177 . . . . 0.0 111.572 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.32 150.78 38.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.424 1.89 . . . . 0.0 107.731 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 29' ' ' ILE . 23.1 m -152.23 177.33 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.797 1.239 . . . . 0.0 110.105 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.86 127.03 53.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 159.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.77 137.58 32.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.0 108.758 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 15.0 tptp -108.11 105.11 14.71 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.7 mtm -76.9 166.66 23.04 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.14 58.33 3.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.485 0.714 . . . . 0.0 112.098 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -46.54 0.44 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.468 1.509 . . . . 0.0 110.907 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -60.19 159.4 22.13 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.696 1.199 . . . . 0.0 110.286 170.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.97 -176.34 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.498 2.799 . . . . 0.0 110.883 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.415 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 26.3 m80 -55.19 107.16 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 107.36 163.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -106.15 128.39 26.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 124.92 1.288 . . . . 0.0 108.115 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HG3' HD22 ' A' ' 85' ' ' LEU . 37.2 Cg_endo -62.54 129.76 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.14 1.893 . . . . 0.0 109.422 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.98 167.51 22.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 3.6 ptm180 -123.55 153.43 40.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.408 HD11 HG11 ' A' ' 15' ' ' VAL . 17.8 mm -84.47 105.4 13.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 169.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.87 -172.88 2.85 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 N--CA 1.445 -0.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.986 164.636 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -129.92 168.42 16.67 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.657 1.117 . . . . 0.0 111.657 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -131.17 153.46 81.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.473 2.309 . . . . 0.0 109.898 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -68.98 104.53 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 124.352 3.368 . . . . 0.0 110.045 169.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -97.19 140.28 17.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -123.89 113.29 18.3 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.086 1.755 . . . . 0.0 106.65 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -85.88 101.22 12.66 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.447 1.099 . . . . 0.0 108.482 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 5.8 m-85 -53.37 152.7 4.49 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.757 1.623 . . . . 0.0 112.192 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.26 -60.25 2.74 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.83 1.205 . . . . 0.0 110.38 -167.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -21.32 59.62 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.0 m170 55.27 11.56 0.58 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.994 1.717 . . . . 0.0 114.092 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.48 161.56 30.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.195 0.997 . . . . 0.0 110.044 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 p -141.56 138.42 32.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.911 2.084 . . . . 0.0 107.255 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.51 154.37 28.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.45 122.75 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.42 156.54 36.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.83 161.76 21.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.99 1.281 . . . . 0.0 111.391 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.65 -34.85 72.89 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.681 2.921 . . . . 0.0 112.119 -166.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mppt? -75.74 -7.41 54.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.11 -20.79 16.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.309 0.958 . . . . 0.0 110.557 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.11 170.23 14.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.523 1.529 . . . . 0.0 109.189 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -139.17 149.4 60.9 Favored Pre-proline 0 C--O 1.236 0.395 0 C-N-CA 123.909 0.884 . . . . 0.0 109.358 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.31 152.57 75.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.813 2.342 . . . . 0.0 112.273 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -71.5 -59.72 2.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.969 -0.457 . . . . 0.0 111.336 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.62 -25.82 68.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.393 0.542 . . . . 0.0 111.853 -163.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.71 -39.83 69.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.635 1.174 . . . . 0.0 110.879 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.41 9.63 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 0.0 112.673 -166.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -54.94 -30.65 59.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.89 1.276 . . . . 0.0 111.248 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -98.79 -34.74 10.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.773 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -68.68 -65.97 0.63 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.478 1.035 . . . . 0.0 109.57 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -84.91 -29.56 25.09 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.872 1.269 . . . . 0.0 111.694 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.19 62.53 3.36 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.11 173.48 11.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.903 -1.351 . . . . 0.0 110.558 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -66.53 153.15 43.71 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.415 1.102 . . . . 0.0 109.483 168.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -135.27 -96.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 159.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 -20.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 146.46 54.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 120.9 1.682 . . . . 0.0 110.759 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -60.17 156.05 16.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.242 1.417 . . . . 0.0 108.039 158.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 -43.82 1.19 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 125.663 1.602 . . . . 0.0 113.406 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -48.04 -54.01 14.44 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 125.626 1.571 . . . . 0.0 109.792 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -57.97 -34.47 69.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.37 0.668 . . . . 0.0 111.729 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.98 -49.29 53.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.356 1.062 . . . . 0.0 110.653 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.64 84.98 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.683 0.674 . . . . 0.0 112.576 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.569 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -69.52 -35.97 76.0 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.407 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -66.12 -39.07 89.63 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.214 0.915 . . . . 0.0 110.19 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.12 -47.96 75.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.848 0.859 . . . . 0.0 110.525 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.9 tt -67.28 -26.81 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 118.887 0.767 . . . . 0.0 111.729 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.48 -15.5 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 0.0 111.959 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 N--CA 1.456 -0.159 0 C-N-CA 124.862 1.265 . . . . 0.0 108.067 -179.645 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.556 0.217 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -149.44 156.68 42.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.133 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 103.25 0.14 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.931 1.693 . . . . 0.0 110.143 -173.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.06 -24.41 2.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.136 1.827 . . . . 0.0 111.637 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.57 162.28 27.22 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.634 1.217 . . . . 0.0 112.334 -173.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.67 134.87 54.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 106.206 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -147.92 176.54 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.983 0.913 . . . . 0.0 111.445 -166.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.4 150.96 30.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 156.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.47 168.18 14.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.067 2.147 . . . . 0.0 109.01 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -141.36 107.11 5.11 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.9 mtp -83.81 160.6 21.17 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 165.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.16 112.21 1.3 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.207 1.003 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.56 -11.59 55.39 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.882 1.229 . . . . 0.0 114.652 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -74.86 158.03 85.04 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 118.347 1.073 . . . . 0.0 109.188 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.79 169.75 16.93 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.581 2.187 . . . . 0.0 108.793 163.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -59.57 103.31 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -87.22 143.5 34.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 108.035 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HG3' HD22 ' A' ' 85' ' ' LEU . 62.2 Cg_endo -72.69 136.82 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.967 1.778 . . . . 0.0 110.484 173.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.99 168.3 21.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.333 0.653 . . . . 0.0 109.39 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -132.84 156.64 46.8 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.573 -0.705 . . . . 0.0 109.517 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -89.28 136.22 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.37 169.74 15.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--O 1.237 0.44 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 168.498 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -144.14 171.46 14.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.155 1.382 . . . . 0.0 109.388 -167.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -131.37 152.53 80.69 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.355 1.862 . . . . 0.0 107.519 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.1 90.99 1.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.728 2.952 . . . . 0.0 109.131 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.8 mm -83.93 114.54 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -85.13 142.34 29.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.55 118.39 36.47 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -65.05 152.69 42.82 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.028 0.918 . . . . 0.0 110.213 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.31 -68.24 2.4 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 125.002 1.286 . . . . 0.0 110.663 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.5 p -68.11 -25.02 65.1 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.839 -0.8 . . . . 0.0 111.5 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 m170 58.12 14.59 2.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.665 1.986 . . . . 0.0 112.977 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.88 168.57 13.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.995 0.902 . . . . 0.0 110.138 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.13 151.43 48.66 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.313 1.445 . . . . 0.0 108.564 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.92 148.48 27.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.988 0.915 . . . . 0.0 108.536 163.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.41 111.77 21.46 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -124.89 151.41 45.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.001 1.32 . . . . 0.0 108.238 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.58 168.2 31.7 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.347 0.975 . . . . 0.0 110.732 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.49 -40.16 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.628 2.218 . . . . 0.0 110.46 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -8.87 16.55 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.5 -17.13 24.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.272 1.396 . . . . 0.0 111.383 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.69 170.2 8.02 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 127.833 2.453 . . . . 0.0 110.647 -168.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -144.71 142.85 19.56 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.002 0.921 . . . . 0.0 109.845 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 129.51 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.573 2.182 . . . . 0.0 110.718 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -53.15 -54.91 28.92 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 121.582 -0.699 . . . . 0.0 111.272 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -66.64 -13.6 61.39 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.14 -26.0 19.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.99 1.316 . . . . 0.0 111.711 175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.42 12.3 13.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.725 1.61 . . . . 0.0 113.112 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.01 -20.37 16.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 128.456 2.702 . . . . 0.0 113.136 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -117.6 -34.68 4.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 119.322 0.965 . . . . 0.0 110.227 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -61.57 -37.91 85.58 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.631 -0.668 . . . . 0.0 111.072 -177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.72 -35.73 4.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 109.514 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.33 85.84 0.33 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -151.1 -173.93 4.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.885 2.074 . . . . 0.0 107.006 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.08 146.2 28.83 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 122.543 1.163 . . . . 0.0 108.421 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -147.38 134.92 20.89 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.785 1.634 . . . . 0.0 107.088 170.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.26 20.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -59.35 155.57 14.4 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.682 2.037 . . . . 0.0 108.784 162.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.76 161.47 30.83 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 160.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -31.05 0.55 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.422 1.963 . . . . 0.0 115.629 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.408 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 74.3 t80 -56.58 -60.78 3.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.437 1.895 . . . . 0.0 110.587 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -60.69 -32.87 72.08 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.524 -0.735 . . . . 0.0 112.163 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -56.07 26.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.435 1.494 . . . . 0.0 110.016 169.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.3 77.02 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.672 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.565 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.5 mm? -68.24 -45.1 74.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 118.328 1.064 . . . . 0.0 111.637 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -56.98 -42.02 79.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.044 0.838 . . . . 0.0 108.803 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.22 -48.33 80.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.45 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.72 -35.9 71.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 119.375 0.989 . . . . 0.0 110.757 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.04 -49.6 77.01 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 113.216 178.238 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.616 0.722 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -132.66 177.66 7.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.13 140.78 24.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.679 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.27 -31.96 6.91 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.329 -1.262 . . . . 0.0 111.862 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.81 100.27 4.0 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 119.275 1.537 . . . . 0.0 108.002 -173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.04 149.92 49.5 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.54 169.42 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -105.7 142.91 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 157.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.65 110.28 13.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 109.792 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -91.55 106.29 18.38 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.052 1.741 . . . . 0.0 107.69 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.83 19.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 174.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 128.65 36.7 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.04 15.59 63.03 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.298 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -128.51 162.05 53.34 Favored Pre-proline 0 C--O 1.232 0.149 0 CA-C-N 118.897 1.349 . . . . 0.0 109.044 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.25 -179.7 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.519 3.479 . . . . 0.0 110.831 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -72.7 88.37 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -71.98 136.72 82.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.291 -169.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.35 124.56 13.08 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.059 1.839 . . . . 0.0 108.789 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.86 168.1 20.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.024 0.916 . . . . 0.0 110.634 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm85 -128.8 148.48 50.88 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 mm -86.08 121.07 36.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 170.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.89 179.11 7.63 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.206 0.527 . . . . 0.0 112.202 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 126.094 1.757 . . . . 0.0 107.891 -178.909 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -102.72 173.64 6.24 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.401 1.08 . . . . 0.0 109.216 160.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -132.32 152.58 80.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.362 1.065 . . . . 0.0 108.799 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 106.95 1.96 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.907 3.071 . . . . 0.0 110.317 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -98.12 115.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.741 1.216 . . . . 0.0 107.943 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -97.37 119.05 35.19 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -78.65 117.35 19.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -66.78 156.03 36.59 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.218 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 -46.48 1.74 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.35 1.453 . . . . 0.0 113.584 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 -29.48 22.26 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.98 1.39 . . . . 0.0 111.501 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.4 m80 69.82 14.23 8.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.036 2.134 . . . . 0.0 112.565 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.16 159.24 35.04 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.532 -0.73 . . . . 0.0 110.047 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.1 p -129.76 128.8 43.16 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.779 1.232 . . . . 0.0 108.441 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.94 172.49 14.12 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.908 0.883 . . . . 0.0 110.083 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -119.65 112.12 18.91 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.0 mt -121.81 150.49 41.81 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.53 166.34 31.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -65.61 -31.37 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.408 2.739 . . . . 0.0 112.108 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -70.28 -11.31 60.81 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.523 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.1 -10.77 34.82 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.078 1.308 . . . . 0.0 110.851 170.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.38 159.83 19.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.566 1.546 . . . . 0.0 109.19 -166.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -138.79 145.69 46.99 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.99 126.53 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.538 2.158 . . . . 0.0 109.932 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -53.86 -62.49 1.62 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -56.37 -40.81 75.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.928 0.786 . . . . 0.0 111.587 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 -34.9 79.54 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 119.141 0.882 . . . . 0.0 112.354 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.85 10.66 38.25 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.855 1.662 . . . . 0.0 111.119 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.21 -47.53 84.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.686 1.195 . . . . 0.0 110.179 -171.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -23.52 55.89 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.242 0.928 . . . . 0.0 112.006 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -77.52 -44.55 28.33 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.224 -0.923 . . . . 0.0 111.386 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -118.7 -23.46 7.03 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.69 1.996 . . . . 0.0 111.235 -165.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.28 58.2 3.66 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -133.25 135.54 45.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.451 1.9 . . . . 0.0 106.568 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.9 97.77 0.03 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.816 1.647 . . . . 0.0 110.938 -170.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB3' ' CG ' ' A' ' 81' ' ' PHE . 13.3 t-20 -71.87 158.79 35.41 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.11 -0.994 . . . . 0.0 108.986 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -71.7 -27.63 63.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.111 0.964 . . . . 0.0 113.06 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -64.28 142.78 58.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.523 1.056 . . . . 0.0 110.399 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -65.33 164.6 13.27 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 160.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.83 -41.85 2.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.498 1.523 . . . . 0.0 110.223 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.407 ' CG ' ' HB3' ' A' ' 76' ' ' ASN . 10.6 t80 -58.48 -46.99 85.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.088 0.955 . . . . 0.0 110.966 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -62.16 -44.8 95.82 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.049 -0.407 . . . . 0.0 110.12 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -69.47 -27.74 65.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.009 0.818 . . . . 0.0 111.68 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 -23.07 35.23 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.125 -0.984 . . . . 0.0 112.83 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.3 -32.13 71.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.99 1.395 . . . . 0.0 110.563 168.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -66.61 -47.9 71.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.557 -0.714 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.63 -48.57 80.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.388 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.3 -41.39 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.222 0.326 . . . . 0.0 110.238 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.67 -37.12 85.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.292 0.637 . . . . 0.0 110.498 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 . . . . . 0 CA--C 1.536 0.416 0 O-C-N 121.421 -0.799 . . . . 0.0 112.384 177.945 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -135.89 178.24 7.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.076 0.853 . . . . 0.0 111.483 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.93 132.54 32.26 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.903 0.881 . . . . 0.0 111.33 -167.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.6 -17.39 58.65 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.096 -0.835 . . . . 0.0 111.775 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.18 161.28 19.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.044 1.402 . . . . 0.0 109.312 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD22 HG13 ' A' ' 88' ' ' ILE . 96.0 mt -124.74 156.37 37.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.817 1.647 . . . . 0.0 106.682 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.71 171.88 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.916 0.886 . . . . 0.0 108.861 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -105.85 122.24 45.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 159.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.06 134.87 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.762 1.225 . . . . 0.0 109.39 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -106.79 108.59 20.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.5 mtp -86.39 167.17 14.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.1 150.0 22.25 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 163.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.86 -68.29 1.05 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.226 0.917 . . . . 0.0 111.999 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -56.02 156.05 10.96 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.301 2.24 . . . . 0.0 112.547 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.33 173.44 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.752 2.968 . . . . 0.0 109.88 163.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -62.9 108.04 1.11 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -91.17 140.26 25.77 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 123.934 0.894 . . . . 0.0 108.792 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.01 126.62 16.83 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.216 1.944 . . . . 0.0 110.482 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.22 157.16 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.262 0.553 . . . . 0.0 111.113 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -103.8 152.42 21.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.14 99.95 8.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -74.18 -177.32 2.92 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.955 0.407 . . . . 0.0 109.966 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--N 1.325 -0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 107.712 176.265 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 . . . . . 0 CA--C 1.516 -0.334 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -140.27 145.65 37.59 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -114.46 153.61 46.6 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.332 1.853 . . . . 0.0 110.176 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 91.63 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.399 3.399 . . . . 0.0 111.107 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.24 121.5 43.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -113.21 116.54 29.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -87.55 97.22 10.73 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.104 1.762 . . . . 0.0 108.52 -169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 10.7 m-85 -52.21 150.55 4.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.495 1.118 . . . . 0.0 112.085 -175.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.11 4.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.638 1.59 . . . . 0.0 111.976 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.58 -31.51 68.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.92 0.888 . . . . 0.0 110.849 167.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.1 m80 53.52 25.98 5.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.61 1.964 . . . . 0.0 112.043 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.31 165.73 23.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.975 2.11 . . . . 0.0 109.475 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -127.76 151.61 48.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.849 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.19 155.74 23.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 154.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -86.51 123.95 32.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.71 149.94 50.0 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.191 1.396 . . . . 0.0 108.341 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.21 165.08 27.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.37 -24.12 43.56 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.867 2.378 . . . . 0.0 112.118 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -54.14 -15.22 1.38 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.502 1.521 . . . . 0.0 114.151 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -118.1 7.39 12.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.515 1.526 . . . . 0.0 110.712 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.28 168.67 9.75 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.673 1.589 . . . . 0.0 109.388 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -144.53 146.14 31.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 127.214 2.206 . . . . 0.0 107.124 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.69 152.71 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.652 2.235 . . . . 0.0 111.74 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.0 -62.69 1.37 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.193 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -46.99 -46.4 21.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.861 1.21 . . . . 0.0 111.308 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -18.12 65.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -172.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -130.31 13.6 5.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.502 1.121 . . . . 0.0 111.39 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -55.33 -36.85 66.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.799 1.639 . . . . 0.0 112.225 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -104.83 -15.96 15.04 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.667 0.787 . . . . 0.0 109.723 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -85.66 -57.36 3.08 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 120.918 -1.114 . . . . 0.0 110.079 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -89.6 -36.14 15.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 109.726 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.89 71.11 0.57 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.782 1.658 . . . . 0.0 111.681 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.8 150.09 48.14 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 126.069 1.748 . . . . 0.0 107.465 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.0 p -59.58 105.35 0.35 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.971 0.508 . . . . 0.0 110.015 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -93.82 152.57 18.81 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -89.89 54.5 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 109.355 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -115.54 123.61 48.93 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -67.97 103.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.42 -25.96 4.2 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.551 1.548 . . . . 0.0 111.269 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -65.02 -51.79 59.66 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.404 1.102 . . . . 0.0 111.146 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -73.27 -23.04 60.26 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.409 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -65.04 -48.13 74.92 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 124.34 1.056 . . . . 0.0 108.888 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.92 -31.22 78.92 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.309 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' HA ' HG22 ' A' ' 88' ' ' ILE . 17.2 mt -63.35 -46.7 85.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.376 171.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -57.16 -41.26 78.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.594 1.543 . . . . 0.0 111.043 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.09 -51.11 65.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.774 0.715 . . . . 0.0 111.511 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 85' ' ' LEU . 13.5 tt -70.35 -38.89 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.432 0.693 . . . . 0.0 110.382 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.56 -27.63 69.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.835 0.854 . . . . 0.0 110.032 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 125.721 1.609 . . . . 0.0 113.019 176.504 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 120.658 0.266 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -147.74 168.16 22.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 108.867 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.27 135.81 57.77 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 123.288 0.367 . . . . 0.0 111.034 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.5 35.58 5.4 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 117.878 -1.512 . . . . 0.0 112.233 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.18 172.8 12.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.238 1.519 . . . . 0.0 111.151 172.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -117.43 142.27 47.34 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.257 1.423 . . . . 0.0 108.414 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 29' ' ' ILE . 22.9 m -154.46 171.08 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.029 0.931 . . . . 0.0 111.95 -165.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.07 117.41 30.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.244 1.018 . . . . 0.0 111.652 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.07 163.96 13.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.607 1.163 . . . . 0.0 110.469 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -147.67 106.97 3.88 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.261 -0.899 . . . . 0.0 110.452 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.5 mtm -83.76 168.05 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.026 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -81.15 83.61 6.75 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.967 1.307 . . . . 0.0 109.155 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.42 -56.74 0.67 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -61.66 159.22 35.39 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.445 1.498 . . . . 0.0 113.222 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.07 176.0 10.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.284 3.989 . . . . 0.0 111.153 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -64.02 97.04 0.16 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.982 1.313 . . . . 0.0 108.166 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -89.6 134.9 31.51 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.181 -165.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.74 121.01 8.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.579 2.186 . . . . 0.0 109.658 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.5 19.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 110.236 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -124.58 148.27 47.95 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 HD11 HG11 ' A' ' 15' ' ' VAL . 9.1 mm -78.59 99.96 3.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.278 -2.489 . . . . 0.0 104.278 163.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -65.77 173.34 2.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.095 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--N 1.322 -0.618 0 C-N-CA 125.153 1.381 . . . . 0.0 108.972 179.619 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -112.89 160.29 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.014 1.279 . . . . 0.0 111.384 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -115.26 149.85 43.42 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 126.713 2.005 . . . . 0.0 108.161 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.009 3.139 . . . . 0.0 108.919 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.0 mm -102.61 112.89 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -99.3 124.05 44.08 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.3 98.02 11.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -50.43 148.38 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.033 0.933 . . . . 0.0 110.89 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.47 -15.2 1.6 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.963 1.268 . . . . 0.0 115.862 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -115.68 -17.27 11.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.26 1.53 . . . . 0.0 111.596 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.37 16.17 7.2 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.808 2.043 . . . . 0.0 112.749 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -83.55 165.65 18.9 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.428 -0.795 . . . . 0.0 110.219 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -127.5 150.61 49.6 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.176 0.99 . . . . 0.0 110.648 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.3 29.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.155 1.382 . . . . 0.0 109.369 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.53 107.38 16.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.7 mt -123.54 143.69 50.03 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 162.55 28.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.48 -20.5 47.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 113.676 -160.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -52.86 -32.2 43.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.82 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -94.96 9.23 40.17 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 111.506 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 mt -135.28 157.38 47.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.568 1.147 . . . . 0.0 111.144 -161.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -141.64 155.81 66.57 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.016 1.326 . . . . 0.0 110.726 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -68.89 134.11 28.97 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.126 2.55 . . . . 0.0 112.273 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -65.1 -48.1 74.86 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.864 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -62.19 -27.54 69.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.853 1.206 . . . . 0.0 112.361 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.47 -51.08 11.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 111.023 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -97.23 8.85 43.71 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.014 -1.054 . . . . 0.0 113.816 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -53.3 -49.45 66.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.646 1.178 . . . . 0.0 108.684 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.59 -53.09 38.17 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.39 0.431 . . . . 0.0 110.743 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -64.64 -33.87 76.96 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 113.713 -169.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -118.36 -29.21 5.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 112.518 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.58 70.86 3.07 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 153.81 51.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.615 1.566 . . . . 0.0 109.317 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.0 p -74.93 99.9 3.96 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -80.92 168.61 18.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.937 -1.102 . . . . 0.0 111.404 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -89.04 -5.33 57.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -73.15 141.96 47.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.277 1.853 . . . . 0.0 109.023 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.464 ' HE3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.29 164.29 16.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.509 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.17 -40.95 1.27 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.355 0.979 . . . . 0.0 111.564 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.02 -37.94 84.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.185 1.493 . . . . 0.0 111.154 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -48.76 78.32 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.433 0.693 . . . . 0.0 110.167 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.95 -38.42 86.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.856 1.662 . . . . 0.0 110.438 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -72.45 -32.9 61.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.56 1.076 . . . . 0.0 111.944 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.612 1.206 . . . . 0.0 111.16 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -66.31 -44.06 84.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.629 0.649 . . . . 0.0 109.557 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -60.96 -55.38 33.57 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.102 0.961 . . . . 0.0 111.248 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 tt -62.07 -28.36 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.079 0.854 . . . . 0.0 111.187 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -60.05 3.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.013 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 C--O 1.235 0.329 0 C-N-CA 125.399 1.48 . . . . 0.0 112.04 -176.072 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -137.25 176.14 8.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.672 1.589 . . . . 0.0 110.684 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.71 135.2 41.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.42 -28.39 15.8 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.609 1.576 . . . . 0.0 112.31 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -75.74 123.86 26.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.479 1.14 . . . . 0.0 109.325 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.97 145.03 28.76 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.29 168.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.587 0.708 . . . . 0.0 112.699 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -112.85 121.79 45.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.643 1.177 . . . . 0.0 108.189 161.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.34 121.82 35.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.72 1.208 . . . . 0.0 109.147 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -91.49 107.24 19.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mtm -74.01 169.42 17.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.376 0.534 . . . . 0.0 110.433 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -61.69 127.51 31.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.81 -60.48 3.38 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.657 1.122 . . . . 0.0 113.343 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -51.43 155.85 2.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.786 1.635 . . . . 0.0 111.488 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.45 -175.55 2.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.454 3.436 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -62.53 89.75 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.89 2.476 . . . . 0.0 108.251 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -86.45 135.33 36.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HG3' HD22 ' A' ' 85' ' ' LEU . 31.8 Cg_endo -67.47 130.8 23.1 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.298 1.332 . . . . 0.0 108.669 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.65 151.66 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.496 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 12.7 ptm180 -103.06 160.63 14.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.437 1.017 . . . . 0.0 109.162 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.6 124.89 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 151.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.91 -156.42 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 O-C-N 119.501 -2.0 . . . . 0.0 109.189 147.443 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.52 0.676 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -138.35 134.18 33.9 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.41 2.284 . . . . 0.0 110.046 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -102.27 147.45 33.98 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.809 2.444 . . . . 0.0 111.241 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.03 100.38 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.053 2.502 . . . . 0.0 111.464 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 mm -83.07 155.5 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -142.08 106.78 4.86 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.22 1.808 . . . . 0.0 107.286 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.93 98.7 3.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.83 1.252 . . . . 0.0 109.107 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m-85 -49.27 139.04 11.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 127.222 2.209 . . . . 0.0 111.999 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.98 -37.55 1.5 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.638 1.589 . . . . 0.0 113.552 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.4 -28.14 52.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.418 1.109 . . . . 0.0 111.753 171.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.9 m80 48.98 60.02 4.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 110.081 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.0 147.84 32.77 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 108.215 163.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 p -121.41 142.99 49.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.421 1.089 . . . . 0.0 109.027 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.05 169.76 21.02 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.596 1.559 . . . . 0.0 108.082 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.65 107.44 18.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.58 133.79 50.71 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.077 1.751 . . . . 0.0 110.586 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.28 167.73 54.12 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.02 -32.07 94.47 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.465 2.776 . . . . 0.0 114.421 -175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.32 -15.79 18.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.39 0.995 . . . . 0.0 113.4 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -103.03 4.0 36.77 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.024 1.284 . . . . 0.0 111.225 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -135.27 134.78 40.3 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.684 1.594 . . . . 0.0 109.767 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.05 145.48 43.94 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 110.851 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.8 116.1 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.104 3.202 . . . . 0.0 109.615 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -49.14 -52.23 27.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.472 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -55.99 -35.96 67.35 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.114 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -41.79 66.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.839 1.199 . . . . 0.0 111.208 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.71 16.16 24.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.741 1.216 . . . . 0.0 110.756 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -61.51 -40.58 95.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.332 0.969 . . . . 0.0 110.471 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.53 -49.95 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.059 -1.026 . . . . 0.0 108.999 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -60.05 -33.82 72.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.245 1.418 . . . . 0.0 113.604 -169.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -125.66 -18.58 5.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.277 1.831 . . . . 0.0 112.649 -173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.97 30.62 1.8 Allowed Glycine 0 N--CA 1.474 1.194 0 CA-C-N 121.32 1.873 . . . . 0.0 113.472 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -115.47 158.65 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.201 2.2 . . . . 0.0 109.062 -167.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -75.44 164.08 26.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.345 1.545 . . . . 0.0 112.302 -163.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -153.85 155.68 36.21 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 128.715 2.806 . . . . 0.0 107.778 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.46 2.27 33.54 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.582 1.153 . . . . 0.0 113.52 -171.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.66 133.78 55.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.895 1.278 . . . . 0.0 108.785 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -62.09 162.27 9.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.38 -46.32 2.76 Favored Glycine 0 N--CA 1.461 0.335 0 O-C-N 120.969 -1.082 . . . . 0.0 111.052 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -54.89 -54.84 37.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.729 0.812 . . . . 0.0 111.202 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.02 -39.72 66.39 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.269 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.33 -43.52 98.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 110.303 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.97 -32.94 82.33 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.648 -0.658 . . . . 0.0 112.386 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.513 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -76.19 -24.59 54.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.007 0.904 . . . . 0.0 112.08 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -68.64 -52.62 29.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 2.4 mm-40 -56.59 -54.56 44.51 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.322 0.649 . . . . 0.0 111.187 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.2 tt -58.56 -36.37 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.37 0.532 . . . . 0.0 111.759 -172.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.22 -48.53 64.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 125.213 1.405 . . . . 0.0 112.66 -173.281 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -147.33 169.82 18.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.978 0.808 . . . . 0.0 111.284 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.69 124.87 14.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.81 0.844 . . . . 0.0 109.816 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.16 -9.16 61.2 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.777 -1.013 . . . . 0.0 112.836 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.78 159.6 32.69 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 119.285 1.543 . . . . 0.0 108.88 163.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.2 150.14 39.23 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.74 173.85 3.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.856 0.836 . . . . 0.0 111.296 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.29 133.71 52.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 157.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -109.69 125.86 53.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.228 1.411 . . . . 0.0 108.449 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -105.18 105.89 16.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mtm -77.58 170.21 16.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.122 0.963 . . . . 0.0 109.398 164.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -64.91 130.85 44.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.77 -48.24 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.853 0.739 . . . . 0.0 113.257 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -54.31 152.07 12.31 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 169.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.73 175.26 9.15 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.719 2.946 . . . . 0.0 109.713 171.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -63.07 97.61 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -79.27 140.26 56.57 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.817 1.647 . . . . 0.0 109.22 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.19 128.93 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.771 1.647 . . . . 0.0 109.069 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.84 165.64 27.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.112 0.958 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -116.4 147.67 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.76 108.82 14.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 161.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.61 -174.54 4.34 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 110.129 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 124.858 1.263 . . . . 0.0 109.627 169.011 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 62.5 mttt -131.37 147.48 52.57 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 124.437 1.095 . . . . 0.0 108.368 167.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.79 153.06 43.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 124.609 1.163 . . . . 0.0 110.146 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.18 94.57 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.441 2.761 . . . . 0.0 108.808 167.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.3 mm -85.07 141.18 14.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 52' ' ' HIS . 56.0 t80 -125.95 122.46 36.03 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -87.15 99.8 12.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.05 1.34 . . . . 0.0 108.743 -174.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 7.1 m-85 -53.14 144.88 14.58 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.506 1.122 . . . . 0.0 111.163 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 -33.15 0.9 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.248 1.404 . . . . 0.0 114.342 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 p -95.63 -11.96 26.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.295 1.548 . . . . 0.0 112.723 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.435 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.9 m170 56.4 26.23 10.49 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.648 1.979 . . . . 0.0 113.542 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -92.01 161.7 14.68 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.726 0.81 . . . . 0.0 109.874 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -127.68 142.92 51.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.652 1.181 . . . . 0.0 109.449 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.52 174.11 13.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 110.16 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.88 107.5 15.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.7 mt -117.93 150.5 39.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . -92.33 164.96 28.57 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.44 -28.03 86.49 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.129 2.553 . . . . 0.0 111.878 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -61.28 -10.72 7.49 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.61 10.35 9.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 110.645 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 17' ' ' ALA . 78.2 mt -129.4 153.82 47.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 109.346 -172.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -132.61 148.16 68.45 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.664 0.785 . . . . 0.0 111.356 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.53 125.23 13.03 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.326 3.351 . . . . 0.0 111.049 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.6 -58.04 9.78 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.076 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -55.44 -27.94 51.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.36 -173.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -60.44 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.091 0.86 . . . . 0.0 109.039 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.55 13.13 14.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.928 1.691 . . . . 0.0 112.947 -170.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -57.0 -24.21 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.15 1.78 . . . . 0.0 112.162 -172.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.13 -35.51 5.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.522 1.129 . . . . 0.0 108.472 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.46 81.9 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.818 -1.176 . . . . 0.0 113.035 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -106.7 -27.17 10.97 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.837 1.655 . . . . 0.0 109.273 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.94 73.78 2.58 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 133.77 16.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.042 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.2 p -65.15 137.0 57.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.706 1.603 . . . . 0.0 107.677 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -142.12 -6.01 0.97 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -154.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 tttt 121.64 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 131.402 3.881 . . . . 0.0 111.495 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 133.49 53.16 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.938 0.79 . . . . 0.0 110.076 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -60.25 167.43 2.44 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 125.182 1.551 . . . . 0.0 109.831 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.75 -54.61 0.73 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.897 1.713 . . . . 0.0 111.685 -172.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -46.51 -43.73 17.13 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 126.678 1.991 . . . . 0.0 113.398 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -68.45 -47.6 66.74 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.488 0.715 . . . . 0.0 111.928 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -52.96 -38.93 62.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.994 1.317 . . . . 0.0 109.958 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.17 -28.61 65.97 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.542 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.58 -47.32 70.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.903 1.352 . . . . 0.0 109.659 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -53.79 -45.46 70.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.59 0.556 . . . . 0.0 109.545 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.06 -52.18 60.58 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.86 -30.28 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.484 1.038 . . . . 0.0 111.249 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.91 -31.71 68.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.546 0.612 . . . . 0.0 111.881 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 . . . . . 0 C--O 1.231 0.102 0 C-N-CA 123.633 0.773 . . . . 0.0 112.582 -178.248 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 121.265 0.555 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -160.33 162.77 33.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 109.194 -173.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.02 112.72 0.91 Allowed 'General case' 0 C--O 1.236 0.348 0 O-C-N 124.157 0.911 . . . . 0.0 109.167 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.61 -33.89 2.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.008 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.2 134.66 45.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.819 1.809 . . . . 0.0 108.616 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.86 147.94 25.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 162.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 m -147.92 167.78 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -108.4 148.34 30.28 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 156.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.98 127.8 45.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.278 1.831 . . . . 0.0 108.327 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.17 104.94 16.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.9 mtm -76.26 159.57 30.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 161.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -67.36 142.69 56.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.72 -41.31 0.83 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.717 1.627 . . . . 0.0 113.343 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.72 161.79 68.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 126.898 2.079 . . . . 0.0 112.266 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.6 179.97 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.106 3.204 . . . . 0.0 109.835 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -67.09 98.42 0.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -81.7 139.04 47.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.407 1.083 . . . . 0.0 108.289 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.536 ' HG3' HD22 ' A' ' 85' ' ' LEU . 34.4 Cg_endo -66.04 140.74 61.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.266 1.311 . . . . 0.0 110.222 174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.56 168.37 22.15 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.11 0.964 . . . . 0.0 109.493 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.0 mm -71.0 115.3 10.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 162.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.31 176.43 8.73 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.712 0.767 . . . . 0.0 109.644 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.457 0 C-N-CA 124.71 1.204 . . . . 0.0 107.941 157.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 . . . . . 0 C--O 1.237 0.395 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -129.79 157.57 41.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 160.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.98 153.54 47.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 126.004 1.722 . . . . 0.0 107.182 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.16 104.47 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.773 2.315 . . . . 0.0 109.641 167.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.8 mm -103.49 111.66 34.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.14 124.29 34.7 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.875 1.27 . . . . 0.0 108.275 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -90.7 101.88 14.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.143 0.977 . . . . 0.0 109.283 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -52.92 145.2 13.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.593 1.157 . . . . 0.0 111.904 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.17 -46.31 2.43 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.363 1.458 . . . . 0.0 111.883 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 p -80.89 -22.32 39.88 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.149 -1.207 . . . . 0.0 112.321 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 m170 55.27 20.35 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.908 2.483 . . . . 0.0 113.822 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -78.43 166.65 22.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 p -125.42 152.64 44.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.35 161.03 39.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 154.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -88.06 123.3 32.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 166.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.3 mt -130.17 152.6 49.43 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.046 0.938 . . . . 0.0 108.525 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.41 169.19 18.24 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.022 0.82 . . . . 0.0 111.682 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.81 5.71 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.371 1 C-N-CA 125.503 4.135 . . . . 0.0 115.838 -166.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -102.14 -6.67 22.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -110.03 7.57 23.68 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.91 -1.119 . . . . 0.0 111.013 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.59 134.95 31.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.69 1.596 . . . . 0.0 108.717 -157.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -126.64 160.5 58.18 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.63 1.172 . . . . 0.0 109.649 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.14 131.67 27.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.742 2.295 . . . . 0.0 110.454 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.96 -57.63 12.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.994 1.27 . . . . 0.0 110.803 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -49.11 -40.61 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.171 0.988 . . . . 0.0 112.402 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -40.95 89.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.806 1.643 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -104.86 6.36 33.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.495 1.518 . . . . 0.0 112.603 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -61.41 -17.18 53.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.277 1.831 . . . . 0.0 111.51 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -115.19 -33.84 5.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.366 1.466 . . . . 0.0 111.856 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -64.1 -55.99 18.08 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.207 1.003 . . . . 0.0 109.937 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -92.66 -39.51 11.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.909 1.284 . . . . 0.0 110.146 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.6 77.94 0.75 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -122.97 179.0 4.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.611 1.564 . . . . 0.0 107.548 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 p -80.82 150.21 29.26 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.404 ' HB2' ' CE2' ' A' ' 81' ' ' PHE . 1.2 m-20 -153.03 144.04 22.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.074 172.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -81.68 68.49 8.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.492 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -128.26 119.25 24.78 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.807 2.043 . . . . 0.0 106.333 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -72.87 116.54 13.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -171.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.12 14.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.991 0.805 . . . . 0.0 111.783 -171.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 76' ' ' ASN . 82.8 t80 -62.07 -60.59 3.38 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.949 1.375 . . . . 0.0 108.48 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -56.98 -21.81 33.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.98 -39.53 42.09 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.464 0.706 . . . . 0.0 109.552 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.81 97.22 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.382 -0.824 . . . . 0.0 111.945 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.536 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.1 mm? -68.74 -14.46 63.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.08 0.94 . . . . 0.0 112.613 173.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -79.76 -48.56 13.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.189 0.904 . . . . 0.0 108.742 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.31 -52.49 65.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.703 0.683 . . . . 0.0 110.446 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.64 -43.69 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.598 0.635 . . . . 0.0 111.622 -170.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.07 -46.63 89.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.356 1.062 . . . . 0.0 109.661 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.337 1.055 . . . . 0.0 112.931 -173.921 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -138.11 170.53 15.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.121 0.968 . . . . 0.0 110.053 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 149.6 18.66 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.615 0.572 . . . . 0.0 110.629 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 -1.63 88.09 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.973 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -101.27 173.62 6.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.022 1.411 . . . . 0.0 109.464 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -131.38 149.31 52.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.757 1.223 . . . . 0.0 109.859 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.42 164.72 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 109.914 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.81 126.59 50.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 158.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.94 165.8 12.7 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -140.07 105.67 5.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.8 mtm -73.65 168.8 18.61 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 168.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -59.44 129.63 42.96 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 162.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.92 -30.03 2.07 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.627 2.061 . . . . 0.0 115.823 168.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.89 163.66 66.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 118.793 1.297 . . . . 0.0 111.576 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.64 175.67 10.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.573 3.515 . . . . 0.0 110.993 168.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -62.59 88.09 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.227 2.211 . . . . 0.0 109.786 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -86.75 137.88 33.56 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 120.904 -1.122 . . . . 0.0 109.252 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.07 137.79 63.84 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 111.665 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.04 167.44 22.67 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.159 0.98 . . . . 0.0 111.09 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 ptm180 -112.45 156.06 23.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.1 mm -82.45 107.48 14.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 159.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.74 -174.55 4.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 CA--C 1.532 0.252 0 O-C-N 120.647 -1.283 . . . . 0.0 109.296 176.662 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -132.85 168.1 19.0 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.913 -1.117 . . . . 0.0 112.916 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -125.2 152.87 71.53 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 130.232 3.413 . . . . 0.0 110.206 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.44 102.03 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.99 3.126 . . . . 0.0 109.543 166.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -87.86 116.31 25.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.626 1.97 . . . . 0.0 107.623 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.83 99.61 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.801 2.041 . . . . 0.0 109.435 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 3.3 m-85 -49.28 143.73 5.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.484 1.514 . . . . 0.0 113.141 -172.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.46 -58.26 2.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.175 1.369 . . . . 0.0 111.394 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -21.35 64.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.327 -1.102 . . . . 0.0 113.056 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 m170 58.09 3.15 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.08 2.152 . . . . 0.0 114.398 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.82 164.63 11.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.297 1.046 . . . . 0.0 109.407 172.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 p -141.24 136.22 31.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -166.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.28 151.09 36.04 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -89.08 107.34 18.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 mt -128.79 150.77 50.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 169.13 21.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.87 1.224 . . . . 0.0 112.762 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -68.42 -23.65 37.6 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.331 2.687 . . . . 0.0 113.924 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -57.25 -19.12 19.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.796 1.18 . . . . 0.0 113.31 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.0 7.05 23.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 109.507 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.3 166.22 11.89 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.389 1.875 . . . . 0.0 110.187 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -148.36 154.28 41.69 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.317 1.847 . . . . 0.0 106.847 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -69.97 127.4 14.38 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.135 2.557 . . . . 0.0 111.148 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -55.35 -53.73 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.456 1.102 . . . . 0.0 111.271 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.01 -21.91 59.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.761 0.824 . . . . 0.0 111.881 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -71.21 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.25 1.42 . . . . 0.0 109.031 167.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.26 15.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.379 1.472 . . . . 0.0 113.575 -166.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -52.93 -28.93 25.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.886 1.674 . . . . 0.0 112.019 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -34.86 6.9 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.123 0.874 . . . . 0.0 111.635 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -60.87 -60.9 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.258 1.023 . . . . 0.0 109.011 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -85.19 -52.02 6.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.695 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.33 88.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 126.187 1.851 . . . . 0.0 111.856 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -151.48 158.83 44.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.418 1.887 . . . . 0.0 108.899 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -60.0 150.89 27.75 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.886 1.327 . . . . 0.0 108.966 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.14 149.86 44.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.615 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -86.0 -14.1 45.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.171 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mmt-85 -58.31 123.9 17.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 164.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -64.78 164.17 12.75 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 -40.69 2.28 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.043 0.83 . . . . 0.0 111.719 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -52.43 -34.96 50.88 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.49 1.145 . . . . 0.0 112.168 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -46.43 76.43 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 121.34 -0.85 . . . . 0.0 112.794 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.04 -43.76 86.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.771 1.229 . . . . 0.0 109.294 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.36 -36.45 93.1 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.421 -0.8 . . . . 0.0 113.02 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.04 -16.91 61.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.289 1.036 . . . . 0.0 112.661 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -77.97 -52.73 8.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.02 -46.09 92.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 112.331 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.8 tt -63.58 -33.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.201 0.909 . . . . 0.0 111.806 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.49 -53.38 19.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.624 -0.672 . . . . 0.0 109.272 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 . . . . . 0 CA--C 1.529 0.172 0 O-C-N 123.803 0.689 . . . . 0.0 112.106 -170.844 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -136.97 169.95 16.91 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.527 1.531 . . . . 0.0 108.759 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 144.08 44.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.491 0.662 . . . . 0.0 110.863 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.18 5.9 59.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.418 -1.212 . . . . 0.0 113.328 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.84 140.98 51.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.28 2.04 . . . . 0.0 108.251 166.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.5 mt -88.42 136.38 33.01 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.05 162.38 13.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 123.478 0.711 . . . . 0.0 109.593 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -102.1 126.6 49.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 164.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.9 168.8 10.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.707 0.803 . . . . 0.0 109.507 173.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -133.44 150.2 51.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.472 0.709 . . . . 0.0 109.569 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 55.4 mtm -132.62 172.89 11.93 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.127 1.771 . . . . 0.0 109.463 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -80.55 71.23 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.143 1.377 . . . . 0.0 109.981 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.36 -41.38 1.2 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.414 1.483 . . . . 0.0 111.276 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -60.65 150.6 74.76 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.505 1.122 . . . . 0.0 110.946 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.52 165.44 29.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.549 3.499 . . . . 0.0 111.333 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -55.36 116.57 2.92 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -118.33 132.1 23.93 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.33 137.44 36.71 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.969 1.78 . . . . 0.0 110.751 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.03 167.34 23.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.674 1.19 . . . . 0.0 110.249 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.41 139.5 53.6 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.69 112.5 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -73.97 171.04 14.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.582 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.239 0.525 0 CA-C-O 122.43 1.109 . . . . 0.0 111.147 -172.082 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -128.19 166.7 18.02 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.349 1.06 . . . . 0.0 108.146 162.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -129.71 153.34 80.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 126.491 1.916 . . . . 0.0 107.283 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.12 115.68 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.397 2.065 . . . . 0.0 108.929 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.5 113.47 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -85.98 131.77 34.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -98.44 115.47 28.58 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -54.8 144.75 21.51 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.055 1.342 . . . . 0.0 110.718 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.86 -58.0 4.04 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.76 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 p -83.48 -24.64 31.68 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.849 2.324 . . . . 0.0 111.273 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.0 m170 70.01 17.43 7.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.349 1.459 . . . . 0.0 112.113 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.59 155.41 33.25 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 130.26 32.52 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.991 1.316 . . . . 0.0 108.0 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.02 159.02 42.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.79 121.63 32.11 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.7 mt -126.79 158.56 36.25 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 109.062 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.86 16.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.701 1.143 . . . . 0.0 112.658 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -67.84 -15.73 44.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.33 2.687 . . . . 0.0 115.188 -160.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -63.53 -26.37 68.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.393 1.451 . . . . 0.0 111.664 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.1 10.66 33.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.485 1.514 . . . . 0.0 111.533 -173.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.3 mt -133.35 127.09 32.76 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.927 1.291 . . . . 0.0 109.408 -169.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.33 142.68 37.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.424 1.089 . . . . 0.0 110.745 -167.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.49 121.04 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.821 3.014 . . . . 0.0 111.411 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -56.28 -50.08 72.41 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.8 -0.562 . . . . 0.0 111.064 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -57.87 -31.97 67.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 112.267 -173.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.19 -68.06 0.5 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.013 0.925 . . . . 0.0 108.823 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.4 -2.57 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.374 1.07 . . . . 0.0 113.265 -160.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.49 -46.46 57.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.935 1.694 . . . . 0.0 110.713 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.67 -17.36 53.88 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -97.76 -62.48 1.24 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.683 1.593 . . . . 0.0 109.786 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -86.22 -30.82 22.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.822 1.649 . . . . 0.0 111.782 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.21 73.41 2.0 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -132.38 128.94 38.67 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.504 1.122 . . . . 0.0 108.556 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -41.89 130.74 3.39 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 126.371 1.868 . . . . 0.0 109.208 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -138.85 134.72 33.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -78.1 72.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -120.09 133.96 55.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -68.32 147.74 51.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -58.69 5.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -48.77 -61.1 2.22 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 124.83 1.252 . . . . 0.0 110.67 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.1 -33.41 70.8 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.785 1.234 . . . . 0.0 114.073 -169.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.14 -39.97 68.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.645 0.778 . . . . 0.0 110.732 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -34.69 80.14 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.567 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.94 -24.78 64.31 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.371 1.085 . . . . 0.0 111.832 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -70.69 -50.06 40.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.79 -46.51 87.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.308 1.043 . . . . 0.0 111.545 -172.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 tt -66.69 -42.36 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.409 0.284 . . . . 0.0 110.864 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.02 -20.32 64.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.013 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 126.77 2.028 . . . . 0.0 110.74 177.062 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -128.94 158.67 38.17 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.089 0.859 . . . . 0.0 110.306 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.09 3.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 109.778 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.09 -37.75 2.23 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -69.8 160.7 31.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.716 1.246 . . . . 0.0 110.778 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -117.82 143.63 46.1 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 107.846 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.31 167.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.554 0.742 . . . . 0.0 111.479 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.43 128.34 50.6 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 158.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.1 165.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HE2' ' CE1' ' A' ' 24' ' ' HIS . 6.8 tptp -143.92 106.32 4.41 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.9 mtm -78.28 161.7 27.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 166.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.02 139.34 58.76 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.61 -44.43 2.5 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.078 1.323 . . . . 0.0 113.796 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.67 160.03 78.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.61 1.205 . . . . 0.0 112.384 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 178.46 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.979 3.786 . . . . 0.0 111.482 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.455 ' CE1' ' HE2' ' A' ' 18' ' ' LYS . 55.1 m80 -71.28 89.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.495 1.118 . . . . 0.0 109.234 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -80.69 136.31 51.79 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 110.161 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.43 124.51 12.56 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.895 2.397 . . . . 0.0 110.506 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.82 166.66 24.6 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.717 -0.615 . . . . 0.0 110.28 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 2.8 ptm85 -125.89 159.62 32.08 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.512 -0.743 . . . . 0.0 109.882 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.5 mm -86.27 108.88 18.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -73.28 174.98 7.28 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 164.191 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -114.1 159.33 20.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.003 0.82 . . . . 0.0 110.2 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -122.84 153.11 63.5 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.282 1.833 . . . . 0.0 108.416 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.13 105.24 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.606 2.87 . . . . 0.0 110.487 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.7 mm -92.89 123.36 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.128 0.571 . . . . 0.0 109.527 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -101.87 115.99 31.74 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 107.091 170.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -80.44 115.84 20.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.7 m-85 -65.86 149.04 50.83 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.402 0.62 . . . . 0.0 110.737 -176.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 -34.45 0.34 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.884 2.183 . . . . 0.0 114.059 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -85.68 -28.48 24.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.68 2.24 . . . . 0.0 110.88 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 66.36 13.83 9.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.31 2.244 . . . . 0.0 113.701 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.68 160.07 30.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.2 1.0 . . . . 0.0 109.288 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -122.65 149.55 43.86 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 109.476 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.39 177.65 9.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.762 0.825 . . . . 0.0 109.287 167.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -117.33 122.82 44.94 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.83 156.94 32.18 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.73 0.3 . . . . 0.0 110.5 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.16 161.4 35.88 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.13 -20.97 63.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.957 2.438 . . . . 0.0 111.765 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -60.25 -23.73 64.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.87 0.868 . . . . 0.0 112.386 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.79 -9.94 50.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.489 1.04 . . . . 0.0 111.53 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.9 mt -116.48 160.58 20.39 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.23 1.412 . . . . 0.0 110.795 -162.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.55 146.95 47.14 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.066 0.946 . . . . 0.0 110.767 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -67.12 126.72 15.56 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.426 2.751 . . . . 0.0 110.508 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -52.8 -52.06 58.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.793 0.437 . . . . 0.0 110.841 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -66.66 -6.34 15.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -64.49 1.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.725 -0.609 . . . . 0.0 110.532 164.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -79.96 9.76 5.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.488 1.915 . . . . 0.0 113.525 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -53.71 -20.45 5.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.748 2.019 . . . . 0.0 112.464 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -33.13 4.62 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 119.972 1.26 . . . . 0.0 113.229 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -61.26 -51.56 68.41 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.615 1.098 . . . . 0.0 109.024 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -92.4 -35.06 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.108 0.963 . . . . 0.0 110.112 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.97 80.25 0.59 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.64 -1.089 . . . . 0.0 110.993 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -141.86 142.59 33.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.095 1.758 . . . . 0.0 107.648 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -54.4 103.54 0.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.853 2.461 . . . . 0.0 111.7 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.71 150.5 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.344 -0.848 . . . . 0.0 112.268 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -45.62 -49.39 14.29 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.8 1.64 . . . . 0.0 113.232 168.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -58.49 139.39 55.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.83 0.741 . . . . 0.0 110.598 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -71.27 172.5 9.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 162.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.34 -88.01 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 104.611 -3.396 . . . . 0.0 104.611 -143.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -32.24 -53.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.535 2.734 . . . . 0.0 115.547 -151.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -23.7 62.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.39 -57.29 4.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.633 2.373 . . . . 0.0 108.501 170.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.42 -27.75 61.19 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.332 -0.705 . . . . 0.0 112.563 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.48 -48.85 73.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.14 0.97 . . . . 0.0 111.384 170.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -60.89 -40.58 93.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.666 1.121 . . . . 0.0 110.178 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.58 -51.64 67.71 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.356 0.663 . . . . 0.0 111.678 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.2 tt -66.57 -29.4 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 118.892 0.769 . . . . 0.0 110.945 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.69 -30.99 69.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.214 -0.929 . . . . 0.0 110.905 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 . . . . . 0 C--O 1.236 0.388 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 179.476 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -134.5 167.95 19.84 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.974 1.31 . . . . 0.0 108.83 169.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.23 139.57 8.38 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.16 25.12 49.76 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.08 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -109.76 167.42 10.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.548 1.674 . . . . 0.0 109.693 164.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.45 138.25 46.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.766 2.026 . . . . 0.0 106.751 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -140.63 175.3 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 108.901 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -109.38 151.9 26.03 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 157.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.13 147.09 49.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.461 1.505 . . . . 0.0 109.056 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -134.63 104.81 6.21 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -164.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.8 mtm -88.95 167.2 13.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.302 0.573 . . . . 0.0 110.349 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -51.06 113.32 0.9 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.892 1.677 . . . . 0.0 109.154 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.77 -36.13 3.16 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.781 1.658 . . . . 0.0 114.26 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.54 163.65 19.2 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.54 1.536 . . . . 0.0 112.515 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -85.55 -179.04 3.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 125.126 3.884 . . . . 0.0 110.68 168.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -67.18 92.66 0.27 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.269 1.028 . . . . 0.0 108.655 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -78.13 139.1 60.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.986 1.314 . . . . 0.0 108.089 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.4 137.22 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.352 2.034 . . . . 0.0 108.914 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.77 156.86 43.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 141.72 49.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mm -78.12 105.37 7.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.27 170.87 6.5 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.655 0.782 . . . . 0.0 108.896 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 121.179 -0.951 . . . . 0.0 108.584 162.68 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.631 0.253 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -141.02 164.19 30.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.927 1.291 . . . . 0.0 108.187 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.67 152.67 59.03 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 124.412 1.085 . . . . 0.0 110.158 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.03 91.06 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.637 2.891 . . . . 0.0 109.476 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.6 mm -82.36 118.1 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -85.09 149.51 25.5 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 163.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -111.86 113.34 25.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -64.8 160.4 20.34 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.933 0.873 . . . . 0.0 110.455 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.49 -47.31 2.38 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.92 2.2 . . . . 0.0 113.201 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -96.77 -21.64 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.485 1.143 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.0 m80 66.79 21.71 10.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.454 1.902 . . . . 0.0 112.065 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -71.66 163.37 27.9 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.219 1.009 . . . . 0.0 109.845 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -142.79 142.85 31.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 109.254 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.52 -175.81 5.53 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.986 2.514 . . . . 0.0 107.055 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.82 125.29 48.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 109.386 165.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 mt -130.48 150.89 51.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.518 1.927 . . . . 0.0 108.769 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.81 165.54 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.34 0.971 . . . . 0.0 111.687 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.66 -22.33 50.63 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.937 3.091 . . . . 0.0 113.385 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -60.96 -13.33 15.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.127 -0.939 . . . . 0.0 112.142 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.44 -5.26 21.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 113.734 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.2 mt -122.39 146.96 46.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.565 1.075 . . . . 0.0 109.911 -157.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.15 143.28 46.48 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.579 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -65.02 114.88 2.99 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.619 2.213 . . . . 0.0 108.664 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -46.98 -54.26 10.55 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 123.929 0.892 . . . . 0.0 109.471 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -60.11 -25.24 65.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.502 0.502 . . . . 0.0 112.299 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -57.03 4.18 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -83.42 17.06 2.27 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 112.434 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -66.65 -31.36 71.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.278 1.431 . . . . 0.0 108.968 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.62 -57.07 3.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.414 0.552 . . . . 0.0 111.253 162.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.92 -41.85 83.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.115 0.87 . . . . 0.0 110.843 -162.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -102.73 -14.78 16.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.027 1.731 . . . . 0.0 112.541 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.64 75.17 2.14 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 119.719 1.145 . . . . 0.0 110.268 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -133.3 132.67 41.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.251 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 p -61.62 79.79 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.833 2.053 . . . . 0.0 112.867 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -95.41 147.11 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 110.181 -168.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -91.97 41.96 1.09 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -149.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -105.09 147.14 28.22 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.21 155.37 37.26 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.2 1.64 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.973 1.273 . . . . 0.0 112.197 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.28 -49.61 63.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.905 1.353 . . . . 0.0 112.932 -164.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -66.82 -22.64 66.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.625 0.77 . . . . 0.0 110.754 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -75.53 -47.52 26.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 108.39 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.66 -26.79 72.99 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 120.11 -0.272 . . . . 0.0 113.366 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 mt -72.23 -29.72 64.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.65 1.225 . . . . 0.0 111.584 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -70.72 -42.59 70.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.33 -0.856 . . . . 0.0 109.161 171.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.84 -55.22 37.2 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.156 0.582 . . . . 0.0 110.409 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.02 -34.12 64.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.989 0.813 . . . . 0.0 111.316 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.38 -29.94 65.54 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.496 -0.752 . . . . 0.0 111.631 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 125.071 1.348 . . . . 0.0 112.795 175.539 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.73 156.52 46.74 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.794 -1.191 . . . . 0.0 110.058 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 141.8 50.44 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.63 40.41 10.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -136.55 173.08 12.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.248 1.024 . . . . 0.0 110.588 159.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -119.25 147.2 44.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.877 2.471 . . . . 0.0 106.801 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.424 HG11 HD11 ' A' ' 29' ' ' ILE . 33.9 m -149.73 171.33 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.381 1.073 . . . . 0.0 108.759 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.76 125.56 52.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.03 151.55 20.81 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.041 0.936 . . . . 0.0 110.796 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -126.9 106.32 9.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.2 mtp -83.99 167.78 16.58 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 162.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.18 119.79 11.51 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.05 -16.53 2.0 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.038 -1.423 . . . . 0.0 116.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -67.16 159.19 78.35 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 119.741 1.77 . . . . 0.0 110.907 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.13 164.28 34.52 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.61 2.873 . . . . 0.0 110.037 168.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -65.47 103.15 0.79 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -95.28 138.44 21.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.389 -164.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.56 124.49 14.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.695 2.264 . . . . 0.0 110.345 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.83 164.16 30.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.047 0.539 . . . . 0.0 110.324 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -128.85 146.13 51.01 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.037 -0.414 . . . . 0.0 110.612 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.424 HD11 HG11 ' A' ' 15' ' ' VAL . 17.7 mm -85.24 98.63 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 172.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -85.68 -175.88 5.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.754 1.622 . . . . 0.0 109.252 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 126.576 1.951 . . . . 0.0 108.907 167.135 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -136.9 -177.04 4.57 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.924 1.29 . . . . 0.0 109.679 -163.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -140.65 152.44 66.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.36 1.464 . . . . 0.0 109.084 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.81 92.01 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.424 3.416 . . . . 0.0 110.867 170.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.84 141.15 14.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -118.59 133.02 56.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.018 1.727 . . . . 0.0 108.2 172.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -89.85 112.53 23.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.242 1.417 . . . . 0.0 108.357 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 17.1 m-85 -62.39 154.56 27.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 171.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.49 -21.53 0.9 Allowed Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.725 -1.597 . . . . 0.0 115.951 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.96 -14.05 7.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 121.079 2.439 . . . . 0.0 113.879 178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 61.65 16.3 7.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.569 2.348 . . . . 0.0 112.832 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.1 170.4 10.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.373 1.082 . . . . 0.0 109.954 170.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -141.79 147.73 37.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 108.198 -172.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.42 24.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.318 0.508 . . . . 0.0 109.695 167.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -110.28 112.34 24.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 mt -125.13 142.0 51.76 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.55 164.17 37.68 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -64.4 -32.61 60.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.27 2.647 . . . . 0.0 112.363 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -58.95 -32.95 70.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.856 0.862 . . . . 0.0 112.788 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -82.72 -10.36 58.94 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.236 0.925 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.1 mt -108.15 154.7 21.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.614 1.965 . . . . 0.0 109.687 -171.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -134.01 140.89 37.66 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.797 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.76 126.12 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.442 2.761 . . . . 0.0 109.591 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.42 -48.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.706 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.56 -43.63 72.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.72 1.145 . . . . 0.0 112.731 -172.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -54.11 36.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.403 0.681 . . . . 0.0 110.61 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -85.47 2.85 42.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -55.76 -49.87 71.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.144 1.777 . . . . 0.0 108.991 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.27 -16.99 44.18 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -82.17 -64.76 1.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.885 1.221 . . . . 0.0 112.085 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -88.68 -31.48 18.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.818 2.447 . . . . 0.0 113.712 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.62 63.87 1.14 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.463 1.506 . . . . 0.0 113.367 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -128.99 142.6 50.87 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 p -56.75 150.13 16.71 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.382 1.087 . . . . 0.0 109.801 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.97 167.11 17.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.732 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -83.47 -16.83 44.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.155 0.889 . . . . 0.0 112.846 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -58.85 138.59 57.2 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.558 1.072 . . . . 0.0 109.768 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -67.29 154.69 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.356 0.663 . . . . 0.0 109.411 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.14 -31.97 1.11 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.389 0.995 . . . . 0.0 112.642 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.35 -26.23 66.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.922 1.861 . . . . 0.0 112.487 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -49.9 21.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.135 -0.978 . . . . 0.0 109.742 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -55.45 -47.69 75.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.131 1.372 . . . . 0.0 108.572 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 49' ' ' PHE . . . -66.97 -34.75 88.02 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.425 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.57 -20.38 64.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.581 1.691 . . . . 0.0 111.872 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -83.62 -42.69 16.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 120.765 1.621 . . . . 0.0 110.334 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -55.1 -49.93 70.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.045 0.538 . . . . 0.0 109.884 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.69 -31.79 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.527 -0.733 . . . . 0.0 111.94 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.66 -21.56 65.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.617 1.167 . . . . 0.0 111.769 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 . . . . . 0 C--O 1.234 0.267 0 C-N-CA 123.562 0.745 . . . . 0.0 112.058 -168.24 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.065 -0.017 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -143.07 167.63 21.64 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.409 1.084 . . . . 0.0 110.214 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.21 132.37 23.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.065 0.946 . . . . 0.0 110.659 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.71 76.77 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.26 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.93 144.29 57.38 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.371 1.585 . . . . 0.0 107.926 165.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -101.25 144.1 30.52 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 171.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.87 173.98 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.327 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -114.35 138.07 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 154.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.87 172.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.156 1.383 . . . . 0.0 107.92 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -141.89 106.32 4.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.78 172.8 12.88 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.297 1.046 . . . . 0.0 110.628 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -80.74 44.28 0.72 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.864 2.066 . . . . 0.0 112.956 -165.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.83 -43.11 0.68 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.536 1.541 . . . . 0.0 109.758 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -55.95 155.61 11.55 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 117.284 0.542 . . . . 0.0 110.41 170.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.57 -178.2 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.187 3.258 . . . . 0.0 109.894 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -74.54 79.29 1.96 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.441 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -63.31 134.31 95.79 Favored Pre-proline 0 CA--C 1.539 0.549 0 O-C-N 120.855 -1.153 . . . . 0.0 111.27 -170.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.646 ' HG3' HD22 ' A' ' 85' ' ' LEU . 50.6 Cg_endo -67.95 131.38 23.78 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.587 2.191 . . . . 0.0 110.032 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.99 168.65 22.53 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.078 0.466 . . . . 0.0 109.843 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.47 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 7.5 ptm180 -134.67 160.29 38.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.692 -0.63 . . . . 0.0 110.878 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.2 mm -84.13 117.13 29.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -82.64 -179.4 7.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.382 1.473 . . . . 0.0 108.587 166.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 108.04 172.857 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -115.26 143.96 44.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.725 1.602 . . . . 0.0 110.972 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -103.81 150.74 38.5 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.32 104.49 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.663 2.242 . . . . 0.0 108.555 159.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.55 140.83 16.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -112.97 121.16 43.81 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.563 2.345 . . . . 0.0 107.513 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -78.11 115.71 18.04 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.47 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.6 m-85 -67.79 155.77 38.54 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.906 0.384 . . . . 0.0 110.653 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.47 -58.8 4.1 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.979 0.8 . . . . 0.0 111.548 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -81.82 -21.16 37.8 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 112.152 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.4 m170 55.56 18.01 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.012 2.125 . . . . 0.0 112.619 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.86 166.56 19.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 109.095 173.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 p -142.56 148.11 37.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.229 1.011 . . . . 0.0 108.523 -171.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.52 179.47 7.65 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.521 1.128 . . . . 0.0 109.002 173.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -123.01 107.39 11.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.4 146.54 47.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.454 1.901 . . . . 0.0 107.96 -176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.46 162.13 23.37 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.91 -24.07 61.22 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.846 3.031 . . . . 0.0 113.961 -165.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -67.06 -9.1 35.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.239 1.381 . . . . 0.0 112.457 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.62 4.86 36.06 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.782 1.174 . . . . 0.0 111.501 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.51 153.93 50.44 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.298 1.439 . . . . 0.0 109.601 -166.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.13 143.93 26.7 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.901 0.88 . . . . 0.0 110.362 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.26 129.31 21.28 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.841 2.361 . . . . 0.0 110.568 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.54 -48.05 75.35 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 121.926 -0.484 . . . . 0.0 110.137 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.82 -24.74 66.08 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.75 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -43.28 18.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.523 1.129 . . . . 0.0 110.203 174.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.428 ' CD1' ' CE2' ' A' ' 72' ' ' PHE . 54.3 m-85 -100.84 6.29 43.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.538 1.535 . . . . 0.0 114.047 -164.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -58.81 -33.72 70.7 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 127.249 2.219 . . . . 0.0 112.78 -167.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -98.85 -21.36 16.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.027 0.83 . . . . 0.0 110.346 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -76.13 -68.77 0.55 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.685 1.194 . . . . 0.0 108.576 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 68' ' ' TYR . 22.1 m-30 -81.0 -44.36 18.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.938 1.695 . . . . 0.0 108.975 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.36 96.0 0.05 OUTLIER Glycine 0 C--N 1.339 0.723 0 C-N-CA 125.862 1.696 . . . . 0.0 109.081 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -140.27 133.13 29.16 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.675 1.99 . . . . 0.0 106.245 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 122.57 21.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -145.06 171.76 14.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.256 1.823 . . . . 0.0 108.988 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -88.24 -60.05 2.07 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.083 0.856 . . . . 0.0 112.262 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.304 0.3 OUTLIER 44.5 -126.1 1.02 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.824 0.85 . . . . 0.0 109.876 -173.367 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -136.99 105.64 5.84 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 127.706 2.402 . . . . 0.0 105.975 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.1 89.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 119.927 1.239 . . . . 0.0 114.207 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 33.2 t80 -76.55 -52.91 8.84 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.243 1.522 . . . . 0.0 110.816 -170.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -40.97 69.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.882 1.219 . . . . 0.0 110.561 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -61.7 -52.0 66.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.059 1.344 . . . . 0.0 110.591 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.62 92.21 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 123.39 0.519 . . . . 0.0 112.676 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.646 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -63.53 -49.48 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -57.58 -35.86 70.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.469 0.577 . . . . 0.0 110.935 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.58 -47.63 69.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.924 0.784 . . . . 0.0 110.681 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -67.76 -34.65 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.867 0.758 . . . . 0.0 109.79 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.52 -17.83 60.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.789 1.235 . . . . 0.0 111.648 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 . . . . . 0 N--CA 1.463 0.194 0 C-N-CA 125.541 1.536 . . . . 0.0 112.658 -169.592 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.475 ' N ' ' HH ' ' A' ' 44' ' ' TYR . 58.7 m-85 . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -139.83 172.25 13.05 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.899 -1.125 . . . . 0.0 108.557 168.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.1 55.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.6 73.79 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.767 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -97.74 157.69 15.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.753 1.276 . . . . 0.0 108.697 161.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -118.14 134.45 54.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.56 1.944 . . . . 0.0 106.328 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.98 171.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 118.942 0.792 . . . . 0.0 110.414 -167.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.36 142.11 34.78 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.499 -1.376 . . . . 0.0 107.791 162.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.58 161.47 15.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.433 1.493 . . . . 0.0 109.118 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -143.79 107.17 4.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.6 171.5 8.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.69 0.757 . . . . 0.0 109.816 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -53.08 119.13 4.33 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.025 1.73 . . . . 0.0 108.7 173.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.08 -48.36 3.54 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.397 0.999 . . . . 0.0 112.801 172.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -54.45 158.14 4.34 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.908 1.683 . . . . 0.0 112.297 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.36 179.58 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.031 3.154 . . . . 0.0 110.698 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.86 94.12 0.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -85.62 134.91 38.95 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.809 1.243 . . . . 0.0 109.495 -170.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.81 126.18 17.6 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.052 2.501 . . . . 0.0 110.225 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.69 168.11 20.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.764 1.226 . . . . 0.0 109.493 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.23 52.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -80.18 105.15 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 168.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -89.61 -172.39 3.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 121.987 0.899 . . . . 0.0 111.258 -173.112 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -136.01 153.58 51.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.387 1.075 . . . . 0.0 110.068 -171.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HH ' ' N ' ' A' ' 9' ' ' TYR . 86.3 m-85 -106.11 148.18 36.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 125.121 1.368 . . . . 0.0 107.719 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.3 122.16 10.24 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.124 1.883 . . . . 0.0 107.625 155.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.88 111.38 32.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.656 1.582 . . . . 0.0 107.589 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -85.47 129.14 34.88 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.121 0.969 . . . . 0.0 108.656 171.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -93.62 93.84 8.27 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 108.149 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.18 151.01 1.48 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.637 1.175 . . . . 0.0 110.572 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.57 -74.07 2.3 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -68.34 -20.89 64.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m170 46.35 50.56 12.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.511 1.925 . . . . 0.0 111.001 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -97.09 162.06 13.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 161.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.0 p -134.76 130.81 36.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 157.6 43.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.636 0.653 . . . . 0.0 111.189 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -94.98 108.44 20.5 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.8 mt -126.06 146.71 49.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.069 0.548 . . . . 0.0 110.305 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.4 161.9 23.35 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.09 0.852 . . . . 0.0 111.506 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.2 -20.81 42.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.734 2.956 . . . . 0.0 113.857 -164.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -70.54 -14.57 62.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.655 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.64 0.39 44.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.005 1.322 . . . . 0.0 111.047 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -115.62 160.73 19.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.387 1.449 . . . . 0.0 110.482 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.8 145.63 28.61 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.14 130.91 26.88 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -51.25 -58.05 7.21 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.183 0.993 . . . . 0.0 110.853 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.5 -34.26 72.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.964 1.305 . . . . 0.0 111.508 -168.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -56.38 6.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -86.16 6.38 29.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.831 1.253 . . . . 0.0 113.57 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -57.33 -40.83 78.8 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.271 1.828 . . . . 0.0 110.739 -172.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.58 -45.19 39.15 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.899 0.772 . . . . 0.0 111.475 172.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -66.24 -41.25 90.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.58 0.752 . . . . 0.0 111.767 -169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -114.83 -31.01 6.26 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.844 1.658 . . . . 0.0 110.969 -167.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.19 70.68 2.55 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -140.67 139.2 34.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.498 1.119 . . . . 0.0 108.256 -167.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 p -54.54 140.51 34.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.27 1.428 . . . . 0.0 109.993 -176.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.22 154.92 50.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.232 174.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -77.99 66.97 3.74 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 109.739 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 mmt-85 -133.94 112.68 11.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.167 1.787 . . . . 0.0 106.529 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -57.93 150.13 21.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.36 -18.26 0.56 Allowed Glycine 0 CA--C 1.537 1.457 0 CA-C-O 118.477 -1.18 . . . . 0.0 115.031 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -73.47 -55.93 5.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 121.426 2.613 . . . . 0.0 110.527 -174.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -66.06 -27.92 68.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.703 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -65.25 -41.02 94.72 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.775 2.03 . . . . 0.0 110.594 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.37 -35.24 81.74 Favored Glycine 0 CA--C 1.523 0.543 0 O-C-N 121.399 -0.813 . . . . 0.0 111.697 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.65 -32.82 74.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.901 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -59.77 -47.58 85.12 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.92 1.236 . . . . 0.0 110.435 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.39 -57.69 8.59 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.077 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 tt -59.24 -32.5 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 118.688 0.676 . . . . 0.0 111.732 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.98 -52.31 56.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.432 1.093 . . . . 0.0 109.799 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.816 0.846 . . . . 0.0 112.807 -178.958 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -135.43 157.89 45.76 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.962 1.705 . . . . 0.0 110.099 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.75 134.42 56.73 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.711 0.632 . . . . 0.0 109.981 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.98 47.33 5.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.54 174.59 10.45 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.021 0.529 . . . . 0.0 110.275 161.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.1 mt -125.08 140.31 53.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.805 2.042 . . . . 0.0 106.262 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.91 172.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -105.7 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 152.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.42 154.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.181 1.392 . . . . 0.0 108.216 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -128.92 106.32 8.82 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mtm -86.21 167.59 14.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 167.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.26 125.43 20.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.719 1.207 . . . . 0.0 108.532 177.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.77 -33.58 1.22 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.371 1.462 . . . . 0.0 115.132 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.13 158.69 62.22 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 118.887 1.344 . . . . 0.0 112.072 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 178.21 6.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.55 3.5 . . . . 0.0 110.247 168.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.7 96.31 0.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.565 0.746 . . . . 0.0 109.093 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -78.81 135.22 59.67 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.109 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.04 122.5 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.537 2.158 . . . . 0.0 108.914 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.15 165.91 25.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 109.908 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -129.86 164.11 24.85 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.101 -1.0 . . . . 0.0 110.621 -178.671 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.17 96.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -86.4 -169.12 2.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.69 2.396 . . . . 0.0 110.834 -166.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.535 0.367 0 O-C-N 120.23 -1.544 . . . . 0.0 112.281 -175.772 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -132.36 145.3 51.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.768 1.227 . . . . 0.0 108.972 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -107.75 148.6 37.64 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 124.002 0.921 . . . . 0.0 108.629 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.83 105.2 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.446 2.764 . . . . 0.0 109.19 162.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.64 156.77 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -133.13 124.96 28.48 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.338 1.855 . . . . 0.0 107.299 166.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -89.62 94.65 9.94 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 16.5 m-85 -46.68 148.13 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.493 1.117 . . . . 0.0 111.069 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.99 -35.87 1.06 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.093 0.854 . . . . 0.0 113.869 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.8 p -87.07 -26.81 23.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.586 1.693 . . . . 0.0 110.864 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.8 m80 62.01 24.46 14.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.496 2.318 . . . . 0.0 112.194 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -97.03 149.87 21.44 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.544 1.138 . . . . 0.0 108.994 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -123.74 147.42 47.51 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 -172.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.96 165.27 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.681 1.193 . . . . 0.0 109.122 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.95 106.94 17.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.19 156.58 19.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 161.25 22.54 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 166.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -63.32 -16.71 56.21 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.085 3.19 . . . . 0.0 115.076 -166.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -69.3 -17.79 63.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.446 1.476 . . . . 0.0 111.606 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -89.23 1.84 55.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.619 1.168 . . . . 0.0 110.905 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.7 mt -117.58 167.77 11.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.751 1.62 . . . . 0.0 111.463 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -143.69 152.31 55.77 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.025 1.73 . . . . 0.0 109.169 162.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.58 118.27 5.4 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 0.0 111.034 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -44.33 -62.27 1.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 125.075 1.35 . . . . 0.0 112.324 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -42.52 62.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.473 1.033 . . . . 0.0 112.055 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.41 -33.09 74.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.908 0.883 . . . . 0.0 111.426 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.31 8.82 18.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.198 -1.564 . . . . 0.0 112.787 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -56.77 -42.57 79.62 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.347 1.859 . . . . 0.0 111.144 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -74.54 -37.17 63.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.877 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -82.26 -49.37 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.895 1.278 . . . . 0.0 111.48 -162.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -94.75 -33.34 12.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.752 2.021 . . . . 0.0 110.363 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.29 61.76 3.47 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.278 1.418 . . . . 0.0 111.366 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.558 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 11.1 mmpt? -131.24 136.95 48.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.566 1.947 . . . . 0.0 107.799 -172.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.6 m -40.34 110.31 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.435 2.294 . . . . 0.0 110.824 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.65 176.6 7.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.046 0.45 . . . . 0.0 109.829 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -83.83 -38.8 20.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.537 -1.221 . . . . 0.0 110.047 164.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 125.81 16.63 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.669 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.23 163.65 8.01 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 0.0 109.675 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.08 -42.32 1.86 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -56.91 -44.74 82.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.455 1.102 . . . . 0.0 111.861 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.52 -36.81 71.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.24 0.927 . . . . 0.0 110.445 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -63.11 -31.71 72.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.608 0.763 . . . . 0.0 110.39 172.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.19 -32.69 42.73 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.566 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.6 -41.81 99.2 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.387 1.094 . . . . 0.0 110.137 172.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -54.87 -43.77 73.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.191 0.45 . . . . 0.0 111.101 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.62 -53.06 57.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.849 0.295 . . . . 0.0 111.357 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.4 tt -67.45 -33.97 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.785 0.266 . . . . 0.0 110.589 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -62.87 -38.06 89.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.7 0.8 . . . . 0.0 110.06 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 . . . . . 0 N--CA 1.463 0.201 0 O-C-N 121.538 -0.726 . . . . 0.0 110.473 177.697 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -144.93 95.6 2.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.836 0.855 . . . . 0.0 108.748 -155.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m -57.54 149.51 21.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.438 1.095 . . . . 0.0 111.369 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.74 127.31 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 -171.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -65.68 -33.2 75.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.434 1.117 . . . . 0.0 110.892 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 t 44.71 41.12 4.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.522 1.929 . . . . 0.0 112.296 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.37 81.63 1.07 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.58 109.22 0.42 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.34 2.656 . . . . 0.0 106.403 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -75.56 155.3 36.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -155.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -132.59 153.95 50.52 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.707 1.203 . . . . 0.0 109.799 -169.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.14 52.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.5 -12.0 68.24 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.748 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.28 166.58 21.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.609 1.705 . . . . 0.0 109.589 166.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.44 148.81 47.4 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 29' ' ' ILE . 28.9 m -148.66 170.46 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 C-N-CA 123.363 0.665 . . . . 0.0 111.083 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.69 138.23 40.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.64 120.73 39.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 108.158 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 18.2 tptp -104.99 106.53 17.07 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -87.91 158.05 18.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -64.5 93.46 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 111.404 -172.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -18.78 42.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.631 1.11 . . . . 0.0 112.593 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -72.63 162.11 75.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.646 1.223 . . . . 0.0 108.753 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -61.78 178.73 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.645 2.23 . . . . 0.0 112.284 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.426 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 55.6 m80 -64.96 92.33 0.1 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 158.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -76.37 141.06 69.44 Favored Pre-proline 0 C--O 1.234 0.266 0 C-N-CA 123.979 0.911 . . . . 0.0 109.414 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.96 121.06 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.617 2.211 . . . . 0.0 109.187 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 163.47 32.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.5 0.667 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 13.2 ptt180 -119.93 152.33 37.58 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.42 HD11 HG11 ' A' ' 15' ' ' VAL . 11.2 mm -78.46 121.87 32.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 163.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -102.5 -174.39 2.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 168.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.72 -171.48 1.88 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -113.74 136.84 22.07 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.53 164.23 33.7 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.944 1.762 . . . . 0.0 109.927 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -78.45 51.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.881 1.672 . . . . 0.0 109.439 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.88 10.08 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 118.783 2.273 . . . . 0.0 118.783 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.9 -159.74 0.76 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.81 2.805 . . . . 0.0 111.512 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.14 142.05 16.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 109.483 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 113.41 54.26 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.048 0.939 . . . . 0.0 109.709 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.24 170.13 17.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.82 2.347 . . . . 0.0 112.401 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.47 153.94 31.15 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.196 1.264 . . . . 0.0 111.342 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.0 136.36 57.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 97.92 -26.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 1 C-N-CA 132.424 4.29 . . . . 0.0 110.946 -175.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -83.16 166.99 18.17 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.501 1.046 . . . . 0.0 111.352 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -130.26 149.4 73.21 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.426 1.09 . . . . 0.0 109.225 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 92.26 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.723 2.949 . . . . 0.0 108.976 163.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.47 122.93 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -102.12 117.43 34.76 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.151 1.38 . . . . 0.0 107.476 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -84.1 105.17 14.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.69 1.596 . . . . 0.0 107.658 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 11.5 m-85 -60.69 156.77 16.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.107 0.479 . . . . 0.0 110.731 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.16 -23.42 0.91 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.448 1.975 . . . . 0.0 115.616 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -113.55 -18.46 11.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.931 1.366 . . . . 0.0 110.604 170.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.6 m170 61.85 18.43 9.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.06 2.544 . . . . 0.0 111.578 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.19 160.2 32.32 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.753 0.821 . . . . 0.0 110.005 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.3 p -125.71 131.01 52.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.734 1.214 . . . . 0.0 108.157 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.78 170.22 16.29 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.653 166.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.16 118.06 35.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.49 154.23 40.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.45 167.05 19.94 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -61.56 -32.76 87.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.982 2.455 . . . . 0.0 112.86 -163.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -63.25 -28.8 70.28 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.763 0.825 . . . . 0.0 112.799 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.78 -1.16 50.88 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 111.716 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -126.85 160.75 30.03 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.957 1.703 . . . . 0.0 109.34 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -140.39 136.38 16.72 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.31 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.62 128.69 21.73 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.785 2.323 . . . . 0.0 110.128 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -51.15 -59.48 4.15 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.355 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -61.31 -23.54 65.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.629 1.559 . . . . 0.0 113.26 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -29.71 41.55 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.189 1.358 . . . . 0.0 111.507 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -114.55 6.19 15.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.742 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -57.08 -44.49 83.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.073 1.749 . . . . 0.0 109.854 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -89.87 -27.99 19.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -68.54 -44.05 75.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.741 1.616 . . . . 0.0 112.55 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -114.19 -27.25 7.71 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.938 2.095 . . . . 0.0 111.017 -172.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 63.5 3.86 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.814 1.197 . . . . 0.0 110.894 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -142.67 157.65 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.614 1.165 . . . . 0.0 109.158 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m -73.38 71.41 1.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.218 1.807 . . . . 0.0 115.34 -151.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.99 -11.12 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.563 1.545 . . . . 0.0 113.031 -170.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.6 tttt 53.69 29.14 8.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.078 2.151 . . . . 0.0 115.865 165.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -71.73 11.28 0.53 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 61.98 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.333 2.253 . . . . 0.0 109.393 -152.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.64 -40.91 0.65 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.441 -1.412 . . . . 0.0 112.632 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -30.43 68.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.917 1.687 . . . . 0.0 114.277 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -33.16 32.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 120.967 -1.083 . . . . 0.0 110.483 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.2 -58.22 9.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.79 1.636 . . . . 0.0 106.866 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.69 -33.69 87.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 118.998 0.817 . . . . 0.0 113.288 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.7 -29.61 69.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.689 1.245 . . . . 0.0 111.842 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -75.48 -43.38 49.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.929 0.786 . . . . 0.0 109.28 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.75 -38.21 90.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.028 1.331 . . . . 0.0 110.143 -171.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 tt -73.46 -45.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.341 1.057 . . . . 0.0 111.281 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.45 -55.91 26.27 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -75.56 -3.46 34.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.112 1.365 . . . . 0.0 112.773 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 t -83.74 -36.76 23.41 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.298 1.408 . . . . 0.0 110.199 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.61 170.32 36.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.81 112.0 1.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.791 2.327 . . . . 0.0 107.756 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.4 t -137.38 149.0 46.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.358 2.263 . . . . 0.0 104.919 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.1 m 57.65 2.26 0.15 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.719 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -177.999 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.406 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -140.95 -51.79 0.46 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.36 1.064 . . . . 0.0 110.271 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t 57.68 58.39 3.74 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.844 0.858 . . . . 0.0 110.612 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.26 67.88 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.22 120.34 40.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.232 1.013 . . . . 0.0 109.815 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.4 m -67.82 -25.17 65.44 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.892 0.877 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.67 108.09 2.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 -153.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -138.21 175.5 9.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.13 2.572 . . . . 0.0 105.118 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.13 156.6 44.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -142.58 161.81 37.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.518 1.527 . . . . 0.0 107.774 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 133.66 56.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.85 -12.73 68.84 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.614 -1.103 . . . . 0.0 112.915 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 128.07 34.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.349 1.575 . . . . 0.0 107.576 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -85.65 147.7 26.25 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.85 168.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.655 0.74 . . . . 0.0 111.781 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.52 125.5 50.11 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 160.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.402 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -92.82 154.17 18.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -130.19 105.89 8.23 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mtm -73.14 168.96 18.04 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 110.042 171.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.75 55.01 2.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 110.768 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.5 -28.22 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.946 0.784 . . . . 0.0 112.494 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -70.5 160.43 81.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.882 -0.775 . . . . 0.0 110.258 167.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.11 177.84 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.965 3.11 . . . . 0.0 111.749 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -62.65 112.57 2.56 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -114.56 143.56 30.15 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 124.91 1.284 . . . . 0.0 108.037 -166.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.77 123.85 11.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 110.973 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.48 159.38 42.52 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.274 0.559 . . . . 0.0 110.153 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 138.84 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -75.53 92.49 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 163.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -78.21 -164.08 0.5 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -125.74 -167.75 1.74 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.77 -1.206 . . . . 0.0 108.318 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.72 124.51 18.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.166 -166.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.32 168.71 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.811 2.341 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.23 73.83 0.96 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.02 1.728 . . . . 0.0 109.738 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 84.73 1.7 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -166.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 -172.02 2.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 150.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.06 151.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 163.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.21 147.02 39.37 Favored Pre-proline 0 C--O 1.237 0.415 0 O-C-N 121.553 -0.717 . . . . 0.0 109.182 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.98 150.27 26.49 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.646 2.231 . . . . 0.0 110.317 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.63 170.69 17.99 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.597 1.531 . . . . 0.0 112.054 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.97 125.87 22.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.019 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m120 77.71 17.32 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.55 2.34 . . . . 0.0 112.494 171.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -125.58 160.98 28.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.715 1.143 . . . . 0.0 111.985 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -123.31 152.81 64.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.03 1.732 . . . . 0.0 109.015 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.59 93.39 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 124.506 3.47 . . . . 0.0 111.358 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mm -86.03 108.4 17.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.031 0.933 . . . . 0.0 108.577 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -94.5 119.16 32.78 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 111.64 18.55 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 107.85 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -61.04 157.18 16.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.745 0.783 . . . . 0.0 110.377 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.92 -70.68 1.75 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.745 1.164 . . . . 0.0 111.894 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 p -69.02 -22.29 64.07 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.948 -1.325 . . . . 0.0 112.275 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 66.45 10.17 7.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.1 2.16 . . . . 0.0 113.679 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.14 159.17 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.914 -1.116 . . . . 0.0 110.262 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.25 130.38 40.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.24 -176.15 5.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.82 1.248 . . . . 0.0 109.952 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.95 125.99 40.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 171.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.2 mt -128.85 155.93 44.45 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 108.247 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.87 171.83 22.12 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.744 1.164 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.85 -26.36 32.18 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.483 2.122 . . . . 0.0 113.07 -160.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.86 -14.16 61.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.061 0.846 . . . . 0.0 112.494 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -94.38 -4.59 48.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.761 0.709 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 17' ' ' ALA . 90.1 mt -127.84 153.66 46.36 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.277 1.831 . . . . 0.0 109.927 -163.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -136.29 147.1 58.9 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 109.72 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -63.1 140.41 78.22 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.595 2.197 . . . . 0.0 109.456 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -59.1 -65.69 0.63 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -24.96 67.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -162.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -68.44 -58.77 3.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.552 0.741 . . . . 0.0 109.937 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.48 16.46 7.61 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.968 1.707 . . . . 0.0 111.055 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -60.42 -40.17 90.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.698 1.199 . . . . 0.0 109.518 -164.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.421 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 t70 -80.19 -53.39 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.579 170.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -51.06 -39.94 57.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.676 1.59 . . . . 0.0 113.84 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -110.23 -24.33 10.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.164 1.385 . . . . 0.0 110.643 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.16 71.07 2.89 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 70' ' ' ASP . 9.3 mmpt? -121.66 145.03 48.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 107.659 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -58.04 99.03 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.867 1.667 . . . . 0.0 109.053 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -77.75 173.27 12.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.506 0.669 . . . . 0.0 110.058 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -73.44 -39.34 65.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.694 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.57 141.18 56.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.452 0.569 . . . . 0.0 110.606 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -64.5 163.22 13.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.782 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -47.29 0.83 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.946 1.736 . . . . 0.0 112.167 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -49.58 -49.01 48.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.16 1.384 . . . . 0.0 111.404 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.69 -29.15 69.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.52 -46.93 71.39 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -28.7 73.79 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.24 -0.755 . . . . 0.0 112.895 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.97 -49.8 59.57 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.604 1.202 . . . . 0.0 110.593 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -59.68 -39.01 83.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.891 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.03 -63.11 1.32 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.671 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.85 -32.58 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 119.747 1.158 . . . . 0.0 112.247 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.15 -53.73 40.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.503 0.321 . . . . 0.0 110.141 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -68.35 -38.31 81.33 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 121.869 -0.519 . . . . 0.0 111.204 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.9 m -73.59 -0.16 14.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.661 1.584 . . . . 0.0 112.404 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.86 82.66 0.34 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.919 -1.49 . . . . 0.0 111.458 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.94 64.87 4.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.671 3.581 . . . . 0.0 112.111 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -66.63 149.21 50.82 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.662 -1.274 . . . . 0.0 110.248 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 p -73.75 117.81 15.96 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 -179.724 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.7 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m 37.6 43.96 0.49 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.751 2.02 . . . . 0.0 115.36 162.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.9 m -99.89 146.43 26.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 169.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.97 -149.65 46.91 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 p -145.39 79.18 1.57 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.07 1.748 . . . . 0.0 109.851 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 m -65.44 169.93 5.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.368 -0.833 . . . . 0.0 110.387 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.12 -128.7 2.91 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 56.0 94.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.523 1.929 . . . . 0.0 113.794 170.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -67.66 158.54 31.97 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.757 1.223 . . . . 0.0 110.475 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -143.36 167.96 20.93 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.673 1.589 . . . . 0.0 108.269 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.6 26.61 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.61 32.96 4.61 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.785 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.48 168.85 16.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.202 1.001 . . . . 0.0 108.636 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.1 mt -123.08 147.89 46.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.839 1.656 . . . . 0.0 106.665 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.09 171.52 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.333 0.653 . . . . 0.0 110.26 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.36 149.54 27.73 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.17 144.46 50.43 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.944 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE2' ' NE2' ' A' ' 24' ' ' HIS . 5.0 tptp -128.53 105.83 8.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.023 0.829 . . . . 0.0 110.369 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.9 mtp -90.18 170.8 9.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.56 1.144 . . . . 0.0 109.527 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -60.01 138.89 57.75 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.644 -0.66 . . . . 0.0 109.375 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 -36.25 0.74 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.704 1.145 . . . . 0.0 114.738 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.44 160.72 81.73 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.75 2.02 . . . . 0.0 112.277 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.34 -177.6 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.89 1 C-N-CA 125.574 4.182 . . . . 0.0 110.454 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.415 ' NE2' ' HE2' ' A' ' 18' ' ' LYS . 16.4 m80 -71.79 90.39 1.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -77.74 141.74 64.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.821 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.0 127.56 17.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.411 2.074 . . . . 0.0 110.564 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.17 166.03 26.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.114 0.566 . . . . 0.0 110.596 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -128.02 162.91 25.73 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 120.929 -1.107 . . . . 0.0 111.584 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -94.87 101.93 13.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.7 -177.09 6.5 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.161 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -122.81 140.52 52.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.186 1.394 . . . . 0.0 108.141 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 mt -76.69 119.03 75.66 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.14 158.07 26.63 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.093 2.529 . . . . 0.0 111.35 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.65 103.77 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.68 2.392 . . . . 0.0 112.498 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.28 7.68 51.56 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.029 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.5 -168.79 0.13 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.089 1.356 . . . . 0.0 111.855 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -65.07 162.55 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.016 0.926 . . . . 0.0 108.698 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.7 97.77 49.56 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 110.333 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.37 163.29 38.16 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.587 2.192 . . . . 0.0 111.937 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.48 156.93 64.08 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.899 1.733 . . . . 0.0 110.859 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.44 27.4 0.43 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.772 1.229 . . . . 0.0 114.151 -163.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -153.79 21.35 0.52 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.827 2.451 . . . . 0.0 109.51 -161.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -141.56 171.74 13.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.786 2.835 . . . . 0.0 107.999 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -131.74 152.34 80.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.182 1.393 . . . . 0.0 108.894 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.13 91.32 1.21 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.863 3.708 . . . . 0.0 110.684 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.9 mm -89.18 110.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -169.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -88.87 132.18 34.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 108.304 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -103.08 94.56 5.61 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.103 1.361 . . . . 0.0 108.552 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -47.53 147.81 1.63 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.82 1.648 . . . . 0.0 112.365 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 -39.16 0.75 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.977 1.751 . . . . 0.0 114.241 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -22.65 24.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.467 1.507 . . . . 0.0 112.429 173.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.4 m80 58.72 11.91 2.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.676 2.39 . . . . 0.0 114.749 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -74.13 169.62 17.18 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.629 0.649 . . . . 0.0 110.225 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -127.97 166.14 18.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.39 166.1 34.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.148 1.379 . . . . 0.0 108.165 163.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -105.96 114.32 28.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 166.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.07 150.51 52.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.508 0.723 . . . . 0.0 109.307 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.33 25.62 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.14 -10.62 29.23 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.933 3.089 . . . . 0.0 113.314 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -76.75 -5.66 49.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.869 1.268 . . . . 0.0 113.744 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -122.17 12.05 10.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.0 110.723 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 mt -135.2 162.26 33.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.514 1.526 . . . . 0.0 110.574 -170.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.36 148.17 52.77 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.981 1.313 . . . . 0.0 111.703 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.77 142.83 95.14 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -67.49 -56.07 11.03 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.436 -0.79 . . . . 0.0 109.961 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.61 -9.3 53.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.86 -77.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 155.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -72.48 10.39 0.83 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.766 2.826 . . . . 0.0 114.523 -164.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -59.99 -35.23 74.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.073 1.349 . . . . 0.0 109.009 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.55 -45.45 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.115 1.325 . . . . 0.0 111.551 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -60.52 -55.01 38.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.406 0.682 . . . . 0.0 111.065 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -97.77 -16.23 19.96 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.795 1.238 . . . . 0.0 111.965 -171.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.3 37.75 1.58 Allowed Glycine 0 CA--C 1.541 1.658 0 O-C-N 120.985 -1.072 . . . . 0.0 114.564 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -115.15 135.51 54.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.837 1.318 . . . . 0.0 109.302 -164.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.8 p -57.52 107.45 0.44 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.567 1.147 . . . . 0.0 109.594 -171.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -94.21 163.88 13.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.307 -173.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -92.88 -7.66 45.58 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -66.06 136.84 56.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 158.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -66.73 168.45 9.49 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.471 0.708 . . . . 0.0 109.181 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.96 -32.0 1.07 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.983 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -55.33 -42.04 73.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.925 1.29 . . . . 0.0 110.571 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -65.43 -45.94 81.87 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.213 0.605 . . . . 0.0 111.348 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.96 -49.05 74.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.5 -38.37 96.22 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.329 -0.706 . . . . 0.0 112.777 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.46 -30.13 71.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.413 1.106 . . . . 0.0 111.832 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -73.7 -48.18 33.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.926 0.784 . . . . 0.0 109.017 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.76 -49.26 73.59 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.104 0.962 . . . . 0.0 111.19 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 tt -67.42 -37.52 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.585 0.354 . . . . 0.0 111.07 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.34 -41.05 96.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.609 -0.682 . . . . 0.0 109.96 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -83.32 25.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.653 1.581 . . . . 0.0 110.678 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 m -130.55 145.7 51.92 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 128.433 2.693 . . . . 0.0 103.748 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.62 175.7 16.48 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.791 2.138 . . . . 0.0 110.496 -166.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.18 167.59 8.98 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.895 3.063 . . . . 0.0 113.225 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -84.37 67.02 9.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.464 0.706 . . . . 0.0 109.247 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m -156.11 -174.17 4.83 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 127.236 2.214 . . . . 0.0 107.951 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.01 0.814 . . . . 0.0 113.572 169.499 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.777 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -150.84 -52.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 117.909 0.854 . . . . 0.0 110.975 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.1 t -58.17 107.54 0.49 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.301 1.04 . . . . 0.0 110.823 -172.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.74 113.41 3.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -169.85 114.57 0.52 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.851 1.261 . . . . 0.0 108.226 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.9 m -155.89 140.59 17.02 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 53.11 55.53 23.62 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.74 158.05 41.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 166.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -144.71 153.7 41.98 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.899 1.679 . . . . 0.0 107.17 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -141.74 161.21 38.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.633 1.173 . . . . 0.0 109.315 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 141.2 46.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 110.956 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.37 54.65 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.221 -1.321 . . . . 0.0 113.036 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 169.0 18.93 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 119.61 1.705 . . . . 0.0 110.69 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 88' ' ' ILE . 93.6 mt -123.09 142.85 50.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.943 1.297 . . . . 0.0 108.082 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 175.78 2.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 123.377 0.671 . . . . 0.0 110.701 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.39 131.6 54.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 156.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.97 164.4 13.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.868 2.867 . . . . 0.0 108.324 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -149.48 106.04 3.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.4 mtm -90.15 -179.76 5.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.324 1.049 . . . . 0.0 109.751 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.89 61.41 6.81 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.12 -0.988 . . . . 0.0 112.859 -164.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.54 -27.55 2.6 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 124.451 1.024 . . . . 0.0 110.614 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -60.62 150.86 73.59 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 122.264 -0.55 . . . . 0.0 109.525 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.47 174.03 5.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.388 3.392 . . . . 0.0 110.724 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.25 96.93 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -88.75 131.67 40.91 Favored Pre-proline 0 N--CA 1.456 -0.128 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.43 136.0 38.36 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.261 1.307 . . . . 0.0 109.1 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.27 163.88 34.1 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.973 0.909 . . . . 0.0 109.554 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.61 146.18 50.93 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.462 -0.774 . . . . 0.0 110.26 -178.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mm -80.9 103.14 7.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -78.79 -175.53 4.49 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -130.61 136.73 49.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.573 1.149 . . . . 0.0 108.504 -170.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.5 mt -83.13 120.34 75.74 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.127 -161.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.59 166.1 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.397 2.731 . . . . 0.0 112.277 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.21 53.73 0.52 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.965 1.306 . . . . 0.0 110.191 162.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.37 68.13 0.01 OUTLIER Glycine 0 C--N 1.333 0.412 0 O-C-N 121.15 -0.969 . . . . 0.0 111.269 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.91 179.88 7.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.163 1.385 . . . . 0.0 108.634 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.03 165.7 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.25 -0.907 . . . . 0.0 109.595 170.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 127.88 29.58 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.04 166.13 28.5 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.972 2.448 . . . . 0.0 112.51 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.85 149.58 72.7 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 120.737 0.958 . . . . 0.0 109.779 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.42 53.0 1.45 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.269 0.627 . . . . 0.0 111.836 -168.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.33 9.83 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.346 1.858 . . . . 0.0 111.76 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -140.99 163.67 32.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.418 1.087 . . . . 0.0 109.295 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.88 153.55 67.29 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 124.872 1.269 . . . . 0.0 109.239 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -67.26 95.31 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.734 2.956 . . . . 0.0 110.066 167.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.41 113.21 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -85.16 150.8 24.57 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.46 93.26 3.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.8 m-85 -47.58 150.25 1.03 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.826 2.051 . . . . 0.0 111.257 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.18 -49.88 3.62 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.28 1.419 . . . . 0.0 111.774 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -91.61 -16.08 27.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 113.603 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.7 m170 53.11 16.53 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.261 2.624 . . . . 0.0 114.77 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -71.97 164.39 26.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.898 -1.126 . . . . 0.0 110.194 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -139.72 137.89 35.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.032 1.333 . . . . 0.0 108.091 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.68 163.87 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.391 0.615 . . . . 0.0 109.42 169.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -101.99 109.69 21.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -127.83 151.35 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.014 0.926 . . . . 0.0 108.554 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.72 173.74 29.82 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.702 1.144 . . . . 0.0 110.479 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.74 -21.67 58.14 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.259 2.64 . . . . 0.0 112.366 -165.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -64.59 -18.48 64.93 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.293 -0.879 . . . . 0.0 113.055 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -109.07 10.96 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.915 1.286 . . . . 0.0 110.345 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.84 162.24 30.03 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.458 1.903 . . . . 0.0 109.364 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -148.17 143.11 17.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.422 1.089 . . . . 0.0 109.545 176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -63.27 126.38 17.68 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.592 2.861 . . . . 0.0 112.196 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.46 -51.89 67.62 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 121.337 -0.852 . . . . 0.0 111.252 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -59.79 -24.03 63.78 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.39 -72.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -82.25 9.9 7.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.298 1.439 . . . . 0.0 113.461 -164.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -54.89 -34.69 63.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.655 1.582 . . . . 0.0 110.91 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.28 -59.36 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.741 1.216 . . . . 0.0 110.179 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -55.92 -43.13 77.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.501 1.52 . . . . 0.0 113.335 -167.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.85 -26.79 9.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.63 1.972 . . . . 0.0 111.592 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.48 84.04 1.6 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -147.12 166.36 27.16 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 123.503 0.721 . . . . 0.0 110.108 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.8 m -73.57 124.94 26.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -117.13 146.48 43.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.297 1.439 . . . . 0.0 109.63 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -67.98 -14.66 63.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 127.46 32.69 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 120.671 1.578 . . . . 0.0 108.39 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -61.2 162.51 7.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -36.82 1.83 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 112.126 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.007 1.403 . . . . 0.0 110.804 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -67.05 -42.75 84.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 111.694 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.05 -42.38 76.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.06 21.87 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.1 -20.93 57.97 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.352 1.076 . . . . 0.0 113.548 -174.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -68.67 -42.04 78.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.499 1.045 . . . . 0.0 111.442 170.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -55.24 14.44 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 110.535 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 HD22 ' A' ' 14' ' ' LEU . 16.9 tt -55.33 -27.32 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.052 0.842 . . . . 0.0 112.802 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -78.18 -51.91 9.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.315 1.446 . . . . 0.0 111.044 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -73.69 -12.59 60.77 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.111 0.565 . . . . 0.0 112.239 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 t -73.9 82.43 1.68 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.545 1.538 . . . . 0.0 108.644 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.5 136.9 3.23 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 161.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.4 140.2 62.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 106.829 -2.027 . . . . 0.0 106.829 152.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.97 126.97 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.053 1.741 . . . . 0.0 108.227 -166.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.1 p -160.2 147.75 16.39 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.945 -0.472 . . . . 0.0 110.217 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.361 0 C-N-CA 125.849 1.69 . . . . 0.0 109.652 177.266 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.949 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -157.15 156.28 32.43 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.271 -1.135 . . . . 0.0 109.963 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.42 177.95 4.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.27 1.828 . . . . 0.0 108.941 171.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.48 -144.64 8.27 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 159.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 t -140.81 -51.5 0.46 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.963 1.305 . . . . 0.0 109.842 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.7 m 63.36 170.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.019 1.728 . . . . 0.0 114.195 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.44 -67.1 2.87 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 126.007 1.765 . . . . 0.0 113.552 169.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -142.25 -149.05 0.26 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.882 2.073 . . . . 0.0 107.276 -171.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.65 148.69 49.06 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.922 1.689 . . . . 0.0 107.932 172.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -142.46 173.16 11.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.994 1.717 . . . . 0.0 109.383 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.64 15.12 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.621 0.768 . . . . 0.0 111.433 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 -22.24 30.37 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 124.561 1.077 . . . . 0.0 112.533 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.35 167.91 20.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 122.572 1.177 . . . . 0.0 111.572 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.32 150.78 38.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.424 1.89 . . . . 0.0 107.731 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 29' ' ' ILE . 23.1 m -152.23 177.33 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.797 1.239 . . . . 0.0 110.105 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.86 127.03 53.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 159.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.77 137.58 32.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.0 108.758 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 15.0 tptp -108.11 105.11 14.71 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.7 mtm -76.9 166.66 23.04 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.14 58.33 3.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.485 0.714 . . . . 0.0 112.098 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -46.54 0.44 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.468 1.509 . . . . 0.0 110.907 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -60.19 159.4 22.13 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.696 1.199 . . . . 0.0 110.286 170.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.97 -176.34 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.498 2.799 . . . . 0.0 110.883 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.415 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 26.3 m80 -55.19 107.16 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 107.36 163.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -106.15 128.39 26.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 124.92 1.288 . . . . 0.0 108.115 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HG3' HD22 ' A' ' 85' ' ' LEU . 37.2 Cg_endo -62.54 129.76 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.14 1.893 . . . . 0.0 109.422 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.98 167.51 22.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 3.6 ptm180 -123.55 153.43 40.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.408 HD11 HG11 ' A' ' 15' ' ' VAL . 17.8 mm -84.47 105.4 13.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 169.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.87 -172.88 2.85 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -126.68 -161.65 1.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.986 164.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -138.93 148.17 56.85 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 127.132 2.173 . . . . 0.0 106.785 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -77.16 179.79 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.945 2.43 . . . . 0.0 109.597 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.75 158.79 33.96 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.896 -1.128 . . . . 0.0 110.094 165.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.15 61.22 5.54 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.586 1.565 . . . . 0.0 112.881 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.24 -171.69 3.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.089 1.356 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.67 144.37 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 155.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -141.3 157.9 65.17 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.743 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 154.56 55.87 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.617 2.211 . . . . 0.0 111.063 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.15 173.6 12.7 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.662 1.575 . . . . 0.0 110.677 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.13 41.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 122.341 1.067 . . . . 0.0 108.569 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 m120 62.15 17.4 9.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 127.571 2.348 . . . . 0.0 113.007 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -129.92 168.42 16.67 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.657 1.117 . . . . 0.0 111.657 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -131.17 153.46 81.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.473 2.309 . . . . 0.0 109.898 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -68.98 104.53 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 124.352 3.368 . . . . 0.0 110.045 169.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -97.19 140.28 17.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -123.89 113.29 18.3 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.086 1.755 . . . . 0.0 106.65 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -85.88 101.22 12.66 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.447 1.099 . . . . 0.0 108.482 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 5.8 m-85 -53.37 152.7 4.49 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.757 1.623 . . . . 0.0 112.192 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.26 -60.25 2.74 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.83 1.205 . . . . 0.0 110.38 -167.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -21.32 59.62 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.0 m170 55.27 11.56 0.58 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.994 1.717 . . . . 0.0 114.092 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.48 161.56 30.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.195 0.997 . . . . 0.0 110.044 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 p -141.56 138.42 32.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.911 2.084 . . . . 0.0 107.255 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.51 154.37 28.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.45 122.75 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.42 156.54 36.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.83 161.76 21.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.99 1.281 . . . . 0.0 111.391 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.65 -34.85 72.89 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.681 2.921 . . . . 0.0 112.119 -166.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mppt? -75.74 -7.41 54.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.11 -20.79 16.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.309 0.958 . . . . 0.0 110.557 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.11 170.23 14.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.523 1.529 . . . . 0.0 109.189 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -139.17 149.4 60.9 Favored Pre-proline 0 C--O 1.236 0.395 0 C-N-CA 123.909 0.884 . . . . 0.0 109.358 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.31 152.57 75.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.813 2.342 . . . . 0.0 112.273 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -71.5 -59.72 2.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.969 -0.457 . . . . 0.0 111.336 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.62 -25.82 68.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.393 0.542 . . . . 0.0 111.853 -163.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.71 -39.83 69.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.635 1.174 . . . . 0.0 110.879 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.41 9.63 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 0.0 112.673 -166.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -54.94 -30.65 59.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.89 1.276 . . . . 0.0 111.248 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -98.79 -34.74 10.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.773 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -68.68 -65.97 0.63 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.478 1.035 . . . . 0.0 109.57 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -84.91 -29.56 25.09 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.872 1.269 . . . . 0.0 111.694 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.19 62.53 3.36 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.11 173.48 11.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.903 -1.351 . . . . 0.0 110.558 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -66.53 153.15 43.71 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.415 1.102 . . . . 0.0 109.483 168.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -135.27 -96.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 159.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 -20.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 146.46 54.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 120.9 1.682 . . . . 0.0 110.759 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -60.17 156.05 16.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.242 1.417 . . . . 0.0 108.039 158.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 -43.82 1.19 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 125.663 1.602 . . . . 0.0 113.406 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -48.04 -54.01 14.44 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 125.626 1.571 . . . . 0.0 109.792 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -57.97 -34.47 69.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.37 0.668 . . . . 0.0 111.729 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.98 -49.29 53.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.356 1.062 . . . . 0.0 110.653 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.64 84.98 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.683 0.674 . . . . 0.0 112.576 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.569 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -69.52 -35.97 76.0 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.407 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -66.12 -39.07 89.63 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.214 0.915 . . . . 0.0 110.19 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.12 -47.96 75.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.848 0.859 . . . . 0.0 110.525 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.9 tt -67.28 -26.81 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 118.887 0.767 . . . . 0.0 111.729 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.48 -15.5 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 0.0 111.959 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -103.96 -71.34 0.74 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.862 1.265 . . . . 0.0 108.067 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.4 t 46.42 55.5 7.39 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.157 1.783 . . . . 0.0 109.71 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.13 170.31 40.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.133 0.873 . . . . 0.0 111.931 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.65 177.44 8.83 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.675 2.917 . . . . 0.0 110.883 166.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.74 168.96 20.78 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.592 0.757 . . . . 0.0 109.967 167.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 p -153.02 122.87 6.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.465 1.506 . . . . 0.0 108.016 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.738 0 C-N-CA 126.271 1.891 . . . . 0.0 108.572 -171.353 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 p -139.57 175.04 9.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -149.65 159.29 44.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.57 173.93 49.87 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 p -90.66 -51.35 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.487 1.115 . . . . 0.0 109.97 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 m 49.16 66.64 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -159.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.77 -122.47 2.09 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.971 1.272 . . . . 0.0 109.933 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -77.53 103.52 7.51 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.638 0.733 . . . . 0.0 110.166 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -48.34 155.86 0.46 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.779 2.032 . . . . 0.0 111.409 166.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -149.44 156.68 42.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.133 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 103.25 0.14 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.931 1.693 . . . . 0.0 110.143 -173.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.06 -24.41 2.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.136 1.827 . . . . 0.0 111.637 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.57 162.28 27.22 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.634 1.217 . . . . 0.0 112.334 -173.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.67 134.87 54.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 106.206 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -147.92 176.54 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.983 0.913 . . . . 0.0 111.445 -166.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.4 150.96 30.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 156.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.47 168.18 14.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.067 2.147 . . . . 0.0 109.01 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -141.36 107.11 5.11 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.9 mtp -83.81 160.6 21.17 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 165.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.16 112.21 1.3 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.207 1.003 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.56 -11.59 55.39 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.882 1.229 . . . . 0.0 114.652 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -74.86 158.03 85.04 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 118.347 1.073 . . . . 0.0 109.188 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.79 169.75 16.93 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.581 2.187 . . . . 0.0 108.793 163.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -59.57 103.31 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -87.22 143.5 34.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 108.035 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HG3' HD22 ' A' ' 85' ' ' LEU . 62.2 Cg_endo -72.69 136.82 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.967 1.778 . . . . 0.0 110.484 173.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.99 168.3 21.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.333 0.653 . . . . 0.0 109.39 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -132.84 156.64 46.8 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.573 -0.705 . . . . 0.0 109.517 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -89.28 136.22 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.37 169.74 15.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.44 160.39 29.57 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 168.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -76.37 136.57 68.35 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-O 117.553 -1.213 . . . . 0.0 107.922 163.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.97 158.96 44.6 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.992 1.795 . . . . 0.0 109.865 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.0 82.97 1.24 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.894 0.854 . . . . 0.0 110.338 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.84 83.92 0.96 Allowed Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.25 169.08 18.02 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.964 1.705 . . . . 0.0 107.946 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.01 127.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.55 125.08 91.79 Favored Pre-proline 0 C--O 1.238 0.453 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.302 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . 73.8 Cg_endo -81.8 164.69 18.06 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.894 3.063 . . . . 0.0 112.949 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.67 155.04 65.6 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 121.577 1.518 . . . . 0.0 111.986 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.94 69.52 5.12 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.282 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.92 0.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.911 1.284 . . . . 0.0 113.382 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -144.14 171.46 14.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.155 1.382 . . . . 0.0 109.388 -167.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -131.37 152.53 80.69 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.355 1.862 . . . . 0.0 107.519 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.1 90.99 1.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.728 2.952 . . . . 0.0 109.131 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.8 mm -83.93 114.54 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -85.13 142.34 29.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.55 118.39 36.47 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -65.05 152.69 42.82 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.028 0.918 . . . . 0.0 110.213 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.31 -68.24 2.4 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 125.002 1.286 . . . . 0.0 110.663 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.5 p -68.11 -25.02 65.1 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.839 -0.8 . . . . 0.0 111.5 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 m170 58.12 14.59 2.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.665 1.986 . . . . 0.0 112.977 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.88 168.57 13.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.995 0.902 . . . . 0.0 110.138 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.13 151.43 48.66 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.313 1.445 . . . . 0.0 108.564 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.92 148.48 27.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.988 0.915 . . . . 0.0 108.536 163.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 39' ' ' PRO . 50.4 m-85 -87.41 111.77 21.46 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -124.89 151.41 45.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.001 1.32 . . . . 0.0 108.238 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.58 168.2 31.7 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.347 0.975 . . . . 0.0 110.732 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.49 -40.16 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.628 2.218 . . . . 0.0 110.46 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -8.87 16.55 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.5 -17.13 24.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.272 1.396 . . . . 0.0 111.383 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.69 170.2 8.02 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 127.833 2.453 . . . . 0.0 110.647 -168.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -144.71 142.85 19.56 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.002 0.921 . . . . 0.0 109.845 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 129.51 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.573 2.182 . . . . 0.0 110.718 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -53.15 -54.91 28.92 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 121.582 -0.699 . . . . 0.0 111.272 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -66.64 -13.6 61.39 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.14 -26.0 19.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.99 1.316 . . . . 0.0 111.711 175.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.42 12.3 13.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.725 1.61 . . . . 0.0 113.112 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.01 -20.37 16.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 128.456 2.702 . . . . 0.0 113.136 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -117.6 -34.68 4.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 119.322 0.965 . . . . 0.0 110.227 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -61.57 -37.91 85.58 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.631 -0.668 . . . . 0.0 111.072 -177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.72 -35.73 4.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 109.514 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.33 85.84 0.33 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -151.1 -173.93 4.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.885 2.074 . . . . 0.0 107.006 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.08 146.2 28.83 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 122.543 1.163 . . . . 0.0 108.421 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -147.38 134.92 20.89 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.785 1.634 . . . . 0.0 107.088 170.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.26 20.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -59.35 155.57 14.4 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.682 2.037 . . . . 0.0 108.784 162.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.76 161.47 30.83 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 160.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -31.05 0.55 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.422 1.963 . . . . 0.0 115.629 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.408 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 74.3 t80 -56.58 -60.78 3.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.437 1.895 . . . . 0.0 110.587 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -60.69 -32.87 72.08 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.524 -0.735 . . . . 0.0 112.163 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -56.07 26.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.435 1.494 . . . . 0.0 110.016 169.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.3 77.02 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.672 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.565 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.5 mm? -68.24 -45.1 74.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 118.328 1.064 . . . . 0.0 111.637 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -56.98 -42.02 79.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.044 0.838 . . . . 0.0 108.803 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.22 -48.33 80.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.45 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.72 -35.9 71.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 119.375 0.989 . . . . 0.0 110.757 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.04 -49.6 77.01 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -73.33 -8.23 54.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 113.216 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 t -76.31 6.81 5.0 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.451 -1.405 . . . . 0.0 112.93 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.47 177.32 19.72 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.719 1.145 . . . . 0.0 111.191 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.0 56.58 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.719 3.612 . . . . 0.0 108.991 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 m -77.05 136.76 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.201 1.4 . . . . 0.0 108.686 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.94 3.19 43.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.419 1.087 . . . . 0.0 113.081 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 174.577 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 p -170.99 109.66 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.246 1.818 . . . . 0.0 107.889 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.59 48.4 0.55 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.203 1.401 . . . . 0.0 110.39 172.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.89 -112.6 1.09 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.597 2.046 . . . . 0.0 108.472 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m 59.59 92.75 0.04 OUTLIER 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.233 1.813 . . . . 0.0 110.777 -167.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m 59.22 166.57 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.916 2.086 . . . . 0.0 112.274 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.45 107.12 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -171.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.54 140.91 24.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.788 1.235 . . . . 0.0 107.808 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -85.8 133.46 33.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.616 0.722 . . . . 0.0 110.274 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -132.66 177.66 7.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.13 140.78 24.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.679 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.27 -31.96 6.91 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.329 -1.262 . . . . 0.0 111.862 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.81 100.27 4.0 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 119.275 1.537 . . . . 0.0 108.002 -173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.04 149.92 49.5 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.54 169.42 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -105.7 142.91 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 157.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.65 110.28 13.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 109.792 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -91.55 106.29 18.38 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.052 1.741 . . . . 0.0 107.69 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.83 19.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 174.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 128.65 36.7 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.04 15.59 63.03 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.298 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -128.51 162.05 53.34 Favored Pre-proline 0 C--O 1.232 0.149 0 CA-C-N 118.897 1.349 . . . . 0.0 109.044 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.25 -179.7 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.519 3.479 . . . . 0.0 110.831 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -72.7 88.37 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -71.98 136.72 82.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.291 -169.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.35 124.56 13.08 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.059 1.839 . . . . 0.0 108.789 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.86 168.1 20.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.024 0.916 . . . . 0.0 110.634 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm85 -128.8 148.48 50.88 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 mm -86.08 121.07 36.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 170.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.89 179.11 7.63 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.206 0.527 . . . . 0.0 112.202 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.97 112.07 15.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.094 1.757 . . . . 0.0 107.891 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.44 137.81 83.71 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.081 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.77 163.1 39.98 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.351 2.034 . . . . 0.0 111.844 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.9 131.69 47.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.844 0.858 . . . . 0.0 109.224 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 61.83 5.04 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.69 174.23 10.83 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.92 1.288 . . . . 0.0 109.316 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 p -52.74 159.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.225 1.01 . . . . 0.0 111.102 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -130.44 149.96 74.91 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.206 1.802 . . . . 0.0 108.417 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 162.22 43.05 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.586 2.191 . . . . 0.0 112.795 -166.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.72 -179.48 5.19 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 122.346 2.031 . . . . 0.0 109.445 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -43.74 91.96 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.694 1.998 . . . . 0.0 115.626 -164.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 33.64 58.19 0.55 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.038 2.535 . . . . 0.0 111.432 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -102.72 173.64 6.24 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.401 1.08 . . . . 0.0 109.216 160.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -132.32 152.58 80.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.362 1.065 . . . . 0.0 108.799 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 106.95 1.96 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.907 3.071 . . . . 0.0 110.317 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -98.12 115.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.741 1.216 . . . . 0.0 107.943 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -97.37 119.05 35.19 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -78.65 117.35 19.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -66.78 156.03 36.59 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.218 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 -46.48 1.74 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.35 1.453 . . . . 0.0 113.584 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 -29.48 22.26 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.98 1.39 . . . . 0.0 111.501 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.4 m80 69.82 14.23 8.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.036 2.134 . . . . 0.0 112.565 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.16 159.24 35.04 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.532 -0.73 . . . . 0.0 110.047 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.1 p -129.76 128.8 43.16 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.779 1.232 . . . . 0.0 108.441 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.94 172.49 14.12 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.908 0.883 . . . . 0.0 110.083 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -119.65 112.12 18.91 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.0 mt -121.81 150.49 41.81 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.53 166.34 31.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -65.61 -31.37 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.408 2.739 . . . . 0.0 112.108 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -70.28 -11.31 60.81 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.523 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.1 -10.77 34.82 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.078 1.308 . . . . 0.0 110.851 170.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.38 159.83 19.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.566 1.546 . . . . 0.0 109.19 -166.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -138.79 145.69 46.99 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.99 126.53 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.538 2.158 . . . . 0.0 109.932 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -53.86 -62.49 1.62 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -56.37 -40.81 75.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.928 0.786 . . . . 0.0 111.587 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 -34.9 79.54 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 119.141 0.882 . . . . 0.0 112.354 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.85 10.66 38.25 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.855 1.662 . . . . 0.0 111.119 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.21 -47.53 84.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.686 1.195 . . . . 0.0 110.179 -171.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -23.52 55.89 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.242 0.928 . . . . 0.0 112.006 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -77.52 -44.55 28.33 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.224 -0.923 . . . . 0.0 111.386 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -118.7 -23.46 7.03 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.69 1.996 . . . . 0.0 111.235 -165.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.28 58.2 3.66 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -133.25 135.54 45.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.451 1.9 . . . . 0.0 106.568 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.9 97.77 0.03 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.816 1.647 . . . . 0.0 110.938 -170.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB3' ' CG ' ' A' ' 81' ' ' PHE . 13.3 t-20 -71.87 158.79 35.41 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.11 -0.994 . . . . 0.0 108.986 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -71.7 -27.63 63.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.111 0.964 . . . . 0.0 113.06 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -64.28 142.78 58.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.523 1.056 . . . . 0.0 110.399 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -65.33 164.6 13.27 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 160.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.83 -41.85 2.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.498 1.523 . . . . 0.0 110.223 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.407 ' CG ' ' HB3' ' A' ' 76' ' ' ASN . 10.6 t80 -58.48 -46.99 85.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.088 0.955 . . . . 0.0 110.966 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -62.16 -44.8 95.82 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.049 -0.407 . . . . 0.0 110.12 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -69.47 -27.74 65.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.009 0.818 . . . . 0.0 111.68 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 -23.07 35.23 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.125 -0.984 . . . . 0.0 112.83 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.3 -32.13 71.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.99 1.395 . . . . 0.0 110.563 168.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -66.61 -47.9 71.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.557 -0.714 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.63 -48.57 80.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.388 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.3 -41.39 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.222 0.326 . . . . 0.0 110.238 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.67 -37.12 85.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.292 0.637 . . . . 0.0 110.498 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -72.76 -10.66 60.05 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.421 -0.799 . . . . 0.0 112.384 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.27 22.74 1.18 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 113.524 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.59 159.24 24.42 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.57 -1.331 . . . . 0.0 110.57 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.13 13.83 1.46 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.455 3.437 . . . . 0.0 113.001 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 152.13 45.95 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.688 -1.258 . . . . 0.0 109.111 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.8 m -155.01 -53.57 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 N-CA-C 106.659 -2.577 . . . . 0.0 106.659 135.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.831 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 57.19 157.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.858 2.463 . . . . 0.0 112.114 -158.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.2 m 50.48 -154.81 0.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.168 0.587 . . . . 0.0 110.829 -164.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.4 -162.69 28.21 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.45 105.28 4.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 p -160.83 -87.4 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.37 93.72 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.1 177.06 9.05 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.076 1.35 . . . . 0.0 107.865 168.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.38 131.35 29.79 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.717 2.007 . . . . 0.0 105.992 170.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -135.89 178.24 7.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.076 0.853 . . . . 0.0 111.483 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.93 132.54 32.26 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.903 0.881 . . . . 0.0 111.33 -167.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.6 -17.39 58.65 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.096 -0.835 . . . . 0.0 111.775 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.18 161.28 19.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.044 1.402 . . . . 0.0 109.312 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD22 HG13 ' A' ' 88' ' ' ILE . 96.0 mt -124.74 156.37 37.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.817 1.647 . . . . 0.0 106.682 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.71 171.88 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.916 0.886 . . . . 0.0 108.861 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -105.85 122.24 45.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 159.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.06 134.87 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.762 1.225 . . . . 0.0 109.39 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -106.79 108.59 20.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.5 mtp -86.39 167.17 14.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.1 150.0 22.25 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 163.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.86 -68.29 1.05 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.226 0.917 . . . . 0.0 111.999 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -56.02 156.05 10.96 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.301 2.24 . . . . 0.0 112.547 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.33 173.44 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.752 2.968 . . . . 0.0 109.88 163.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -62.9 108.04 1.11 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -91.17 140.26 25.77 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 123.934 0.894 . . . . 0.0 108.792 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.01 126.62 16.83 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.216 1.944 . . . . 0.0 110.482 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.22 157.16 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.262 0.553 . . . . 0.0 111.113 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -103.8 152.42 21.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.14 99.95 8.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -74.18 -177.32 2.92 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.955 0.407 . . . . 0.0 109.966 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -114.71 -171.08 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 107.712 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.6 mt -140.63 116.82 7.68 Favored Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 153.63 72.56 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 121.3 1.333 . . . . 0.0 109.808 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.97 21.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.869 3.268 . . . . 0.0 113.852 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.4 47.5 0.2 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.21 1.386 . . . . 0.0 110.255 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.24 -173.88 2.97 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.239 1.816 . . . . 0.0 109.335 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.6 150.69 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.383 1.073 . . . . 0.0 109.789 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -118.72 139.33 26.97 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.823 1.249 . . . . 0.0 108.833 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.85 160.22 14.0 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.781 2.321 . . . . 0.0 110.656 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.16 170.32 19.35 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.182 1.255 . . . . 0.0 111.149 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.35 58.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.069 0.938 . . . . 0.0 108.796 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 47.18 50.12 14.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.501 -2.136 . . . . 0.0 109.896 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -140.27 145.65 37.59 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -114.46 153.61 46.6 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.332 1.853 . . . . 0.0 110.176 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 91.63 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.399 3.399 . . . . 0.0 111.107 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.24 121.5 43.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -113.21 116.54 29.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -87.55 97.22 10.73 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.104 1.762 . . . . 0.0 108.52 -169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 10.7 m-85 -52.21 150.55 4.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.495 1.118 . . . . 0.0 112.085 -175.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.11 4.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.638 1.59 . . . . 0.0 111.976 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.58 -31.51 68.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.92 0.888 . . . . 0.0 110.849 167.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.1 m80 53.52 25.98 5.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.61 1.964 . . . . 0.0 112.043 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.31 165.73 23.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.975 2.11 . . . . 0.0 109.475 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -127.76 151.61 48.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.849 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.19 155.74 23.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 154.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -86.51 123.95 32.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.71 149.94 50.0 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.191 1.396 . . . . 0.0 108.341 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.21 165.08 27.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.37 -24.12 43.56 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.867 2.378 . . . . 0.0 112.118 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -54.14 -15.22 1.38 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.502 1.521 . . . . 0.0 114.151 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -118.1 7.39 12.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.515 1.526 . . . . 0.0 110.712 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.28 168.67 9.75 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.673 1.589 . . . . 0.0 109.388 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -144.53 146.14 31.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 127.214 2.206 . . . . 0.0 107.124 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.69 152.71 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.652 2.235 . . . . 0.0 111.74 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.0 -62.69 1.37 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.193 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -46.99 -46.4 21.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.861 1.21 . . . . 0.0 111.308 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -18.12 65.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -172.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -130.31 13.6 5.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.502 1.121 . . . . 0.0 111.39 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -55.33 -36.85 66.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.799 1.639 . . . . 0.0 112.225 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -104.83 -15.96 15.04 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.667 0.787 . . . . 0.0 109.723 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -85.66 -57.36 3.08 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 120.918 -1.114 . . . . 0.0 110.079 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -89.6 -36.14 15.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 109.726 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.89 71.11 0.57 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.782 1.658 . . . . 0.0 111.681 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.8 150.09 48.14 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 126.069 1.748 . . . . 0.0 107.465 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.0 p -59.58 105.35 0.35 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.971 0.508 . . . . 0.0 110.015 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -93.82 152.57 18.81 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -89.89 54.5 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 109.355 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -115.54 123.61 48.93 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -67.97 103.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.42 -25.96 4.2 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.551 1.548 . . . . 0.0 111.269 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -65.02 -51.79 59.66 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.404 1.102 . . . . 0.0 111.146 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -73.27 -23.04 60.26 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.409 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -65.04 -48.13 74.92 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 124.34 1.056 . . . . 0.0 108.888 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.92 -31.22 78.92 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.309 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' HA ' HG22 ' A' ' 88' ' ' ILE . 17.2 mt -63.35 -46.7 85.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.376 171.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -57.16 -41.26 78.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.594 1.543 . . . . 0.0 111.043 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.09 -51.11 65.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.774 0.715 . . . . 0.0 111.511 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 85' ' ' LEU . 13.5 tt -70.35 -38.89 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.432 0.693 . . . . 0.0 110.382 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.56 -27.63 69.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.835 0.854 . . . . 0.0 110.032 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -93.47 -8.96 40.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.721 1.609 . . . . 0.0 113.019 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 m -78.38 71.65 4.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 109.609 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.21 151.54 23.52 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.98 25.84 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 115.098 -161.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -77.67 155.46 31.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.213 1.369 . . . . 0.0 107.841 157.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -62.61 -43.55 98.54 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.128 -0.982 . . . . 0.0 110.328 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.266 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 -171.253 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.667 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 62.5 164.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.577 1.951 . . . . 0.0 110.6 -164.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -169.06 -53.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.984 2.113 . . . . 0.0 108.263 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.64 -98.07 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 m 56.78 52.01 10.1 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.989 0.899 . . . . 0.0 109.568 -168.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -72.82 123.0 22.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.11 94.42 1.88 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 -161.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 74.14 88.07 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.936 2.494 . . . . 0.0 112.576 167.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -53.76 166.57 0.32 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.375 1.87 . . . . 0.0 111.47 167.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -147.74 168.16 22.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 108.867 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.27 135.81 57.77 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 123.288 0.367 . . . . 0.0 111.034 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.5 35.58 5.4 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 117.878 -1.512 . . . . 0.0 112.233 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.18 172.8 12.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.238 1.519 . . . . 0.0 111.151 172.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -117.43 142.27 47.34 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.257 1.423 . . . . 0.0 108.414 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 29' ' ' ILE . 22.9 m -154.46 171.08 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.029 0.931 . . . . 0.0 111.95 -165.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.07 117.41 30.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.244 1.018 . . . . 0.0 111.652 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.07 163.96 13.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.607 1.163 . . . . 0.0 110.469 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -147.67 106.97 3.88 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.261 -0.899 . . . . 0.0 110.452 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.5 mtm -83.76 168.05 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.026 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -81.15 83.61 6.75 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.967 1.307 . . . . 0.0 109.155 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.42 -56.74 0.67 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -61.66 159.22 35.39 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.445 1.498 . . . . 0.0 113.222 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.07 176.0 10.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.284 3.989 . . . . 0.0 111.153 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -64.02 97.04 0.16 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.982 1.313 . . . . 0.0 108.166 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -89.6 134.9 31.51 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.181 -165.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.74 121.01 8.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.579 2.186 . . . . 0.0 109.658 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.5 19.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 110.236 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -124.58 148.27 47.95 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 HD11 HG11 ' A' ' 15' ' ' VAL . 9.1 mm -78.59 99.96 3.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.278 -2.489 . . . . 0.0 104.278 163.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -65.77 173.34 2.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.095 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -124.79 161.04 27.32 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.153 1.381 . . . . 0.0 108.972 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.98 101.52 12.61 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -156.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -46.4 139.36 12.83 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.964 3.776 . . . . 0.0 111.45 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.59 110.38 1.69 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.49 -9.56 22.06 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.596 1.57 . . . . 0.0 112.2 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.6 15.69 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 119.173 1.486 . . . . 0.0 111.349 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.24 146.32 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.355 157.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.59 158.61 56.0 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 118.415 0.552 . . . . 0.0 110.557 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.58 161.33 28.51 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.179 2.586 . . . . 0.0 112.214 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.13 168.32 25.06 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 121.835 1.69 . . . . 0.0 111.294 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.24 127.04 27.43 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.04 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 83.55 1.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.892 2.477 . . . . 0.0 112.239 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -112.89 160.29 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.014 1.279 . . . . 0.0 111.384 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -115.26 149.85 43.42 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 126.713 2.005 . . . . 0.0 108.161 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.009 3.139 . . . . 0.0 108.919 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.0 mm -102.61 112.89 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -99.3 124.05 44.08 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.3 98.02 11.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -50.43 148.38 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.033 0.933 . . . . 0.0 110.89 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.47 -15.2 1.6 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.963 1.268 . . . . 0.0 115.862 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -115.68 -17.27 11.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.26 1.53 . . . . 0.0 111.596 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.37 16.17 7.2 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.808 2.043 . . . . 0.0 112.749 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -83.55 165.65 18.9 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.428 -0.795 . . . . 0.0 110.219 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -127.5 150.61 49.6 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.176 0.99 . . . . 0.0 110.648 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.3 29.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.155 1.382 . . . . 0.0 109.369 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.53 107.38 16.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.7 mt -123.54 143.69 50.03 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 162.55 28.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.48 -20.5 47.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 113.676 -160.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -52.86 -32.2 43.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.82 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -94.96 9.23 40.17 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 111.506 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 mt -135.28 157.38 47.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.568 1.147 . . . . 0.0 111.144 -161.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -141.64 155.81 66.57 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.016 1.326 . . . . 0.0 110.726 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -68.89 134.11 28.97 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.126 2.55 . . . . 0.0 112.273 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -65.1 -48.1 74.86 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.864 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -62.19 -27.54 69.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.853 1.206 . . . . 0.0 112.361 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.47 -51.08 11.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 111.023 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -97.23 8.85 43.71 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.014 -1.054 . . . . 0.0 113.816 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -53.3 -49.45 66.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.646 1.178 . . . . 0.0 108.684 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.59 -53.09 38.17 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.39 0.431 . . . . 0.0 110.743 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -64.64 -33.87 76.96 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 113.713 -169.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -118.36 -29.21 5.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 112.518 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.58 70.86 3.07 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 153.81 51.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.615 1.566 . . . . 0.0 109.317 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.0 p -74.93 99.9 3.96 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -80.92 168.61 18.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.937 -1.102 . . . . 0.0 111.404 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -89.04 -5.33 57.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -73.15 141.96 47.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.277 1.853 . . . . 0.0 109.023 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.464 ' HE3' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.29 164.29 16.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.17 -40.95 1.27 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.355 0.979 . . . . 0.0 111.564 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.02 -37.94 84.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.185 1.493 . . . . 0.0 111.154 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -48.76 78.32 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.433 0.693 . . . . 0.0 110.167 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.95 -38.42 86.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.856 1.662 . . . . 0.0 110.438 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -72.45 -32.9 61.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.56 1.076 . . . . 0.0 111.944 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.612 1.206 . . . . 0.0 111.16 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -66.31 -44.06 84.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.629 0.649 . . . . 0.0 109.557 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -60.96 -55.38 33.57 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.102 0.961 . . . . 0.0 111.248 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 tt -62.07 -28.36 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.079 0.854 . . . . 0.0 111.187 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -60.05 3.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.013 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -81.69 43.17 0.74 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.399 1.48 . . . . 0.0 112.04 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.5 t -128.28 -19.3 3.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.649 1.98 . . . . 0.0 109.62 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.01 -161.88 11.52 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.882 1.706 . . . . 0.0 109.393 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.29 137.2 36.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.436 2.09 . . . . 0.0 109.59 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t -152.53 159.07 43.32 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.223 0.535 . . . . 0.0 109.91 165.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.4 m -146.0 -21.26 0.45 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 112.87 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.259 179.768 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.453 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.33 107.15 1.19 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.616 1.166 . . . . 0.0 108.192 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -151.41 173.66 14.28 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 108.427 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.88 163.68 14.53 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 p -68.14 174.09 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.023 -0.692 . . . . 0.0 110.772 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.2 m -140.55 136.79 33.21 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 160.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.31 40.03 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.334 1.921 . . . . 0.0 109.221 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -134.32 -174.4 3.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.426 2.29 . . . . 0.0 107.581 -175.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -131.54 155.82 46.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.924 1.289 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -137.25 176.14 8.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.672 1.589 . . . . 0.0 110.684 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.71 135.2 41.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.42 -28.39 15.8 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.609 1.576 . . . . 0.0 112.31 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -75.74 123.86 26.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.479 1.14 . . . . 0.0 109.325 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.97 145.03 28.76 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.29 168.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.587 0.708 . . . . 0.0 112.699 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -112.85 121.79 45.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.643 1.177 . . . . 0.0 108.189 161.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.34 121.82 35.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.72 1.208 . . . . 0.0 109.147 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -91.49 107.24 19.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mtm -74.01 169.42 17.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.376 0.534 . . . . 0.0 110.433 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -61.69 127.51 31.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.81 -60.48 3.38 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.657 1.122 . . . . 0.0 113.343 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -51.43 155.85 2.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.786 1.635 . . . . 0.0 111.488 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.45 -175.55 2.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.454 3.436 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -62.53 89.75 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.89 2.476 . . . . 0.0 108.251 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -86.45 135.33 36.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HG3' HD22 ' A' ' 85' ' ' LEU . 31.8 Cg_endo -67.47 130.8 23.1 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.298 1.332 . . . . 0.0 108.669 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.65 151.66 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.496 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 12.7 ptm180 -103.06 160.63 14.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.437 1.017 . . . . 0.0 109.162 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.6 124.89 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 151.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.91 -156.42 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -132.86 149.31 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.501 -2.0 . . . . 0.0 109.189 147.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.94 136.57 66.34 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.52 151.19 80.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.652 1.568 . . . . 0.0 110.062 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.77 92.75 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.89 31.57 0.39 Allowed Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.037 -1.424 . . . . 0.0 112.357 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.06 161.84 36.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.76 1.78 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.7 111.99 5.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.856 0.836 . . . . 0.0 109.41 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -57.23 158.4 10.17 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 111.021 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.17 164.84 23.86 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.618 2.212 . . . . 0.0 111.243 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.19 179.52 2.83 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.117 1.211 . . . . 0.0 110.722 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 134.79 57.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.358 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 60.12 42.29 15.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.745 2.418 . . . . 0.0 111.421 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -138.35 134.18 33.9 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.41 2.284 . . . . 0.0 110.046 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -102.27 147.45 33.98 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.809 2.444 . . . . 0.0 111.241 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.03 100.38 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.053 2.502 . . . . 0.0 111.464 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 mm -83.07 155.5 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -142.08 106.78 4.86 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.22 1.808 . . . . 0.0 107.286 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.93 98.7 3.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.83 1.252 . . . . 0.0 109.107 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m-85 -49.27 139.04 11.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 127.222 2.209 . . . . 0.0 111.999 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.98 -37.55 1.5 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.638 1.589 . . . . 0.0 113.552 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.4 -28.14 52.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.418 1.109 . . . . 0.0 111.753 171.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.9 m80 48.98 60.02 4.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 110.081 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.0 147.84 32.77 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 108.215 163.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 p -121.41 142.99 49.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.421 1.089 . . . . 0.0 109.027 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.05 169.76 21.02 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.596 1.559 . . . . 0.0 108.082 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.65 107.44 18.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.58 133.79 50.71 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.077 1.751 . . . . 0.0 110.586 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.28 167.73 54.12 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.02 -32.07 94.47 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.465 2.776 . . . . 0.0 114.421 -175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.32 -15.79 18.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.39 0.995 . . . . 0.0 113.4 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -103.03 4.0 36.77 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.024 1.284 . . . . 0.0 111.225 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -135.27 134.78 40.3 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.684 1.594 . . . . 0.0 109.767 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.05 145.48 43.94 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 110.851 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.8 116.1 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.104 3.202 . . . . 0.0 109.615 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -49.14 -52.23 27.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.472 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -55.99 -35.96 67.35 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.114 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -41.79 66.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.839 1.199 . . . . 0.0 111.208 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.71 16.16 24.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.741 1.216 . . . . 0.0 110.756 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -61.51 -40.58 95.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.332 0.969 . . . . 0.0 110.471 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.53 -49.95 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.059 -1.026 . . . . 0.0 108.999 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -60.05 -33.82 72.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.245 1.418 . . . . 0.0 113.604 -169.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -125.66 -18.58 5.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.277 1.831 . . . . 0.0 112.649 -173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.97 30.62 1.8 Allowed Glycine 0 N--CA 1.474 1.194 0 CA-C-N 121.32 1.873 . . . . 0.0 113.472 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -115.47 158.65 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.201 2.2 . . . . 0.0 109.062 -167.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -75.44 164.08 26.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.345 1.545 . . . . 0.0 112.302 -163.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -153.85 155.68 36.21 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 128.715 2.806 . . . . 0.0 107.778 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.46 2.27 33.54 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.582 1.153 . . . . 0.0 113.52 -171.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.66 133.78 55.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.895 1.278 . . . . 0.0 108.785 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -62.09 162.27 9.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.38 -46.32 2.76 Favored Glycine 0 N--CA 1.461 0.335 0 O-C-N 120.969 -1.082 . . . . 0.0 111.052 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -54.89 -54.84 37.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.729 0.812 . . . . 0.0 111.202 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.02 -39.72 66.39 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.269 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.33 -43.52 98.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 110.303 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.97 -32.94 82.33 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.648 -0.658 . . . . 0.0 112.386 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.513 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -76.19 -24.59 54.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.007 0.904 . . . . 0.0 112.08 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -68.64 -52.62 29.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 2.4 mm-40 -56.59 -54.56 44.51 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.322 0.649 . . . . 0.0 111.187 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.2 tt -58.56 -36.37 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.37 0.532 . . . . 0.0 111.759 -172.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.22 -48.53 64.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.72 -0.09 45.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.213 1.405 . . . . 0.0 112.66 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.3 t -62.16 -58.25 8.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.29 1.836 . . . . 0.0 110.346 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.06 68.38 0.45 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.4 113.32 3.28 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.745 2.297 . . . . 0.0 108.433 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 t 67.9 -41.53 0.44 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.443 2.697 . . . . 0.0 112.698 -167.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.43 18.57 0.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.924 1.69 . . . . 0.0 112.713 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 O-C-N 120.666 -1.271 . . . . 0.0 110.253 -178.586 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t -158.34 171.13 20.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.829 1.252 . . . . 0.0 108.116 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -141.01 174.59 10.37 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.382 1.873 . . . . 0.0 109.302 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.59 -116.1 4.17 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 m -122.67 74.13 1.17 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.9 t -63.09 152.9 35.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.21 -102.86 0.18 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 -173.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 68.25 165.65 0.24 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.76 2.424 . . . . 0.0 109.721 -165.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -119.02 158.76 25.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -147.33 169.82 18.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.978 0.808 . . . . 0.0 111.284 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.69 124.87 14.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.81 0.844 . . . . 0.0 109.816 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.16 -9.16 61.2 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.777 -1.013 . . . . 0.0 112.836 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.78 159.6 32.69 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 119.285 1.543 . . . . 0.0 108.88 163.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.2 150.14 39.23 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.74 173.85 3.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.856 0.836 . . . . 0.0 111.296 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.29 133.71 52.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 157.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -109.69 125.86 53.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.228 1.411 . . . . 0.0 108.449 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -105.18 105.89 16.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mtm -77.58 170.21 16.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.122 0.963 . . . . 0.0 109.398 164.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -64.91 130.85 44.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.77 -48.24 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.853 0.739 . . . . 0.0 113.257 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -54.31 152.07 12.31 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 169.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.73 175.26 9.15 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.719 2.946 . . . . 0.0 109.713 171.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -63.07 97.61 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -79.27 140.26 56.57 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.817 1.647 . . . . 0.0 109.22 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.19 128.93 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.771 1.647 . . . . 0.0 109.069 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.84 165.64 27.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.112 0.958 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -116.4 147.67 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.76 108.82 14.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 161.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.61 -174.54 4.34 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 110.129 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -115.58 178.1 4.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.858 1.263 . . . . 0.0 109.627 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -135.55 112.17 10.77 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.27 152.6 79.01 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.066 2.511 . . . . 0.0 111.194 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.1 91.72 0.71 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.76 -20.67 1.01 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 125.944 1.735 . . . . 0.0 111.121 -169.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.17 178.67 7.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.526 1.163 . . . . 0.0 111.895 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 38' ' ' LYS . 9.6 p -68.27 -173.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 126.523 1.929 . . . . 0.0 110.019 160.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' H ' HG22 ' A' ' 37' ' ' VAL . 6.5 pttt -131.84 146.78 63.26 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.67 1.988 . . . . 0.0 109.246 177.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.27 164.38 32.97 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.242 1.961 . . . . 0.0 110.126 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.67 155.95 58.12 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 167.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.51 146.05 49.89 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.608 1.194 . . . . 0.0 110.913 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 55.48 32.19 18.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.235 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 62.5 mttt -131.37 147.48 52.57 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 124.437 1.095 . . . . 0.0 108.368 167.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.79 153.06 43.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 124.609 1.163 . . . . 0.0 110.146 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.18 94.57 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.441 2.761 . . . . 0.0 108.808 167.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.3 mm -85.07 141.18 14.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 52' ' ' HIS . 56.0 t80 -125.95 122.46 36.03 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -87.15 99.8 12.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.05 1.34 . . . . 0.0 108.743 -174.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 7.1 m-85 -53.14 144.88 14.58 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.506 1.122 . . . . 0.0 111.163 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 -33.15 0.9 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.248 1.404 . . . . 0.0 114.342 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 p -95.63 -11.96 26.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.295 1.548 . . . . 0.0 112.723 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.435 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.9 m170 56.4 26.23 10.49 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.648 1.979 . . . . 0.0 113.542 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -92.01 161.7 14.68 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.726 0.81 . . . . 0.0 109.874 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -127.68 142.92 51.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.652 1.181 . . . . 0.0 109.449 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.52 174.11 13.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 110.16 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.88 107.5 15.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.7 mt -117.93 150.5 39.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . -92.33 164.96 28.57 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.44 -28.03 86.49 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.129 2.553 . . . . 0.0 111.878 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -61.28 -10.72 7.49 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.61 10.35 9.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 110.645 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 17' ' ' ALA . 78.2 mt -129.4 153.82 47.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 109.346 -172.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -132.61 148.16 68.45 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.664 0.785 . . . . 0.0 111.356 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.53 125.23 13.03 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.326 3.351 . . . . 0.0 111.049 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.6 -58.04 9.78 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.076 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -55.44 -27.94 51.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.36 -173.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -60.44 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.091 0.86 . . . . 0.0 109.039 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.55 13.13 14.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.928 1.691 . . . . 0.0 112.947 -170.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -57.0 -24.21 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.15 1.78 . . . . 0.0 112.162 -172.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.13 -35.51 5.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.522 1.129 . . . . 0.0 108.472 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.46 81.9 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.818 -1.176 . . . . 0.0 113.035 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -106.7 -27.17 10.97 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.837 1.655 . . . . 0.0 109.273 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.94 73.78 2.58 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 133.77 16.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.042 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.2 p -65.15 137.0 57.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.706 1.603 . . . . 0.0 107.677 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -142.12 -6.01 0.97 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -154.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 tttt 121.64 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 131.402 3.881 . . . . 0.0 111.495 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 133.49 53.16 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.938 0.79 . . . . 0.0 110.076 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -60.25 167.43 2.44 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 125.182 1.551 . . . . 0.0 109.831 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.75 -54.61 0.73 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.897 1.713 . . . . 0.0 111.685 -172.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -46.51 -43.73 17.13 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 126.678 1.991 . . . . 0.0 113.398 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -68.45 -47.6 66.74 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.488 0.715 . . . . 0.0 111.928 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -52.96 -38.93 62.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.994 1.317 . . . . 0.0 109.958 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.17 -28.61 65.97 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.542 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.58 -47.32 70.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.903 1.352 . . . . 0.0 109.659 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -53.79 -45.46 70.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.59 0.556 . . . . 0.0 109.545 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.06 -52.18 60.58 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.86 -30.28 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.484 1.038 . . . . 0.0 111.249 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.91 -31.71 68.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.546 0.612 . . . . 0.0 111.881 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -98.09 4.06 49.18 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.633 0.773 . . . . 0.0 112.582 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -68.92 74.6 0.29 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.352 1.861 . . . . 0.0 110.707 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.03 163.38 34.88 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.715 2.102 . . . . 0.0 112.92 175.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 95' ' ' SER . 65.8 Cg_endo -81.81 77.86 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.727 1 C-N-CA 125.483 4.122 . . . . 0.0 110.793 -173.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.81 -25.83 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.826 2.05 . . . . 0.0 113.748 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 93' ' ' PRO . 50.3 m 45.79 29.06 0.64 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 128.187 2.595 . . . . 0.0 114.119 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.764 0 CA-C-O 116.598 -2.223 . . . . 0.0 110.812 179.798 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t 63.87 -175.55 0.16 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.79 0.836 . . . . 0.0 109.485 -156.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.59 -174.04 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.858 0.863 . . . . 0.0 109.799 -154.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.21 -171.39 36.18 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.347 -0.845 . . . . 0.0 112.499 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 p -69.9 157.56 37.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.411 1.084 . . . . 0.0 111.334 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -65.18 -34.61 78.8 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.539 -0.726 . . . . 0.0 111.939 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.46 -173.86 54.88 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 107.866 -2.093 . . . . 0.0 107.866 -156.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 112.46 0.92 Allowed 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.392 1.877 . . . . 0.0 109.055 167.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.55 154.49 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.642 1.977 . . . . 0.0 111.18 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -160.33 162.77 33.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 109.194 -173.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.02 112.72 0.91 Allowed 'General case' 0 C--O 1.236 0.348 0 O-C-N 124.157 0.911 . . . . 0.0 109.167 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.61 -33.89 2.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.008 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.2 134.66 45.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.819 1.809 . . . . 0.0 108.616 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.86 147.94 25.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 162.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 m -147.92 167.78 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -108.4 148.34 30.28 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 156.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.98 127.8 45.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.278 1.831 . . . . 0.0 108.327 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.17 104.94 16.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.9 mtm -76.26 159.57 30.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 161.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -67.36 142.69 56.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.72 -41.31 0.83 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.717 1.627 . . . . 0.0 113.343 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.72 161.79 68.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 126.898 2.079 . . . . 0.0 112.266 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.6 179.97 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.106 3.204 . . . . 0.0 109.835 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -67.09 98.42 0.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -81.7 139.04 47.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.407 1.083 . . . . 0.0 108.289 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.536 ' HG3' HD22 ' A' ' 85' ' ' LEU . 34.4 Cg_endo -66.04 140.74 61.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.266 1.311 . . . . 0.0 110.222 174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.56 168.37 22.15 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.11 0.964 . . . . 0.0 109.493 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.0 mm -71.0 115.3 10.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 162.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.31 176.43 8.73 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.712 0.767 . . . . 0.0 109.644 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -169.71 1.67 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.71 1.204 . . . . 0.0 107.941 157.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD11 ' HD3' ' A' ' 39' ' ' PRO . 4.2 mt -127.41 122.46 22.84 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.53 158.27 46.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.85 1.7 . . . . 0.0 109.633 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.0 76.73 5.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.148 0.499 . . . . 0.0 111.264 -167.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.92 -20.03 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.384 -1.231 . . . . 0.0 111.32 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.84 169.53 12.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 119.223 1.511 . . . . 0.0 112.841 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 37' ' ' VAL . 1.9 p -75.26 107.88 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.447 2.299 . . . . 0.0 110.571 -176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -60.29 141.19 91.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.421 -0.799 . . . . 0.0 112.217 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HD3' HD11 ' A' ' 32' ' ' LEU . 72.1 Cg_endo -71.41 158.8 53.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.203 3.269 . . . . 0.0 112.384 -174.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.19 173.51 14.38 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.78 132.27 52.82 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.939 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 40.41 50.14 2.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.501 2.721 . . . . 0.0 110.166 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -129.79 157.57 41.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 160.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.98 153.54 47.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 126.004 1.722 . . . . 0.0 107.182 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.16 104.47 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.773 2.315 . . . . 0.0 109.641 167.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.8 mm -103.49 111.66 34.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.14 124.29 34.7 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.875 1.27 . . . . 0.0 108.275 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -90.7 101.88 14.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.143 0.977 . . . . 0.0 109.283 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -52.92 145.2 13.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.593 1.157 . . . . 0.0 111.904 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.17 -46.31 2.43 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.363 1.458 . . . . 0.0 111.883 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 p -80.89 -22.32 39.88 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.149 -1.207 . . . . 0.0 112.321 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 m170 55.27 20.35 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.908 2.483 . . . . 0.0 113.822 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -78.43 166.65 22.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 p -125.42 152.64 44.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.35 161.03 39.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 154.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -88.06 123.3 32.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 166.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.3 mt -130.17 152.6 49.43 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.046 0.938 . . . . 0.0 108.525 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.41 169.19 18.24 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.022 0.82 . . . . 0.0 111.682 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.81 5.71 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.371 1 C-N-CA 125.503 4.135 . . . . 0.0 115.838 -166.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -102.14 -6.67 22.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -110.03 7.57 23.68 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.91 -1.119 . . . . 0.0 111.013 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.59 134.95 31.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.69 1.596 . . . . 0.0 108.717 -157.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -126.64 160.5 58.18 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.63 1.172 . . . . 0.0 109.649 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.14 131.67 27.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.742 2.295 . . . . 0.0 110.454 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.96 -57.63 12.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.994 1.27 . . . . 0.0 110.803 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -49.11 -40.61 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.171 0.988 . . . . 0.0 112.402 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -40.95 89.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.806 1.643 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -104.86 6.36 33.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.495 1.518 . . . . 0.0 112.603 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -61.41 -17.18 53.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.277 1.831 . . . . 0.0 111.51 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -115.19 -33.84 5.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.366 1.466 . . . . 0.0 111.856 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -64.1 -55.99 18.08 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.207 1.003 . . . . 0.0 109.937 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -92.66 -39.51 11.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.909 1.284 . . . . 0.0 110.146 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.6 77.94 0.75 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -122.97 179.0 4.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.611 1.564 . . . . 0.0 107.548 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 p -80.82 150.21 29.26 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.404 ' HB2' ' CE2' ' A' ' 81' ' ' PHE . 1.2 m-20 -153.03 144.04 22.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.074 172.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -81.68 68.49 8.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.492 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -128.26 119.25 24.78 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.807 2.043 . . . . 0.0 106.333 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -72.87 116.54 13.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -171.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.12 14.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.991 0.805 . . . . 0.0 111.783 -171.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 76' ' ' ASN . 82.8 t80 -62.07 -60.59 3.38 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.949 1.375 . . . . 0.0 108.48 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -56.98 -21.81 33.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.98 -39.53 42.09 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.464 0.706 . . . . 0.0 109.552 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.81 97.22 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.382 -0.824 . . . . 0.0 111.945 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.536 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.1 mm? -68.74 -14.46 63.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.08 0.94 . . . . 0.0 112.613 173.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -79.76 -48.56 13.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.189 0.904 . . . . 0.0 108.742 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.31 -52.49 65.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.703 0.683 . . . . 0.0 110.446 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.64 -43.69 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.598 0.635 . . . . 0.0 111.622 -170.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.07 -46.63 89.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.356 1.062 . . . . 0.0 109.661 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -85.29 -6.81 59.23 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.337 1.055 . . . . 0.0 112.931 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -60.32 -29.93 69.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.538 1.935 . . . . 0.0 111.886 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.9 172.97 30.52 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.96 1.743 . . . . 0.0 109.321 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.84 169.92 20.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.452 3.435 . . . . 0.0 110.143 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -171.75 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.31 0.644 . . . . 0.0 110.148 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 m -77.52 -7.72 56.7 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.9 -1.125 . . . . 0.0 111.66 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 104.826 -3.31 . . . . 0.0 104.826 175.639 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.24 133.34 52.44 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.412 1.106 . . . . 0.0 108.087 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 p -66.43 161.65 22.23 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 122.778 0.431 . . . . 0.0 109.924 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.38 163.23 11.27 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.505 1.05 . . . . 0.0 111.22 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 m 63.72 -70.93 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.824 2.049 . . . . 0.0 112.028 -173.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.6 m -135.48 157.87 45.79 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.487 1.494 . . . . 0.0 109.491 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.86 176.47 39.03 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 124.395 0.998 . . . . 0.0 111.386 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.23 102.86 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 163.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -55.95 151.55 11.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.929 1.292 . . . . 0.0 110.366 172.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -138.11 170.53 15.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.121 0.968 . . . . 0.0 110.053 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 149.6 18.66 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.615 0.572 . . . . 0.0 110.629 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 -1.63 88.09 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.973 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -101.27 173.62 6.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.022 1.411 . . . . 0.0 109.464 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -131.38 149.31 52.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.757 1.223 . . . . 0.0 109.859 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.42 164.72 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 109.914 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.81 126.59 50.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 158.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.94 165.8 12.7 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -140.07 105.67 5.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.8 mtm -73.65 168.8 18.61 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 168.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -59.44 129.63 42.96 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 162.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.92 -30.03 2.07 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.627 2.061 . . . . 0.0 115.823 168.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.89 163.66 66.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 118.793 1.297 . . . . 0.0 111.576 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.64 175.67 10.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.573 3.515 . . . . 0.0 110.993 168.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -62.59 88.09 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.227 2.211 . . . . 0.0 109.786 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -86.75 137.88 33.56 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 120.904 -1.122 . . . . 0.0 109.252 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.07 137.79 63.84 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 111.665 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.04 167.44 22.67 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.159 0.98 . . . . 0.0 111.09 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 ptm180 -112.45 156.06 23.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.1 mm -82.45 107.48 14.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 159.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.74 -174.55 4.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG2' ' H ' ' A' ' 32' ' ' LEU . 4.7 tt0 -128.56 -177.22 4.09 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.647 -1.283 . . . . 0.0 109.296 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.479 ' H ' ' HG2' ' A' ' 31' ' ' GLU . 6.2 mt -142.36 116.39 6.52 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -166.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.9 151.38 56.64 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.462 2.108 . . . . 0.0 109.867 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.75 24.13 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.383 2.273 . . . . 0.0 114.77 -169.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.8 -0.76 1.24 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.479 -1.179 . . . . 0.0 113.3 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.29 175.05 6.41 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.524 1.662 . . . . 0.0 113.053 -167.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -35.19 131.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.766 2.426 . . . . 0.0 109.045 162.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -117.08 141.83 29.03 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.338 0.655 . . . . 0.0 111.336 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.65 161.84 14.44 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 123.628 2.885 . . . . 0.0 112.493 -162.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.26 167.58 17.49 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.668 2.245 . . . . 0.0 111.426 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.58 135.18 57.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 121.304 -0.872 . . . . 0.0 109.641 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 64.13 32.48 12.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.71 2.404 . . . . 0.0 113.039 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -132.85 168.1 19.0 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.913 -1.117 . . . . 0.0 112.916 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -125.2 152.87 71.53 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 130.232 3.413 . . . . 0.0 110.206 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.44 102.03 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.99 3.126 . . . . 0.0 109.543 166.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -87.86 116.31 25.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.626 1.97 . . . . 0.0 107.623 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.83 99.61 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.801 2.041 . . . . 0.0 109.435 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 3.3 m-85 -49.28 143.73 5.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.484 1.514 . . . . 0.0 113.141 -172.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.46 -58.26 2.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.175 1.369 . . . . 0.0 111.394 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -21.35 64.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.327 -1.102 . . . . 0.0 113.056 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 m170 58.09 3.15 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.08 2.152 . . . . 0.0 114.398 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.82 164.63 11.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.297 1.046 . . . . 0.0 109.407 172.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 p -141.24 136.22 31.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -166.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.28 151.09 36.04 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -89.08 107.34 18.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 mt -128.79 150.77 50.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 169.13 21.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.87 1.224 . . . . 0.0 112.762 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -68.42 -23.65 37.6 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.331 2.687 . . . . 0.0 113.924 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -57.25 -19.12 19.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.796 1.18 . . . . 0.0 113.31 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.0 7.05 23.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 109.507 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.3 166.22 11.89 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.389 1.875 . . . . 0.0 110.187 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -148.36 154.28 41.69 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.317 1.847 . . . . 0.0 106.847 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -69.97 127.4 14.38 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.135 2.557 . . . . 0.0 111.148 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -55.35 -53.73 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.456 1.102 . . . . 0.0 111.271 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.01 -21.91 59.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.761 0.824 . . . . 0.0 111.881 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -71.21 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.25 1.42 . . . . 0.0 109.031 167.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.26 15.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.379 1.472 . . . . 0.0 113.575 -166.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -52.93 -28.93 25.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.886 1.674 . . . . 0.0 112.019 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -34.86 6.9 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.123 0.874 . . . . 0.0 111.635 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -60.87 -60.9 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.258 1.023 . . . . 0.0 109.011 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -85.19 -52.02 6.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.695 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.33 88.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 126.187 1.851 . . . . 0.0 111.856 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -151.48 158.83 44.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.418 1.887 . . . . 0.0 108.899 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -60.0 150.89 27.75 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.886 1.327 . . . . 0.0 108.966 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.14 149.86 44.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.615 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -86.0 -14.1 45.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.171 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mmt-85 -58.31 123.9 17.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 164.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -64.78 164.17 12.75 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 -40.69 2.28 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.043 0.83 . . . . 0.0 111.719 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -52.43 -34.96 50.88 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.49 1.145 . . . . 0.0 112.168 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -46.43 76.43 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 121.34 -0.85 . . . . 0.0 112.794 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.04 -43.76 86.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.771 1.229 . . . . 0.0 109.294 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.36 -36.45 93.1 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.421 -0.8 . . . . 0.0 113.02 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.04 -16.91 61.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.289 1.036 . . . . 0.0 112.661 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -77.97 -52.73 8.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.02 -46.09 92.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 112.331 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.8 tt -63.58 -33.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.201 0.909 . . . . 0.0 111.806 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.49 -53.38 19.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.624 -0.672 . . . . 0.0 109.272 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -71.59 -21.94 61.79 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.803 0.689 . . . . 0.0 112.106 -170.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -55.63 -60.82 2.9 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.139 0.976 . . . . 0.0 110.219 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.82 -176.56 42.63 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 121.842 0.69 . . . . 0.0 113.631 -164.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.21 128.75 21.16 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.886 3.057 . . . . 0.0 109.829 -167.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 p -154.77 166.66 32.75 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 108.199 -165.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.57 22.95 13.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.974 0.91 . . . . 0.0 113.393 173.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.716 0 N-CA-C 107.579 -2.209 . . . . 0.0 107.579 178.247 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -131.44 161.65 31.99 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.182 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 125.35 2.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.91 -95.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.208 1.385 . . . . 0.0 110.893 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 p -169.34 -62.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -49.7 128.48 18.0 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.922 1.289 . . . . 0.0 109.978 162.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.57 -157.68 2.25 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 159.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -143.83 156.93 44.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -78.34 169.51 18.14 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -136.97 169.95 16.91 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.527 1.531 . . . . 0.0 108.759 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 144.08 44.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.491 0.662 . . . . 0.0 110.863 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.18 5.9 59.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.418 -1.212 . . . . 0.0 113.328 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.84 140.98 51.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.28 2.04 . . . . 0.0 108.251 166.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.5 mt -88.42 136.38 33.01 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.05 162.38 13.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 123.478 0.711 . . . . 0.0 109.593 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -102.1 126.6 49.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 164.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.9 168.8 10.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.707 0.803 . . . . 0.0 109.507 173.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -133.44 150.2 51.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.472 0.709 . . . . 0.0 109.569 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 55.4 mtm -132.62 172.89 11.93 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.127 1.771 . . . . 0.0 109.463 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -80.55 71.23 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.143 1.377 . . . . 0.0 109.981 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.36 -41.38 1.2 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.414 1.483 . . . . 0.0 111.276 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -60.65 150.6 74.76 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.505 1.122 . . . . 0.0 110.946 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.52 165.44 29.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.549 3.499 . . . . 0.0 111.333 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -55.36 116.57 2.92 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -118.33 132.1 23.93 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.33 137.44 36.71 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.969 1.78 . . . . 0.0 110.751 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.03 167.34 23.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.674 1.19 . . . . 0.0 110.249 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.41 139.5 53.6 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.69 112.5 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -73.97 171.04 14.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.582 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.2 154.31 37.66 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.43 1.109 . . . . 0.0 111.147 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.5 mt -134.37 112.33 11.95 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.589 -1.641 . . . . 0.0 108.068 -161.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.69 166.02 19.1 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 124.477 3.452 . . . . 0.0 110.495 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.72 82.91 7.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.127 -0.983 . . . . 0.0 108.658 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 68.85 0.28 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.49 1.519 . . . . 0.0 110.525 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.94 -171.77 3.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.532 1.533 . . . . 0.0 107.621 160.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.58 140.48 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.096 0.862 . . . . 0.0 108.684 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -121.72 141.71 34.37 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 123.5 0.72 . . . . 0.0 111.668 -168.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -70.79 156.61 60.32 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.702 2.268 . . . . 0.0 110.357 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.69 156.41 35.58 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 C-N-CA 120.823 1.015 . . . . 0.0 109.594 168.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.4 46.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.82 1.295 . . . . 0.0 110.142 -174.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.27 27.2 2.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.363 -169.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -128.19 166.7 18.02 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.349 1.06 . . . . 0.0 108.146 162.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -129.71 153.34 80.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 126.491 1.916 . . . . 0.0 107.283 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.12 115.68 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.397 2.065 . . . . 0.0 108.929 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.5 113.47 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -85.98 131.77 34.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -98.44 115.47 28.58 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -54.8 144.75 21.51 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.055 1.342 . . . . 0.0 110.718 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.86 -58.0 4.04 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.76 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 p -83.48 -24.64 31.68 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.849 2.324 . . . . 0.0 111.273 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.0 m170 70.01 17.43 7.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.349 1.459 . . . . 0.0 112.113 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.59 155.41 33.25 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 130.26 32.52 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.991 1.316 . . . . 0.0 108.0 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.02 159.02 42.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.79 121.63 32.11 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.7 mt -126.79 158.56 36.25 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 109.062 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.86 16.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.701 1.143 . . . . 0.0 112.658 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -67.84 -15.73 44.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.33 2.687 . . . . 0.0 115.188 -160.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -63.53 -26.37 68.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.393 1.451 . . . . 0.0 111.664 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.1 10.66 33.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.485 1.514 . . . . 0.0 111.533 -173.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.3 mt -133.35 127.09 32.76 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.927 1.291 . . . . 0.0 109.408 -169.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.33 142.68 37.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.424 1.089 . . . . 0.0 110.745 -167.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.49 121.04 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.821 3.014 . . . . 0.0 111.411 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -56.28 -50.08 72.41 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.8 -0.562 . . . . 0.0 111.064 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -57.87 -31.97 67.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 112.267 -173.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.19 -68.06 0.5 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.013 0.925 . . . . 0.0 108.823 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.4 -2.57 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.374 1.07 . . . . 0.0 113.265 -160.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.49 -46.46 57.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.935 1.694 . . . . 0.0 110.713 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.67 -17.36 53.88 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -97.76 -62.48 1.24 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.683 1.593 . . . . 0.0 109.786 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -86.22 -30.82 22.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.822 1.649 . . . . 0.0 111.782 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.21 73.41 2.0 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -132.38 128.94 38.67 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.504 1.122 . . . . 0.0 108.556 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -41.89 130.74 3.39 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 126.371 1.868 . . . . 0.0 109.208 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -138.85 134.72 33.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -78.1 72.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -120.09 133.96 55.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -68.32 147.74 51.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -58.69 5.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -48.77 -61.1 2.22 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 124.83 1.252 . . . . 0.0 110.67 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.1 -33.41 70.8 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.785 1.234 . . . . 0.0 114.073 -169.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.14 -39.97 68.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.645 0.778 . . . . 0.0 110.732 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -34.69 80.14 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.567 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.94 -24.78 64.31 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.371 1.085 . . . . 0.0 111.832 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -70.69 -50.06 40.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.79 -46.51 87.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.308 1.043 . . . . 0.0 111.545 -172.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 tt -66.69 -42.36 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.409 0.284 . . . . 0.0 110.864 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.02 -20.32 64.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.013 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -109.53 28.99 7.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.77 2.028 . . . . 0.0 110.74 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 p -61.9 -17.82 57.99 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.12 -177.73 21.01 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.161 1.362 . . . . 0.0 109.926 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.7 154.73 67.61 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.478 2.785 . . . . 0.0 110.929 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 m -103.75 120.03 40.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.211 1.004 . . . . 0.0 110.044 -163.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -137.85 -79.3 0.37 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.9 0.773 . . . . 0.0 111.69 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 104.488 -3.445 . . . . 0.0 104.488 -159.048 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 t -134.97 159.37 41.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.748 1.619 . . . . 0.0 107.902 168.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.99 50.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.748 1.219 . . . . 0.0 108.88 174.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.32 78.6 1.32 Allowed Glycine 0 C--N 1.338 0.64 0 C-N-CA 123.65 0.643 . . . . 0.0 112.448 166.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.5 m -116.85 175.66 5.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.948 1.699 . . . . 0.0 107.766 161.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.8 m -57.96 126.4 27.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 162.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.87 -91.4 0.17 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -138.02 96.49 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -62.48 135.17 57.29 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -128.94 158.67 38.17 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.089 0.859 . . . . 0.0 110.306 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.09 3.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 109.778 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.09 -37.75 2.23 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -69.8 160.7 31.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.716 1.246 . . . . 0.0 110.778 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -117.82 143.63 46.1 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 107.846 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.31 167.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.554 0.742 . . . . 0.0 111.479 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.43 128.34 50.6 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 158.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.1 165.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HE2' ' CE1' ' A' ' 24' ' ' HIS . 6.8 tptp -143.92 106.32 4.41 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.9 mtm -78.28 161.7 27.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 166.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.02 139.34 58.76 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.61 -44.43 2.5 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.078 1.323 . . . . 0.0 113.796 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.67 160.03 78.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.61 1.205 . . . . 0.0 112.384 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 178.46 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.979 3.786 . . . . 0.0 111.482 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.455 ' CE1' ' HE2' ' A' ' 18' ' ' LYS . 55.1 m80 -71.28 89.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.495 1.118 . . . . 0.0 109.234 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -80.69 136.31 51.79 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 110.161 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.43 124.51 12.56 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.895 2.397 . . . . 0.0 110.506 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.82 166.66 24.6 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.717 -0.615 . . . . 0.0 110.28 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 2.8 ptm85 -125.89 159.62 32.08 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.512 -0.743 . . . . 0.0 109.882 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.5 mm -86.27 108.88 18.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -73.28 174.98 7.28 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 32' ' ' LEU . 13.8 tt0 -101.74 -163.91 1.05 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 164.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' H ' ' HG2' ' A' ' 31' ' ' GLU . 1.8 mp -132.12 144.18 52.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.04 161.87 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.205 2.603 . . . . 0.0 112.2 171.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -76.89 18.4 0.36 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.299 -0.876 . . . . 0.0 112.019 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.05 92.82 0.09 OUTLIER Glycine 0 CA--C 1.524 0.606 0 C-N-CA 128.146 2.784 . . . . 0.0 108.025 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -157.64 -169.76 2.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.359 1.079 . . . . 0.0 110.184 -175.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.17 162.75 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 155.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -132.26 146.93 63.69 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 120.93 -1.107 . . . . 0.0 110.375 179.149 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' LYS . 32.2 Cg_exo -61.37 167.5 9.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.476 3.451 . . . . 0.0 115.719 -168.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -67.39 158.46 56.95 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 121.1 1.2 . . . . 0.0 111.647 160.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 131.07 46.54 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 63.04 16.39 9.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.23 2.612 . . . . 0.0 113.851 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -114.1 159.33 20.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.003 0.82 . . . . 0.0 110.2 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -122.84 153.11 63.5 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.282 1.833 . . . . 0.0 108.416 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.13 105.24 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.606 2.87 . . . . 0.0 110.487 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.7 mm -92.89 123.36 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.128 0.571 . . . . 0.0 109.527 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -101.87 115.99 31.74 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 107.091 170.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -80.44 115.84 20.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.7 m-85 -65.86 149.04 50.83 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.402 0.62 . . . . 0.0 110.737 -176.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 -34.45 0.34 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.884 2.183 . . . . 0.0 114.059 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -85.68 -28.48 24.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.68 2.24 . . . . 0.0 110.88 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 66.36 13.83 9.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.31 2.244 . . . . 0.0 113.701 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.68 160.07 30.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.2 1.0 . . . . 0.0 109.288 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -122.65 149.55 43.86 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 109.476 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.39 177.65 9.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.762 0.825 . . . . 0.0 109.287 167.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -117.33 122.82 44.94 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.83 156.94 32.18 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.73 0.3 . . . . 0.0 110.5 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.16 161.4 35.88 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.13 -20.97 63.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.957 2.438 . . . . 0.0 111.765 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -60.25 -23.73 64.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.87 0.868 . . . . 0.0 112.386 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.79 -9.94 50.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.489 1.04 . . . . 0.0 111.53 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.9 mt -116.48 160.58 20.39 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.23 1.412 . . . . 0.0 110.795 -162.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.55 146.95 47.14 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.066 0.946 . . . . 0.0 110.767 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -67.12 126.72 15.56 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.426 2.751 . . . . 0.0 110.508 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -52.8 -52.06 58.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.793 0.437 . . . . 0.0 110.841 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -66.66 -6.34 15.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -64.49 1.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.725 -0.609 . . . . 0.0 110.532 164.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -79.96 9.76 5.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.488 1.915 . . . . 0.0 113.525 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -53.71 -20.45 5.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.748 2.019 . . . . 0.0 112.464 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -33.13 4.62 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 119.972 1.26 . . . . 0.0 113.229 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -61.26 -51.56 68.41 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.615 1.098 . . . . 0.0 109.024 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -92.4 -35.06 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.108 0.963 . . . . 0.0 110.112 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.97 80.25 0.59 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.64 -1.089 . . . . 0.0 110.993 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -141.86 142.59 33.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.095 1.758 . . . . 0.0 107.648 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -54.4 103.54 0.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.853 2.461 . . . . 0.0 111.7 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.71 150.5 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.344 -0.848 . . . . 0.0 112.268 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -45.62 -49.39 14.29 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.8 1.64 . . . . 0.0 113.232 168.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -58.49 139.39 55.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.83 0.741 . . . . 0.0 110.598 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -71.27 172.5 9.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 162.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.34 -88.01 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 104.611 -3.396 . . . . 0.0 104.611 -143.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -32.24 -53.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.535 2.734 . . . . 0.0 115.547 -151.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -23.7 62.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.39 -57.29 4.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.633 2.373 . . . . 0.0 108.501 170.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.42 -27.75 61.19 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.332 -0.705 . . . . 0.0 112.563 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.48 -48.85 73.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.14 0.97 . . . . 0.0 111.384 170.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -60.89 -40.58 93.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.666 1.121 . . . . 0.0 110.178 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.58 -51.64 67.71 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.356 0.663 . . . . 0.0 111.678 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.2 tt -66.57 -29.4 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 118.892 0.769 . . . . 0.0 110.945 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.69 -30.99 69.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.214 -0.929 . . . . 0.0 110.905 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -96.04 39.18 1.15 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.3 m -142.67 125.31 15.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.628 2.771 . . . . 0.0 106.631 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.29 -124.17 5.97 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.433 1.968 . . . . 0.0 110.233 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -63.55 100.85 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.183 2.589 . . . . 0.0 109.233 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -77.54 100.39 6.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 169.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m 56.21 30.84 17.3 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -176.644 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 m 55.0 -91.79 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.889 1.676 . . . . 0.0 112.295 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.6 171.56 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.264 1.393 . . . . 0.0 111.181 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.78 100.46 2.66 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -44.58 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.445 1.498 . . . . 0.0 111.344 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -171.65 -174.57 1.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.535 1.934 . . . . 0.0 108.119 -166.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.13 163.31 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.048 1.308 . . . . 0.0 111.141 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 10.19 98.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 131.811 4.045 . . . . 0.0 115.183 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.73 136.32 57.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.188 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -134.5 167.95 19.84 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.974 1.31 . . . . 0.0 108.83 169.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.23 139.57 8.38 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.16 25.12 49.76 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.08 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -109.76 167.42 10.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.548 1.674 . . . . 0.0 109.693 164.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.45 138.25 46.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.766 2.026 . . . . 0.0 106.751 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -140.63 175.3 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 108.901 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -109.38 151.9 26.03 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 157.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.13 147.09 49.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.461 1.505 . . . . 0.0 109.056 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -134.63 104.81 6.21 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -164.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.8 mtm -88.95 167.2 13.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.302 0.573 . . . . 0.0 110.349 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -51.06 113.32 0.9 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.892 1.677 . . . . 0.0 109.154 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.77 -36.13 3.16 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.781 1.658 . . . . 0.0 114.26 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.54 163.65 19.2 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.54 1.536 . . . . 0.0 112.515 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -85.55 -179.04 3.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 125.126 3.884 . . . . 0.0 110.68 168.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -67.18 92.66 0.27 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.269 1.028 . . . . 0.0 108.655 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -78.13 139.1 60.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.986 1.314 . . . . 0.0 108.089 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.4 137.22 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.352 2.034 . . . . 0.0 108.914 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.77 156.86 43.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 141.72 49.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mm -78.12 105.37 7.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.27 170.87 6.5 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.655 0.782 . . . . 0.0 108.896 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -90.08 167.94 12.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.179 -0.951 . . . . 0.0 108.584 162.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.11 107.71 57.47 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 164.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.72 174.43 5.53 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.557 2.171 . . . . 0.0 109.872 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.1 163.07 6.44 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.576 -0.703 . . . . 0.0 110.138 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.72 -9.56 0.27 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.919 1.247 . . . . 0.0 115.698 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.97 177.64 3.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.284 1.834 . . . . 0.0 111.008 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.89 147.97 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.766 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -108.03 105.39 56.3 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 125.007 1.323 . . . . 0.0 107.84 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.96 169.07 20.05 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.789 2.326 . . . . 0.0 111.187 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.95 160.08 51.31 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 N-CA-C 110.137 -0.755 . . . . 0.0 110.137 169.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.06 13.66 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.98 8.57 1.67 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.38 2.272 . . . . 0.0 111.278 -159.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -141.02 164.19 30.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.927 1.291 . . . . 0.0 108.187 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.67 152.67 59.03 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 124.412 1.085 . . . . 0.0 110.158 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.03 91.06 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.637 2.891 . . . . 0.0 109.476 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.6 mm -82.36 118.1 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -85.09 149.51 25.5 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 163.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -111.86 113.34 25.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -64.8 160.4 20.34 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.933 0.873 . . . . 0.0 110.455 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.49 -47.31 2.38 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.92 2.2 . . . . 0.0 113.201 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -96.77 -21.64 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.485 1.143 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.0 m80 66.79 21.71 10.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.454 1.902 . . . . 0.0 112.065 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -71.66 163.37 27.9 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.219 1.009 . . . . 0.0 109.845 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -142.79 142.85 31.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 109.254 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.52 -175.81 5.53 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.986 2.514 . . . . 0.0 107.055 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.82 125.29 48.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 109.386 165.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 mt -130.48 150.89 51.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.518 1.927 . . . . 0.0 108.769 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.81 165.54 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.34 0.971 . . . . 0.0 111.687 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.66 -22.33 50.63 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.937 3.091 . . . . 0.0 113.385 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -60.96 -13.33 15.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.127 -0.939 . . . . 0.0 112.142 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.44 -5.26 21.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 113.734 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.2 mt -122.39 146.96 46.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.565 1.075 . . . . 0.0 109.911 -157.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.15 143.28 46.48 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.579 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -65.02 114.88 2.99 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.619 2.213 . . . . 0.0 108.664 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -46.98 -54.26 10.55 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 123.929 0.892 . . . . 0.0 109.471 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -60.11 -25.24 65.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.502 0.502 . . . . 0.0 112.299 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -57.03 4.18 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -83.42 17.06 2.27 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 112.434 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -66.65 -31.36 71.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.278 1.431 . . . . 0.0 108.968 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.62 -57.07 3.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.414 0.552 . . . . 0.0 111.253 162.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.92 -41.85 83.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.115 0.87 . . . . 0.0 110.843 -162.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -102.73 -14.78 16.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.027 1.731 . . . . 0.0 112.541 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.64 75.17 2.14 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 119.719 1.145 . . . . 0.0 110.268 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -133.3 132.67 41.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.251 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 p -61.62 79.79 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.833 2.053 . . . . 0.0 112.867 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -95.41 147.11 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 110.181 -168.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -91.97 41.96 1.09 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -149.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -105.09 147.14 28.22 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.21 155.37 37.26 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.2 1.64 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.973 1.273 . . . . 0.0 112.197 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.28 -49.61 63.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.905 1.353 . . . . 0.0 112.932 -164.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -66.82 -22.64 66.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.625 0.77 . . . . 0.0 110.754 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -75.53 -47.52 26.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 108.39 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.66 -26.79 72.99 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 120.11 -0.272 . . . . 0.0 113.366 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 mt -72.23 -29.72 64.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.65 1.225 . . . . 0.0 111.584 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -70.72 -42.59 70.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.33 -0.856 . . . . 0.0 109.161 171.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.84 -55.22 37.2 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.156 0.582 . . . . 0.0 110.409 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.02 -34.12 64.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.989 0.813 . . . . 0.0 111.316 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.38 -29.94 65.54 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.496 -0.752 . . . . 0.0 111.631 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -83.96 -7.86 59.31 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.071 1.348 . . . . 0.0 112.795 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -82.13 77.4 8.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.464 1.506 . . . . 0.0 109.616 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.09 -169.99 39.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.38 157.38 41.22 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.304 3.336 . . . . 0.0 110.421 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.4 m -110.31 112.73 24.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.013 0.925 . . . . 0.0 109.214 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.1 m -152.93 141.59 20.93 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.571 1.948 . . . . 0.0 106.453 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 106.071 -2.812 . . . . 0.0 106.071 -170.875 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m 50.08 82.22 0.05 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.4 1.48 . . . . 0.0 112.95 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 p -72.75 164.18 26.96 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 150.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.3 65.5 0.43 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -77.06 -83.2 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 163.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p -82.76 170.37 15.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.533 0.733 . . . . 0.0 109.988 169.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.75 -83.71 0.31 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 165.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -141.76 135.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -85.07 155.6 21.45 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.73 156.52 46.74 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.794 -1.191 . . . . 0.0 110.058 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 141.8 50.44 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.63 40.41 10.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -136.55 173.08 12.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.248 1.024 . . . . 0.0 110.588 159.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -119.25 147.2 44.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.877 2.471 . . . . 0.0 106.801 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.424 HG11 HD11 ' A' ' 29' ' ' ILE . 33.9 m -149.73 171.33 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.381 1.073 . . . . 0.0 108.759 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.76 125.56 52.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.03 151.55 20.81 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.041 0.936 . . . . 0.0 110.796 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -126.9 106.32 9.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.2 mtp -83.99 167.78 16.58 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 162.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.18 119.79 11.51 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.05 -16.53 2.0 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.038 -1.423 . . . . 0.0 116.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -67.16 159.19 78.35 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 119.741 1.77 . . . . 0.0 110.907 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.13 164.28 34.52 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.61 2.873 . . . . 0.0 110.037 168.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -65.47 103.15 0.79 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -95.28 138.44 21.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.389 -164.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.56 124.49 14.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.695 2.264 . . . . 0.0 110.345 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.83 164.16 30.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.047 0.539 . . . . 0.0 110.324 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -128.85 146.13 51.01 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.037 -0.414 . . . . 0.0 110.612 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.424 HD11 HG11 ' A' ' 15' ' ' VAL . 17.7 mm -85.24 98.63 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 172.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -85.68 -175.88 5.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.754 1.622 . . . . 0.0 109.252 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -107.65 168.45 9.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.576 1.951 . . . . 0.0 108.907 167.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -81.08 151.62 70.31 Favored Pre-proline 0 N--CA 1.467 0.423 0 O-C-N 121.307 -0.871 . . . . 0.0 110.325 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -83.04 -167.49 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 124.721 3.614 . . . . 0.0 109.652 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -112.47 31.38 6.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.671 1.589 . . . . 0.0 112.163 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.23 46.45 0.17 Allowed Glycine 0 C--N 1.338 0.647 0 O-C-N 120.71 -1.244 . . . . 0.0 113.815 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.32 168.55 14.64 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.292 1.037 . . . . 0.0 110.998 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -66.11 119.2 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 143.04 96.0 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.931 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 73.3 Cg_endo -85.7 161.63 10.7 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.156 2.571 . . . . 0.0 114.591 -173.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.5 143.79 27.93 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.137 1.891 . . . . 0.0 111.11 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.81 75.32 3.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.091 -171.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -175.08 6.42 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.181 2.192 . . . . 0.0 110.622 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -136.9 -177.04 4.57 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.924 1.29 . . . . 0.0 109.679 -163.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -140.65 152.44 66.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.36 1.464 . . . . 0.0 109.084 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.81 92.01 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.424 3.416 . . . . 0.0 110.867 170.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.84 141.15 14.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -118.59 133.02 56.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.018 1.727 . . . . 0.0 108.2 172.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -89.85 112.53 23.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.242 1.417 . . . . 0.0 108.357 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 17.1 m-85 -62.39 154.56 27.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 171.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.49 -21.53 0.9 Allowed Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.725 -1.597 . . . . 0.0 115.951 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.96 -14.05 7.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 121.079 2.439 . . . . 0.0 113.879 178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 61.65 16.3 7.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.569 2.348 . . . . 0.0 112.832 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.1 170.4 10.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.373 1.082 . . . . 0.0 109.954 170.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -141.79 147.73 37.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 108.198 -172.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.42 24.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.318 0.508 . . . . 0.0 109.695 167.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' PRO . 50.5 m-85 -110.28 112.34 24.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 163.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 mt -125.13 142.0 51.76 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.55 164.17 37.68 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -64.4 -32.61 60.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.27 2.647 . . . . 0.0 112.363 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -58.95 -32.95 70.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.856 0.862 . . . . 0.0 112.788 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -82.72 -10.36 58.94 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.236 0.925 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.1 mt -108.15 154.7 21.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.614 1.965 . . . . 0.0 109.687 -171.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -134.01 140.89 37.66 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.797 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.76 126.12 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.442 2.761 . . . . 0.0 109.591 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.42 -48.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.706 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.56 -43.63 72.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.72 1.145 . . . . 0.0 112.731 -172.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -54.11 36.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.403 0.681 . . . . 0.0 110.61 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -85.47 2.85 42.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -55.76 -49.87 71.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.144 1.777 . . . . 0.0 108.991 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.27 -16.99 44.18 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -82.17 -64.76 1.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.885 1.221 . . . . 0.0 112.085 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -88.68 -31.48 18.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.818 2.447 . . . . 0.0 113.712 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.62 63.87 1.14 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.463 1.506 . . . . 0.0 113.367 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -128.99 142.6 50.87 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 p -56.75 150.13 16.71 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.382 1.087 . . . . 0.0 109.801 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.97 167.11 17.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.732 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -83.47 -16.83 44.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.155 0.889 . . . . 0.0 112.846 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -58.85 138.59 57.2 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.558 1.072 . . . . 0.0 109.768 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -67.29 154.69 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.356 0.663 . . . . 0.0 109.411 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.14 -31.97 1.11 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.389 0.995 . . . . 0.0 112.642 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.35 -26.23 66.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.922 1.861 . . . . 0.0 112.487 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -49.9 21.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.135 -0.978 . . . . 0.0 109.742 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -55.45 -47.69 75.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.131 1.372 . . . . 0.0 108.572 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 49' ' ' PHE . . . -66.97 -34.75 88.02 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.425 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.57 -20.38 64.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.581 1.691 . . . . 0.0 111.872 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -83.62 -42.69 16.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 120.765 1.621 . . . . 0.0 110.334 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -55.1 -49.93 70.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.045 0.538 . . . . 0.0 109.884 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.69 -31.79 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.527 -0.733 . . . . 0.0 111.94 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.66 -21.56 65.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.617 1.167 . . . . 0.0 111.769 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -117.09 -16.87 10.42 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.562 0.745 . . . . 0.0 112.058 -168.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -53.01 45.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.212 1.405 . . . . 0.0 111.402 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.73 41.71 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 117.95 0.341 . . . . 0.0 113.16 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.19 81.63 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.433 3.422 . . . . 0.0 110.433 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.2 m -147.3 109.44 4.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.72 1.208 . . . . 0.0 108.437 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.0 t -50.61 111.06 0.48 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.385 1.474 . . . . 0.0 108.842 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 C-N-CA 127.715 2.579 . . . . 0.0 107.353 -178.05 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.42 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.4 p -75.11 -161.75 0.15 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.697 0.799 . . . . 0.0 108.925 166.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -142.5 159.95 41.24 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.779 1.632 . . . . 0.0 107.767 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.89 143.84 13.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 174.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -71.95 -4.39 28.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.722 0.809 . . . . 0.0 111.496 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t -154.95 -164.78 1.87 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.112 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 38.69 14.74 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.208 175.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 109.48 141.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 1 C-N-CA 132.163 4.185 . . . . 0.0 108.041 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.78 157.78 15.98 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.705 0.802 . . . . 0.0 110.984 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -143.07 167.63 21.64 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.409 1.084 . . . . 0.0 110.214 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.21 132.37 23.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.065 0.946 . . . . 0.0 110.659 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.71 76.77 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.26 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.93 144.29 57.38 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.371 1.585 . . . . 0.0 107.926 165.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -101.25 144.1 30.52 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 171.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.87 173.98 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.327 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -114.35 138.07 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 154.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.87 172.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.156 1.383 . . . . 0.0 107.92 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -141.89 106.32 4.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.78 172.8 12.88 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.297 1.046 . . . . 0.0 110.628 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -80.74 44.28 0.72 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.864 2.066 . . . . 0.0 112.956 -165.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.83 -43.11 0.68 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.536 1.541 . . . . 0.0 109.758 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -55.95 155.61 11.55 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 117.284 0.542 . . . . 0.0 110.41 170.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.57 -178.2 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.187 3.258 . . . . 0.0 109.894 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -74.54 79.29 1.96 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.441 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -63.31 134.31 95.79 Favored Pre-proline 0 CA--C 1.539 0.549 0 O-C-N 120.855 -1.153 . . . . 0.0 111.27 -170.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.646 ' HG3' HD22 ' A' ' 85' ' ' LEU . 50.6 Cg_endo -67.95 131.38 23.78 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.587 2.191 . . . . 0.0 110.032 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.99 168.65 22.53 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.078 0.466 . . . . 0.0 109.843 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.47 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 7.5 ptm180 -134.67 160.29 38.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.692 -0.63 . . . . 0.0 110.878 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.2 mm -84.13 117.13 29.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -82.64 -179.4 7.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.382 1.473 . . . . 0.0 108.587 166.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -129.01 149.05 51.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 108.04 172.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -80.89 120.71 79.63 Favored Pre-proline 0 C--O 1.239 0.509 0 CA-C-O 117.537 -1.221 . . . . 0.0 109.083 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.37 166.8 8.84 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.738 1.625 . . . . 0.0 109.632 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -76.23 -4.49 42.16 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -160.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.64 51.01 0.83 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 128.396 2.903 . . . . 0.0 109.782 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 -179.7 4.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 122.199 1.0 . . . . 0.0 112.198 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 t -92.66 74.32 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 122.136 0.97 . . . . 0.0 108.95 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -28.22 108.94 0.23 Allowed Pre-proline 0 C--O 1.24 0.6 0 C-N-CA 128.169 2.588 . . . . 0.0 113.695 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.74 162.92 37.34 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.393 2.062 . . . . 0.0 112.012 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.34 138.74 39.91 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 N-CA-C 109.303 -1.076 . . . . 0.0 109.303 160.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.9 111.44 3.78 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 131.67 -4.48 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 131.428 3.891 . . . . 0.0 111.085 -170.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -115.26 143.96 44.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.725 1.602 . . . . 0.0 110.972 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -103.81 150.74 38.5 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.32 104.49 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.663 2.242 . . . . 0.0 108.555 159.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.55 140.83 16.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -112.97 121.16 43.81 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.563 2.345 . . . . 0.0 107.513 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -78.11 115.71 18.04 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.47 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.6 m-85 -67.79 155.77 38.54 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.906 0.384 . . . . 0.0 110.653 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.47 -58.8 4.1 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.979 0.8 . . . . 0.0 111.548 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -81.82 -21.16 37.8 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 112.152 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.4 m170 55.56 18.01 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.012 2.125 . . . . 0.0 112.619 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.86 166.56 19.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 109.095 173.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 p -142.56 148.11 37.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.229 1.011 . . . . 0.0 108.523 -171.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.52 179.47 7.65 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.521 1.128 . . . . 0.0 109.002 173.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -123.01 107.39 11.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.4 146.54 47.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.454 1.901 . . . . 0.0 107.96 -176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.46 162.13 23.37 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.91 -24.07 61.22 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.846 3.031 . . . . 0.0 113.961 -165.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -67.06 -9.1 35.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.239 1.381 . . . . 0.0 112.457 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.62 4.86 36.06 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.782 1.174 . . . . 0.0 111.501 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.51 153.93 50.44 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.298 1.439 . . . . 0.0 109.601 -166.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.13 143.93 26.7 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.901 0.88 . . . . 0.0 110.362 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.26 129.31 21.28 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.841 2.361 . . . . 0.0 110.568 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.54 -48.05 75.35 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 121.926 -0.484 . . . . 0.0 110.137 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.82 -24.74 66.08 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.75 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -43.28 18.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.523 1.129 . . . . 0.0 110.203 174.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.428 ' CD1' ' CE2' ' A' ' 72' ' ' PHE . 54.3 m-85 -100.84 6.29 43.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.538 1.535 . . . . 0.0 114.047 -164.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -58.81 -33.72 70.7 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 127.249 2.219 . . . . 0.0 112.78 -167.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -98.85 -21.36 16.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.027 0.83 . . . . 0.0 110.346 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -76.13 -68.77 0.55 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.685 1.194 . . . . 0.0 108.576 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 68' ' ' TYR . 22.1 m-30 -81.0 -44.36 18.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.938 1.695 . . . . 0.0 108.975 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.36 96.0 0.05 OUTLIER Glycine 0 C--N 1.339 0.723 0 C-N-CA 125.862 1.696 . . . . 0.0 109.081 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -140.27 133.13 29.16 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.675 1.99 . . . . 0.0 106.245 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 122.57 21.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -145.06 171.76 14.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.256 1.823 . . . . 0.0 108.988 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -88.24 -60.05 2.07 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.083 0.856 . . . . 0.0 112.262 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.304 0.3 OUTLIER 44.5 -126.1 1.02 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.824 0.85 . . . . 0.0 109.876 -173.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -136.99 105.64 5.84 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 127.706 2.402 . . . . 0.0 105.975 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.1 89.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 119.927 1.239 . . . . 0.0 114.207 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 33.2 t80 -76.55 -52.91 8.84 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.243 1.522 . . . . 0.0 110.816 -170.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -40.97 69.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.882 1.219 . . . . 0.0 110.561 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -61.7 -52.0 66.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.059 1.344 . . . . 0.0 110.591 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.62 92.21 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 123.39 0.519 . . . . 0.0 112.676 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.646 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -63.53 -49.48 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -57.58 -35.86 70.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.469 0.577 . . . . 0.0 110.935 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.58 -47.63 69.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.924 0.784 . . . . 0.0 110.681 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -67.76 -34.65 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.867 0.758 . . . . 0.0 109.79 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.52 -17.83 60.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.789 1.235 . . . . 0.0 111.648 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -130.88 10.2 5.02 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.541 1.536 . . . . 0.0 112.658 -169.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -15.4 62.93 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -167.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.24 87.94 0.06 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.872 -1.515 . . . . 0.0 109.46 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.94 108.67 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.374 2.716 . . . . 0.0 110.783 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -60.01 156.06 15.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.062 0.545 . . . . 0.0 110.699 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 77.7 p -113.72 168.94 9.35 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.251 1.02 . . . . 0.0 110.164 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.255 -1.303 . . . . 0.0 112.39 171.799 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 p 54.14 34.57 20.4 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.608 -1.524 . . . . 0.0 112.453 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 m -54.2 114.46 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.03 80.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 104.47 -3.452 . . . . 0.0 104.47 -168.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 m -138.57 95.54 3.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.206 1.002 . . . . 0.0 108.371 -154.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 m -133.15 100.11 4.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.985 1.714 . . . . 0.0 110.24 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.47 46.62 0.91 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-O 119.92 -0.378 . . . . 0.0 113.575 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -130.49 157.0 43.84 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 143.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -87.25 177.38 7.18 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -139.83 172.25 13.05 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.899 -1.125 . . . . 0.0 108.557 168.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.1 55.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.6 73.79 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.767 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -97.74 157.69 15.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.753 1.276 . . . . 0.0 108.697 161.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -118.14 134.45 54.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.56 1.944 . . . . 0.0 106.328 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.98 171.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 118.942 0.792 . . . . 0.0 110.414 -167.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.36 142.11 34.78 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.499 -1.376 . . . . 0.0 107.791 162.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.58 161.47 15.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.433 1.493 . . . . 0.0 109.118 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -143.79 107.17 4.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.6 171.5 8.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.69 0.757 . . . . 0.0 109.816 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -53.08 119.13 4.33 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.025 1.73 . . . . 0.0 108.7 173.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.08 -48.36 3.54 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.397 0.999 . . . . 0.0 112.801 172.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -54.45 158.14 4.34 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.908 1.683 . . . . 0.0 112.297 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.36 179.58 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.031 3.154 . . . . 0.0 110.698 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.86 94.12 0.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -85.62 134.91 38.95 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.809 1.243 . . . . 0.0 109.495 -170.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.81 126.18 17.6 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.052 2.501 . . . . 0.0 110.225 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.69 168.11 20.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.764 1.226 . . . . 0.0 109.493 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.23 52.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -80.18 105.15 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 168.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -89.61 -172.39 3.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -126.04 157.33 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.987 0.899 . . . . 0.0 111.258 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 mt -78.7 134.3 61.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 109.336 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.22 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 124.489 3.459 . . . . 0.0 111.262 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.78 -138.45 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.858 2.863 . . . . 0.0 112.197 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.8 21.39 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 129.144 3.259 . . . . 0.0 116.48 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -179.83 0.18 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.389 1.876 . . . . 0.0 111.735 166.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.69 164.22 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.903 1.681 . . . . 0.0 109.509 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -112.07 136.78 21.28 Favored Pre-proline 0 C--O 1.242 0.708 0 O-C-N 120.545 -1.347 . . . . 0.0 109.736 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.4 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 69.0 Cg_endo -72.14 163.61 38.18 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.06 2.507 . . . . 0.0 112.052 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.01 151.36 73.37 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.21 66.17 4.59 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.82 -8.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.582 1.953 . . . . 0.0 111.233 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -136.01 153.58 51.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.387 1.075 . . . . 0.0 110.068 -171.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -106.11 148.18 36.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 125.121 1.368 . . . . 0.0 107.719 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.3 122.16 10.24 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.124 1.883 . . . . 0.0 107.625 155.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.88 111.38 32.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.656 1.582 . . . . 0.0 107.589 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -85.47 129.14 34.88 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.121 0.969 . . . . 0.0 108.656 171.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -93.62 93.84 8.27 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 108.149 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.18 151.01 1.48 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.637 1.175 . . . . 0.0 110.572 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.57 -74.07 2.3 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -68.34 -20.89 64.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m170 46.35 50.56 12.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.511 1.925 . . . . 0.0 111.001 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -97.09 162.06 13.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 161.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.0 p -134.76 130.81 36.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 157.6 43.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.636 0.653 . . . . 0.0 111.189 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 39' ' ' PRO . 60.6 m-85 -94.98 108.44 20.5 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.8 mt -126.06 146.71 49.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.069 0.548 . . . . 0.0 110.305 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.4 161.9 23.35 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.09 0.852 . . . . 0.0 111.506 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.2 -20.81 42.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.734 2.956 . . . . 0.0 113.857 -164.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -70.54 -14.57 62.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.655 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.64 0.39 44.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.005 1.322 . . . . 0.0 111.047 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -115.62 160.73 19.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.387 1.449 . . . . 0.0 110.482 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.8 145.63 28.61 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.14 130.91 26.88 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -51.25 -58.05 7.21 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.183 0.993 . . . . 0.0 110.853 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.5 -34.26 72.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.964 1.305 . . . . 0.0 111.508 -168.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -56.38 6.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -86.16 6.38 29.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.831 1.253 . . . . 0.0 113.57 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -57.33 -40.83 78.8 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.271 1.828 . . . . 0.0 110.739 -172.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.58 -45.19 39.15 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.899 0.772 . . . . 0.0 111.475 172.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -66.24 -41.25 90.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.58 0.752 . . . . 0.0 111.767 -169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -114.83 -31.01 6.26 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.844 1.658 . . . . 0.0 110.969 -167.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.19 70.68 2.55 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -140.67 139.2 34.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.498 1.119 . . . . 0.0 108.256 -167.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.2 p -54.54 140.51 34.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.27 1.428 . . . . 0.0 109.993 -176.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.22 154.92 50.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.232 174.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -77.99 66.97 3.74 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 109.739 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 mmt-85 -133.94 112.68 11.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.167 1.787 . . . . 0.0 106.529 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -57.93 150.13 21.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.36 -18.26 0.56 Allowed Glycine 0 CA--C 1.537 1.457 0 CA-C-O 118.477 -1.18 . . . . 0.0 115.031 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -73.47 -55.93 5.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 121.426 2.613 . . . . 0.0 110.527 -174.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 37.6 m-20 -66.06 -27.92 68.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.703 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -65.25 -41.02 94.72 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.775 2.03 . . . . 0.0 110.594 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.37 -35.24 81.74 Favored Glycine 0 CA--C 1.523 0.543 0 O-C-N 121.399 -0.813 . . . . 0.0 111.697 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.65 -32.82 74.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.901 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -59.77 -47.58 85.12 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.92 1.236 . . . . 0.0 110.435 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.39 -57.69 8.59 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.077 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 tt -59.24 -32.5 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 118.688 0.676 . . . . 0.0 111.732 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.98 -52.31 56.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.432 1.093 . . . . 0.0 109.799 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -73.91 -19.27 60.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.816 0.846 . . . . 0.0 112.807 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.0 m -85.35 2.29 44.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.705 2.002 . . . . 0.0 113.044 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.2 -163.02 9.58 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.637 -1.29 . . . . 0.0 110.181 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.63 94.19 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.207 2.605 . . . . 0.0 108.784 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.0 t -65.68 -40.32 92.22 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m 53.25 -151.9 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.886 0.874 . . . . 0.0 110.558 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.374 0 N-CA-C 106.456 -2.658 . . . . 0.0 106.456 -170.45 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.15 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 p -132.72 137.54 46.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.775 1.23 . . . . 0.0 109.364 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -135.45 -37.57 0.76 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.114 1.365 . . . . 0.0 109.534 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.78 -179.37 51.28 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 124.683 1.135 . . . . 0.0 110.953 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.64 107.48 2.38 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -68.59 113.13 5.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.55 97.55 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.52 159.26 0.07 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.472 2.709 . . . . 0.0 111.283 -167.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -117.5 148.43 41.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.945 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -135.43 157.89 45.76 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.962 1.705 . . . . 0.0 110.099 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.75 134.42 56.73 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.711 0.632 . . . . 0.0 109.981 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.98 47.33 5.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.54 174.59 10.45 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.021 0.529 . . . . 0.0 110.275 161.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.1 mt -125.08 140.31 53.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.805 2.042 . . . . 0.0 106.262 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.91 172.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -105.7 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 152.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.42 154.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.181 1.392 . . . . 0.0 108.216 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -128.92 106.32 8.82 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mtm -86.21 167.59 14.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 167.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.26 125.43 20.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.719 1.207 . . . . 0.0 108.532 177.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.77 -33.58 1.22 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.371 1.462 . . . . 0.0 115.132 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.13 158.69 62.22 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 118.887 1.344 . . . . 0.0 112.072 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 178.21 6.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.55 3.5 . . . . 0.0 110.247 168.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.7 96.31 0.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.565 0.746 . . . . 0.0 109.093 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -78.81 135.22 59.67 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.109 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.04 122.5 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.537 2.158 . . . . 0.0 108.914 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.15 165.91 25.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 109.908 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -129.86 164.11 24.85 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.101 -1.0 . . . . 0.0 110.621 -178.671 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.17 96.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -86.4 -169.12 2.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.69 2.396 . . . . 0.0 110.834 -166.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.16 170.26 14.79 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.23 -1.544 . . . . 0.0 112.281 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.4 mt -148.27 135.95 10.89 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.461 1.904 . . . . 0.0 106.31 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.93 127.99 7.26 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.64 2.227 . . . . 0.0 110.2 164.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.4 125.81 24.88 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.256 0.622 . . . . 0.0 109.696 171.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.56 -38.78 2.45 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.341 1.448 . . . . 0.0 110.012 -172.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -167.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.65 1.18 . . . . 0.0 110.667 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -48.24 143.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.601 1.16 . . . . 0.0 110.802 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -129.01 115.16 18.85 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.814 1.246 . . . . 0.0 109.989 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.79 163.6 37.96 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.76 2.306 . . . . 0.0 111.704 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.22 153.58 74.24 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 121.278 1.318 . . . . 0.0 110.137 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.84 52.19 1.44 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 124.192 0.932 . . . . 0.0 110.949 -172.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.47 7.52 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.748 2.419 . . . . 0.0 110.429 174.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -132.36 145.3 51.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.768 1.227 . . . . 0.0 108.972 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -107.75 148.6 37.64 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 124.002 0.921 . . . . 0.0 108.629 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.83 105.2 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.446 2.764 . . . . 0.0 109.19 162.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.64 156.77 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -133.13 124.96 28.48 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.338 1.855 . . . . 0.0 107.299 166.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -89.62 94.65 9.94 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 16.5 m-85 -46.68 148.13 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.493 1.117 . . . . 0.0 111.069 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.99 -35.87 1.06 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.093 0.854 . . . . 0.0 113.869 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.8 p -87.07 -26.81 23.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.586 1.693 . . . . 0.0 110.864 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.8 m80 62.01 24.46 14.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.496 2.318 . . . . 0.0 112.194 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -97.03 149.87 21.44 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.544 1.138 . . . . 0.0 108.994 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -123.74 147.42 47.51 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 -172.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.96 165.27 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.681 1.193 . . . . 0.0 109.122 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.95 106.94 17.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.19 156.58 19.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 161.25 22.54 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 166.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -63.32 -16.71 56.21 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.085 3.19 . . . . 0.0 115.076 -166.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -69.3 -17.79 63.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.446 1.476 . . . . 0.0 111.606 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -89.23 1.84 55.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.619 1.168 . . . . 0.0 110.905 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.7 mt -117.58 167.77 11.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.751 1.62 . . . . 0.0 111.463 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -143.69 152.31 55.77 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.025 1.73 . . . . 0.0 109.169 162.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.58 118.27 5.4 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 0.0 111.034 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -44.33 -62.27 1.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 125.075 1.35 . . . . 0.0 112.324 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -42.52 62.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.473 1.033 . . . . 0.0 112.055 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.41 -33.09 74.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.908 0.883 . . . . 0.0 111.426 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.31 8.82 18.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.198 -1.564 . . . . 0.0 112.787 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -56.77 -42.57 79.62 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.347 1.859 . . . . 0.0 111.144 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -74.54 -37.17 63.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.877 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -82.26 -49.37 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.895 1.278 . . . . 0.0 111.48 -162.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -94.75 -33.34 12.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.752 2.021 . . . . 0.0 110.363 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.29 61.76 3.47 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.278 1.418 . . . . 0.0 111.366 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.558 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 11.1 mmpt? -131.24 136.95 48.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.566 1.947 . . . . 0.0 107.799 -172.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.6 m -40.34 110.31 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.435 2.294 . . . . 0.0 110.824 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.65 176.6 7.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.046 0.45 . . . . 0.0 109.829 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -83.83 -38.8 20.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.537 -1.221 . . . . 0.0 110.047 164.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 125.81 16.63 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.669 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.23 163.65 8.01 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 0.0 109.675 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.08 -42.32 1.86 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -56.91 -44.74 82.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.455 1.102 . . . . 0.0 111.861 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.52 -36.81 71.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.24 0.927 . . . . 0.0 110.445 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -63.11 -31.71 72.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.608 0.763 . . . . 0.0 110.39 172.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.19 -32.69 42.73 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.566 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.6 -41.81 99.2 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.387 1.094 . . . . 0.0 110.137 172.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -54.87 -43.77 73.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.191 0.45 . . . . 0.0 111.101 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.62 -53.06 57.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.849 0.295 . . . . 0.0 111.357 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.4 tt -67.45 -33.97 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.785 0.266 . . . . 0.0 110.589 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -62.87 -38.06 89.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.7 0.8 . . . . 0.0 110.06 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -76.03 -74.28 0.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.538 -0.726 . . . . 0.0 110.473 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.9 p 48.36 73.2 0.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.203 2.201 . . . . 0.0 112.135 -167.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.07 100.87 0.17 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.905 -0.941 . . . . 0.0 111.54 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.38 156.0 28.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.213 1.942 . . . . 0.0 108.454 164.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 46.2 55.34 7.36 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.45 1.1 . . . . 0.0 112.011 -174.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 103.76 135.72 0.01 OUTLIER 'General case' 0 C--O 1.236 0.375 0 C-N-CA 131.545 3.938 . . . . 0.0 108.311 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.14 0 N-CA-C 103.92 -3.672 . . . . 0.0 103.92 -146.657 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -132.59 153.95 50.52 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.707 1.203 . . . . 0.0 109.799 -169.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.14 52.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.5 -12.0 68.24 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.748 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.28 166.58 21.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.609 1.705 . . . . 0.0 109.589 166.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.44 148.81 47.4 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 29' ' ' ILE . 28.9 m -148.66 170.46 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 C-N-CA 123.363 0.665 . . . . 0.0 111.083 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.69 138.23 40.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.64 120.73 39.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 108.158 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 18.2 tptp -104.99 106.53 17.07 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -87.91 158.05 18.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -64.5 93.46 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 111.404 -172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -18.78 42.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.631 1.11 . . . . 0.0 112.593 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -72.63 162.11 75.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.646 1.223 . . . . 0.0 108.753 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -61.78 178.73 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.645 2.23 . . . . 0.0 112.284 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.426 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 55.6 m80 -64.96 92.33 0.1 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 158.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -76.37 141.06 69.44 Favored Pre-proline 0 C--O 1.234 0.266 0 C-N-CA 123.979 0.911 . . . . 0.0 109.414 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.96 121.06 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.617 2.211 . . . . 0.0 109.187 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 163.47 32.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.5 0.667 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 13.2 ptt180 -119.93 152.33 37.58 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.42 HD11 HG11 ' A' ' 15' ' ' VAL . 11.2 mm -78.46 121.87 32.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 163.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -102.5 -174.39 2.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 168.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.26 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 . . . . . 0 N--CA 1.471 0.612 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -83.16 166.99 18.17 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.501 1.046 . . . . 0.0 111.352 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -130.26 149.4 73.21 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.426 1.09 . . . . 0.0 109.225 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 92.26 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.723 2.949 . . . . 0.0 108.976 163.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.47 122.93 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -102.12 117.43 34.76 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.151 1.38 . . . . 0.0 107.476 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -84.1 105.17 14.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.69 1.596 . . . . 0.0 107.658 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 11.5 m-85 -60.69 156.77 16.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.107 0.479 . . . . 0.0 110.731 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.16 -23.42 0.91 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.448 1.975 . . . . 0.0 115.616 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -113.55 -18.46 11.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.931 1.366 . . . . 0.0 110.604 170.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.6 m170 61.85 18.43 9.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.06 2.544 . . . . 0.0 111.578 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.19 160.2 32.32 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.753 0.821 . . . . 0.0 110.005 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.3 p -125.71 131.01 52.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.734 1.214 . . . . 0.0 108.157 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.78 170.22 16.29 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.653 166.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.16 118.06 35.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.49 154.23 40.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.45 167.05 19.94 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -61.56 -32.76 87.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.982 2.455 . . . . 0.0 112.86 -163.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -63.25 -28.8 70.28 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.763 0.825 . . . . 0.0 112.799 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.78 -1.16 50.88 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 111.716 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -126.85 160.75 30.03 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.957 1.703 . . . . 0.0 109.34 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -140.39 136.38 16.72 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.31 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.62 128.69 21.73 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.785 2.323 . . . . 0.0 110.128 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -51.15 -59.48 4.15 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.355 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -61.31 -23.54 65.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.629 1.559 . . . . 0.0 113.26 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -29.71 41.55 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.189 1.358 . . . . 0.0 111.507 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -114.55 6.19 15.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.742 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -57.08 -44.49 83.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.073 1.749 . . . . 0.0 109.854 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -89.87 -27.99 19.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -68.54 -44.05 75.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.741 1.616 . . . . 0.0 112.55 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -114.19 -27.25 7.71 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.938 2.095 . . . . 0.0 111.017 -172.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 63.5 3.86 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.814 1.197 . . . . 0.0 110.894 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -142.67 157.65 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.614 1.165 . . . . 0.0 109.158 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m -73.38 71.41 1.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.218 1.807 . . . . 0.0 115.34 -151.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.99 -11.12 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.563 1.545 . . . . 0.0 113.031 -170.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.6 tttt 53.69 29.14 8.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.078 2.151 . . . . 0.0 115.865 165.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -71.73 11.28 0.53 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 61.98 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.333 2.253 . . . . 0.0 109.393 -152.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.64 -40.91 0.65 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.441 -1.412 . . . . 0.0 112.632 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -30.43 68.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.917 1.687 . . . . 0.0 114.277 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -33.16 32.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 120.967 -1.083 . . . . 0.0 110.483 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.2 -58.22 9.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.79 1.636 . . . . 0.0 106.866 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.69 -33.69 87.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 118.998 0.817 . . . . 0.0 113.288 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.7 -29.61 69.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.689 1.245 . . . . 0.0 111.842 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -75.48 -43.38 49.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.929 0.786 . . . . 0.0 109.28 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.75 -38.21 90.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.028 1.331 . . . . 0.0 110.143 -171.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 tt -73.46 -45.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.341 1.057 . . . . 0.0 111.281 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.45 -55.91 26.27 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 . . . . . 0 CA--C 1.532 0.271 0 C-N-CA 125.112 1.365 . . . . 0.0 112.773 -177.547 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 . . . . . 0 C--O 1.234 0.271 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -142.58 161.81 37.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.518 1.527 . . . . 0.0 107.774 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 133.66 56.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.85 -12.73 68.84 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.614 -1.103 . . . . 0.0 112.915 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 128.07 34.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.349 1.575 . . . . 0.0 107.576 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -85.65 147.7 26.25 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.85 168.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.655 0.74 . . . . 0.0 111.781 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.52 125.5 50.11 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 160.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.402 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -92.82 154.17 18.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -130.19 105.89 8.23 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mtm -73.14 168.96 18.04 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 110.042 171.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.75 55.01 2.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 110.768 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.5 -28.22 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.946 0.784 . . . . 0.0 112.494 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -70.5 160.43 81.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.882 -0.775 . . . . 0.0 110.258 167.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.11 177.84 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.965 3.11 . . . . 0.0 111.749 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -62.65 112.57 2.56 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -114.56 143.56 30.15 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 124.91 1.284 . . . . 0.0 108.037 -166.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.77 123.85 11.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 110.973 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.48 159.38 42.52 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.274 0.559 . . . . 0.0 110.153 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 138.84 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -75.53 92.49 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 163.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -78.21 -164.08 0.5 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.239 0.529 0 O-C-N 120.77 -1.206 . . . . 0.0 108.318 165.123 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m120 . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -125.58 160.98 28.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.715 1.143 . . . . 0.0 111.985 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -123.31 152.81 64.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.03 1.732 . . . . 0.0 109.015 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.59 93.39 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 124.506 3.47 . . . . 0.0 111.358 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mm -86.03 108.4 17.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.031 0.933 . . . . 0.0 108.577 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -94.5 119.16 32.78 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 111.64 18.55 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 107.85 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -61.04 157.18 16.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.745 0.783 . . . . 0.0 110.377 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.92 -70.68 1.75 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.745 1.164 . . . . 0.0 111.894 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 p -69.02 -22.29 64.07 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.948 -1.325 . . . . 0.0 112.275 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 66.45 10.17 7.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.1 2.16 . . . . 0.0 113.679 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.14 159.17 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.914 -1.116 . . . . 0.0 110.262 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.25 130.38 40.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.24 -176.15 5.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.82 1.248 . . . . 0.0 109.952 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.95 125.99 40.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 171.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.2 mt -128.85 155.93 44.45 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 108.247 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.87 171.83 22.12 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.744 1.164 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.85 -26.36 32.18 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.483 2.122 . . . . 0.0 113.07 -160.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.86 -14.16 61.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.061 0.846 . . . . 0.0 112.494 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -94.38 -4.59 48.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.761 0.709 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 17' ' ' ALA . 90.1 mt -127.84 153.66 46.36 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.277 1.831 . . . . 0.0 109.927 -163.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -136.29 147.1 58.9 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 109.72 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -63.1 140.41 78.22 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.595 2.197 . . . . 0.0 109.456 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -59.1 -65.69 0.63 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -24.96 67.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -162.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -68.44 -58.77 3.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.552 0.741 . . . . 0.0 109.937 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.48 16.46 7.61 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.968 1.707 . . . . 0.0 111.055 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -60.42 -40.17 90.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.698 1.199 . . . . 0.0 109.518 -164.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.421 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 t70 -80.19 -53.39 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.579 170.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -51.06 -39.94 57.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.676 1.59 . . . . 0.0 113.84 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -110.23 -24.33 10.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.164 1.385 . . . . 0.0 110.643 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.16 71.07 2.89 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 70' ' ' ASP . 9.3 mmpt? -121.66 145.03 48.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 107.659 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -58.04 99.03 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.867 1.667 . . . . 0.0 109.053 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -77.75 173.27 12.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.506 0.669 . . . . 0.0 110.058 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -73.44 -39.34 65.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.694 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.57 141.18 56.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.452 0.569 . . . . 0.0 110.606 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -64.5 163.22 13.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.782 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -47.29 0.83 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.946 1.736 . . . . 0.0 112.167 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -49.58 -49.01 48.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.16 1.384 . . . . 0.0 111.404 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.69 -29.15 69.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.52 -46.93 71.39 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -28.7 73.79 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.24 -0.755 . . . . 0.0 112.895 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.97 -49.8 59.57 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.604 1.202 . . . . 0.0 110.593 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -59.68 -39.01 83.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.891 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.03 -63.11 1.32 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.671 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.85 -32.58 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 119.747 1.158 . . . . 0.0 112.247 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.15 -53.73 40.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.503 0.321 . . . . 0.0 110.141 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 . . . . . 0 C--N 1.332 -0.153 0 O-C-N 121.869 -0.519 . . . . 0.0 111.204 -174.595 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -143.36 167.96 20.93 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.673 1.589 . . . . 0.0 108.269 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.6 26.61 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.61 32.96 4.61 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.785 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.48 168.85 16.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.202 1.001 . . . . 0.0 108.636 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.1 mt -123.08 147.89 46.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.839 1.656 . . . . 0.0 106.665 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.09 171.52 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.333 0.653 . . . . 0.0 110.26 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.36 149.54 27.73 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.17 144.46 50.43 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.944 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE2' ' NE2' ' A' ' 24' ' ' HIS . 5.0 tptp -128.53 105.83 8.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.023 0.829 . . . . 0.0 110.369 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.9 mtp -90.18 170.8 9.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.56 1.144 . . . . 0.0 109.527 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -60.01 138.89 57.75 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.644 -0.66 . . . . 0.0 109.375 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 -36.25 0.74 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.704 1.145 . . . . 0.0 114.738 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.44 160.72 81.73 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.75 2.02 . . . . 0.0 112.277 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.34 -177.6 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.89 1 C-N-CA 125.574 4.182 . . . . 0.0 110.454 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.415 ' NE2' ' HE2' ' A' ' 18' ' ' LYS . 16.4 m80 -71.79 90.39 1.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -77.74 141.74 64.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.821 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.0 127.56 17.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.411 2.074 . . . . 0.0 110.564 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.17 166.03 26.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.114 0.566 . . . . 0.0 110.596 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -128.02 162.91 25.73 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 120.929 -1.107 . . . . 0.0 111.584 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -94.87 101.93 13.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.7 -177.09 6.5 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.161 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 . . . . . 0 N--CA 1.451 -0.389 0 C-N-CA 125.186 1.394 . . . . 0.0 108.141 -178.603 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.4 p30 . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.621 0.724 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -141.56 171.74 13.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.786 2.835 . . . . 0.0 107.999 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -131.74 152.34 80.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.182 1.393 . . . . 0.0 108.894 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.13 91.32 1.21 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.863 3.708 . . . . 0.0 110.684 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.9 mm -89.18 110.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -169.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -88.87 132.18 34.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 108.304 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -103.08 94.56 5.61 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.103 1.361 . . . . 0.0 108.552 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -47.53 147.81 1.63 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.82 1.648 . . . . 0.0 112.365 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 -39.16 0.75 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.977 1.751 . . . . 0.0 114.241 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -22.65 24.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.467 1.507 . . . . 0.0 112.429 173.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.4 m80 58.72 11.91 2.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.676 2.39 . . . . 0.0 114.749 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -74.13 169.62 17.18 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.629 0.649 . . . . 0.0 110.225 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -127.97 166.14 18.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.39 166.1 34.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.148 1.379 . . . . 0.0 108.165 163.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -105.96 114.32 28.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 166.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.07 150.51 52.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.508 0.723 . . . . 0.0 109.307 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.33 25.62 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.14 -10.62 29.23 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.933 3.089 . . . . 0.0 113.314 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -76.75 -5.66 49.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.869 1.268 . . . . 0.0 113.744 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -122.17 12.05 10.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.0 110.723 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 mt -135.2 162.26 33.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.514 1.526 . . . . 0.0 110.574 -170.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.36 148.17 52.77 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.981 1.313 . . . . 0.0 111.703 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.77 142.83 95.14 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -67.49 -56.07 11.03 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.436 -0.79 . . . . 0.0 109.961 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.61 -9.3 53.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.86 -77.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 155.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -72.48 10.39 0.83 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.766 2.826 . . . . 0.0 114.523 -164.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -59.99 -35.23 74.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.073 1.349 . . . . 0.0 109.009 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.55 -45.45 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.115 1.325 . . . . 0.0 111.551 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -60.52 -55.01 38.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.406 0.682 . . . . 0.0 111.065 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -97.77 -16.23 19.96 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.795 1.238 . . . . 0.0 111.965 -171.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.3 37.75 1.58 Allowed Glycine 0 CA--C 1.541 1.658 0 O-C-N 120.985 -1.072 . . . . 0.0 114.564 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -115.15 135.51 54.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.837 1.318 . . . . 0.0 109.302 -164.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.463 ' CB ' HD21 ' A' ' 82' ' ' ASN . 10.8 p -57.52 107.45 0.44 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.567 1.147 . . . . 0.0 109.594 -171.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -94.21 163.88 13.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.307 -173.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -92.88 -7.66 45.58 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -66.06 136.84 56.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 158.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -66.73 168.45 9.49 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.471 0.708 . . . . 0.0 109.181 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.96 -32.0 1.07 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.983 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -55.33 -42.04 73.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.925 1.29 . . . . 0.0 110.571 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.463 HD21 ' CB ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -65.43 -45.94 81.87 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.213 0.605 . . . . 0.0 111.348 177.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.96 -49.05 74.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.5 -38.37 96.22 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.329 -0.706 . . . . 0.0 112.777 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.46 -30.13 71.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.413 1.106 . . . . 0.0 111.832 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -73.7 -48.18 33.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.926 0.784 . . . . 0.0 109.017 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.76 -49.26 73.59 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.104 0.962 . . . . 0.0 111.19 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 tt -67.42 -37.52 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.585 0.354 . . . . 0.0 111.07 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.34 -41.05 96.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.609 -0.682 . . . . 0.0 109.96 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 125.653 1.581 . . . . 0.0 110.678 -179.866 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -141.74 161.21 38.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.633 1.173 . . . . 0.0 109.315 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 141.2 46.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 110.956 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.37 54.65 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.221 -1.321 . . . . 0.0 113.036 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 169.0 18.93 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 119.61 1.705 . . . . 0.0 110.69 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 88' ' ' ILE . 93.6 mt -123.09 142.85 50.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.943 1.297 . . . . 0.0 108.082 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 175.78 2.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 123.377 0.671 . . . . 0.0 110.701 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.39 131.6 54.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 156.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.97 164.4 13.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.868 2.867 . . . . 0.0 108.324 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -149.48 106.04 3.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.4 mtm -90.15 -179.76 5.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.324 1.049 . . . . 0.0 109.751 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.89 61.41 6.81 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.12 -0.988 . . . . 0.0 112.859 -164.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.54 -27.55 2.6 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 124.451 1.024 . . . . 0.0 110.614 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -60.62 150.86 73.59 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 122.264 -0.55 . . . . 0.0 109.525 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.47 174.03 5.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.388 3.392 . . . . 0.0 110.724 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.25 96.93 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -88.75 131.67 40.91 Favored Pre-proline 0 N--CA 1.456 -0.128 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.43 136.0 38.36 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.261 1.307 . . . . 0.0 109.1 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.27 163.88 34.1 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.973 0.909 . . . . 0.0 109.554 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.61 146.18 50.93 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.462 -0.774 . . . . 0.0 110.26 -178.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mm -80.9 103.14 7.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -78.79 -175.53 4.49 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.326 -0.427 0 C-N-CA 124.573 1.149 . . . . 0.0 108.504 -170.237 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -140.99 163.67 32.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.418 1.087 . . . . 0.0 109.295 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.88 153.55 67.29 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 124.872 1.269 . . . . 0.0 109.239 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -67.26 95.31 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.734 2.956 . . . . 0.0 110.066 167.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.41 113.21 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -85.16 150.8 24.57 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.46 93.26 3.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.8 m-85 -47.58 150.25 1.03 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.826 2.051 . . . . 0.0 111.257 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.18 -49.88 3.62 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.28 1.419 . . . . 0.0 111.774 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -91.61 -16.08 27.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 113.603 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.7 m170 53.11 16.53 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.261 2.624 . . . . 0.0 114.77 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -71.97 164.39 26.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.898 -1.126 . . . . 0.0 110.194 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -139.72 137.89 35.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.032 1.333 . . . . 0.0 108.091 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.68 163.87 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.391 0.615 . . . . 0.0 109.42 169.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -101.99 109.69 21.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -127.83 151.35 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.014 0.926 . . . . 0.0 108.554 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.72 173.74 29.82 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.702 1.144 . . . . 0.0 110.479 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.74 -21.67 58.14 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.259 2.64 . . . . 0.0 112.366 -165.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -64.59 -18.48 64.93 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.293 -0.879 . . . . 0.0 113.055 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -109.07 10.96 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.915 1.286 . . . . 0.0 110.345 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.84 162.24 30.03 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.458 1.903 . . . . 0.0 109.364 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -148.17 143.11 17.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.422 1.089 . . . . 0.0 109.545 176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -63.27 126.38 17.68 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.592 2.861 . . . . 0.0 112.196 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.46 -51.89 67.62 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 121.337 -0.852 . . . . 0.0 111.252 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -59.79 -24.03 63.78 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.39 -72.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -82.25 9.9 7.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.298 1.439 . . . . 0.0 113.461 -164.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -54.89 -34.69 63.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.655 1.582 . . . . 0.0 110.91 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.28 -59.36 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.741 1.216 . . . . 0.0 110.179 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -55.92 -43.13 77.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.501 1.52 . . . . 0.0 113.335 -167.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.85 -26.79 9.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.63 1.972 . . . . 0.0 111.592 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.48 84.04 1.6 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -147.12 166.36 27.16 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 123.503 0.721 . . . . 0.0 110.108 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.8 m -73.57 124.94 26.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -117.13 146.48 43.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.297 1.439 . . . . 0.0 109.63 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -67.98 -14.66 63.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 127.46 32.69 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 120.671 1.578 . . . . 0.0 108.39 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -61.2 162.51 7.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -36.82 1.83 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 112.126 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.007 1.403 . . . . 0.0 110.804 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -67.05 -42.75 84.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 111.694 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.05 -42.38 76.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.06 21.87 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.1 -20.93 57.97 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.352 1.076 . . . . 0.0 113.548 -174.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -68.67 -42.04 78.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.499 1.045 . . . . 0.0 111.442 170.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -55.24 14.44 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 110.535 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 HD22 ' A' ' 14' ' ' LEU . 16.9 tt -55.33 -27.32 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.052 0.842 . . . . 0.0 112.802 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -78.18 -51.91 9.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.315 1.446 . . . . 0.0 111.044 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 . . . . . 0 C--O 1.234 0.246 0 C-N-CA 123.111 0.565 . . . . 0.0 112.239 -177.913 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--O 1.232 0.158 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -142.46 173.16 11.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.994 1.717 . . . . 0.0 109.383 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.64 15.12 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.621 0.768 . . . . 0.0 111.433 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 -22.24 30.37 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 124.561 1.077 . . . . 0.0 112.533 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.35 167.91 20.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 122.572 1.177 . . . . 0.0 111.572 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.32 150.78 38.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.424 1.89 . . . . 0.0 107.731 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 29' ' ' ILE . 23.1 m -152.23 177.33 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.797 1.239 . . . . 0.0 110.105 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.86 127.03 53.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 159.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.77 137.58 32.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.0 108.758 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 15.0 tptp -108.11 105.11 14.71 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.7 mtm -76.9 166.66 23.04 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.14 58.33 3.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.485 0.714 . . . . 0.0 112.098 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -46.54 0.44 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.468 1.509 . . . . 0.0 110.907 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -60.19 159.4 22.13 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.696 1.199 . . . . 0.0 110.286 170.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.97 -176.34 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.498 2.799 . . . . 0.0 110.883 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.415 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 26.3 m80 -55.19 107.16 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 107.36 163.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -106.15 128.39 26.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 124.92 1.288 . . . . 0.0 108.115 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HG3' HD22 ' A' ' 85' ' ' LEU . 37.2 Cg_endo -62.54 129.76 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.14 1.893 . . . . 0.0 109.422 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.98 167.51 22.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 3.6 ptm180 -123.55 153.43 40.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.408 HD11 HG11 ' A' ' 15' ' ' VAL . 17.8 mm -84.47 105.4 13.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 169.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.87 -172.88 2.85 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 N--CA 1.445 -0.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.986 164.636 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 m120 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -129.92 168.42 16.67 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.657 1.117 . . . . 0.0 111.657 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -131.17 153.46 81.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.473 2.309 . . . . 0.0 109.898 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -68.98 104.53 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 124.352 3.368 . . . . 0.0 110.045 169.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -97.19 140.28 17.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -123.89 113.29 18.3 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.086 1.755 . . . . 0.0 106.65 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -85.88 101.22 12.66 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.447 1.099 . . . . 0.0 108.482 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 5.8 m-85 -53.37 152.7 4.49 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.757 1.623 . . . . 0.0 112.192 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.26 -60.25 2.74 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.83 1.205 . . . . 0.0 110.38 -167.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -21.32 59.62 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.0 m170 55.27 11.56 0.58 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.994 1.717 . . . . 0.0 114.092 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.48 161.56 30.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.195 0.997 . . . . 0.0 110.044 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 p -141.56 138.42 32.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.911 2.084 . . . . 0.0 107.255 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.51 154.37 28.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.45 122.75 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.42 156.54 36.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.83 161.76 21.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.99 1.281 . . . . 0.0 111.391 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.65 -34.85 72.89 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.681 2.921 . . . . 0.0 112.119 -166.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mppt? -75.74 -7.41 54.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.11 -20.79 16.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.309 0.958 . . . . 0.0 110.557 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.11 170.23 14.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.523 1.529 . . . . 0.0 109.189 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -139.17 149.4 60.9 Favored Pre-proline 0 C--O 1.236 0.395 0 C-N-CA 123.909 0.884 . . . . 0.0 109.358 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.31 152.57 75.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.813 2.342 . . . . 0.0 112.273 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -71.5 -59.72 2.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.969 -0.457 . . . . 0.0 111.336 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.62 -25.82 68.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.393 0.542 . . . . 0.0 111.853 -163.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.71 -39.83 69.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.635 1.174 . . . . 0.0 110.879 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.41 9.63 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 0.0 112.673 -166.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -54.94 -30.65 59.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.89 1.276 . . . . 0.0 111.248 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -98.79 -34.74 10.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.773 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -68.68 -65.97 0.63 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.478 1.035 . . . . 0.0 109.57 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -84.91 -29.56 25.09 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.872 1.269 . . . . 0.0 111.694 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.19 62.53 3.36 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.11 173.48 11.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.903 -1.351 . . . . 0.0 110.558 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -66.53 153.15 43.71 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.415 1.102 . . . . 0.0 109.483 168.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -135.27 -96.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 159.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 -20.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 146.46 54.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 120.9 1.682 . . . . 0.0 110.759 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -60.17 156.05 16.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.242 1.417 . . . . 0.0 108.039 158.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 -43.82 1.19 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 125.663 1.602 . . . . 0.0 113.406 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -48.04 -54.01 14.44 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 125.626 1.571 . . . . 0.0 109.792 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -57.97 -34.47 69.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.37 0.668 . . . . 0.0 111.729 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.98 -49.29 53.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.356 1.062 . . . . 0.0 110.653 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.64 84.98 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.683 0.674 . . . . 0.0 112.576 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.569 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -69.52 -35.97 76.0 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.407 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -66.12 -39.07 89.63 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.214 0.915 . . . . 0.0 110.19 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.12 -47.96 75.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.848 0.859 . . . . 0.0 110.525 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.9 tt -67.28 -26.81 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 118.887 0.767 . . . . 0.0 111.729 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.48 -15.5 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 0.0 111.959 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 . . . . . 0 N--CA 1.456 -0.159 0 C-N-CA 124.862 1.265 . . . . 0.0 108.067 -179.645 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.556 0.217 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -149.44 156.68 42.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.133 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 103.25 0.14 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.931 1.693 . . . . 0.0 110.143 -173.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.06 -24.41 2.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.136 1.827 . . . . 0.0 111.637 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.57 162.28 27.22 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.634 1.217 . . . . 0.0 112.334 -173.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.67 134.87 54.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 106.206 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -147.92 176.54 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.983 0.913 . . . . 0.0 111.445 -166.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.4 150.96 30.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 156.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.47 168.18 14.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.067 2.147 . . . . 0.0 109.01 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -141.36 107.11 5.11 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.9 mtp -83.81 160.6 21.17 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 165.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.16 112.21 1.3 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.207 1.003 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.56 -11.59 55.39 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.882 1.229 . . . . 0.0 114.652 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -74.86 158.03 85.04 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 118.347 1.073 . . . . 0.0 109.188 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.79 169.75 16.93 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.581 2.187 . . . . 0.0 108.793 163.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -59.57 103.31 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -87.22 143.5 34.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 108.035 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HG3' HD22 ' A' ' 85' ' ' LEU . 62.2 Cg_endo -72.69 136.82 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.967 1.778 . . . . 0.0 110.484 173.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.99 168.3 21.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.333 0.653 . . . . 0.0 109.39 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -132.84 156.64 46.8 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.573 -0.705 . . . . 0.0 109.517 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -89.28 136.22 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.37 169.74 15.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--O 1.237 0.44 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 168.498 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -144.14 171.46 14.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.155 1.382 . . . . 0.0 109.388 -167.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -131.37 152.53 80.69 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.355 1.862 . . . . 0.0 107.519 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.1 90.99 1.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.728 2.952 . . . . 0.0 109.131 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.8 mm -83.93 114.54 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -85.13 142.34 29.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.55 118.39 36.47 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -65.05 152.69 42.82 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.028 0.918 . . . . 0.0 110.213 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.31 -68.24 2.4 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 125.002 1.286 . . . . 0.0 110.663 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.5 p -68.11 -25.02 65.1 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.839 -0.8 . . . . 0.0 111.5 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 m170 58.12 14.59 2.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.665 1.986 . . . . 0.0 112.977 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.88 168.57 13.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.995 0.902 . . . . 0.0 110.138 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.13 151.43 48.66 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.313 1.445 . . . . 0.0 108.564 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.92 148.48 27.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.988 0.915 . . . . 0.0 108.536 163.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.41 111.77 21.46 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -124.89 151.41 45.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.001 1.32 . . . . 0.0 108.238 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.58 168.2 31.7 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.347 0.975 . . . . 0.0 110.732 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.49 -40.16 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.628 2.218 . . . . 0.0 110.46 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -8.87 16.55 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.5 -17.13 24.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.272 1.396 . . . . 0.0 111.383 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.69 170.2 8.02 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 127.833 2.453 . . . . 0.0 110.647 -168.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -144.71 142.85 19.56 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.002 0.921 . . . . 0.0 109.845 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 129.51 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.573 2.182 . . . . 0.0 110.718 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -53.15 -54.91 28.92 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 121.582 -0.699 . . . . 0.0 111.272 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -66.64 -13.6 61.39 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.14 -26.0 19.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.99 1.316 . . . . 0.0 111.711 175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.42 12.3 13.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.725 1.61 . . . . 0.0 113.112 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.01 -20.37 16.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 128.456 2.702 . . . . 0.0 113.136 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -117.6 -34.68 4.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 119.322 0.965 . . . . 0.0 110.227 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -61.57 -37.91 85.58 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.631 -0.668 . . . . 0.0 111.072 -177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.72 -35.73 4.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 109.514 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.33 85.84 0.33 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -151.1 -173.93 4.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.885 2.074 . . . . 0.0 107.006 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.08 146.2 28.83 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 122.543 1.163 . . . . 0.0 108.421 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -147.38 134.92 20.89 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.785 1.634 . . . . 0.0 107.088 170.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.26 20.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -59.35 155.57 14.4 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.682 2.037 . . . . 0.0 108.784 162.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.76 161.47 30.83 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 160.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -31.05 0.55 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.422 1.963 . . . . 0.0 115.629 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.408 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 74.3 t80 -56.58 -60.78 3.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.437 1.895 . . . . 0.0 110.587 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -32.87 72.08 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.524 -0.735 . . . . 0.0 112.163 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -56.07 26.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.435 1.494 . . . . 0.0 110.016 169.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.3 77.02 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.672 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.565 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.5 mm? -68.24 -45.1 74.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 118.328 1.064 . . . . 0.0 111.637 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -56.98 -42.02 79.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.044 0.838 . . . . 0.0 108.803 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.22 -48.33 80.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.45 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.72 -35.9 71.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 119.375 0.989 . . . . 0.0 110.757 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.04 -49.6 77.01 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 113.216 178.238 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.616 0.722 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -132.66 177.66 7.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.13 140.78 24.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.679 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.27 -31.96 6.91 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.329 -1.262 . . . . 0.0 111.862 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.81 100.27 4.0 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 119.275 1.537 . . . . 0.0 108.002 -173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.04 149.92 49.5 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.54 169.42 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -105.7 142.91 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 157.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.65 110.28 13.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 109.792 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -91.55 106.29 18.38 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.052 1.741 . . . . 0.0 107.69 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.83 19.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 174.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 128.65 36.7 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.04 15.59 63.03 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.298 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -128.51 162.05 53.34 Favored Pre-proline 0 C--O 1.232 0.149 0 CA-C-N 118.897 1.349 . . . . 0.0 109.044 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.25 -179.7 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.519 3.479 . . . . 0.0 110.831 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -72.7 88.37 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -71.98 136.72 82.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.291 -169.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.35 124.56 13.08 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.059 1.839 . . . . 0.0 108.789 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.86 168.1 20.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.024 0.916 . . . . 0.0 110.634 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm85 -128.8 148.48 50.88 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 mm -86.08 121.07 36.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 170.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.89 179.11 7.63 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.206 0.527 . . . . 0.0 112.202 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 126.094 1.757 . . . . 0.0 107.891 -178.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.831 0.824 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -102.72 173.64 6.24 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.401 1.08 . . . . 0.0 109.216 160.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -132.32 152.58 80.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.362 1.065 . . . . 0.0 108.799 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 106.95 1.96 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.907 3.071 . . . . 0.0 110.317 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -98.12 115.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.741 1.216 . . . . 0.0 107.943 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -97.37 119.05 35.19 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -78.65 117.35 19.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -66.78 156.03 36.59 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.218 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 -46.48 1.74 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.35 1.453 . . . . 0.0 113.584 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 -29.48 22.26 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.98 1.39 . . . . 0.0 111.501 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.4 m80 69.82 14.23 8.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.036 2.134 . . . . 0.0 112.565 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.16 159.24 35.04 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.532 -0.73 . . . . 0.0 110.047 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.1 p -129.76 128.8 43.16 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.779 1.232 . . . . 0.0 108.441 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.94 172.49 14.12 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.908 0.883 . . . . 0.0 110.083 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -119.65 112.12 18.91 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.0 mt -121.81 150.49 41.81 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.53 166.34 31.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -65.61 -31.37 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.408 2.739 . . . . 0.0 112.108 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -70.28 -11.31 60.81 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.523 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.1 -10.77 34.82 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.078 1.308 . . . . 0.0 110.851 170.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.38 159.83 19.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.566 1.546 . . . . 0.0 109.19 -166.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -138.79 145.69 46.99 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.99 126.53 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.538 2.158 . . . . 0.0 109.932 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -53.86 -62.49 1.62 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -56.37 -40.81 75.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.928 0.786 . . . . 0.0 111.587 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 -34.9 79.54 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 119.141 0.882 . . . . 0.0 112.354 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.85 10.66 38.25 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.855 1.662 . . . . 0.0 111.119 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.21 -47.53 84.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.686 1.195 . . . . 0.0 110.179 -171.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -23.52 55.89 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.242 0.928 . . . . 0.0 112.006 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -77.52 -44.55 28.33 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.224 -0.923 . . . . 0.0 111.386 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -118.7 -23.46 7.03 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.69 1.996 . . . . 0.0 111.235 -165.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.28 58.2 3.66 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -133.25 135.54 45.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.451 1.9 . . . . 0.0 106.568 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.9 97.77 0.03 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.816 1.647 . . . . 0.0 110.938 -170.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB3' ' CG ' ' A' ' 81' ' ' PHE . 13.3 t-20 -71.87 158.79 35.41 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.11 -0.994 . . . . 0.0 108.986 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -71.7 -27.63 63.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.111 0.964 . . . . 0.0 113.06 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -64.28 142.78 58.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.523 1.056 . . . . 0.0 110.399 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -65.33 164.6 13.27 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 160.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.83 -41.85 2.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.498 1.523 . . . . 0.0 110.223 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.407 ' CG ' ' HB3' ' A' ' 76' ' ' ASN . 10.6 t80 -58.48 -46.99 85.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.088 0.955 . . . . 0.0 110.966 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -62.16 -44.8 95.82 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.049 -0.407 . . . . 0.0 110.12 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -69.47 -27.74 65.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.009 0.818 . . . . 0.0 111.68 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 -23.07 35.23 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.125 -0.984 . . . . 0.0 112.83 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.3 -32.13 71.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.99 1.395 . . . . 0.0 110.563 168.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -66.61 -47.9 71.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.557 -0.714 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.63 -48.57 80.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.388 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.3 -41.39 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.222 0.326 . . . . 0.0 110.238 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.67 -37.12 85.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.292 0.637 . . . . 0.0 110.498 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 . . . . . 0 CA--C 1.536 0.416 0 O-C-N 121.421 -0.799 . . . . 0.0 112.384 177.945 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -135.89 178.24 7.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.076 0.853 . . . . 0.0 111.483 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.93 132.54 32.26 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.903 0.881 . . . . 0.0 111.33 -167.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.6 -17.39 58.65 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.096 -0.835 . . . . 0.0 111.775 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.18 161.28 19.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.044 1.402 . . . . 0.0 109.312 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD22 HG13 ' A' ' 88' ' ' ILE . 96.0 mt -124.74 156.37 37.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.817 1.647 . . . . 0.0 106.682 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.71 171.88 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.916 0.886 . . . . 0.0 108.861 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -105.85 122.24 45.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 159.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.06 134.87 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.762 1.225 . . . . 0.0 109.39 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -106.79 108.59 20.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.5 mtp -86.39 167.17 14.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.1 150.0 22.25 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 163.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.86 -68.29 1.05 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.226 0.917 . . . . 0.0 111.999 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -56.02 156.05 10.96 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.301 2.24 . . . . 0.0 112.547 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.33 173.44 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.752 2.968 . . . . 0.0 109.88 163.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -62.9 108.04 1.11 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -91.17 140.26 25.77 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 123.934 0.894 . . . . 0.0 108.792 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.01 126.62 16.83 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.216 1.944 . . . . 0.0 110.482 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.22 157.16 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.262 0.553 . . . . 0.0 111.113 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -103.8 152.42 21.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.14 99.95 8.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -74.18 -177.32 2.92 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.955 0.407 . . . . 0.0 109.966 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--N 1.325 -0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 107.712 176.265 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 . . . . . 0 CA--C 1.516 -0.334 0 CA-C-O 119.23 -0.414 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -140.27 145.65 37.59 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -114.46 153.61 46.6 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.332 1.853 . . . . 0.0 110.176 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 91.63 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.399 3.399 . . . . 0.0 111.107 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.24 121.5 43.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -113.21 116.54 29.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -87.55 97.22 10.73 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.104 1.762 . . . . 0.0 108.52 -169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 10.7 m-85 -52.21 150.55 4.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.495 1.118 . . . . 0.0 112.085 -175.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.11 4.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.638 1.59 . . . . 0.0 111.976 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.58 -31.51 68.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.92 0.888 . . . . 0.0 110.849 167.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.1 m80 53.52 25.98 5.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.61 1.964 . . . . 0.0 112.043 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.31 165.73 23.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.975 2.11 . . . . 0.0 109.475 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -127.76 151.61 48.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.849 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.19 155.74 23.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 154.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -86.51 123.95 32.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.71 149.94 50.0 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.191 1.396 . . . . 0.0 108.341 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.21 165.08 27.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.37 -24.12 43.56 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.867 2.378 . . . . 0.0 112.118 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -54.14 -15.22 1.38 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.502 1.521 . . . . 0.0 114.151 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -118.1 7.39 12.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.515 1.526 . . . . 0.0 110.712 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.28 168.67 9.75 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.673 1.589 . . . . 0.0 109.388 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -144.53 146.14 31.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 127.214 2.206 . . . . 0.0 107.124 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.69 152.71 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.652 2.235 . . . . 0.0 111.74 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.0 -62.69 1.37 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.193 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -46.99 -46.4 21.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.861 1.21 . . . . 0.0 111.308 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -18.12 65.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -172.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -130.31 13.6 5.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.502 1.121 . . . . 0.0 111.39 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -55.33 -36.85 66.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.799 1.639 . . . . 0.0 112.225 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -104.83 -15.96 15.04 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.667 0.787 . . . . 0.0 109.723 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -85.66 -57.36 3.08 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 120.918 -1.114 . . . . 0.0 110.079 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -89.6 -36.14 15.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 109.726 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.89 71.11 0.57 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.782 1.658 . . . . 0.0 111.681 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.8 150.09 48.14 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 126.069 1.748 . . . . 0.0 107.465 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.0 p -59.58 105.35 0.35 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.971 0.508 . . . . 0.0 110.015 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -93.82 152.57 18.81 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -89.89 54.5 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 109.355 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -115.54 123.61 48.93 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -67.97 103.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.42 -25.96 4.2 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.551 1.548 . . . . 0.0 111.269 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -65.02 -51.79 59.66 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.404 1.102 . . . . 0.0 111.146 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -73.27 -23.04 60.26 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.409 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -65.04 -48.13 74.92 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 124.34 1.056 . . . . 0.0 108.888 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.92 -31.22 78.92 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.309 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' HA ' HG22 ' A' ' 88' ' ' ILE . 17.2 mt -63.35 -46.7 85.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.376 171.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -57.16 -41.26 78.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.594 1.543 . . . . 0.0 111.043 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.09 -51.11 65.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.774 0.715 . . . . 0.0 111.511 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 85' ' ' LEU . 13.5 tt -70.35 -38.89 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.432 0.693 . . . . 0.0 110.382 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.56 -27.63 69.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.835 0.854 . . . . 0.0 110.032 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 125.721 1.609 . . . . 0.0 113.019 176.504 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 . . . . . 0 N--CA 1.467 0.406 0 CA-C-O 120.658 0.266 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -147.74 168.16 22.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 108.867 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.27 135.81 57.77 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 123.288 0.367 . . . . 0.0 111.034 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.5 35.58 5.4 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 117.878 -1.512 . . . . 0.0 112.233 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.18 172.8 12.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.238 1.519 . . . . 0.0 111.151 172.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -117.43 142.27 47.34 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.257 1.423 . . . . 0.0 108.414 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 29' ' ' ILE . 22.9 m -154.46 171.08 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.029 0.931 . . . . 0.0 111.95 -165.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.07 117.41 30.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.244 1.018 . . . . 0.0 111.652 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.07 163.96 13.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.607 1.163 . . . . 0.0 110.469 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -147.67 106.97 3.88 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.261 -0.899 . . . . 0.0 110.452 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.5 mtm -83.76 168.05 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.026 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -81.15 83.61 6.75 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.967 1.307 . . . . 0.0 109.155 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.42 -56.74 0.67 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -61.66 159.22 35.39 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.445 1.498 . . . . 0.0 113.222 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.07 176.0 10.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.284 3.989 . . . . 0.0 111.153 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -64.02 97.04 0.16 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.982 1.313 . . . . 0.0 108.166 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -89.6 134.9 31.51 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.181 -165.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.74 121.01 8.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.579 2.186 . . . . 0.0 109.658 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.5 19.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 110.236 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -124.58 148.27 47.95 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 HD11 HG11 ' A' ' 15' ' ' VAL . 9.1 mm -78.59 99.96 3.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.278 -2.489 . . . . 0.0 104.278 163.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -65.77 173.34 2.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.095 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--N 1.322 -0.618 0 C-N-CA 125.153 1.381 . . . . 0.0 108.972 179.619 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 118.696 -0.669 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -112.89 160.29 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.014 1.279 . . . . 0.0 111.384 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -115.26 149.85 43.42 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 126.713 2.005 . . . . 0.0 108.161 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.009 3.139 . . . . 0.0 108.919 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.0 mm -102.61 112.89 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -99.3 124.05 44.08 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.3 98.02 11.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -50.43 148.38 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.033 0.933 . . . . 0.0 110.89 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.47 -15.2 1.6 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.963 1.268 . . . . 0.0 115.862 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -115.68 -17.27 11.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.26 1.53 . . . . 0.0 111.596 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.37 16.17 7.2 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.808 2.043 . . . . 0.0 112.749 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -83.55 165.65 18.9 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.428 -0.795 . . . . 0.0 110.219 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -127.5 150.61 49.6 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.176 0.99 . . . . 0.0 110.648 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.3 29.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.155 1.382 . . . . 0.0 109.369 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.53 107.38 16.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.7 mt -123.54 143.69 50.03 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 162.55 28.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.48 -20.5 47.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 113.676 -160.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -52.86 -32.2 43.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.82 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -94.96 9.23 40.17 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 111.506 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 mt -135.28 157.38 47.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.568 1.147 . . . . 0.0 111.144 -161.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -141.64 155.81 66.57 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.016 1.326 . . . . 0.0 110.726 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -68.89 134.11 28.97 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.126 2.55 . . . . 0.0 112.273 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -65.1 -48.1 74.86 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.864 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -62.19 -27.54 69.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.853 1.206 . . . . 0.0 112.361 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.47 -51.08 11.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 111.023 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -97.23 8.85 43.71 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.014 -1.054 . . . . 0.0 113.816 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -53.3 -49.45 66.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.646 1.178 . . . . 0.0 108.684 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.59 -53.09 38.17 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.39 0.431 . . . . 0.0 110.743 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -64.64 -33.87 76.96 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 113.713 -169.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -118.36 -29.21 5.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 112.518 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.58 70.86 3.07 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 153.81 51.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.615 1.566 . . . . 0.0 109.317 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.0 p -74.93 99.9 3.96 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -80.92 168.61 18.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.937 -1.102 . . . . 0.0 111.404 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -89.04 -5.33 57.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -73.15 141.96 47.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.277 1.853 . . . . 0.0 109.023 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.464 ' N ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.29 164.29 16.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.17 -40.95 1.27 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.355 0.979 . . . . 0.0 111.564 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.02 -37.94 84.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.185 1.493 . . . . 0.0 111.154 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -48.76 78.32 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.433 0.693 . . . . 0.0 110.167 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.95 -38.42 86.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.856 1.662 . . . . 0.0 110.438 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -72.45 -32.9 61.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.56 1.076 . . . . 0.0 111.944 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.612 1.206 . . . . 0.0 111.16 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -66.31 -44.06 84.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.629 0.649 . . . . 0.0 109.557 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -60.96 -55.38 33.57 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.102 0.961 . . . . 0.0 111.248 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 tt -62.07 -28.36 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.079 0.854 . . . . 0.0 111.187 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -60.05 3.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.013 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 C--O 1.235 0.329 0 C-N-CA 125.399 1.48 . . . . 0.0 112.04 -176.072 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -137.25 176.14 8.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.672 1.589 . . . . 0.0 110.684 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.71 135.2 41.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.42 -28.39 15.8 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.609 1.576 . . . . 0.0 112.31 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -75.74 123.86 26.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.479 1.14 . . . . 0.0 109.325 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.97 145.03 28.76 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.29 168.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.587 0.708 . . . . 0.0 112.699 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -112.85 121.79 45.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.643 1.177 . . . . 0.0 108.189 161.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.34 121.82 35.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.72 1.208 . . . . 0.0 109.147 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -91.49 107.24 19.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mtm -74.01 169.42 17.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.376 0.534 . . . . 0.0 110.433 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -61.69 127.51 31.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.81 -60.48 3.38 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.657 1.122 . . . . 0.0 113.343 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -51.43 155.85 2.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.786 1.635 . . . . 0.0 111.488 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.45 -175.55 2.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.454 3.436 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -62.53 89.75 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.89 2.476 . . . . 0.0 108.251 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -86.45 135.33 36.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HG3' HD22 ' A' ' 85' ' ' LEU . 31.8 Cg_endo -67.47 130.8 23.1 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.298 1.332 . . . . 0.0 108.669 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.65 151.66 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.496 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 12.7 ptm180 -103.06 160.63 14.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.437 1.017 . . . . 0.0 109.162 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.6 124.89 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 151.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.91 -156.42 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 O-C-N 119.501 -2.0 . . . . 0.0 109.189 147.443 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.52 0.676 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -138.35 134.18 33.9 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.41 2.284 . . . . 0.0 110.046 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -102.27 147.45 33.98 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.809 2.444 . . . . 0.0 111.241 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.03 100.38 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.053 2.502 . . . . 0.0 111.464 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 mm -83.07 155.5 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -142.08 106.78 4.86 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.22 1.808 . . . . 0.0 107.286 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.93 98.7 3.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.83 1.252 . . . . 0.0 109.107 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m-85 -49.27 139.04 11.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 127.222 2.209 . . . . 0.0 111.999 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.98 -37.55 1.5 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.638 1.589 . . . . 0.0 113.552 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.4 -28.14 52.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.418 1.109 . . . . 0.0 111.753 171.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.9 m80 48.98 60.02 4.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 110.081 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.0 147.84 32.77 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 108.215 163.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 p -121.41 142.99 49.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.421 1.089 . . . . 0.0 109.027 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.05 169.76 21.02 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.596 1.559 . . . . 0.0 108.082 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.65 107.44 18.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.58 133.79 50.71 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.077 1.751 . . . . 0.0 110.586 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.28 167.73 54.12 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.02 -32.07 94.47 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.465 2.776 . . . . 0.0 114.421 -175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.32 -15.79 18.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.39 0.995 . . . . 0.0 113.4 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -103.03 4.0 36.77 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.024 1.284 . . . . 0.0 111.225 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -135.27 134.78 40.3 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.684 1.594 . . . . 0.0 109.767 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.05 145.48 43.94 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 110.851 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.8 116.1 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.104 3.202 . . . . 0.0 109.615 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -49.14 -52.23 27.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.472 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -55.99 -35.96 67.35 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.114 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -41.79 66.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.839 1.199 . . . . 0.0 111.208 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.71 16.16 24.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.741 1.216 . . . . 0.0 110.756 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -61.51 -40.58 95.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.332 0.969 . . . . 0.0 110.471 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.53 -49.95 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.059 -1.026 . . . . 0.0 108.999 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -60.05 -33.82 72.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.245 1.418 . . . . 0.0 113.604 -169.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -125.66 -18.58 5.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.277 1.831 . . . . 0.0 112.649 -173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.97 30.62 1.8 Allowed Glycine 0 N--CA 1.474 1.194 0 CA-C-N 121.32 1.873 . . . . 0.0 113.472 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -115.47 158.65 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.201 2.2 . . . . 0.0 109.062 -167.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -75.44 164.08 26.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.345 1.545 . . . . 0.0 112.302 -163.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -153.85 155.68 36.21 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 128.715 2.806 . . . . 0.0 107.778 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.46 2.27 33.54 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.582 1.153 . . . . 0.0 113.52 -171.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.66 133.78 55.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.895 1.278 . . . . 0.0 108.785 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -62.09 162.27 9.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.38 -46.32 2.76 Favored Glycine 0 N--CA 1.461 0.335 0 O-C-N 120.969 -1.082 . . . . 0.0 111.052 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -54.89 -54.84 37.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.729 0.812 . . . . 0.0 111.202 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.02 -39.72 66.39 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.269 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.33 -43.52 98.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 110.303 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.97 -32.94 82.33 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.648 -0.658 . . . . 0.0 112.386 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.513 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -76.19 -24.59 54.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.007 0.904 . . . . 0.0 112.08 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -68.64 -52.62 29.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 2.4 mm-40 -56.59 -54.56 44.51 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.322 0.649 . . . . 0.0 111.187 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.2 tt -58.56 -36.37 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.37 0.532 . . . . 0.0 111.759 -172.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.22 -48.53 64.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 125.213 1.405 . . . . 0.0 112.66 -173.281 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -147.33 169.82 18.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.978 0.808 . . . . 0.0 111.284 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.69 124.87 14.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.81 0.844 . . . . 0.0 109.816 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.16 -9.16 61.2 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.777 -1.013 . . . . 0.0 112.836 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.78 159.6 32.69 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 119.285 1.543 . . . . 0.0 108.88 163.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.2 150.14 39.23 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.74 173.85 3.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.856 0.836 . . . . 0.0 111.296 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.29 133.71 52.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 157.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -109.69 125.86 53.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.228 1.411 . . . . 0.0 108.449 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -105.18 105.89 16.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mtm -77.58 170.21 16.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.122 0.963 . . . . 0.0 109.398 164.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -64.91 130.85 44.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.77 -48.24 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.853 0.739 . . . . 0.0 113.257 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -54.31 152.07 12.31 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 169.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.73 175.26 9.15 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.719 2.946 . . . . 0.0 109.713 171.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -63.07 97.61 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -79.27 140.26 56.57 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.817 1.647 . . . . 0.0 109.22 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.19 128.93 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.771 1.647 . . . . 0.0 109.069 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.84 165.64 27.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.112 0.958 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -116.4 147.67 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.76 108.82 14.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 161.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.61 -174.54 4.34 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 110.129 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 124.858 1.263 . . . . 0.0 109.627 169.011 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 119.655 -0.212 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 62.5 mttt -131.37 147.48 52.57 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 124.437 1.095 . . . . 0.0 108.368 167.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.79 153.06 43.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 124.609 1.163 . . . . 0.0 110.146 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.18 94.57 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.441 2.761 . . . . 0.0 108.808 167.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.3 mm -85.07 141.18 14.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 52' ' ' HIS . 56.0 t80 -125.95 122.46 36.03 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -87.15 99.8 12.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.05 1.34 . . . . 0.0 108.743 -174.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 7.1 m-85 -53.14 144.88 14.58 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.506 1.122 . . . . 0.0 111.163 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 -33.15 0.9 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.248 1.404 . . . . 0.0 114.342 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 p -95.63 -11.96 26.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.295 1.548 . . . . 0.0 112.723 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.435 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.9 m170 56.4 26.23 10.49 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.648 1.979 . . . . 0.0 113.542 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -92.01 161.7 14.68 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.726 0.81 . . . . 0.0 109.874 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -127.68 142.92 51.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.652 1.181 . . . . 0.0 109.449 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.52 174.11 13.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 110.16 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.88 107.5 15.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.7 mt -117.93 150.5 39.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . -92.33 164.96 28.57 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.44 -28.03 86.49 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.129 2.553 . . . . 0.0 111.878 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -61.28 -10.72 7.49 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.61 10.35 9.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 110.645 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 17' ' ' ALA . 78.2 mt -129.4 153.82 47.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 109.346 -172.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -132.61 148.16 68.45 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.664 0.785 . . . . 0.0 111.356 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.53 125.23 13.03 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.326 3.351 . . . . 0.0 111.049 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.6 -58.04 9.78 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.076 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -55.44 -27.94 51.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.36 -173.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -60.44 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.091 0.86 . . . . 0.0 109.039 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.55 13.13 14.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.928 1.691 . . . . 0.0 112.947 -170.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -57.0 -24.21 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.15 1.78 . . . . 0.0 112.162 -172.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.13 -35.51 5.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.522 1.129 . . . . 0.0 108.472 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.46 81.9 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.818 -1.176 . . . . 0.0 113.035 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -106.7 -27.17 10.97 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.837 1.655 . . . . 0.0 109.273 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.94 73.78 2.58 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 133.77 16.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.042 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.2 p -65.15 137.0 57.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.706 1.603 . . . . 0.0 107.677 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -142.12 -6.01 0.97 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -154.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 tttt 121.64 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 131.402 3.881 . . . . 0.0 111.495 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 133.49 53.16 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.938 0.79 . . . . 0.0 110.076 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -60.25 167.43 2.44 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 125.182 1.551 . . . . 0.0 109.831 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.75 -54.61 0.73 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.897 1.713 . . . . 0.0 111.685 -172.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -46.51 -43.73 17.13 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 126.678 1.991 . . . . 0.0 113.398 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -68.45 -47.6 66.74 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.488 0.715 . . . . 0.0 111.928 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -52.96 -38.93 62.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.994 1.317 . . . . 0.0 109.958 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.17 -28.61 65.97 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.542 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.58 -47.32 70.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.903 1.352 . . . . 0.0 109.659 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -53.79 -45.46 70.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.59 0.556 . . . . 0.0 109.545 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.06 -52.18 60.58 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.86 -30.28 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.484 1.038 . . . . 0.0 111.249 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.91 -31.71 68.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.546 0.612 . . . . 0.0 111.881 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 . . . . . 0 C--O 1.231 0.102 0 C-N-CA 123.633 0.773 . . . . 0.0 112.582 -178.248 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 121.265 0.555 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -160.33 162.77 33.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 109.194 -173.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.02 112.72 0.91 Allowed 'General case' 0 C--O 1.236 0.348 0 O-C-N 124.157 0.911 . . . . 0.0 109.167 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.61 -33.89 2.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.008 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.2 134.66 45.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.819 1.809 . . . . 0.0 108.616 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.86 147.94 25.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 162.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 m -147.92 167.78 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -108.4 148.34 30.28 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 156.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.98 127.8 45.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.278 1.831 . . . . 0.0 108.327 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.17 104.94 16.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.9 mtm -76.26 159.57 30.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 161.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -67.36 142.69 56.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.72 -41.31 0.83 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.717 1.627 . . . . 0.0 113.343 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.72 161.79 68.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 126.898 2.079 . . . . 0.0 112.266 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.6 179.97 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.106 3.204 . . . . 0.0 109.835 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -67.09 98.42 0.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -81.7 139.04 47.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.407 1.083 . . . . 0.0 108.289 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.536 ' HG3' HD22 ' A' ' 85' ' ' LEU . 34.4 Cg_endo -66.04 140.74 61.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.266 1.311 . . . . 0.0 110.222 174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.56 168.37 22.15 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.11 0.964 . . . . 0.0 109.493 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.0 mm -71.0 115.3 10.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 162.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.31 176.43 8.73 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.712 0.767 . . . . 0.0 109.644 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.457 0 C-N-CA 124.71 1.204 . . . . 0.0 107.941 157.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 . . . . . 0 C--O 1.237 0.395 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -129.79 157.57 41.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 160.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.98 153.54 47.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 126.004 1.722 . . . . 0.0 107.182 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.16 104.47 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.773 2.315 . . . . 0.0 109.641 167.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.8 mm -103.49 111.66 34.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.14 124.29 34.7 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.875 1.27 . . . . 0.0 108.275 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -90.7 101.88 14.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.143 0.977 . . . . 0.0 109.283 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -52.92 145.2 13.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.593 1.157 . . . . 0.0 111.904 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.17 -46.31 2.43 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.363 1.458 . . . . 0.0 111.883 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 p -80.89 -22.32 39.88 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.149 -1.207 . . . . 0.0 112.321 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 m170 55.27 20.35 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.908 2.483 . . . . 0.0 113.822 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -78.43 166.65 22.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 p -125.42 152.64 44.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.35 161.03 39.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 154.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -88.06 123.3 32.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 166.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.3 mt -130.17 152.6 49.43 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.046 0.938 . . . . 0.0 108.525 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.41 169.19 18.24 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.022 0.82 . . . . 0.0 111.682 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.81 5.71 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.371 1 C-N-CA 125.503 4.135 . . . . 0.0 115.838 -166.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -102.14 -6.67 22.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -110.03 7.57 23.68 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.91 -1.119 . . . . 0.0 111.013 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.59 134.95 31.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.69 1.596 . . . . 0.0 108.717 -157.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -126.64 160.5 58.18 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.63 1.172 . . . . 0.0 109.649 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.14 131.67 27.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.742 2.295 . . . . 0.0 110.454 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.96 -57.63 12.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.994 1.27 . . . . 0.0 110.803 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -49.11 -40.61 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.171 0.988 . . . . 0.0 112.402 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -40.95 89.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.806 1.643 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -104.86 6.36 33.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.495 1.518 . . . . 0.0 112.603 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -61.41 -17.18 53.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.277 1.831 . . . . 0.0 111.51 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -115.19 -33.84 5.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.366 1.466 . . . . 0.0 111.856 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -64.1 -55.99 18.08 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.207 1.003 . . . . 0.0 109.937 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -92.66 -39.51 11.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.909 1.284 . . . . 0.0 110.146 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.6 77.94 0.75 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -122.97 179.0 4.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.611 1.564 . . . . 0.0 107.548 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 p -80.82 150.21 29.26 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.404 ' HB2' ' CE2' ' A' ' 81' ' ' PHE . 1.2 m-20 -153.03 144.04 22.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.074 172.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -81.68 68.49 8.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.492 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -128.26 119.25 24.78 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.807 2.043 . . . . 0.0 106.333 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -72.87 116.54 13.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -171.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.12 14.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.991 0.805 . . . . 0.0 111.783 -171.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 76' ' ' ASN . 82.8 t80 -62.07 -60.59 3.38 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.949 1.375 . . . . 0.0 108.48 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -56.98 -21.81 33.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.98 -39.53 42.09 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.464 0.706 . . . . 0.0 109.552 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.81 97.22 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.382 -0.824 . . . . 0.0 111.945 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.536 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.1 mm? -68.74 -14.46 63.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.08 0.94 . . . . 0.0 112.613 173.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -79.76 -48.56 13.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.189 0.904 . . . . 0.0 108.742 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.31 -52.49 65.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.703 0.683 . . . . 0.0 110.446 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.64 -43.69 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.598 0.635 . . . . 0.0 111.622 -170.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.07 -46.63 89.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.356 1.062 . . . . 0.0 109.661 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 CA--C 1.537 0.469 0 C-N-CA 124.337 1.055 . . . . 0.0 112.931 -173.921 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -138.11 170.53 15.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.121 0.968 . . . . 0.0 110.053 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 149.6 18.66 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.615 0.572 . . . . 0.0 110.629 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 -1.63 88.09 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.973 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -101.27 173.62 6.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.022 1.411 . . . . 0.0 109.464 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -131.38 149.31 52.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.757 1.223 . . . . 0.0 109.859 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.42 164.72 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 109.914 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.81 126.59 50.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 158.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.94 165.8 12.7 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -140.07 105.67 5.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.8 mtm -73.65 168.8 18.61 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 168.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -59.44 129.63 42.96 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 162.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.92 -30.03 2.07 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.627 2.061 . . . . 0.0 115.823 168.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.89 163.66 66.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 118.793 1.297 . . . . 0.0 111.576 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.64 175.67 10.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.573 3.515 . . . . 0.0 110.993 168.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -62.59 88.09 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.227 2.211 . . . . 0.0 109.786 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -86.75 137.88 33.56 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 120.904 -1.122 . . . . 0.0 109.252 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.07 137.79 63.84 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 111.665 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.04 167.44 22.67 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.159 0.98 . . . . 0.0 111.09 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 ptm180 -112.45 156.06 23.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.1 mm -82.45 107.48 14.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 159.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.74 -174.55 4.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 CA--C 1.532 0.252 0 O-C-N 120.647 -1.283 . . . . 0.0 109.296 176.662 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -132.85 168.1 19.0 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.913 -1.117 . . . . 0.0 112.916 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -125.2 152.87 71.53 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 130.232 3.413 . . . . 0.0 110.206 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.44 102.03 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.99 3.126 . . . . 0.0 109.543 166.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -87.86 116.31 25.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.626 1.97 . . . . 0.0 107.623 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.83 99.61 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.801 2.041 . . . . 0.0 109.435 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 3.3 m-85 -49.28 143.73 5.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.484 1.514 . . . . 0.0 113.141 -172.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.46 -58.26 2.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.175 1.369 . . . . 0.0 111.394 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -21.35 64.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.327 -1.102 . . . . 0.0 113.056 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 m170 58.09 3.15 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.08 2.152 . . . . 0.0 114.398 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.82 164.63 11.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.297 1.046 . . . . 0.0 109.407 172.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 p -141.24 136.22 31.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -166.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.28 151.09 36.04 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -89.08 107.34 18.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 mt -128.79 150.77 50.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 169.13 21.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.87 1.224 . . . . 0.0 112.762 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -68.42 -23.65 37.6 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.331 2.687 . . . . 0.0 113.924 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -57.25 -19.12 19.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.796 1.18 . . . . 0.0 113.31 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.0 7.05 23.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 109.507 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.3 166.22 11.89 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.389 1.875 . . . . 0.0 110.187 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -148.36 154.28 41.69 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.317 1.847 . . . . 0.0 106.847 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -69.97 127.4 14.38 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.135 2.557 . . . . 0.0 111.148 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -55.35 -53.73 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.456 1.102 . . . . 0.0 111.271 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.01 -21.91 59.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.761 0.824 . . . . 0.0 111.881 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -71.21 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.25 1.42 . . . . 0.0 109.031 167.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.26 15.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.379 1.472 . . . . 0.0 113.575 -166.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -52.93 -28.93 25.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.886 1.674 . . . . 0.0 112.019 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -34.86 6.9 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.123 0.874 . . . . 0.0 111.635 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -60.87 -60.9 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.258 1.023 . . . . 0.0 109.011 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -85.19 -52.02 6.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.695 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.33 88.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 126.187 1.851 . . . . 0.0 111.856 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -151.48 158.83 44.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.418 1.887 . . . . 0.0 108.899 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -60.0 150.89 27.75 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.886 1.327 . . . . 0.0 108.966 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.14 149.86 44.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.615 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -86.0 -14.1 45.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.171 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mmt-85 -58.31 123.9 17.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 164.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -64.78 164.17 12.75 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 -40.69 2.28 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.043 0.83 . . . . 0.0 111.719 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -52.43 -34.96 50.88 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.49 1.145 . . . . 0.0 112.168 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -46.43 76.43 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 121.34 -0.85 . . . . 0.0 112.794 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.04 -43.76 86.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.771 1.229 . . . . 0.0 109.294 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.36 -36.45 93.1 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.421 -0.8 . . . . 0.0 113.02 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.04 -16.91 61.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.289 1.036 . . . . 0.0 112.661 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -77.97 -52.73 8.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.02 -46.09 92.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 112.331 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.8 tt -63.58 -33.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.201 0.909 . . . . 0.0 111.806 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.49 -53.38 19.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.624 -0.672 . . . . 0.0 109.272 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 . . . . . 0 CA--C 1.529 0.172 0 O-C-N 123.803 0.689 . . . . 0.0 112.106 -170.844 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -136.97 169.95 16.91 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.527 1.531 . . . . 0.0 108.759 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 144.08 44.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.491 0.662 . . . . 0.0 110.863 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.18 5.9 59.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.418 -1.212 . . . . 0.0 113.328 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.84 140.98 51.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.28 2.04 . . . . 0.0 108.251 166.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.5 mt -88.42 136.38 33.01 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.05 162.38 13.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 123.478 0.711 . . . . 0.0 109.593 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -102.1 126.6 49.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 164.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.9 168.8 10.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.707 0.803 . . . . 0.0 109.507 173.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -133.44 150.2 51.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.472 0.709 . . . . 0.0 109.569 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 55.4 mtm -132.62 172.89 11.93 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.127 1.771 . . . . 0.0 109.463 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -80.55 71.23 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.143 1.377 . . . . 0.0 109.981 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.36 -41.38 1.2 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.414 1.483 . . . . 0.0 111.276 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -60.65 150.6 74.76 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.505 1.122 . . . . 0.0 110.946 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.52 165.44 29.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.549 3.499 . . . . 0.0 111.333 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -55.36 116.57 2.92 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -118.33 132.1 23.93 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.33 137.44 36.71 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.969 1.78 . . . . 0.0 110.751 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.03 167.34 23.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.674 1.19 . . . . 0.0 110.249 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.41 139.5 53.6 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.69 112.5 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -73.97 171.04 14.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.582 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.239 0.525 0 CA-C-O 122.43 1.109 . . . . 0.0 111.147 -172.082 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -128.19 166.7 18.02 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.349 1.06 . . . . 0.0 108.146 162.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -129.71 153.34 80.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 126.491 1.916 . . . . 0.0 107.283 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.12 115.68 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.397 2.065 . . . . 0.0 108.929 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.5 113.47 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -85.98 131.77 34.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -98.44 115.47 28.58 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -54.8 144.75 21.51 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.055 1.342 . . . . 0.0 110.718 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.86 -58.0 4.04 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.76 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 p -83.48 -24.64 31.68 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.849 2.324 . . . . 0.0 111.273 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.0 m170 70.01 17.43 7.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.349 1.459 . . . . 0.0 112.113 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.59 155.41 33.25 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 130.26 32.52 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.991 1.316 . . . . 0.0 108.0 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.02 159.02 42.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.79 121.63 32.11 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.7 mt -126.79 158.56 36.25 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 109.062 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.86 16.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.701 1.143 . . . . 0.0 112.658 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -67.84 -15.73 44.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.33 2.687 . . . . 0.0 115.188 -160.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -63.53 -26.37 68.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.393 1.451 . . . . 0.0 111.664 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.1 10.66 33.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.485 1.514 . . . . 0.0 111.533 -173.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.3 mt -133.35 127.09 32.76 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.927 1.291 . . . . 0.0 109.408 -169.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.33 142.68 37.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.424 1.089 . . . . 0.0 110.745 -167.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.49 121.04 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.821 3.014 . . . . 0.0 111.411 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -56.28 -50.08 72.41 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.8 -0.562 . . . . 0.0 111.064 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -57.87 -31.97 67.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 112.267 -173.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.19 -68.06 0.5 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.013 0.925 . . . . 0.0 108.823 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.4 -2.57 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.374 1.07 . . . . 0.0 113.265 -160.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.49 -46.46 57.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.935 1.694 . . . . 0.0 110.713 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.67 -17.36 53.88 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -97.76 -62.48 1.24 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.683 1.593 . . . . 0.0 109.786 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -86.22 -30.82 22.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.822 1.649 . . . . 0.0 111.782 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.21 73.41 2.0 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -132.38 128.94 38.67 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.504 1.122 . . . . 0.0 108.556 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -41.89 130.74 3.39 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 126.371 1.868 . . . . 0.0 109.208 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -138.85 134.72 33.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -78.1 72.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -120.09 133.96 55.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -68.32 147.74 51.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -58.69 5.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -48.77 -61.1 2.22 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 124.83 1.252 . . . . 0.0 110.67 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.1 -33.41 70.8 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.785 1.234 . . . . 0.0 114.073 -169.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.14 -39.97 68.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.645 0.778 . . . . 0.0 110.732 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -34.69 80.14 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.567 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.94 -24.78 64.31 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.371 1.085 . . . . 0.0 111.832 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -70.69 -50.06 40.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.79 -46.51 87.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.308 1.043 . . . . 0.0 111.545 -172.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 tt -66.69 -42.36 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.409 0.284 . . . . 0.0 110.864 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.02 -20.32 64.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.013 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 126.77 2.028 . . . . 0.0 110.74 177.062 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -128.94 158.67 38.17 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.089 0.859 . . . . 0.0 110.306 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.09 3.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 109.778 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.09 -37.75 2.23 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -69.8 160.7 31.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.716 1.246 . . . . 0.0 110.778 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -117.82 143.63 46.1 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 107.846 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.31 167.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.554 0.742 . . . . 0.0 111.479 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.43 128.34 50.6 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 158.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.1 165.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HE2' ' CE1' ' A' ' 24' ' ' HIS . 6.8 tptp -143.92 106.32 4.41 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.9 mtm -78.28 161.7 27.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 166.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.02 139.34 58.76 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.61 -44.43 2.5 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.078 1.323 . . . . 0.0 113.796 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.67 160.03 78.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.61 1.205 . . . . 0.0 112.384 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 178.46 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.979 3.786 . . . . 0.0 111.482 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.455 ' CE1' ' HE2' ' A' ' 18' ' ' LYS . 55.1 m80 -71.28 89.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.495 1.118 . . . . 0.0 109.234 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -80.69 136.31 51.79 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 110.161 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.43 124.51 12.56 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.895 2.397 . . . . 0.0 110.506 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.82 166.66 24.6 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.717 -0.615 . . . . 0.0 110.28 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 2.8 ptm85 -125.89 159.62 32.08 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.512 -0.743 . . . . 0.0 109.882 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.5 mm -86.27 108.88 18.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -73.28 174.98 7.28 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 164.191 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -114.1 159.33 20.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.003 0.82 . . . . 0.0 110.2 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -122.84 153.11 63.5 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.282 1.833 . . . . 0.0 108.416 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.13 105.24 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.606 2.87 . . . . 0.0 110.487 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.7 mm -92.89 123.36 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.128 0.571 . . . . 0.0 109.527 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -101.87 115.99 31.74 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 107.091 170.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -80.44 115.84 20.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.7 m-85 -65.86 149.04 50.83 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.402 0.62 . . . . 0.0 110.737 -176.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 -34.45 0.34 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.884 2.183 . . . . 0.0 114.059 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -85.68 -28.48 24.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.68 2.24 . . . . 0.0 110.88 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 66.36 13.83 9.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.31 2.244 . . . . 0.0 113.701 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.68 160.07 30.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.2 1.0 . . . . 0.0 109.288 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -122.65 149.55 43.86 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 109.476 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.39 177.65 9.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.762 0.825 . . . . 0.0 109.287 167.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -117.33 122.82 44.94 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.83 156.94 32.18 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.73 0.3 . . . . 0.0 110.5 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.16 161.4 35.88 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.13 -20.97 63.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.957 2.438 . . . . 0.0 111.765 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -60.25 -23.73 64.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.87 0.868 . . . . 0.0 112.386 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.79 -9.94 50.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.489 1.04 . . . . 0.0 111.53 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.9 mt -116.48 160.58 20.39 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.23 1.412 . . . . 0.0 110.795 -162.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.55 146.95 47.14 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.066 0.946 . . . . 0.0 110.767 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -67.12 126.72 15.56 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.426 2.751 . . . . 0.0 110.508 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -52.8 -52.06 58.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.793 0.437 . . . . 0.0 110.841 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -66.66 -6.34 15.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -64.49 1.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.725 -0.609 . . . . 0.0 110.532 164.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -79.96 9.76 5.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.488 1.915 . . . . 0.0 113.525 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -53.71 -20.45 5.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.748 2.019 . . . . 0.0 112.464 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -33.13 4.62 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 119.972 1.26 . . . . 0.0 113.229 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -61.26 -51.56 68.41 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.615 1.098 . . . . 0.0 109.024 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -92.4 -35.06 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.108 0.963 . . . . 0.0 110.112 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.97 80.25 0.59 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.64 -1.089 . . . . 0.0 110.993 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -141.86 142.59 33.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.095 1.758 . . . . 0.0 107.648 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -54.4 103.54 0.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.853 2.461 . . . . 0.0 111.7 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.71 150.5 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.344 -0.848 . . . . 0.0 112.268 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -45.62 -49.39 14.29 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.8 1.64 . . . . 0.0 113.232 168.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -58.49 139.39 55.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.83 0.741 . . . . 0.0 110.598 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -71.27 172.5 9.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 162.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.34 -88.01 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 104.611 -3.396 . . . . 0.0 104.611 -143.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -32.24 -53.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.535 2.734 . . . . 0.0 115.547 -151.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -23.7 62.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.39 -57.29 4.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.633 2.373 . . . . 0.0 108.501 170.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.42 -27.75 61.19 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.332 -0.705 . . . . 0.0 112.563 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.48 -48.85 73.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.14 0.97 . . . . 0.0 111.384 170.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -60.89 -40.58 93.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.666 1.121 . . . . 0.0 110.178 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.58 -51.64 67.71 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.356 0.663 . . . . 0.0 111.678 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.2 tt -66.57 -29.4 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 118.892 0.769 . . . . 0.0 110.945 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.69 -30.99 69.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.214 -0.929 . . . . 0.0 110.905 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 . . . . . 0 C--O 1.236 0.388 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 179.476 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -134.5 167.95 19.84 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.974 1.31 . . . . 0.0 108.83 169.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.23 139.57 8.38 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.16 25.12 49.76 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.08 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -109.76 167.42 10.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.548 1.674 . . . . 0.0 109.693 164.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.45 138.25 46.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.766 2.026 . . . . 0.0 106.751 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -140.63 175.3 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 108.901 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -109.38 151.9 26.03 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 157.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.13 147.09 49.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.461 1.505 . . . . 0.0 109.056 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -134.63 104.81 6.21 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -164.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.8 mtm -88.95 167.2 13.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.302 0.573 . . . . 0.0 110.349 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -51.06 113.32 0.9 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.892 1.677 . . . . 0.0 109.154 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.77 -36.13 3.16 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.781 1.658 . . . . 0.0 114.26 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.54 163.65 19.2 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.54 1.536 . . . . 0.0 112.515 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -85.55 -179.04 3.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 125.126 3.884 . . . . 0.0 110.68 168.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -67.18 92.66 0.27 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.269 1.028 . . . . 0.0 108.655 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -78.13 139.1 60.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.986 1.314 . . . . 0.0 108.089 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.4 137.22 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.352 2.034 . . . . 0.0 108.914 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.77 156.86 43.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 141.72 49.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mm -78.12 105.37 7.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.27 170.87 6.5 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.655 0.782 . . . . 0.0 108.896 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 121.179 -0.951 . . . . 0.0 108.584 162.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.631 0.253 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -141.02 164.19 30.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.927 1.291 . . . . 0.0 108.187 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.67 152.67 59.03 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 124.412 1.085 . . . . 0.0 110.158 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.03 91.06 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.637 2.891 . . . . 0.0 109.476 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.6 mm -82.36 118.1 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -85.09 149.51 25.5 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 163.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -111.86 113.34 25.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -64.8 160.4 20.34 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.933 0.873 . . . . 0.0 110.455 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.49 -47.31 2.38 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.92 2.2 . . . . 0.0 113.201 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -96.77 -21.64 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.485 1.143 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.0 m80 66.79 21.71 10.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.454 1.902 . . . . 0.0 112.065 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -71.66 163.37 27.9 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.219 1.009 . . . . 0.0 109.845 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -142.79 142.85 31.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 109.254 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.52 -175.81 5.53 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.986 2.514 . . . . 0.0 107.055 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.82 125.29 48.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 109.386 165.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 mt -130.48 150.89 51.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.518 1.927 . . . . 0.0 108.769 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.81 165.54 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.34 0.971 . . . . 0.0 111.687 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.66 -22.33 50.63 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.937 3.091 . . . . 0.0 113.385 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -60.96 -13.33 15.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.127 -0.939 . . . . 0.0 112.142 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.44 -5.26 21.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 113.734 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.2 mt -122.39 146.96 46.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.565 1.075 . . . . 0.0 109.911 -157.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.15 143.28 46.48 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.579 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -65.02 114.88 2.99 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.619 2.213 . . . . 0.0 108.664 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -46.98 -54.26 10.55 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 123.929 0.892 . . . . 0.0 109.471 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -60.11 -25.24 65.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.502 0.502 . . . . 0.0 112.299 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -57.03 4.18 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -83.42 17.06 2.27 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 112.434 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -66.65 -31.36 71.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.278 1.431 . . . . 0.0 108.968 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.62 -57.07 3.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.414 0.552 . . . . 0.0 111.253 162.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.92 -41.85 83.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.115 0.87 . . . . 0.0 110.843 -162.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -102.73 -14.78 16.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.027 1.731 . . . . 0.0 112.541 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.64 75.17 2.14 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 119.719 1.145 . . . . 0.0 110.268 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -133.3 132.67 41.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.251 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 p -61.62 79.79 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.833 2.053 . . . . 0.0 112.867 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -95.41 147.11 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 110.181 -168.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -91.97 41.96 1.09 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -149.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -105.09 147.14 28.22 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.21 155.37 37.26 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.2 1.64 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.973 1.273 . . . . 0.0 112.197 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.28 -49.61 63.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.905 1.353 . . . . 0.0 112.932 -164.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -66.82 -22.64 66.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.625 0.77 . . . . 0.0 110.754 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -75.53 -47.52 26.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 108.39 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.66 -26.79 72.99 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 120.11 -0.272 . . . . 0.0 113.366 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 mt -72.23 -29.72 64.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.65 1.225 . . . . 0.0 111.584 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -70.72 -42.59 70.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.33 -0.856 . . . . 0.0 109.161 171.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.84 -55.22 37.2 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.156 0.582 . . . . 0.0 110.409 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.02 -34.12 64.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.989 0.813 . . . . 0.0 111.316 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.38 -29.94 65.54 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.496 -0.752 . . . . 0.0 111.631 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 . . . . . 0 C--O 1.235 0.313 0 C-N-CA 125.071 1.348 . . . . 0.0 112.795 175.539 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.73 156.52 46.74 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.794 -1.191 . . . . 0.0 110.058 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 141.8 50.44 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.63 40.41 10.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -136.55 173.08 12.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.248 1.024 . . . . 0.0 110.588 159.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -119.25 147.2 44.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.877 2.471 . . . . 0.0 106.801 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.424 HG11 HD11 ' A' ' 29' ' ' ILE . 33.9 m -149.73 171.33 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.381 1.073 . . . . 0.0 108.759 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.76 125.56 52.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.03 151.55 20.81 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.041 0.936 . . . . 0.0 110.796 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -126.9 106.32 9.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.2 mtp -83.99 167.78 16.58 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 162.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.18 119.79 11.51 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.05 -16.53 2.0 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.038 -1.423 . . . . 0.0 116.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -67.16 159.19 78.35 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 119.741 1.77 . . . . 0.0 110.907 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.13 164.28 34.52 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.61 2.873 . . . . 0.0 110.037 168.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -65.47 103.15 0.79 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -95.28 138.44 21.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.389 -164.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.56 124.49 14.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.695 2.264 . . . . 0.0 110.345 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.83 164.16 30.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.047 0.539 . . . . 0.0 110.324 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -128.85 146.13 51.01 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.037 -0.414 . . . . 0.0 110.612 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.424 HD11 HG11 ' A' ' 15' ' ' VAL . 17.7 mm -85.24 98.63 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 172.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -85.68 -175.88 5.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.754 1.622 . . . . 0.0 109.252 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 126.576 1.951 . . . . 0.0 108.907 167.135 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -136.9 -177.04 4.57 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.924 1.29 . . . . 0.0 109.679 -163.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -140.65 152.44 66.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.36 1.464 . . . . 0.0 109.084 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.81 92.01 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.424 3.416 . . . . 0.0 110.867 170.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.84 141.15 14.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -118.59 133.02 56.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.018 1.727 . . . . 0.0 108.2 172.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -89.85 112.53 23.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.242 1.417 . . . . 0.0 108.357 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 17.1 m-85 -62.39 154.56 27.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 171.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.49 -21.53 0.9 Allowed Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.725 -1.597 . . . . 0.0 115.951 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.96 -14.05 7.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 121.079 2.439 . . . . 0.0 113.879 178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.65 16.3 7.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.569 2.348 . . . . 0.0 112.832 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.1 170.4 10.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.373 1.082 . . . . 0.0 109.954 170.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -141.79 147.73 37.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 108.198 -172.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.42 24.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.318 0.508 . . . . 0.0 109.695 167.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -110.28 112.34 24.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 163.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 mt -125.13 142.0 51.76 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.55 164.17 37.68 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -64.4 -32.61 60.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.27 2.647 . . . . 0.0 112.363 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -58.95 -32.95 70.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.856 0.862 . . . . 0.0 112.788 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -82.72 -10.36 58.94 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.236 0.925 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.1 mt -108.15 154.7 21.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.614 1.965 . . . . 0.0 109.687 -171.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -134.01 140.89 37.66 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.797 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.76 126.12 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.442 2.761 . . . . 0.0 109.591 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.42 -48.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.706 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.56 -43.63 72.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.72 1.145 . . . . 0.0 112.731 -172.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -54.11 36.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.403 0.681 . . . . 0.0 110.61 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -85.47 2.85 42.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -55.76 -49.87 71.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.144 1.777 . . . . 0.0 108.991 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.27 -16.99 44.18 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -82.17 -64.76 1.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.885 1.221 . . . . 0.0 112.085 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -88.68 -31.48 18.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.818 2.447 . . . . 0.0 113.712 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.62 63.87 1.14 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.463 1.506 . . . . 0.0 113.367 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -128.99 142.6 50.87 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 p -56.75 150.13 16.71 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.382 1.087 . . . . 0.0 109.801 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.97 167.11 17.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.732 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -83.47 -16.83 44.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.155 0.889 . . . . 0.0 112.846 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -58.85 138.59 57.2 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.558 1.072 . . . . 0.0 109.768 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -67.29 154.69 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.356 0.663 . . . . 0.0 109.411 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.14 -31.97 1.11 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.389 0.995 . . . . 0.0 112.642 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.35 -26.23 66.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.922 1.861 . . . . 0.0 112.487 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -49.9 21.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.135 -0.978 . . . . 0.0 109.742 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -55.45 -47.69 75.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.131 1.372 . . . . 0.0 108.572 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 49' ' ' PHE . . . -66.97 -34.75 88.02 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.425 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.57 -20.38 64.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.581 1.691 . . . . 0.0 111.872 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -83.62 -42.69 16.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 120.765 1.621 . . . . 0.0 110.334 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -55.1 -49.93 70.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.045 0.538 . . . . 0.0 109.884 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.69 -31.79 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.527 -0.733 . . . . 0.0 111.94 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.66 -21.56 65.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.617 1.167 . . . . 0.0 111.769 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 . . . . . 0 C--O 1.234 0.267 0 C-N-CA 123.562 0.745 . . . . 0.0 112.058 -168.24 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.065 -0.017 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -143.07 167.63 21.64 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.409 1.084 . . . . 0.0 110.214 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.21 132.37 23.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.065 0.946 . . . . 0.0 110.659 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.71 76.77 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.26 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.93 144.29 57.38 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.371 1.585 . . . . 0.0 107.926 165.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -101.25 144.1 30.52 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 171.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.87 173.98 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.327 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -114.35 138.07 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 154.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.87 172.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.156 1.383 . . . . 0.0 107.92 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -141.89 106.32 4.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.78 172.8 12.88 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.297 1.046 . . . . 0.0 110.628 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -80.74 44.28 0.72 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.864 2.066 . . . . 0.0 112.956 -165.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.83 -43.11 0.68 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.536 1.541 . . . . 0.0 109.758 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -55.95 155.61 11.55 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 117.284 0.542 . . . . 0.0 110.41 170.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.57 -178.2 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.187 3.258 . . . . 0.0 109.894 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -74.54 79.29 1.96 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.441 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -63.31 134.31 95.79 Favored Pre-proline 0 CA--C 1.539 0.549 0 O-C-N 120.855 -1.153 . . . . 0.0 111.27 -170.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.646 ' HG3' HD22 ' A' ' 85' ' ' LEU . 50.6 Cg_endo -67.95 131.38 23.78 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.587 2.191 . . . . 0.0 110.032 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.99 168.65 22.53 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.078 0.466 . . . . 0.0 109.843 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.47 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 7.5 ptm180 -134.67 160.29 38.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.692 -0.63 . . . . 0.0 110.878 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.2 mm -84.13 117.13 29.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -82.64 -179.4 7.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.382 1.473 . . . . 0.0 108.587 166.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--N 1.325 -0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 108.04 172.857 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -115.26 143.96 44.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.725 1.602 . . . . 0.0 110.972 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -103.81 150.74 38.5 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.32 104.49 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.663 2.242 . . . . 0.0 108.555 159.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.55 140.83 16.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -112.97 121.16 43.81 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.563 2.345 . . . . 0.0 107.513 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -78.11 115.71 18.04 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.47 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.6 m-85 -67.79 155.77 38.54 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.906 0.384 . . . . 0.0 110.653 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.47 -58.8 4.1 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.979 0.8 . . . . 0.0 111.548 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -81.82 -21.16 37.8 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 112.152 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.4 m170 55.56 18.01 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.012 2.125 . . . . 0.0 112.619 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.86 166.56 19.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 109.095 173.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 p -142.56 148.11 37.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.229 1.011 . . . . 0.0 108.523 -171.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.52 179.47 7.65 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.521 1.128 . . . . 0.0 109.002 173.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -123.01 107.39 11.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.4 146.54 47.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.454 1.901 . . . . 0.0 107.96 -176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.46 162.13 23.37 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.91 -24.07 61.22 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.846 3.031 . . . . 0.0 113.961 -165.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -67.06 -9.1 35.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.239 1.381 . . . . 0.0 112.457 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.62 4.86 36.06 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.782 1.174 . . . . 0.0 111.501 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.51 153.93 50.44 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.298 1.439 . . . . 0.0 109.601 -166.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.13 143.93 26.7 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.901 0.88 . . . . 0.0 110.362 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.26 129.31 21.28 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.841 2.361 . . . . 0.0 110.568 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.54 -48.05 75.35 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 121.926 -0.484 . . . . 0.0 110.137 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.82 -24.74 66.08 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.75 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -43.28 18.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.523 1.129 . . . . 0.0 110.203 174.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.428 ' CD1' ' CE2' ' A' ' 72' ' ' PHE . 54.3 m-85 -100.84 6.29 43.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.538 1.535 . . . . 0.0 114.047 -164.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -58.81 -33.72 70.7 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 127.249 2.219 . . . . 0.0 112.78 -167.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -98.85 -21.36 16.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.027 0.83 . . . . 0.0 110.346 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -76.13 -68.77 0.55 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.685 1.194 . . . . 0.0 108.576 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 68' ' ' TYR . 22.1 m-30 -81.0 -44.36 18.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.938 1.695 . . . . 0.0 108.975 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.36 96.0 0.05 OUTLIER Glycine 0 C--N 1.339 0.723 0 C-N-CA 125.862 1.696 . . . . 0.0 109.081 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -140.27 133.13 29.16 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.675 1.99 . . . . 0.0 106.245 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 122.57 21.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -145.06 171.76 14.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.256 1.823 . . . . 0.0 108.988 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -88.24 -60.05 2.07 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.083 0.856 . . . . 0.0 112.262 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.304 0.3 OUTLIER 44.5 -126.1 1.02 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.824 0.85 . . . . 0.0 109.876 -173.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -136.99 105.64 5.84 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 127.706 2.402 . . . . 0.0 105.975 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.1 89.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 119.927 1.239 . . . . 0.0 114.207 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 33.2 t80 -76.55 -52.91 8.84 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.243 1.522 . . . . 0.0 110.816 -170.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -40.97 69.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.882 1.219 . . . . 0.0 110.561 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -61.7 -52.0 66.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.059 1.344 . . . . 0.0 110.591 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.62 92.21 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 123.39 0.519 . . . . 0.0 112.676 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.646 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -63.53 -49.48 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -57.58 -35.86 70.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.469 0.577 . . . . 0.0 110.935 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.58 -47.63 69.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.924 0.784 . . . . 0.0 110.681 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -67.76 -34.65 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.867 0.758 . . . . 0.0 109.79 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.52 -17.83 60.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.789 1.235 . . . . 0.0 111.648 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 . . . . . 0 N--CA 1.463 0.194 0 C-N-CA 125.541 1.536 . . . . 0.0 112.658 -169.592 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.475 ' N ' ' HH ' ' A' ' 44' ' ' TYR . 58.7 m-85 . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -139.83 172.25 13.05 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.899 -1.125 . . . . 0.0 108.557 168.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.1 55.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.6 73.79 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.767 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -97.74 157.69 15.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.753 1.276 . . . . 0.0 108.697 161.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -118.14 134.45 54.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.56 1.944 . . . . 0.0 106.328 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.98 171.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 118.942 0.792 . . . . 0.0 110.414 -167.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.36 142.11 34.78 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.499 -1.376 . . . . 0.0 107.791 162.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.58 161.47 15.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.433 1.493 . . . . 0.0 109.118 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -143.79 107.17 4.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.6 171.5 8.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.69 0.757 . . . . 0.0 109.816 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -53.08 119.13 4.33 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.025 1.73 . . . . 0.0 108.7 173.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.08 -48.36 3.54 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.397 0.999 . . . . 0.0 112.801 172.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -54.45 158.14 4.34 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.908 1.683 . . . . 0.0 112.297 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.36 179.58 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.031 3.154 . . . . 0.0 110.698 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.86 94.12 0.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -85.62 134.91 38.95 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.809 1.243 . . . . 0.0 109.495 -170.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.81 126.18 17.6 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.052 2.501 . . . . 0.0 110.225 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.69 168.11 20.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.764 1.226 . . . . 0.0 109.493 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.23 52.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -80.18 105.15 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 168.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -89.61 -172.39 3.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 121.987 0.899 . . . . 0.0 111.258 -173.112 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -136.01 153.58 51.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.387 1.075 . . . . 0.0 110.068 -171.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.475 ' HH ' ' N ' ' A' ' 9' ' ' TYR . 86.3 m-85 -106.11 148.18 36.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 125.121 1.368 . . . . 0.0 107.719 177.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.3 122.16 10.24 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.124 1.883 . . . . 0.0 107.625 155.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.88 111.38 32.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.656 1.582 . . . . 0.0 107.589 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -85.47 129.14 34.88 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.121 0.969 . . . . 0.0 108.656 171.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -93.62 93.84 8.27 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 108.149 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.18 151.01 1.48 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.637 1.175 . . . . 0.0 110.572 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.57 -74.07 2.3 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -68.34 -20.89 64.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m170 46.35 50.56 12.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.511 1.925 . . . . 0.0 111.001 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -97.09 162.06 13.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 161.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.0 p -134.76 130.81 36.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 157.6 43.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.636 0.653 . . . . 0.0 111.189 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -94.98 108.44 20.5 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.8 mt -126.06 146.71 49.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.069 0.548 . . . . 0.0 110.305 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.4 161.9 23.35 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.09 0.852 . . . . 0.0 111.506 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.2 -20.81 42.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.734 2.956 . . . . 0.0 113.857 -164.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -70.54 -14.57 62.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.655 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.64 0.39 44.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.005 1.322 . . . . 0.0 111.047 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -115.62 160.73 19.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.387 1.449 . . . . 0.0 110.482 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.8 145.63 28.61 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.14 130.91 26.88 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -51.25 -58.05 7.21 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.183 0.993 . . . . 0.0 110.853 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.5 -34.26 72.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.964 1.305 . . . . 0.0 111.508 -168.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -56.38 6.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -86.16 6.38 29.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.831 1.253 . . . . 0.0 113.57 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -57.33 -40.83 78.8 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.271 1.828 . . . . 0.0 110.739 -172.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.58 -45.19 39.15 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.899 0.772 . . . . 0.0 111.475 172.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -66.24 -41.25 90.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.58 0.752 . . . . 0.0 111.767 -169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -114.83 -31.01 6.26 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.844 1.658 . . . . 0.0 110.969 -167.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.19 70.68 2.55 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -140.67 139.2 34.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.498 1.119 . . . . 0.0 108.256 -167.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.47 ' HA ' HD21 ' A' ' 82' ' ' ASN . 2.2 p -54.54 140.51 34.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.27 1.428 . . . . 0.0 109.993 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.22 154.92 50.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.232 174.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -77.99 66.97 3.74 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 109.739 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 mmt-85 -133.94 112.68 11.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.167 1.787 . . . . 0.0 106.529 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -57.93 150.13 21.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.36 -18.26 0.56 Allowed Glycine 0 CA--C 1.537 1.457 0 CA-C-O 118.477 -1.18 . . . . 0.0 115.031 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -73.47 -55.93 5.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 121.426 2.613 . . . . 0.0 110.527 -174.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.47 HD21 ' HA ' ' A' ' 75' ' ' SER . 8.3 m120 -66.06 -27.92 68.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.703 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -65.25 -41.02 94.72 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.775 2.03 . . . . 0.0 110.594 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.37 -35.24 81.74 Favored Glycine 0 CA--C 1.523 0.543 0 O-C-N 121.399 -0.813 . . . . 0.0 111.697 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.65 -32.82 74.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.901 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -59.77 -47.58 85.12 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.92 1.236 . . . . 0.0 110.435 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.39 -57.69 8.59 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.077 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 tt -59.24 -32.5 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 118.688 0.676 . . . . 0.0 111.732 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.98 -52.31 56.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.432 1.093 . . . . 0.0 109.799 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.816 0.846 . . . . 0.0 112.807 -178.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -135.43 157.89 45.76 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.962 1.705 . . . . 0.0 110.099 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.75 134.42 56.73 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.711 0.632 . . . . 0.0 109.981 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.98 47.33 5.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.54 174.59 10.45 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.021 0.529 . . . . 0.0 110.275 161.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.1 mt -125.08 140.31 53.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.805 2.042 . . . . 0.0 106.262 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.91 172.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -105.7 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 152.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.42 154.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.181 1.392 . . . . 0.0 108.216 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -128.92 106.32 8.82 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mtm -86.21 167.59 14.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 167.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.26 125.43 20.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.719 1.207 . . . . 0.0 108.532 177.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.77 -33.58 1.22 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.371 1.462 . . . . 0.0 115.132 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.13 158.69 62.22 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 118.887 1.344 . . . . 0.0 112.072 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 178.21 6.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.55 3.5 . . . . 0.0 110.247 168.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.7 96.31 0.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.565 0.746 . . . . 0.0 109.093 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -78.81 135.22 59.67 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.109 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.04 122.5 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.537 2.158 . . . . 0.0 108.914 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.15 165.91 25.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 109.908 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -129.86 164.11 24.85 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.101 -1.0 . . . . 0.0 110.621 -178.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.17 96.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -86.4 -169.12 2.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.69 2.396 . . . . 0.0 110.834 -166.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.535 0.367 0 O-C-N 120.23 -1.544 . . . . 0.0 112.281 -175.772 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -132.36 145.3 51.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.768 1.227 . . . . 0.0 108.972 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -107.75 148.6 37.64 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 124.002 0.921 . . . . 0.0 108.629 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.83 105.2 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.446 2.764 . . . . 0.0 109.19 162.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.64 156.77 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -133.13 124.96 28.48 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.338 1.855 . . . . 0.0 107.299 166.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -89.62 94.65 9.94 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 16.5 m-85 -46.68 148.13 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.493 1.117 . . . . 0.0 111.069 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.99 -35.87 1.06 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.093 0.854 . . . . 0.0 113.869 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.8 p -87.07 -26.81 23.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.586 1.693 . . . . 0.0 110.864 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.8 m80 62.01 24.46 14.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.496 2.318 . . . . 0.0 112.194 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -97.03 149.87 21.44 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.544 1.138 . . . . 0.0 108.994 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -123.74 147.42 47.51 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 -172.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.96 165.27 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.681 1.193 . . . . 0.0 109.122 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.95 106.94 17.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.19 156.58 19.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 161.25 22.54 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 166.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -63.32 -16.71 56.21 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.085 3.19 . . . . 0.0 115.076 -166.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -69.3 -17.79 63.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.446 1.476 . . . . 0.0 111.606 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -89.23 1.84 55.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.619 1.168 . . . . 0.0 110.905 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.7 mt -117.58 167.77 11.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.751 1.62 . . . . 0.0 111.463 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -143.69 152.31 55.77 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.025 1.73 . . . . 0.0 109.169 162.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.58 118.27 5.4 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 0.0 111.034 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -44.33 -62.27 1.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 125.075 1.35 . . . . 0.0 112.324 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -42.52 62.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.473 1.033 . . . . 0.0 112.055 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.41 -33.09 74.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.908 0.883 . . . . 0.0 111.426 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.31 8.82 18.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.198 -1.564 . . . . 0.0 112.787 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -56.77 -42.57 79.62 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.347 1.859 . . . . 0.0 111.144 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -74.54 -37.17 63.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.877 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -82.26 -49.37 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.895 1.278 . . . . 0.0 111.48 -162.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -94.75 -33.34 12.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.752 2.021 . . . . 0.0 110.363 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.29 61.76 3.47 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.278 1.418 . . . . 0.0 111.366 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.558 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 11.1 mmpt? -131.24 136.95 48.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.566 1.947 . . . . 0.0 107.799 -172.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.6 m -40.34 110.31 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.435 2.294 . . . . 0.0 110.824 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.65 176.6 7.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.046 0.45 . . . . 0.0 109.829 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -83.83 -38.8 20.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.537 -1.221 . . . . 0.0 110.047 164.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 125.81 16.63 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.669 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.23 163.65 8.01 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 0.0 109.675 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.08 -42.32 1.86 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -56.91 -44.74 82.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.455 1.102 . . . . 0.0 111.861 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.52 -36.81 71.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.24 0.927 . . . . 0.0 110.445 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -63.11 -31.71 72.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.608 0.763 . . . . 0.0 110.39 172.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.19 -32.69 42.73 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.566 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.6 -41.81 99.2 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.387 1.094 . . . . 0.0 110.137 172.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -54.87 -43.77 73.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.191 0.45 . . . . 0.0 111.101 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.62 -53.06 57.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.849 0.295 . . . . 0.0 111.357 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.4 tt -67.45 -33.97 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.785 0.266 . . . . 0.0 110.589 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -62.87 -38.06 89.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.7 0.8 . . . . 0.0 110.06 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 . . . . . 0 N--CA 1.463 0.201 0 O-C-N 121.538 -0.726 . . . . 0.0 110.473 177.697 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 p -144.93 95.6 2.72 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.836 0.855 . . . . 0.0 108.748 -155.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m -57.54 149.51 21.09 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.438 1.095 . . . . 0.0 111.369 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.74 127.31 3.2 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 -171.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -65.68 -33.2 75.33 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.434 1.117 . . . . 0.0 110.892 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 t 44.71 41.12 4.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.522 1.929 . . . . 0.0 112.296 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.37 81.63 1.07 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.58 109.22 0.42 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.34 2.656 . . . . 0.0 106.403 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -75.56 155.3 36.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -155.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -132.59 153.95 50.52 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.707 1.203 . . . . 0.0 109.799 -169.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 140.14 52.17 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.5 -12.0 68.24 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.748 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.28 166.58 21.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.609 1.705 . . . . 0.0 109.589 166.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -124.44 148.81 47.4 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 29' ' ' ILE . 28.9 m -148.66 170.46 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 C-N-CA 123.363 0.665 . . . . 0.0 111.083 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.69 138.23 40.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.64 120.73 39.56 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.306 1.442 . . . . 0.0 108.158 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 18.2 tptp -104.99 106.53 17.07 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -87.91 158.05 18.79 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -64.5 93.46 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.579 1.151 . . . . 0.0 111.404 -172.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.08 -18.78 42.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.631 1.11 . . . . 0.0 112.593 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -72.63 162.11 75.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.646 1.223 . . . . 0.0 108.753 164.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -61.78 178.73 0.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.645 2.23 . . . . 0.0 112.284 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.426 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 55.6 m80 -64.96 92.33 0.1 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 158.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -76.37 141.06 69.44 Favored Pre-proline 0 C--O 1.234 0.266 0 C-N-CA 123.979 0.911 . . . . 0.0 109.414 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.96 121.06 8.05 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.617 2.211 . . . . 0.0 109.187 172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 163.47 32.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.5 0.667 . . . . 0.0 110.139 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 13.2 ptt180 -119.93 152.33 37.58 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.42 HD11 HG11 ' A' ' 15' ' ' VAL . 11.2 mm -78.46 121.87 32.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 163.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -102.5 -174.39 2.55 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 168.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.72 -171.48 1.88 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -113.74 136.84 22.07 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.53 164.23 33.7 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.944 1.762 . . . . 0.0 109.927 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -78.45 51.36 1.04 Allowed 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.881 1.672 . . . . 0.0 109.439 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 161.88 10.08 0.04 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 118.783 2.273 . . . . 0.0 118.783 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.9 -159.74 0.76 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.81 2.805 . . . . 0.0 111.512 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.14 142.05 16.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.55 1.14 . . . . 0.0 109.483 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.68 113.41 54.26 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.048 0.939 . . . . 0.0 109.709 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.24 170.13 17.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.82 2.347 . . . . 0.0 112.401 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.47 153.94 31.15 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 121.196 1.264 . . . . 0.0 111.342 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.0 136.36 57.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 97.92 -26.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.612 1 C-N-CA 132.424 4.29 . . . . 0.0 110.946 -175.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -83.16 166.99 18.17 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.501 1.046 . . . . 0.0 111.352 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -130.26 149.4 73.21 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.426 1.09 . . . . 0.0 109.225 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.69 92.26 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.723 2.949 . . . . 0.0 108.976 163.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mm -84.47 122.93 38.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -102.12 117.43 34.76 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.151 1.38 . . . . 0.0 107.476 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -84.1 105.17 14.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.69 1.596 . . . . 0.0 107.658 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 11.5 m-85 -60.69 156.77 16.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.107 0.479 . . . . 0.0 110.731 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.16 -23.42 0.91 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.448 1.975 . . . . 0.0 115.616 178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 p -113.55 -18.46 11.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.931 1.366 . . . . 0.0 110.604 170.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.6 m170 61.85 18.43 9.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.06 2.544 . . . . 0.0 111.578 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -73.19 160.2 32.32 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.753 0.821 . . . . 0.0 110.005 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.3 p -125.71 131.01 52.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.734 1.214 . . . . 0.0 108.157 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.78 170.22 16.29 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.653 166.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.16 118.06 35.72 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.7 mt -124.49 154.23 40.83 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.45 167.05 19.94 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 173.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -61.56 -32.76 87.98 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.982 2.455 . . . . 0.0 112.86 -163.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -63.25 -28.8 70.28 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.763 0.825 . . . . 0.0 112.799 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -82.78 -1.16 50.88 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.639 1.109 . . . . 0.0 111.716 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 69.9 mt -126.85 160.75 30.03 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.957 1.703 . . . . 0.0 109.34 -162.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -140.39 136.38 16.72 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.31 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.62 128.69 21.73 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.785 2.323 . . . . 0.0 110.128 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -51.15 -59.48 4.15 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.694 -1.146 . . . . 0.0 111.355 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -61.31 -23.54 65.79 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.629 1.559 . . . . 0.0 113.26 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.53 -29.71 41.55 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 120.189 1.358 . . . . 0.0 111.507 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -114.55 6.19 15.75 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.742 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -57.08 -44.49 83.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.073 1.749 . . . . 0.0 109.854 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -89.87 -27.99 19.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -68.54 -44.05 75.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.741 1.616 . . . . 0.0 112.55 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -114.19 -27.25 7.71 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.938 2.095 . . . . 0.0 111.017 -172.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 63.5 3.86 Favored Glycine 0 C--N 1.338 0.684 0 C-N-CA 124.814 1.197 . . . . 0.0 110.894 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -142.67 157.65 44.46 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.614 1.165 . . . . 0.0 109.158 -171.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.9 m -73.38 71.41 1.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.218 1.807 . . . . 0.0 115.34 -151.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -74.99 -11.12 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.563 1.545 . . . . 0.0 113.031 -170.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.6 tttt 53.69 29.14 8.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.078 2.151 . . . . 0.0 115.865 165.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -71.73 11.28 0.53 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 61.98 143.35 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.333 2.253 . . . . 0.0 109.393 -152.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.64 -40.91 0.65 Allowed Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.441 -1.412 . . . . 0.0 112.632 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -59.28 -30.43 68.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.917 1.687 . . . . 0.0 114.277 -169.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.51 -33.16 32.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 120.967 -1.083 . . . . 0.0 110.483 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -59.2 -58.22 9.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.79 1.636 . . . . 0.0 106.866 169.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.69 -33.69 87.9 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 118.998 0.817 . . . . 0.0 113.288 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.7 -29.61 69.64 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.689 1.245 . . . . 0.0 111.842 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -75.48 -43.38 49.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 118.929 0.786 . . . . 0.0 109.28 170.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.75 -38.21 90.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.028 1.331 . . . . 0.0 110.143 -171.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 tt -73.46 -45.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 124.341 1.057 . . . . 0.0 111.281 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -55.45 -55.91 26.27 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -75.56 -3.46 34.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.112 1.365 . . . . 0.0 112.773 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 t -83.74 -36.76 23.41 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 120.298 1.408 . . . . 0.0 110.199 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.61 170.32 36.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -165.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.81 112.0 1.52 Allowed 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.791 2.327 . . . . 0.0 107.756 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.4 t -137.38 149.0 46.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 127.358 2.263 . . . . 0.0 104.919 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.1 m 57.65 2.26 0.15 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.719 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -177.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.406 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -140.95 -51.79 0.46 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.36 1.064 . . . . 0.0 110.271 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t 57.68 58.39 3.74 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.844 0.858 . . . . 0.0 110.612 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.26 67.88 0.04 OUTLIER Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.22 120.34 40.85 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.232 1.013 . . . . 0.0 109.815 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.4 m -67.82 -25.17 65.44 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.892 0.877 . . . . 0.0 113.337 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.67 108.09 2.12 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 107.033 -2.427 . . . . 0.0 107.033 -153.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -138.21 175.5 9.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.13 2.572 . . . . 0.0 105.118 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -131.13 156.6 44.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -142.58 161.81 37.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.518 1.527 . . . . 0.0 107.774 -168.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.72 133.66 56.3 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.85 -12.73 68.84 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.614 -1.103 . . . . 0.0 112.915 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.27 128.07 34.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.349 1.575 . . . . 0.0 107.576 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -85.65 147.7 26.25 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.85 168.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.655 0.74 . . . . 0.0 111.781 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.52 125.5 50.11 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 160.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.402 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -92.82 154.17 18.41 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -130.19 105.89 8.23 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mtm -73.14 168.96 18.04 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.872 0.844 . . . . 0.0 110.042 171.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.75 55.01 2.57 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.869 1.267 . . . . 0.0 110.768 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.5 -28.22 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.946 0.784 . . . . 0.0 112.494 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -70.5 160.43 81.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.882 -0.775 . . . . 0.0 110.258 167.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -74.11 177.84 7.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.965 3.11 . . . . 0.0 111.749 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -62.65 112.57 2.56 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -114.56 143.56 30.15 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 124.91 1.284 . . . . 0.0 108.037 -166.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -66.77 123.85 11.57 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.849 2.366 . . . . 0.0 110.973 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.48 159.38 42.52 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.274 0.559 . . . . 0.0 110.153 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 138.84 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.8 mm -75.53 92.49 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 163.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -78.21 -164.08 0.5 Allowed 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 -177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -125.74 -167.75 1.74 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 120.77 -1.206 . . . . 0.0 108.318 165.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -132.72 124.51 18.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 117.453 -1.26 . . . . 0.0 108.166 -166.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.32 168.71 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.811 2.341 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.23 73.83 0.96 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.02 1.728 . . . . 0.0 109.738 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.38 84.73 1.7 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 -166.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 -172.02 2.58 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 150.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.7 p -66.06 151.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 163.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -88.21 147.02 39.37 Favored Pre-proline 0 C--O 1.237 0.415 0 O-C-N 121.553 -0.717 . . . . 0.0 109.182 174.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.98 150.27 26.49 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.646 2.231 . . . . 0.0 110.317 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.63 170.69 17.99 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.597 1.531 . . . . 0.0 112.054 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.97 125.87 22.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.019 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m120 77.71 17.32 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.55 2.34 . . . . 0.0 112.494 171.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -125.58 160.98 28.22 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.715 1.143 . . . . 0.0 111.985 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -123.31 152.81 64.82 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.03 1.732 . . . . 0.0 109.015 -173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -70.59 93.39 0.6 Allowed 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 124.506 3.47 . . . . 0.0 111.358 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mm -86.03 108.4 17.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.031 0.933 . . . . 0.0 108.577 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -94.5 119.16 32.78 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 165.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 111.64 18.55 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.742 1.217 . . . . 0.0 107.85 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -61.04 157.18 16.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.745 0.783 . . . . 0.0 110.377 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.92 -70.68 1.75 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.745 1.164 . . . . 0.0 111.894 -174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 p -69.02 -22.29 64.07 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 120.948 -1.325 . . . . 0.0 112.275 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 66.45 10.17 7.08 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.1 2.16 . . . . 0.0 113.679 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -67.14 159.17 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 120.914 -1.116 . . . . 0.0 110.262 176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.25 130.38 40.84 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -149.24 -176.15 5.25 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.82 1.248 . . . . 0.0 109.952 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -127.95 125.99 40.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 171.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.2 mt -128.85 155.93 44.45 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.353 1.461 . . . . 0.0 108.247 172.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.87 171.83 22.12 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.744 1.164 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -68.85 -26.36 32.18 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.483 2.122 . . . . 0.0 113.07 -160.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.86 -14.16 61.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.061 0.846 . . . . 0.0 112.494 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -94.38 -4.59 48.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.761 0.709 . . . . 0.0 111.204 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 17' ' ' ALA . 90.1 mt -127.84 153.66 46.36 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.277 1.831 . . . . 0.0 109.927 -163.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -136.29 147.1 58.9 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.548 0.739 . . . . 0.0 109.72 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -63.1 140.41 78.22 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.595 2.197 . . . . 0.0 109.456 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -59.1 -65.69 0.63 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -24.96 67.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -162.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -68.44 -58.77 3.83 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.552 0.741 . . . . 0.0 109.937 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -89.48 16.46 7.61 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.968 1.707 . . . . 0.0 111.055 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -60.42 -40.17 90.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.698 1.199 . . . . 0.0 109.518 -164.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.421 ' O ' ' HE3' ' A' ' 74' ' ' LYS . 28.1 t70 -80.19 -53.39 6.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.579 170.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -51.06 -39.94 57.17 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.676 1.59 . . . . 0.0 113.84 -171.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -110.23 -24.33 10.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.164 1.385 . . . . 0.0 110.643 -177.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.16 71.07 2.89 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 70' ' ' ASP . 9.3 mmpt? -121.66 145.03 48.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.384 1.474 . . . . 0.0 107.659 176.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 m -58.04 99.03 0.04 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.867 1.667 . . . . 0.0 109.053 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -77.75 173.27 12.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.506 0.669 . . . . 0.0 110.058 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -73.44 -39.34 65.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.992 0.917 . . . . 0.0 111.694 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.57 141.18 56.92 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.452 0.569 . . . . 0.0 110.606 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -64.5 163.22 13.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.782 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -47.29 0.83 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.946 1.736 . . . . 0.0 112.167 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -49.58 -49.01 48.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.16 1.384 . . . . 0.0 111.404 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -66.69 -29.15 69.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.52 -46.93 71.39 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.91 -28.7 73.79 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.24 -0.755 . . . . 0.0 112.895 -176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.97 -49.8 59.57 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.604 1.202 . . . . 0.0 110.593 174.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 78.9 t90 -59.68 -39.01 83.09 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.021 -0.514 . . . . 0.0 109.891 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -57.03 -63.11 1.32 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.671 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.4 tt -61.85 -32.58 54.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 119.747 1.158 . . . . 0.0 112.247 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -65.15 -53.73 40.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.503 0.321 . . . . 0.0 110.141 173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -68.35 -38.31 81.33 Favored 'General case' 0 C--N 1.332 -0.153 0 O-C-N 121.869 -0.519 . . . . 0.0 111.204 -174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.9 m -73.59 -0.16 14.45 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.661 1.584 . . . . 0.0 112.404 171.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -126.86 82.66 0.34 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.919 -1.49 . . . . 0.0 111.458 -172.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.94 64.87 4.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.671 3.581 . . . . 0.0 112.111 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -66.63 149.21 50.82 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.662 -1.274 . . . . 0.0 110.248 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.6 p -73.75 117.81 15.96 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 N-CA-C 107.484 -2.247 . . . . 0.0 107.484 -179.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.7 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m 37.6 43.96 0.49 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.751 2.02 . . . . 0.0 115.36 162.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.9 m -99.89 146.43 26.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 169.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.97 -149.65 46.91 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 p -145.39 79.18 1.57 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.07 1.748 . . . . 0.0 109.851 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 m -65.44 169.93 5.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.368 -0.833 . . . . 0.0 110.387 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.12 -128.7 2.91 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 56.0 94.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.523 1.929 . . . . 0.0 113.794 170.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -67.66 158.54 31.97 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.757 1.223 . . . . 0.0 110.475 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -143.36 167.96 20.93 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.673 1.589 . . . . 0.0 108.269 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.01 126.6 26.61 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.61 32.96 4.61 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.284 -0.731 . . . . 0.0 111.785 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.48 168.85 16.93 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 118.202 1.001 . . . . 0.0 108.636 165.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.1 mt -123.08 147.89 46.24 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.839 1.656 . . . . 0.0 106.665 170.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -149.09 171.52 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.333 0.653 . . . . 0.0 110.26 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -107.36 149.54 27.73 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.17 144.46 50.43 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.944 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE2' ' NE2' ' A' ' 24' ' ' HIS . 5.0 tptp -128.53 105.83 8.56 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.023 0.829 . . . . 0.0 110.369 -174.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.9 mtp -90.18 170.8 9.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.56 1.144 . . . . 0.0 109.527 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -60.01 138.89 57.75 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.644 -0.66 . . . . 0.0 109.375 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.94 -36.25 0.74 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.704 1.145 . . . . 0.0 114.738 176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -73.44 160.72 81.73 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.75 2.02 . . . . 0.0 112.277 -175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.34 -177.6 3.65 Favored 'Trans proline' 0 N--CA 1.453 -0.89 1 C-N-CA 125.574 4.182 . . . . 0.0 110.454 172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.415 ' NE2' ' HE2' ' A' ' 18' ' ' LYS . 16.4 m80 -71.79 90.39 1.09 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 170.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -77.74 141.74 64.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.821 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.0 127.56 17.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.411 2.074 . . . . 0.0 110.564 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.17 166.03 26.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.114 0.566 . . . . 0.0 110.596 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -128.02 162.91 25.73 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 120.929 -1.107 . . . . 0.0 111.584 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.3 mm -94.87 101.93 13.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -84.7 -177.09 6.5 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.161 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -122.81 140.52 52.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.186 1.394 . . . . 0.0 108.141 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.5 mt -76.69 119.03 75.66 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.14 158.07 26.63 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 123.093 2.529 . . . . 0.0 111.35 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.65 103.77 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.68 2.392 . . . . 0.0 112.498 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.28 7.68 51.56 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.029 174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.5 -168.79 0.13 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.089 1.356 . . . . 0.0 111.855 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.8 t -65.07 162.55 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.016 0.926 . . . . 0.0 108.698 172.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.7 97.77 49.56 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 110.333 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.37 163.29 38.16 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.587 2.192 . . . . 0.0 111.937 172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.48 156.93 64.08 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.899 1.733 . . . . 0.0 110.859 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.44 27.4 0.43 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.772 1.229 . . . . 0.0 114.151 -163.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.4 p30 -153.79 21.35 0.52 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 127.827 2.451 . . . . 0.0 109.51 -161.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.4 mttt -141.56 171.74 13.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.786 2.835 . . . . 0.0 107.999 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -131.74 152.34 80.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.182 1.393 . . . . 0.0 108.894 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.13 91.32 1.21 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.863 3.708 . . . . 0.0 110.684 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.9 mm -89.18 110.23 21.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -169.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -88.87 132.18 34.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.34 1.056 . . . . 0.0 108.304 172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -103.08 94.56 5.61 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.103 1.361 . . . . 0.0 108.552 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -47.53 147.81 1.63 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.82 1.648 . . . . 0.0 112.365 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.67 -39.16 0.75 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.977 1.751 . . . . 0.0 114.241 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -22.65 24.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.467 1.507 . . . . 0.0 112.429 173.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.4 m80 58.72 11.91 2.0 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.676 2.39 . . . . 0.0 114.749 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -74.13 169.62 17.18 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.629 0.649 . . . . 0.0 110.225 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.4 p -127.97 166.14 18.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.975 0.91 . . . . 0.0 109.605 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.39 166.1 34.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.148 1.379 . . . . 0.0 108.165 163.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -105.96 114.32 28.39 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 166.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.8 mt -131.07 150.51 52.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.508 0.723 . . . . 0.0 109.307 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.75 169.33 25.62 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.14 -10.62 29.23 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.933 3.089 . . . . 0.0 113.314 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -76.75 -5.66 49.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.869 1.268 . . . . 0.0 113.744 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -122.17 12.05 10.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.39 1.476 . . . . 0.0 110.723 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.6 mt -135.2 162.26 33.04 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.514 1.526 . . . . 0.0 110.574 -170.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -140.36 148.17 52.77 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 124.981 1.313 . . . . 0.0 111.703 173.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.77 142.83 95.14 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 111.477 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -67.49 -56.07 11.03 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.436 -0.79 . . . . 0.0 109.961 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -69.61 -9.3 53.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -168.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.86 -77.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 155.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -72.48 10.39 0.83 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.766 2.826 . . . . 0.0 114.523 -164.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -59.99 -35.23 74.57 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.073 1.349 . . . . 0.0 109.009 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -84.55 -45.45 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.115 1.325 . . . . 0.0 111.551 171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -60.52 -55.01 38.61 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.406 0.682 . . . . 0.0 111.065 -171.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -97.77 -16.23 19.96 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.795 1.238 . . . . 0.0 111.965 -171.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.3 37.75 1.58 Allowed Glycine 0 CA--C 1.541 1.658 0 O-C-N 120.985 -1.072 . . . . 0.0 114.564 -173.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -115.15 135.51 54.11 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.837 1.318 . . . . 0.0 109.302 -164.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.463 ' CB ' HD21 ' A' ' 82' ' ' ASN . 10.8 p -57.52 107.45 0.44 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.567 1.147 . . . . 0.0 109.594 -171.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -94.21 163.88 13.27 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.307 -173.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -92.88 -7.66 45.58 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -171.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 50.2 mmt-85 -66.06 136.84 56.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 158.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -66.73 168.45 9.49 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.471 0.708 . . . . 0.0 109.181 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.96 -32.0 1.07 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.983 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -55.33 -42.04 73.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.925 1.29 . . . . 0.0 110.571 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.463 HD21 ' CB ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -65.43 -45.94 81.87 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.213 0.605 . . . . 0.0 111.348 177.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -55.96 -49.05 74.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.5 -38.37 96.22 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.329 -0.706 . . . . 0.0 112.777 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.46 -30.13 71.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.413 1.106 . . . . 0.0 111.832 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -73.7 -48.18 33.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.926 0.784 . . . . 0.0 109.017 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.76 -49.26 73.59 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.104 0.962 . . . . 0.0 111.19 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.6 tt -67.42 -37.52 79.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.585 0.354 . . . . 0.0 111.07 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.34 -41.05 96.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 121.609 -0.682 . . . . 0.0 109.96 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -83.32 25.45 0.73 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.653 1.581 . . . . 0.0 110.678 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 m -130.55 145.7 51.92 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 128.433 2.693 . . . . 0.0 103.748 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.62 175.7 16.48 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 126.791 2.138 . . . . 0.0 110.496 -166.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.18 167.59 8.98 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 123.895 3.063 . . . . 0.0 113.225 -177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -84.37 67.02 9.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.464 0.706 . . . . 0.0 109.247 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m -156.11 -174.17 4.83 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 127.236 2.214 . . . . 0.0 107.951 165.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.01 0.814 . . . . 0.0 113.572 169.499 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.777 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 t -150.84 -52.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 117.909 0.854 . . . . 0.0 110.975 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.1 t -58.17 107.54 0.49 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.301 1.04 . . . . 0.0 110.823 -172.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.74 113.41 3.62 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -169.85 114.57 0.52 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.851 1.261 . . . . 0.0 108.226 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.9 m -155.89 140.59 17.02 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 53.11 55.53 23.62 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.74 158.05 41.17 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 166.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -144.71 153.7 41.98 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.899 1.679 . . . . 0.0 107.17 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -141.74 161.21 38.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.633 1.173 . . . . 0.0 109.315 -176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 141.2 46.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.972 0.415 . . . . 0.0 110.956 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.37 54.65 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.221 -1.321 . . . . 0.0 113.036 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 169.0 18.93 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 119.61 1.705 . . . . 0.0 110.69 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.556 HD22 HG13 ' A' ' 88' ' ' ILE . 93.6 mt -123.09 142.85 50.43 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.943 1.297 . . . . 0.0 108.082 -171.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.93 175.78 2.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 123.377 0.671 . . . . 0.0 110.701 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -109.39 131.6 54.91 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 156.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -91.97 164.4 13.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 128.868 2.867 . . . . 0.0 108.324 174.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -149.48 106.04 3.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 68.4 mtm -90.15 -179.76 5.73 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.324 1.049 . . . . 0.0 109.751 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -84.89 61.41 6.81 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.12 -0.988 . . . . 0.0 112.859 -164.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.54 -27.55 2.6 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 124.451 1.024 . . . . 0.0 110.614 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -60.62 150.86 73.59 Favored Pre-proline 0 N--CA 1.449 -0.489 0 O-C-N 122.264 -0.55 . . . . 0.0 109.525 167.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.47 174.03 5.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.388 3.392 . . . . 0.0 110.724 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -60.25 96.93 0.04 OUTLIER 'General case' 0 C--O 1.234 0.241 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -88.75 131.67 40.91 Favored Pre-proline 0 N--CA 1.456 -0.128 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -170.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -67.43 136.0 38.36 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.261 1.307 . . . . 0.0 109.1 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.27 163.88 34.1 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.973 0.909 . . . . 0.0 109.554 -172.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.61 146.18 50.93 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.462 -0.774 . . . . 0.0 110.26 -178.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mm -80.9 103.14 7.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -78.79 -175.53 4.49 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -130.61 136.73 49.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.573 1.149 . . . . 0.0 108.504 -170.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.5 mt -83.13 120.34 75.74 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.127 -161.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.59 166.1 27.02 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.397 2.731 . . . . 0.0 112.277 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.21 53.73 0.52 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.965 1.306 . . . . 0.0 110.191 162.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.37 68.13 0.01 OUTLIER Glycine 0 C--N 1.333 0.412 0 O-C-N 121.15 -0.969 . . . . 0.0 111.269 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -145.91 179.88 7.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.163 1.385 . . . . 0.0 108.634 166.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.03 165.7 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 121.25 -0.907 . . . . 0.0 109.595 170.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 127.88 29.58 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 171.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.04 166.13 28.5 Favored 'Trans proline' 0 C--O 1.241 0.663 0 C-N-CA 122.972 2.448 . . . . 0.0 112.51 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.85 149.58 72.7 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 120.737 0.958 . . . . 0.0 109.779 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.42 53.0 1.45 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.269 0.627 . . . . 0.0 111.836 -168.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.33 9.83 0.1 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.346 1.858 . . . . 0.0 111.76 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -140.99 163.67 32.34 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.418 1.087 . . . . 0.0 109.295 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.88 153.55 67.29 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 124.872 1.269 . . . . 0.0 109.239 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -67.26 95.31 0.37 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.734 2.956 . . . . 0.0 110.066 167.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.41 113.21 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -85.16 150.8 24.57 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 163.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.46 93.26 3.95 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -175.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.8 m-85 -47.58 150.25 1.03 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.826 2.051 . . . . 0.0 111.257 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.18 -49.88 3.62 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 125.28 1.419 . . . . 0.0 111.774 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -91.61 -16.08 27.62 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.467 1.507 . . . . 0.0 113.603 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.7 m170 53.11 16.53 0.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.261 2.624 . . . . 0.0 114.77 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -71.97 164.39 26.18 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.898 -1.126 . . . . 0.0 110.194 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -139.72 137.89 35.5 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.032 1.333 . . . . 0.0 108.091 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.68 163.87 38.17 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.391 0.615 . . . . 0.0 109.42 169.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -101.99 109.69 21.47 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -127.83 151.35 49.16 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.014 0.926 . . . . 0.0 108.554 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.72 173.74 29.82 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.702 1.144 . . . . 0.0 110.479 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.74 -21.67 58.14 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.259 2.64 . . . . 0.0 112.366 -165.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -64.59 -18.48 64.93 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.293 -0.879 . . . . 0.0 113.055 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -109.07 10.96 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.915 1.286 . . . . 0.0 110.345 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.3 mt -130.84 162.24 30.03 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 126.458 1.903 . . . . 0.0 109.364 -172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -148.17 143.11 17.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.422 1.089 . . . . 0.0 109.545 176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -63.27 126.38 17.68 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.592 2.861 . . . . 0.0 112.196 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.46 -51.89 67.62 Favored 'General case' 0 C--O 1.221 -0.398 0 O-C-N 121.337 -0.852 . . . . 0.0 111.252 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -59.79 -24.03 63.78 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.39 -72.25 0.21 Allowed 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 168.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -82.25 9.9 7.93 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.298 1.439 . . . . 0.0 113.461 -164.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -54.89 -34.69 63.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.655 1.582 . . . . 0.0 110.91 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -79.28 -59.36 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.741 1.216 . . . . 0.0 110.179 167.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -55.92 -43.13 77.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.501 1.52 . . . . 0.0 113.335 -167.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -110.85 -26.79 9.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.63 1.972 . . . . 0.0 111.592 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.48 84.04 1.6 Allowed Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -147.12 166.36 27.16 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 123.503 0.721 . . . . 0.0 110.108 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.8 m -73.57 124.94 26.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -117.13 146.48 43.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.297 1.439 . . . . 0.0 109.63 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -67.98 -14.66 63.14 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 127.46 32.69 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 120.671 1.578 . . . . 0.0 108.39 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -61.2 162.51 7.39 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 -36.82 1.83 Allowed Glycine 0 CA--C 1.526 0.733 0 O-C-N 121.02 -1.05 . . . . 0.0 112.126 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.007 1.403 . . . . 0.0 110.804 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -67.05 -42.75 84.24 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 111.694 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.05 -42.38 76.49 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -57.06 21.87 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.4 mt -59.1 -20.93 57.97 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.352 1.076 . . . . 0.0 113.548 -174.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -68.67 -42.04 78.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.499 1.045 . . . . 0.0 111.442 170.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.45 -55.24 14.44 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 123.944 0.898 . . . . 0.0 110.535 -173.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 HG13 HD22 ' A' ' 14' ' ' LEU . 16.9 tt -55.33 -27.32 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.052 0.842 . . . . 0.0 112.802 -176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -78.18 -51.91 9.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.315 1.446 . . . . 0.0 111.044 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -73.69 -12.59 60.77 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.111 0.565 . . . . 0.0 112.239 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 t -73.9 82.43 1.68 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.545 1.538 . . . . 0.0 108.644 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -177.5 136.9 3.23 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 107.646 -2.182 . . . . 0.0 107.646 161.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.4 140.2 62.63 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 106.829 -2.027 . . . . 0.0 106.829 152.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.97 126.97 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.053 1.741 . . . . 0.0 108.227 -166.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.1 p -160.2 147.75 16.39 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.945 -0.472 . . . . 0.0 110.217 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.361 0 C-N-CA 125.849 1.69 . . . . 0.0 109.652 177.266 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.949 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -157.15 156.28 32.43 Favored 'General case' 0 C--O 1.238 0.465 0 O-C-N 121.271 -1.135 . . . . 0.0 109.963 174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.42 177.95 4.46 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.27 1.828 . . . . 0.0 108.941 171.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.48 -144.64 8.27 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 159.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 t -140.81 -51.5 0.46 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.963 1.305 . . . . 0.0 109.842 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.7 m 63.36 170.2 0.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.019 1.728 . . . . 0.0 114.195 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.44 -67.1 2.87 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 126.007 1.765 . . . . 0.0 113.552 169.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -142.25 -149.05 0.26 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.882 2.073 . . . . 0.0 107.276 -171.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.65 148.69 49.06 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.922 1.689 . . . . 0.0 107.932 172.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -142.46 173.16 11.78 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.994 1.717 . . . . 0.0 109.383 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.64 15.12 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.621 0.768 . . . . 0.0 111.433 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.15 -22.24 30.37 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 124.561 1.077 . . . . 0.0 112.533 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.35 167.91 20.9 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 122.572 1.177 . . . . 0.0 111.572 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.32 150.78 38.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.424 1.89 . . . . 0.0 107.731 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 29' ' ' ILE . 23.1 m -152.23 177.33 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 124.797 1.239 . . . . 0.0 110.105 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.86 127.03 53.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 159.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.77 137.58 32.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.0 108.758 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE3' ' NE2' ' A' ' 24' ' ' HIS . 15.0 tptp -108.11 105.11 14.71 Favored 'General case' 0 C--N 1.345 0.412 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.7 mtm -76.9 166.66 23.04 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -82.14 58.33 3.94 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.485 0.714 . . . . 0.0 112.098 -176.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 158.81 -46.54 0.44 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.468 1.509 . . . . 0.0 110.907 172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -60.19 159.4 22.13 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.696 1.199 . . . . 0.0 110.286 170.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.97 -176.34 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.498 2.799 . . . . 0.0 110.883 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.415 ' NE2' ' HE3' ' A' ' 18' ' ' LYS . 26.3 m80 -55.19 107.16 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.698 1.599 . . . . 0.0 107.36 163.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.5 t-105 -106.15 128.39 26.43 Favored Pre-proline 0 C--N 1.332 -0.158 0 C-N-CA 124.92 1.288 . . . . 0.0 108.115 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HG3' HD22 ' A' ' 85' ' ' LEU . 37.2 Cg_endo -62.54 129.76 27.62 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.14 1.893 . . . . 0.0 109.422 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.98 167.51 22.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 3.6 ptm180 -123.55 153.43 40.62 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.408 HD11 HG11 ' A' ' 15' ' ' VAL . 17.8 mm -84.47 105.4 13.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 169.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -77.87 -172.88 2.85 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 171.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -126.68 -161.65 1.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 120.951 -1.093 . . . . 0.0 108.986 164.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -138.93 148.17 56.85 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 127.132 2.173 . . . . 0.0 106.785 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -77.16 179.79 6.18 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.945 2.43 . . . . 0.0 109.597 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.75 158.79 33.96 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.896 -1.128 . . . . 0.0 110.094 165.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.15 61.22 5.54 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.586 1.565 . . . . 0.0 112.881 167.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.24 -171.69 3.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.089 1.356 . . . . 0.0 110.723 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.67 144.37 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 155.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -141.3 157.9 65.17 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.743 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.4 154.56 55.87 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.617 2.211 . . . . 0.0 111.063 -172.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.15 173.6 12.7 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.662 1.575 . . . . 0.0 110.677 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.72 150.13 41.96 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 122.341 1.067 . . . . 0.0 108.569 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 m120 62.15 17.4 9.16 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 127.571 2.348 . . . . 0.0 113.007 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.7 mttt -129.92 168.42 16.67 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.657 1.117 . . . . 0.0 111.657 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -131.17 153.46 81.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 127.473 2.309 . . . . 0.0 109.898 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -68.98 104.53 1.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 124.352 3.368 . . . . 0.0 110.045 169.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -97.19 140.28 17.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -123.89 113.29 18.3 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.086 1.755 . . . . 0.0 106.65 177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -85.88 101.22 12.66 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.447 1.099 . . . . 0.0 108.482 -172.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 5.8 m-85 -53.37 152.7 4.49 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.757 1.623 . . . . 0.0 112.192 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.26 -60.25 2.74 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.83 1.205 . . . . 0.0 110.38 -167.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.5 -21.32 59.62 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -168.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 25.0 m170 55.27 11.56 0.58 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.994 1.717 . . . . 0.0 114.092 -169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.48 161.56 30.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.195 0.997 . . . . 0.0 110.044 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.8 p -141.56 138.42 32.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.911 2.084 . . . . 0.0 107.255 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -157.51 154.37 28.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 165.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -87.45 122.75 31.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.42 156.54 36.96 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.83 161.76 21.11 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.99 1.281 . . . . 0.0 111.391 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.65 -34.85 72.89 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.681 2.921 . . . . 0.0 112.119 -166.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.0 mppt? -75.74 -7.41 54.31 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -99.11 -20.79 16.49 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.309 0.958 . . . . 0.0 110.557 169.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.7 mt -84.11 170.23 14.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.523 1.529 . . . . 0.0 109.189 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -139.17 149.4 60.9 Favored Pre-proline 0 C--O 1.236 0.395 0 C-N-CA 123.909 0.884 . . . . 0.0 109.358 171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.31 152.57 75.82 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.813 2.342 . . . . 0.0 112.273 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -71.5 -59.72 2.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.969 -0.457 . . . . 0.0 111.336 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -63.62 -25.82 68.4 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.393 0.542 . . . . 0.0 111.853 -163.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.71 -39.83 69.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.635 1.174 . . . . 0.0 110.879 175.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.41 9.63 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 0.0 112.673 -166.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -54.94 -30.65 59.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.89 1.276 . . . . 0.0 111.248 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -98.79 -34.74 10.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 118.593 -0.718 . . . . 0.0 110.773 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -68.68 -65.97 0.63 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.478 1.035 . . . . 0.0 109.57 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -84.91 -29.56 25.09 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.872 1.269 . . . . 0.0 111.694 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.19 62.53 3.36 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.11 173.48 11.58 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 120.903 -1.351 . . . . 0.0 110.558 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.3 m -66.53 153.15 43.71 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 122.415 1.102 . . . . 0.0 109.483 168.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -135.27 -96.99 0.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 159.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 -20.93 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -172.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 146.46 54.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 120.9 1.682 . . . . 0.0 110.759 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -60.17 156.05 16.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.242 1.417 . . . . 0.0 108.039 158.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.76 -43.82 1.19 Allowed Glycine 0 N--CA 1.467 0.727 0 C-N-CA 125.663 1.602 . . . . 0.0 113.406 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -48.04 -54.01 14.44 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 125.626 1.571 . . . . 0.0 109.792 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -57.97 -34.47 69.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.37 0.668 . . . . 0.0 111.729 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -69.98 -49.29 53.11 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.356 1.062 . . . . 0.0 110.653 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.64 84.98 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 118.683 0.674 . . . . 0.0 112.576 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.569 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -69.52 -35.97 76.0 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.11 -0.948 . . . . 0.0 111.407 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -66.12 -39.07 89.63 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.214 0.915 . . . . 0.0 110.19 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -65.12 -47.96 75.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.848 0.859 . . . . 0.0 110.525 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.9 tt -67.28 -26.81 37.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 118.887 0.767 . . . . 0.0 111.729 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.48 -15.5 61.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 0.0 111.959 172.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -103.96 -71.34 0.74 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.862 1.265 . . . . 0.0 108.067 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.4 t 46.42 55.5 7.39 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 126.157 1.783 . . . . 0.0 109.71 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.13 170.31 40.86 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.133 0.873 . . . . 0.0 111.931 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.65 177.44 8.83 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.675 2.917 . . . . 0.0 110.883 166.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.74 168.96 20.78 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.592 0.757 . . . . 0.0 109.967 167.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 p -153.02 122.87 6.9 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.465 1.506 . . . . 0.0 108.016 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.738 0 C-N-CA 126.271 1.891 . . . . 0.0 108.572 -171.353 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 p -139.57 175.04 9.9 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.383 1.073 . . . . 0.0 109.495 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -149.65 159.29 44.46 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.57 173.93 49.87 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 p -90.66 -51.35 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.487 1.115 . . . . 0.0 109.97 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 m 49.16 66.64 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.573 1.549 . . . . 0.0 109.266 -159.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.77 -122.47 2.09 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.971 1.272 . . . . 0.0 109.933 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -77.53 103.52 7.51 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.638 0.733 . . . . 0.0 110.166 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -48.34 155.86 0.46 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.779 2.032 . . . . 0.0 111.409 166.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -149.44 156.68 42.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.133 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 103.25 0.14 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.931 1.693 . . . . 0.0 110.143 -173.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.06 -24.41 2.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.136 1.827 . . . . 0.0 111.637 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.57 162.28 27.22 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.634 1.217 . . . . 0.0 112.334 -173.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 22.2 mt -117.67 134.87 54.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 106.206 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.2 m -147.92 176.54 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.983 0.913 . . . . 0.0 111.445 -166.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.4 150.96 30.39 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 156.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.47 168.18 14.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.067 2.147 . . . . 0.0 109.01 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -141.36 107.11 5.11 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 65.9 mtp -83.81 160.6 21.17 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 165.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -57.16 112.21 1.3 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.207 1.003 . . . . 0.0 109.275 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.56 -11.59 55.39 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.882 1.229 . . . . 0.0 114.652 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -74.86 158.03 85.04 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 118.347 1.073 . . . . 0.0 109.188 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.79 169.75 16.93 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.581 2.187 . . . . 0.0 108.793 163.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -59.57 103.31 0.19 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -87.22 143.5 34.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.791 1.236 . . . . 0.0 108.035 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HG3' HD22 ' A' ' 85' ' ' LEU . 62.2 Cg_endo -72.69 136.82 26.31 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.967 1.778 . . . . 0.0 110.484 173.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.99 168.3 21.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.333 0.653 . . . . 0.0 109.39 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -132.84 156.64 46.8 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.573 -0.705 . . . . 0.0 109.517 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 mm -89.28 136.22 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.37 169.74 15.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -76.44 160.39 29.57 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 168.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mt -76.37 136.57 68.35 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-O 117.553 -1.213 . . . . 0.0 107.922 163.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.97 158.96 44.6 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.992 1.795 . . . . 0.0 109.865 168.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.0 82.97 1.24 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.894 0.854 . . . . 0.0 110.338 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.84 83.92 0.96 Allowed Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.25 169.08 18.02 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 125.964 1.705 . . . . 0.0 107.946 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.01 127.32 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 170.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.55 125.08 91.79 Favored Pre-proline 0 C--O 1.238 0.453 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.302 -177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . 73.8 Cg_endo -81.8 164.69 18.06 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.894 3.063 . . . . 0.0 112.949 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.67 155.04 65.6 Favored 'Trans proline' 0 N--CA 1.438 -1.792 0 C-N-CA 121.577 1.518 . . . . 0.0 111.986 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.94 69.52 5.12 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 113.807 -1.542 . . . . 0.0 108.282 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -174.92 0.97 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.911 1.284 . . . . 0.0 113.382 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -144.14 171.46 14.26 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.155 1.382 . . . . 0.0 109.388 -167.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -131.37 152.53 80.69 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.355 1.862 . . . . 0.0 107.519 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.1 90.99 1.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.728 2.952 . . . . 0.0 109.131 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.8 mm -83.93 114.54 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -85.13 142.34 29.57 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.55 118.39 36.47 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -65.05 152.69 42.82 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.028 0.918 . . . . 0.0 110.213 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.31 -68.24 2.4 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 125.002 1.286 . . . . 0.0 110.663 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 65.5 p -68.11 -25.02 65.1 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.839 -0.8 . . . . 0.0 111.5 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 m170 58.12 14.59 2.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.665 1.986 . . . . 0.0 112.977 -172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.88 168.57 13.27 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.995 0.902 . . . . 0.0 110.138 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.13 151.43 48.66 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.313 1.445 . . . . 0.0 108.564 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.92 148.48 27.18 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.988 0.915 . . . . 0.0 108.536 163.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 39' ' ' PRO . 50.4 m-85 -87.41 111.77 21.46 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.0 mt -124.89 151.41 45.38 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.001 1.32 . . . . 0.0 108.238 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.58 168.2 31.7 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.347 0.975 . . . . 0.0 110.732 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.49 -40.16 25.23 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.628 2.218 . . . . 0.0 110.46 -177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -8.87 16.55 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.5 -17.13 24.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.272 1.396 . . . . 0.0 111.383 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.69 170.2 8.02 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 127.833 2.453 . . . . 0.0 110.647 -168.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -144.71 142.85 19.56 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 124.002 0.921 . . . . 0.0 109.845 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 129.51 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.573 2.182 . . . . 0.0 110.718 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -53.15 -54.91 28.92 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 121.582 -0.699 . . . . 0.0 111.272 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -66.64 -13.6 61.39 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -167.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.14 -26.0 19.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.99 1.316 . . . . 0.0 111.711 175.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -118.42 12.3 13.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.725 1.61 . . . . 0.0 113.112 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.01 -20.37 16.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 128.456 2.702 . . . . 0.0 113.136 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -117.6 -34.68 4.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 119.322 0.965 . . . . 0.0 110.227 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 tttm -61.57 -37.91 85.58 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 121.631 -0.668 . . . . 0.0 111.072 -177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -115.72 -35.73 4.42 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.97 1.708 . . . . 0.0 109.514 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.33 85.84 0.33 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -151.1 -173.93 4.65 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.885 2.074 . . . . 0.0 107.006 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.08 146.2 28.83 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 122.543 1.163 . . . . 0.0 108.421 177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -147.38 134.92 20.89 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.785 1.634 . . . . 0.0 107.088 170.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -83.26 20.15 1.35 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 mmt-85 -59.35 155.57 14.4 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 121.682 2.037 . . . . 0.0 108.784 162.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.76 161.47 30.83 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 160.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.19 -31.05 0.55 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.422 1.963 . . . . 0.0 115.629 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.408 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 74.3 t80 -56.58 -60.78 3.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.437 1.895 . . . . 0.0 110.587 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -32.87 72.08 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.524 -0.735 . . . . 0.0 112.163 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -56.07 26.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.435 1.494 . . . . 0.0 110.016 169.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.3 77.02 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.672 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.565 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.5 mm? -68.24 -45.1 74.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 118.328 1.064 . . . . 0.0 111.637 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -56.98 -42.02 79.46 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.044 0.838 . . . . 0.0 108.803 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.22 -48.33 80.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 117.926 -1.035 . . . . 0.0 112.45 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.72 -35.9 71.91 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 119.375 0.989 . . . . 0.0 110.757 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -60.04 -49.6 77.01 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -73.33 -8.23 54.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.937 1.295 . . . . 0.0 113.216 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 t -76.31 6.81 5.0 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.451 -1.405 . . . . 0.0 112.93 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.47 177.32 19.72 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.719 1.145 . . . . 0.0 111.191 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -80.0 56.58 6.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.719 3.612 . . . . 0.0 108.991 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 m -77.05 136.76 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.201 1.4 . . . . 0.0 108.686 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.94 3.19 43.08 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.419 1.087 . . . . 0.0 113.081 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.911 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 174.577 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.975 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 p -170.99 109.66 0.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.246 1.818 . . . . 0.0 107.889 170.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.59 48.4 0.55 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.203 1.401 . . . . 0.0 110.39 172.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.89 -112.6 1.09 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.597 2.046 . . . . 0.0 108.472 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m 59.59 92.75 0.04 OUTLIER 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.233 1.813 . . . . 0.0 110.777 -167.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m 59.22 166.57 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.916 2.086 . . . . 0.0 112.274 -172.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.45 107.12 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -171.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.54 140.91 24.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.788 1.235 . . . . 0.0 107.808 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -85.8 133.46 33.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.616 0.722 . . . . 0.0 110.274 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -132.66 177.66 7.45 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.994 . . . . 0.0 110.032 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.13 140.78 24.84 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.679 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.27 -31.96 6.91 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.329 -1.262 . . . . 0.0 111.862 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.81 100.27 4.0 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 119.275 1.537 . . . . 0.0 108.002 -173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.04 149.92 49.5 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 169.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -143.54 169.42 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-O 121.608 0.718 . . . . 0.0 110.039 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -105.7 142.91 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 157.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.65 110.28 13.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.121 1.368 . . . . 0.0 109.792 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -91.55 106.29 18.38 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.052 1.741 . . . . 0.0 107.69 -172.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.18 162.83 19.05 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.364 0.602 . . . . 0.0 109.465 174.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 128.65 36.7 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.04 15.59 63.03 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.298 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -128.51 162.05 53.34 Favored Pre-proline 0 C--O 1.232 0.149 0 CA-C-N 118.897 1.349 . . . . 0.0 109.044 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.25 -179.7 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.519 3.479 . . . . 0.0 110.831 174.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -72.7 88.37 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -71.98 136.72 82.27 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.248 -0.882 . . . . 0.0 109.291 -169.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.35 124.56 13.08 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.059 1.839 . . . . 0.0 108.789 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.86 168.1 20.59 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 122.024 0.916 . . . . 0.0 110.634 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm85 -128.8 148.48 50.88 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 mm -86.08 121.07 36.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 170.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.89 179.11 7.63 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.206 0.527 . . . . 0.0 112.202 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.97 112.07 15.5 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.094 1.757 . . . . 0.0 107.891 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -71.44 137.81 83.71 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 113.822 -1.535 . . . . 0.0 108.081 -174.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.77 163.1 39.98 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.351 2.034 . . . . 0.0 111.844 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -64.9 131.69 47.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.844 0.858 . . . . 0.0 109.224 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.59 61.83 5.04 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.69 174.23 10.83 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.92 1.288 . . . . 0.0 109.316 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 p -52.74 159.19 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.225 1.01 . . . . 0.0 111.102 171.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 pttt -130.44 149.96 74.91 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.206 1.802 . . . . 0.0 108.417 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.42 162.22 43.05 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.586 2.191 . . . . 0.0 112.795 -166.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -75.72 -179.48 5.19 Favored 'Trans proline' 0 N--CA 1.444 -1.423 0 C-N-CA 122.346 2.031 . . . . 0.0 109.445 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -43.74 91.96 0.0 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.694 1.998 . . . . 0.0 115.626 -164.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 33.64 58.19 0.55 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.038 2.535 . . . . 0.0 111.432 -170.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -102.72 173.64 6.24 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.401 1.08 . . . . 0.0 109.216 160.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -132.32 152.58 80.34 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.362 1.065 . . . . 0.0 108.799 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 106.95 1.96 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.907 3.071 . . . . 0.0 110.317 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -98.12 115.04 37.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.741 1.216 . . . . 0.0 107.943 -178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -97.37 119.05 35.19 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 166.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -78.65 117.35 19.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -66.78 156.03 36.59 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.394 0.616 . . . . 0.0 110.218 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.82 -46.48 1.74 Allowed Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.35 1.453 . . . . 0.0 113.584 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p -86.8 -29.48 22.26 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 118.98 1.39 . . . . 0.0 111.501 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.4 m80 69.82 14.23 8.02 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.036 2.134 . . . . 0.0 112.565 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -71.16 159.24 35.04 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.532 -0.73 . . . . 0.0 110.047 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.1 p -129.76 128.8 43.16 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.779 1.232 . . . . 0.0 108.441 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.94 172.49 14.12 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.908 0.883 . . . . 0.0 110.083 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -119.65 112.12 18.91 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 169.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.0 mt -121.81 150.49 41.81 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.53 166.34 31.67 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -65.61 -31.37 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.408 2.739 . . . . 0.0 112.108 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -70.28 -11.31 60.81 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.523 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -93.1 -10.77 34.82 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.078 1.308 . . . . 0.0 110.851 170.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.38 159.83 19.03 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.566 1.546 . . . . 0.0 109.19 -166.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -138.79 145.69 46.99 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.99 126.53 16.69 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.538 2.158 . . . . 0.0 109.932 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -53.86 -62.49 1.62 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.606 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 mtmm -56.37 -40.81 75.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.928 0.786 . . . . 0.0 111.587 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 -34.9 79.54 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 119.141 0.882 . . . . 0.0 112.354 -177.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -102.85 10.66 38.25 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.855 1.662 . . . . 0.0 111.119 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.21 -47.53 84.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.686 1.195 . . . . 0.0 110.179 -171.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.79 -23.52 55.89 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 119.242 0.928 . . . . 0.0 112.006 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -77.52 -44.55 28.33 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.224 -0.923 . . . . 0.0 111.386 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -118.7 -23.46 7.03 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.69 1.996 . . . . 0.0 111.235 -165.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.28 58.2 3.66 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -133.25 135.54 45.02 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.451 1.9 . . . . 0.0 106.568 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.9 97.77 0.03 OUTLIER 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.816 1.647 . . . . 0.0 110.938 -170.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB3' ' CG ' ' A' ' 81' ' ' PHE . 13.3 t-20 -71.87 158.79 35.41 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.11 -0.994 . . . . 0.0 108.986 175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -71.7 -27.63 63.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.111 0.964 . . . . 0.0 113.06 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -64.28 142.78 58.29 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.523 1.056 . . . . 0.0 110.399 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -65.33 164.6 13.27 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.354 0.597 . . . . 0.0 110.122 160.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.83 -41.85 2.21 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.498 1.523 . . . . 0.0 110.223 -173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.407 ' CG ' ' HB3' ' A' ' 76' ' ' ASN . 10.6 t80 -58.48 -46.99 85.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.088 0.955 . . . . 0.0 110.966 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -62.16 -44.8 95.82 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 122.049 -0.407 . . . . 0.0 110.12 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -69.47 -27.74 65.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.009 0.818 . . . . 0.0 111.68 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.4 -23.07 35.23 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.125 -0.984 . . . . 0.0 112.83 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.3 -32.13 71.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.99 1.395 . . . . 0.0 110.563 168.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -66.61 -47.9 71.19 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.557 -0.714 . . . . 0.0 109.892 171.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -61.63 -48.57 80.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 119.104 -0.474 . . . . 0.0 111.388 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.0 tt -63.3 -41.39 92.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.222 0.326 . . . . 0.0 110.238 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.67 -37.12 85.15 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.292 0.637 . . . . 0.0 110.498 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -72.76 -10.66 60.05 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.421 -0.799 . . . . 0.0 112.384 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.27 22.74 1.18 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.783 1.233 . . . . 0.0 113.524 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.59 159.24 24.42 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 120.57 -1.331 . . . . 0.0 110.57 166.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.13 13.83 1.46 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.455 3.437 . . . . 0.0 113.001 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 152.13 45.95 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.688 -1.258 . . . . 0.0 109.111 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.8 m -155.01 -53.57 0.09 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 172.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 N-CA-C 106.659 -2.577 . . . . 0.0 106.659 135.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.831 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 57.19 157.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.858 2.463 . . . . 0.0 112.114 -158.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.2 m 50.48 -154.81 0.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.168 0.587 . . . . 0.0 110.829 -164.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.4 -162.69 28.21 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.45 105.28 4.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 p -160.83 -87.4 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.37 93.72 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.357 -1.897 . . . . 0.0 108.357 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -145.1 177.06 9.05 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.076 1.35 . . . . 0.0 107.865 168.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -138.38 131.35 29.79 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.717 2.007 . . . . 0.0 105.992 170.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -135.89 178.24 7.2 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.076 0.853 . . . . 0.0 111.483 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.93 132.54 32.26 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.903 0.881 . . . . 0.0 111.33 -167.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.6 -17.39 58.65 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 119.096 -0.835 . . . . 0.0 111.775 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.18 161.28 19.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 123.044 1.402 . . . . 0.0 109.312 169.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD22 HG13 ' A' ' 88' ' ' ILE . 96.0 mt -124.74 156.37 37.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.817 1.647 . . . . 0.0 106.682 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.71 171.88 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.916 0.886 . . . . 0.0 108.861 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -105.85 122.24 45.7 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 159.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.06 134.87 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.762 1.225 . . . . 0.0 109.39 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -106.79 108.59 20.17 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.5 mtp -86.39 167.17 14.98 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.1 150.0 22.25 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 163.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.86 -68.29 1.05 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.226 0.917 . . . . 0.0 111.999 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -56.02 156.05 10.96 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 127.301 2.24 . . . . 0.0 112.547 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.33 173.44 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.752 2.968 . . . . 0.0 109.88 163.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -62.9 108.04 1.11 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -91.17 140.26 25.77 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 123.934 0.894 . . . . 0.0 108.792 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.01 126.62 16.83 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.216 1.944 . . . . 0.0 110.482 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.22 157.16 46.03 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.262 0.553 . . . . 0.0 111.113 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -103.8 152.42 21.9 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.5 mm -86.14 99.95 8.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -74.18 -177.32 2.92 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.955 0.407 . . . . 0.0 109.966 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -114.71 -171.08 1.86 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 107.712 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.6 mt -140.63 116.82 7.68 Favored Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 153.63 72.56 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 121.3 1.333 . . . . 0.0 109.808 169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.97 21.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.869 3.268 . . . . 0.0 113.852 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.4 47.5 0.2 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 125.21 1.386 . . . . 0.0 110.255 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.24 -173.88 2.97 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.239 1.816 . . . . 0.0 109.335 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.6 150.69 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 124.383 1.073 . . . . 0.0 109.789 173.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -118.72 139.33 26.97 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 124.823 1.249 . . . . 0.0 108.833 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.85 160.22 14.0 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.781 2.321 . . . . 0.0 110.656 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.16 170.32 19.35 Favored 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 121.182 1.255 . . . . 0.0 111.149 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.45 141.35 58.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 122.069 0.938 . . . . 0.0 108.796 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 47.18 50.12 14.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.501 -2.136 . . . . 0.0 109.896 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.5 mttt -140.27 145.65 37.59 Favored 'General case' 0 C--N 1.341 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -114.46 153.61 46.6 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.332 1.853 . . . . 0.0 110.176 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.45 91.63 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 124.399 3.399 . . . . 0.0 111.107 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.24 121.5 43.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -113.21 116.54 29.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -87.55 97.22 10.73 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.104 1.762 . . . . 0.0 108.52 -169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 10.7 m-85 -52.21 150.55 4.48 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.495 1.118 . . . . 0.0 112.085 -175.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.8 -53.11 4.29 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.638 1.59 . . . . 0.0 111.976 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.58 -31.51 68.55 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.92 0.888 . . . . 0.0 110.849 167.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.1 m80 53.52 25.98 5.23 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.61 1.964 . . . . 0.0 112.043 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.31 165.73 23.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.975 2.11 . . . . 0.0 109.475 171.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.2 p -127.76 151.61 48.79 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.073 1.349 . . . . 0.0 107.849 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -161.19 155.74 23.26 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 154.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -86.51 123.95 32.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 90.5 mt -127.71 149.94 50.0 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.191 1.396 . . . . 0.0 108.341 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.21 165.08 27.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.37 -24.12 43.56 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.867 2.378 . . . . 0.0 112.118 -169.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -54.14 -15.22 1.38 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.502 1.521 . . . . 0.0 114.151 168.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -118.1 7.39 12.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.515 1.526 . . . . 0.0 110.712 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.5 mt -115.28 168.67 9.75 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.673 1.589 . . . . 0.0 109.388 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -144.53 146.14 31.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 127.214 2.206 . . . . 0.0 107.124 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.69 152.71 67.3 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.652 2.235 . . . . 0.0 111.74 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -73.0 -62.69 1.37 Allowed 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.193 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -46.99 -46.4 21.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.861 1.21 . . . . 0.0 111.308 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -18.12 65.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -172.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -130.31 13.6 5.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.502 1.121 . . . . 0.0 111.39 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -55.33 -36.85 66.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.799 1.639 . . . . 0.0 112.225 -175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -104.83 -15.96 15.04 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.667 0.787 . . . . 0.0 109.723 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -85.66 -57.36 3.08 Favored 'General case' 0 N--CA 1.462 0.146 0 O-C-N 120.918 -1.114 . . . . 0.0 110.079 -173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -89.6 -36.14 15.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 109.726 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.89 71.11 0.57 Allowed Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.782 1.658 . . . . 0.0 111.681 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.8 150.09 48.14 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 126.069 1.748 . . . . 0.0 107.465 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.0 p -59.58 105.35 0.35 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.971 0.508 . . . . 0.0 110.015 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -93.82 152.57 18.81 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 167.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -89.89 54.5 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 0.0 109.355 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -115.54 123.61 48.93 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -67.97 103.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 130.42 -25.96 4.2 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.551 1.548 . . . . 0.0 111.269 -173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -65.02 -51.79 59.66 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.404 1.102 . . . . 0.0 111.146 -170.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -73.27 -23.04 60.26 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.768 -0.158 . . . . 0.0 111.409 -174.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -65.04 -48.13 74.92 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 124.34 1.056 . . . . 0.0 108.888 170.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.92 -31.22 78.92 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.094 -0.837 . . . . 0.0 112.309 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' HA ' HG22 ' A' ' 88' ' ' ILE . 17.2 mt -63.35 -46.7 85.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.376 171.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 70.2 t90 -57.16 -41.26 78.87 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 120.594 1.543 . . . . 0.0 111.043 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.09 -51.11 65.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.774 0.715 . . . . 0.0 111.511 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 85' ' ' LEU . 13.5 tt -70.35 -38.89 75.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.432 0.693 . . . . 0.0 110.382 -172.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -64.56 -27.63 69.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.835 0.854 . . . . 0.0 110.032 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -93.47 -8.96 40.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.721 1.609 . . . . 0.0 113.019 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 m -78.38 71.65 4.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.657 1.183 . . . . 0.0 109.609 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.21 151.54 23.52 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.98 25.84 0.45 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 115.098 -161.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.2 t -77.67 155.46 31.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 120.213 1.369 . . . . 0.0 107.841 157.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -62.61 -43.55 98.54 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.128 -0.982 . . . . 0.0 110.328 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.266 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 -171.253 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.667 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 62.5 164.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.577 1.951 . . . . 0.0 110.6 -164.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -169.06 -53.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.984 2.113 . . . . 0.0 108.263 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.64 -98.07 0.14 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 m 56.78 52.01 10.1 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.989 0.899 . . . . 0.0 109.568 -168.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -72.82 123.0 22.49 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.11 94.42 1.88 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 -161.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 74.14 88.07 0.09 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.936 2.494 . . . . 0.0 112.576 167.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -53.76 166.57 0.32 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.375 1.87 . . . . 0.0 111.47 167.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -147.74 168.16 22.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.004 0.922 . . . . 0.0 108.867 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.27 135.81 57.77 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 123.288 0.367 . . . . 0.0 111.034 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.5 35.58 5.4 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 117.878 -1.512 . . . . 0.0 112.233 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.18 172.8 12.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.238 1.519 . . . . 0.0 111.151 172.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 53.8 mt -117.43 142.27 47.34 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.257 1.423 . . . . 0.0 108.414 -173.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG11 HD11 ' A' ' 29' ' ' ILE . 22.9 m -154.46 171.08 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.029 0.931 . . . . 0.0 111.95 -165.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.07 117.41 30.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.244 1.018 . . . . 0.0 111.652 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.07 163.96 13.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.607 1.163 . . . . 0.0 110.469 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -147.67 106.97 3.88 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.261 -0.899 . . . . 0.0 110.452 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 64.5 mtm -83.76 168.05 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.915 0.864 . . . . 0.0 110.026 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -81.15 83.61 6.75 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.967 1.307 . . . . 0.0 109.155 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.42 -56.74 0.67 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -61.66 159.22 35.39 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 125.445 1.498 . . . . 0.0 113.222 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.07 176.0 10.28 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 125.284 3.989 . . . . 0.0 111.153 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -64.02 97.04 0.16 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.982 1.313 . . . . 0.0 108.166 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -89.6 134.9 31.51 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.181 -165.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -62.74 121.01 8.76 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.579 2.186 . . . . 0.0 109.658 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.5 19.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.736 0.814 . . . . 0.0 110.236 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -124.58 148.27 47.95 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 HD11 HG11 ' A' ' 15' ' ' VAL . 9.1 mm -78.59 99.96 3.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 104.278 -2.489 . . . . 0.0 104.278 163.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -65.77 173.34 2.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.095 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -124.79 161.04 27.32 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 125.153 1.381 . . . . 0.0 108.972 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.98 101.52 12.61 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 -156.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -46.4 139.36 12.83 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.964 3.776 . . . . 0.0 111.45 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.59 110.38 1.69 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.49 -9.56 22.06 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.596 1.57 . . . . 0.0 112.2 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.06 170.6 15.69 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 119.173 1.486 . . . . 0.0 111.349 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -53.24 146.32 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 113.953 -1.476 . . . . 0.0 108.355 157.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.59 158.61 56.0 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 118.415 0.552 . . . . 0.0 110.557 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.58 161.33 28.51 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 123.179 2.586 . . . . 0.0 112.214 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.13 168.32 25.06 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 121.835 1.69 . . . . 0.0 111.294 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.24 127.04 27.43 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.04 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 83.55 1.19 1.03 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.892 2.477 . . . . 0.0 112.239 171.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -112.89 160.29 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.014 1.279 . . . . 0.0 111.384 -172.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -115.26 149.85 43.42 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 126.713 2.005 . . . . 0.0 108.161 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 124.009 3.139 . . . . 0.0 108.919 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.0 mm -102.61 112.89 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -99.3 124.05 44.08 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -90.3 98.02 11.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.387 1.475 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -50.43 148.38 3.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.033 0.933 . . . . 0.0 110.89 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.47 -15.2 1.6 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.963 1.268 . . . . 0.0 115.862 -178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.9 p -115.68 -17.27 11.14 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.26 1.53 . . . . 0.0 111.596 168.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.37 16.17 7.2 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.808 2.043 . . . . 0.0 112.749 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -83.55 165.65 18.9 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.428 -0.795 . . . . 0.0 110.219 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.2 p -127.5 150.61 49.6 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.176 0.99 . . . . 0.0 110.648 177.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.26 165.3 29.64 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.155 1.382 . . . . 0.0 109.369 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -111.53 107.38 16.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 45.7 mt -123.54 143.69 50.03 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.16 162.55 28.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 172.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.48 -20.5 47.78 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 124.602 3.535 . . . . 0.0 113.676 -160.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -52.86 -32.2 43.5 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.82 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -94.96 9.23 40.17 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 111.506 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 mt -135.28 157.38 47.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.568 1.147 . . . . 0.0 111.144 -161.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -141.64 155.81 66.57 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.016 1.326 . . . . 0.0 110.726 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -68.89 134.11 28.97 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.126 2.55 . . . . 0.0 112.273 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -65.1 -48.1 74.86 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.864 173.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -62.19 -27.54 69.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.853 1.206 . . . . 0.0 112.361 -171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -77.47 -51.08 11.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.544 0.738 . . . . 0.0 111.023 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -97.23 8.85 43.71 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.014 -1.054 . . . . 0.0 113.816 -168.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -53.3 -49.45 66.97 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.646 1.178 . . . . 0.0 108.684 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.59 -53.09 38.17 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.39 0.431 . . . . 0.0 110.743 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 ttmm -64.64 -33.87 76.96 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.655 1.182 . . . . 0.0 113.713 -169.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -118.36 -29.21 5.56 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.981 1.713 . . . . 0.0 112.518 -170.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.58 70.86 3.07 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 153.81 51.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.615 1.566 . . . . 0.0 109.317 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.0 p -74.93 99.9 3.96 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -161.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -80.92 168.61 18.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.937 -1.102 . . . . 0.0 111.404 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -89.04 -5.33 57.96 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -73.15 141.96 47.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.277 1.853 . . . . 0.0 109.023 173.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.464 ' N ' ' HE3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -66.29 164.29 16.26 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 162.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.17 -40.95 1.27 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.355 0.979 . . . . 0.0 111.564 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -61.02 -37.94 84.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.185 1.493 . . . . 0.0 111.154 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -48.76 78.32 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.433 0.693 . . . . 0.0 110.167 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -66.95 -38.42 86.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.856 1.662 . . . . 0.0 110.438 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -72.45 -32.9 61.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.56 1.076 . . . . 0.0 111.944 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.0 mt -66.47 -36.02 81.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.612 1.206 . . . . 0.0 111.16 172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 63.4 t90 -66.31 -44.06 84.48 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.629 0.649 . . . . 0.0 109.557 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -60.96 -55.38 33.57 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 124.102 0.961 . . . . 0.0 111.248 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.3 tt -62.07 -28.36 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 119.079 0.854 . . . . 0.0 111.187 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -64.92 -60.05 3.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 121.423 -0.798 . . . . 0.0 109.013 170.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -81.69 43.17 0.74 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.399 1.48 . . . . 0.0 112.04 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.5 t -128.28 -19.3 3.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.649 1.98 . . . . 0.0 109.62 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.01 -161.88 11.52 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.882 1.706 . . . . 0.0 109.393 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.29 137.2 36.23 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.436 2.09 . . . . 0.0 109.59 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t -152.53 159.07 43.32 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.223 0.535 . . . . 0.0 109.91 165.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.4 m -146.0 -21.26 0.45 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.077 1.751 . . . . 0.0 112.87 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.259 179.768 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.453 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.33 107.15 1.19 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.616 1.166 . . . . 0.0 108.192 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m -151.41 173.66 14.28 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.042 1.737 . . . . 0.0 108.427 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.88 163.68 14.53 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 p -68.14 174.09 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.023 -0.692 . . . . 0.0 110.772 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.2 m -140.55 136.79 33.21 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 160.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.31 40.03 0.24 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 126.334 1.921 . . . . 0.0 109.221 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -134.32 -174.4 3.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.426 2.29 . . . . 0.0 107.581 -175.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -131.54 155.82 46.79 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.924 1.289 . . . . 0.0 109.28 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -137.25 176.14 8.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.672 1.589 . . . . 0.0 110.684 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.71 135.2 41.5 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 171.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.42 -28.39 15.8 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.609 1.576 . . . . 0.0 112.31 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -75.74 123.86 26.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.479 1.14 . . . . 0.0 109.325 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.97 145.03 28.76 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -142.29 168.57 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.587 0.708 . . . . 0.0 112.699 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -112.85 121.79 45.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.643 1.177 . . . . 0.0 108.189 161.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.34 121.82 35.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.72 1.208 . . . . 0.0 109.147 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -91.49 107.24 19.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 2.0 mtm -74.01 169.42 17.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.376 0.534 . . . . 0.0 110.433 171.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -61.69 127.51 31.78 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 163.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.81 -60.48 3.38 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.657 1.122 . . . . 0.0 113.343 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -51.43 155.85 2.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.786 1.635 . . . . 0.0 111.488 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.45 -175.55 2.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 124.454 3.436 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -62.53 89.75 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.89 2.476 . . . . 0.0 108.251 171.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -86.45 135.33 36.53 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HG3' HD22 ' A' ' 85' ' ' LEU . 31.8 Cg_endo -67.47 130.8 23.1 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.298 1.332 . . . . 0.0 108.669 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.65 151.66 37.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.496 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 12.7 ptm180 -103.06 160.63 14.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.437 1.017 . . . . 0.0 109.162 175.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.4 mm -78.6 124.89 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 104.127 -2.545 . . . . 0.0 104.127 151.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.91 -156.42 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -132.86 149.31 52.27 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 119.501 -2.0 . . . . 0.0 109.189 147.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.94 136.57 66.34 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.52 151.19 80.14 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.652 1.568 . . . . 0.0 110.062 177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -71.77 92.75 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.89 31.57 0.39 Allowed Glycine 0 CA--C 1.523 0.59 0 CA-C-O 118.037 -1.424 . . . . 0.0 112.357 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.06 161.84 36.64 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.76 1.78 . . . . 0.0 110.239 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -70.7 111.99 5.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.856 0.836 . . . . 0.0 109.41 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -57.23 158.4 10.17 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 126.347 1.859 . . . . 0.0 111.021 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.17 164.84 23.86 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.618 2.212 . . . . 0.0 111.243 169.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.19 179.52 2.83 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.117 1.211 . . . . 0.0 110.722 167.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.69 134.79 57.43 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.358 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 60.12 42.29 15.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 127.745 2.418 . . . . 0.0 111.421 170.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -138.35 134.18 33.9 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.41 2.284 . . . . 0.0 110.046 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -102.27 147.45 33.98 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.809 2.444 . . . . 0.0 111.241 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.03 100.38 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.053 2.502 . . . . 0.0 111.464 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.5 mm -83.07 155.5 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -142.08 106.78 4.86 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.22 1.808 . . . . 0.0 107.286 173.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -73.93 98.7 3.08 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.83 1.252 . . . . 0.0 109.107 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 1.3 m-85 -49.27 139.04 11.85 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 127.222 2.209 . . . . 0.0 111.999 -172.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.98 -37.55 1.5 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.638 1.589 . . . . 0.0 113.552 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.4 -28.14 52.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.418 1.109 . . . . 0.0 111.753 171.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.9 m80 48.98 60.02 4.03 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 110.081 -171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.0 147.84 32.77 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 108.215 163.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.9 p -121.41 142.99 49.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.421 1.089 . . . . 0.0 109.027 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.05 169.76 21.02 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.596 1.559 . . . . 0.0 108.082 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -105.65 107.44 18.43 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 72.4 mt -106.58 133.79 50.71 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.077 1.751 . . . . 0.0 110.586 173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.28 167.73 54.12 Favored Glycine 0 CA--C 1.54 1.634 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.02 -32.07 94.47 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.465 2.776 . . . . 0.0 114.421 -175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.32 -15.79 18.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.39 0.995 . . . . 0.0 113.4 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -103.03 4.0 36.77 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 120.024 1.284 . . . . 0.0 111.225 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.1 mt -135.27 134.78 40.3 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.684 1.594 . . . . 0.0 109.767 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -122.05 145.48 43.94 Favored Pre-proline 0 C--O 1.236 0.379 0 C-N-CA 123.649 0.78 . . . . 0.0 110.851 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.8 116.1 3.78 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 124.104 3.202 . . . . 0.0 109.615 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -49.14 -52.23 27.43 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.472 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -55.99 -35.96 67.35 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.516 -0.754 . . . . 0.0 112.114 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -41.79 66.84 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.839 1.199 . . . . 0.0 111.208 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.71 16.16 24.43 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.741 1.216 . . . . 0.0 110.756 -174.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -61.51 -40.58 95.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 119.332 0.969 . . . . 0.0 110.471 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -74.53 -49.95 19.98 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.059 -1.026 . . . . 0.0 108.999 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -60.05 -33.82 72.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.245 1.418 . . . . 0.0 113.604 -169.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -125.66 -18.58 5.17 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.277 1.831 . . . . 0.0 112.649 -173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.97 30.62 1.8 Allowed Glycine 0 N--CA 1.474 1.194 0 CA-C-N 121.32 1.873 . . . . 0.0 113.472 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -115.47 158.65 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.201 2.2 . . . . 0.0 109.062 -167.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.9 m -75.44 164.08 26.75 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.345 1.545 . . . . 0.0 112.302 -163.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -153.85 155.68 36.21 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 128.715 2.806 . . . . 0.0 107.778 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.46 2.27 33.54 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.582 1.153 . . . . 0.0 113.52 -171.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.66 133.78 55.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.895 1.278 . . . . 0.0 108.785 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -62.09 162.27 9.67 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 161.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.38 -46.32 2.76 Favored Glycine 0 N--CA 1.461 0.335 0 O-C-N 120.969 -1.082 . . . . 0.0 111.052 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -54.89 -54.84 37.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.729 0.812 . . . . 0.0 111.202 -172.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.02 -39.72 66.39 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.269 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.33 -43.52 98.63 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.641 0.777 . . . . 0.0 110.303 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.97 -32.94 82.33 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.648 -0.658 . . . . 0.0 112.386 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.513 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -76.19 -24.59 54.73 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.007 0.904 . . . . 0.0 112.08 176.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 74.4 t90 -68.64 -52.62 29.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 165.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 49' ' ' PHE . 2.4 mm-40 -56.59 -54.56 44.51 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.322 0.649 . . . . 0.0 111.187 -174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.2 tt -58.56 -36.37 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 118.37 0.532 . . . . 0.0 111.759 -172.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.22 -48.53 64.89 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.327 1.051 . . . . 0.0 110.448 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.72 -0.09 45.95 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.213 1.405 . . . . 0.0 112.66 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.3 t -62.16 -58.25 8.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.29 1.836 . . . . 0.0 110.346 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.06 68.38 0.45 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.4 113.32 3.28 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.745 2.297 . . . . 0.0 108.433 -168.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 t 67.9 -41.53 0.44 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.443 2.697 . . . . 0.0 112.698 -167.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.43 18.57 0.7 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.924 1.69 . . . . 0.0 112.713 -173.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 O-C-N 120.666 -1.271 . . . . 0.0 110.253 -178.586 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t -158.34 171.13 20.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.829 1.252 . . . . 0.0 108.116 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -141.01 174.59 10.37 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.382 1.873 . . . . 0.0 109.302 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.59 -116.1 4.17 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.3 m -122.67 74.13 1.17 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.9 t -63.09 152.9 35.84 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.21 -102.86 0.18 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 -173.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 68.25 165.65 0.24 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 127.76 2.424 . . . . 0.0 109.721 -165.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -119.02 158.76 25.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.492 1.517 . . . . 0.0 108.593 172.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -147.33 169.82 18.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.978 0.808 . . . . 0.0 111.284 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.69 124.87 14.93 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.81 0.844 . . . . 0.0 109.816 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.16 -9.16 61.2 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.777 -1.013 . . . . 0.0 112.836 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -73.78 159.6 32.69 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 119.285 1.543 . . . . 0.0 108.88 163.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.7 mt -117.2 150.14 39.23 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.74 173.85 3.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.856 0.836 . . . . 0.0 111.296 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -109.29 133.71 52.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 157.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HA ' HD23 ' A' ' 62' ' ' LEU . . . -109.69 125.86 53.09 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.228 1.411 . . . . 0.0 108.449 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -105.18 105.89 16.14 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 18.0 mtm -77.58 170.21 16.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.122 0.963 . . . . 0.0 109.398 164.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -64.91 130.85 44.96 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 174.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.77 -48.24 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.853 0.739 . . . . 0.0 113.257 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -54.31 152.07 12.31 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 169.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.73 175.26 9.15 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.719 2.946 . . . . 0.0 109.713 171.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -63.07 97.61 0.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -79.27 140.26 56.57 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.817 1.647 . . . . 0.0 109.22 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.19 128.93 21.58 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.771 1.647 . . . . 0.0 109.069 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.84 165.64 27.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.112 0.958 . . . . 0.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -116.4 147.67 41.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.76 108.82 14.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 161.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.61 -174.54 4.34 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.672 0.749 . . . . 0.0 110.129 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -115.58 178.1 4.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.858 1.263 . . . . 0.0 109.627 169.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -135.55 112.17 10.77 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.27 152.6 79.01 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.066 2.511 . . . . 0.0 111.194 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.1 91.72 0.71 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 168.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.76 -20.67 1.01 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 125.944 1.735 . . . . 0.0 111.121 -169.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.17 178.67 7.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.526 1.163 . . . . 0.0 111.895 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.595 HG22 ' H ' ' A' ' 38' ' ' LYS . 9.6 p -68.27 -173.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 126.523 1.929 . . . . 0.0 110.019 160.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' H ' HG22 ' A' ' 37' ' ' VAL . 6.5 pttt -131.84 146.78 63.26 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 126.67 1.988 . . . . 0.0 109.246 177.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.27 164.38 32.97 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.242 1.961 . . . . 0.0 110.126 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.67 155.95 58.12 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 167.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.51 146.05 49.89 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.608 1.194 . . . . 0.0 110.913 -172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 55.48 32.19 18.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.235 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 62.5 mttt -131.37 147.48 52.57 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 124.437 1.095 . . . . 0.0 108.368 167.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -110.79 153.06 43.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 124.609 1.163 . . . . 0.0 110.146 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.18 94.57 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.441 2.761 . . . . 0.0 108.808 167.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.3 mm -85.07 141.18 14.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 52' ' ' HIS . 56.0 t80 -125.95 122.46 36.03 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -87.15 99.8 12.19 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.05 1.34 . . . . 0.0 108.743 -174.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 7.1 m-85 -53.14 144.88 14.58 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.506 1.122 . . . . 0.0 111.163 -176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.92 -33.15 0.9 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.248 1.404 . . . . 0.0 114.342 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 p -95.63 -11.96 26.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.295 1.548 . . . . 0.0 112.723 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.435 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.9 m170 56.4 26.23 10.49 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.648 1.979 . . . . 0.0 113.542 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -92.01 161.7 14.68 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.726 0.81 . . . . 0.0 109.874 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -127.68 142.92 51.21 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.652 1.181 . . . . 0.0 109.449 176.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.52 174.11 13.8 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 110.16 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -115.88 107.5 15.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.7 mt -117.93 150.5 39.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 43' ' ' LYS . . . -92.33 164.96 28.57 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.44 -28.03 86.49 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.129 2.553 . . . . 0.0 111.878 -173.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -61.28 -10.72 7.49 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.61 10.35 9.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 110.645 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 17' ' ' ALA . 78.2 mt -129.4 153.82 47.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 109.346 -172.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -132.61 148.16 68.45 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.664 0.785 . . . . 0.0 111.356 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.53 125.23 13.03 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 124.326 3.351 . . . . 0.0 111.049 -175.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -56.6 -58.04 9.78 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.076 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -55.44 -27.94 51.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 117.748 -1.12 . . . . 0.0 112.36 -173.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.36 -60.44 2.27 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.091 0.86 . . . . 0.0 109.039 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.55 13.13 14.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.928 1.691 . . . . 0.0 112.947 -170.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -57.0 -24.21 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.15 1.78 . . . . 0.0 112.162 -172.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.13 -35.51 5.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.522 1.129 . . . . 0.0 108.472 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.46 81.9 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.818 -1.176 . . . . 0.0 113.035 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -106.7 -27.17 10.97 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.837 1.655 . . . . 0.0 109.273 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.94 73.78 2.58 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 133.77 16.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.516 1.126 . . . . 0.0 109.042 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.2 p -65.15 137.0 57.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.706 1.603 . . . . 0.0 107.677 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -142.12 -6.01 0.97 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -154.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.7 tttt 121.64 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 131.402 3.881 . . . . 0.0 111.495 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 133.49 53.16 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.938 0.79 . . . . 0.0 110.076 -176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -60.25 167.43 2.44 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 125.182 1.551 . . . . 0.0 109.831 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.75 -54.61 0.73 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 125.897 1.713 . . . . 0.0 111.685 -172.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -46.51 -43.73 17.13 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 126.678 1.991 . . . . 0.0 113.398 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -68.45 -47.6 66.74 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.488 0.715 . . . . 0.0 111.928 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -52.96 -38.93 62.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.994 1.317 . . . . 0.0 109.958 169.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.17 -28.61 65.97 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 119.239 -0.756 . . . . 0.0 113.542 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.58 -47.32 70.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.903 1.352 . . . . 0.0 109.659 173.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 59.5 t90 -53.79 -45.46 70.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.59 0.556 . . . . 0.0 109.545 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.06 -52.18 60.58 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.378 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.4 tt -65.86 -30.28 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 119.484 1.038 . . . . 0.0 111.249 -173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.91 -31.71 68.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.546 0.612 . . . . 0.0 111.881 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -98.09 4.06 49.18 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.633 0.773 . . . . 0.0 112.582 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.4 m -68.92 74.6 0.29 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.352 1.861 . . . . 0.0 110.707 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.03 163.38 34.88 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.715 2.102 . . . . 0.0 112.92 175.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 95' ' ' SER . 65.8 Cg_endo -81.81 77.86 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.727 1 C-N-CA 125.483 4.122 . . . . 0.0 110.793 -173.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.81 -25.83 0.1 Allowed 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.826 2.05 . . . . 0.0 113.748 -171.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 93' ' ' PRO . 50.3 m 45.79 29.06 0.64 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 128.187 2.595 . . . . 0.0 114.119 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.764 0 CA-C-O 116.598 -2.223 . . . . 0.0 110.812 179.798 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t 63.87 -175.55 0.16 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.79 0.836 . . . . 0.0 109.485 -156.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.59 -174.04 0.08 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.858 0.863 . . . . 0.0 109.799 -154.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.21 -171.39 36.18 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.347 -0.845 . . . . 0.0 112.499 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.5 p -69.9 157.56 37.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.411 1.084 . . . . 0.0 111.334 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.5 m -65.18 -34.61 78.8 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.539 -0.726 . . . . 0.0 111.939 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.46 -173.86 54.88 Favored Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 107.866 -2.093 . . . . 0.0 107.866 -156.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.65 112.46 0.92 Allowed 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 126.392 1.877 . . . . 0.0 109.055 167.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -52.55 154.49 2.58 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.642 1.977 . . . . 0.0 111.18 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -160.33 162.77 33.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.632 1.173 . . . . 0.0 109.194 -173.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.02 112.72 0.91 Allowed 'General case' 0 C--O 1.236 0.348 0 O-C-N 124.157 0.911 . . . . 0.0 109.167 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.61 -33.89 2.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.88 -1.511 . . . . 0.0 111.008 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.2 134.66 45.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 119.819 1.809 . . . . 0.0 108.616 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.7 mt -86.86 147.94 25.59 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 162.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.5 m -147.92 167.78 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -108.4 148.34 30.28 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 156.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -126.98 127.8 45.38 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.278 1.831 . . . . 0.0 108.327 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -96.17 104.94 16.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.9 mtm -76.26 159.57 30.48 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 161.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -67.36 142.69 56.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.72 -41.31 0.83 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.717 1.627 . . . . 0.0 113.343 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -68.72 161.79 68.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 126.898 2.079 . . . . 0.0 112.266 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.6 179.97 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 124.106 3.204 . . . . 0.0 109.835 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -67.09 98.42 0.58 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -81.7 139.04 47.04 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.407 1.083 . . . . 0.0 108.289 -177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.536 ' HG3' HD22 ' A' ' 85' ' ' LEU . 34.4 Cg_endo -66.04 140.74 61.24 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 121.266 1.311 . . . . 0.0 110.222 174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.56 168.37 22.15 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.11 0.964 . . . . 0.0 109.493 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.29 139.7 53.1 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.0 mm -71.0 115.3 10.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 162.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.31 176.43 8.73 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.712 0.767 . . . . 0.0 109.644 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.04 -169.71 1.67 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.71 1.204 . . . . 0.0 107.941 157.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD11 ' HD3' ' A' ' 39' ' ' PRO . 4.2 mt -127.41 122.46 22.84 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.53 158.27 46.56 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.85 1.7 . . . . 0.0 109.633 170.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.0 76.73 5.49 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.148 0.499 . . . . 0.0 111.264 -167.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.92 -20.03 0.36 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.384 -1.231 . . . . 0.0 111.32 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.84 169.53 12.9 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 119.223 1.511 . . . . 0.0 112.841 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 37' ' ' VAL . 1.9 p -75.26 107.88 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.447 2.299 . . . . 0.0 110.571 -176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -60.29 141.19 91.17 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.421 -0.799 . . . . 0.0 112.217 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HD3' HD11 ' A' ' 32' ' ' LEU . 72.1 Cg_endo -71.41 158.8 53.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.203 3.269 . . . . 0.0 112.384 -174.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.19 173.51 14.38 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.621 2.214 . . . . 0.0 111.586 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.78 132.27 52.82 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.939 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 40.41 50.14 2.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.501 2.721 . . . . 0.0 110.166 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -129.79 157.57 41.82 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 160.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.98 153.54 47.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 126.004 1.722 . . . . 0.0 107.182 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.16 104.47 0.73 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.773 2.315 . . . . 0.0 109.641 167.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.8 mm -103.49 111.66 34.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -90.14 124.29 34.7 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.875 1.27 . . . . 0.0 108.275 171.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -90.7 101.88 14.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.143 0.977 . . . . 0.0 109.283 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -52.92 145.2 13.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.593 1.157 . . . . 0.0 111.904 -176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.17 -46.31 2.43 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.363 1.458 . . . . 0.0 111.883 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.3 p -80.89 -22.32 39.88 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.149 -1.207 . . . . 0.0 112.321 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 m170 55.27 20.35 3.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.908 2.483 . . . . 0.0 113.822 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -78.43 166.65 22.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 p -125.42 152.64 44.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 164.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.35 161.03 39.08 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 154.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -88.06 123.3 32.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 166.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.3 mt -130.17 152.6 49.43 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.046 0.938 . . . . 0.0 108.525 174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.41 169.19 18.24 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.022 0.82 . . . . 0.0 111.682 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -66.81 5.71 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.371 1 C-N-CA 125.503 4.135 . . . . 0.0 115.838 -166.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -102.14 -6.67 22.98 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -110.03 7.57 23.68 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.91 -1.119 . . . . 0.0 111.013 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.6 mt -140.59 134.95 31.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.69 1.596 . . . . 0.0 108.717 -157.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -126.64 160.5 58.18 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.63 1.172 . . . . 0.0 109.649 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.14 131.67 27.57 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.742 2.295 . . . . 0.0 110.454 170.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -59.96 -57.63 12.01 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.994 1.27 . . . . 0.0 110.803 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -49.11 -40.61 32.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.171 0.988 . . . . 0.0 112.402 -170.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -66.41 -40.95 89.88 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.806 1.643 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -104.86 6.36 33.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.495 1.518 . . . . 0.0 112.603 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -61.41 -17.18 53.01 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.277 1.831 . . . . 0.0 111.51 -169.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -115.19 -33.84 5.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.366 1.466 . . . . 0.0 111.856 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -64.1 -55.99 18.08 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.207 1.003 . . . . 0.0 109.937 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.2 m-30 -92.66 -39.51 11.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.909 1.284 . . . . 0.0 110.146 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.6 77.94 0.75 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -122.97 179.0 4.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.611 1.564 . . . . 0.0 107.548 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 p -80.82 150.21 29.26 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.404 ' HB2' ' CE2' ' A' ' 81' ' ' PHE . 1.2 m-20 -153.03 144.04 22.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.074 172.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -81.68 68.49 8.06 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.846 0.858 . . . . 0.0 109.492 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.0 mmt-85 -128.26 119.25 24.78 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.807 2.043 . . . . 0.0 106.333 169.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -72.87 116.54 13.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -171.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.48 -27.12 14.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 123.991 0.805 . . . . 0.0 111.783 -171.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 76' ' ' ASN . 82.8 t80 -62.07 -60.59 3.38 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.949 1.375 . . . . 0.0 108.48 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -56.98 -21.81 33.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.98 -39.53 42.09 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.464 0.706 . . . . 0.0 109.552 173.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.01 -38.81 97.22 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.382 -0.824 . . . . 0.0 111.945 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.536 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.1 mm? -68.74 -14.46 63.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.08 0.94 . . . . 0.0 112.613 173.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -79.76 -48.56 13.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.189 0.904 . . . . 0.0 108.742 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.31 -52.49 65.44 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.703 0.683 . . . . 0.0 110.446 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.64 -43.69 84.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 118.598 0.635 . . . . 0.0 111.622 -170.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.07 -46.63 89.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.356 1.062 . . . . 0.0 109.661 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -85.29 -6.81 59.23 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.337 1.055 . . . . 0.0 112.931 -173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.8 t -60.32 -29.93 69.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.538 1.935 . . . . 0.0 111.886 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -150.9 172.97 30.52 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.96 1.743 . . . . 0.0 109.321 173.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.84 169.92 20.9 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.452 3.435 . . . . 0.0 110.143 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -171.75 -78.06 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.31 0.644 . . . . 0.0 110.148 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.2 m -77.52 -7.72 56.7 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 120.9 -1.125 . . . . 0.0 111.66 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.993 0 N-CA-C 104.826 -3.31 . . . . 0.0 104.826 175.639 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.24 133.34 52.44 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.412 1.106 . . . . 0.0 108.087 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 p -66.43 161.65 22.23 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 122.778 0.431 . . . . 0.0 109.924 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.38 163.23 11.27 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.505 1.05 . . . . 0.0 111.22 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 m 63.72 -70.93 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.824 2.049 . . . . 0.0 112.028 -173.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.6 m -135.48 157.87 45.79 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.487 1.494 . . . . 0.0 109.491 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.86 176.47 39.03 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 124.395 0.998 . . . . 0.0 111.386 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.23 102.86 3.18 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 163.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -55.95 151.55 11.56 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.929 1.292 . . . . 0.0 110.366 172.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -138.11 170.53 15.88 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.121 0.968 . . . . 0.0 110.053 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.01 149.6 18.66 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 123.615 0.572 . . . . 0.0 110.629 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 -1.63 88.09 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.973 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -101.27 173.62 6.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.022 1.411 . . . . 0.0 109.464 168.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -131.38 149.31 52.59 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.757 1.223 . . . . 0.0 109.859 -172.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.8 m -147.42 164.72 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 109.914 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -102.81 126.59 50.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 158.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.94 165.8 12.7 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.682 1.593 . . . . 0.0 109.745 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -140.07 105.67 5.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.8 mtm -73.65 168.8 18.61 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 168.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -59.44 129.63 42.96 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 162.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.92 -30.03 2.07 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 126.627 2.061 . . . . 0.0 115.823 168.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.89 163.66 66.62 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 118.793 1.297 . . . . 0.0 111.576 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -75.64 175.67 10.98 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 124.573 3.515 . . . . 0.0 110.993 168.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -62.59 88.09 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.227 2.211 . . . . 0.0 109.786 177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.2 t-105 -86.75 137.88 33.56 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 120.904 -1.122 . . . . 0.0 109.252 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.07 137.79 63.84 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.699 2.266 . . . . 0.0 111.665 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.04 167.44 22.67 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.159 0.98 . . . . 0.0 111.09 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 1.2 ptm180 -112.45 156.06 23.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.1 mm -82.45 107.48 14.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 159.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.74 -174.55 4.81 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HG2' ' H ' ' A' ' 32' ' ' LEU . 4.7 tt0 -128.56 -177.22 4.09 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.647 -1.283 . . . . 0.0 109.296 176.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.479 ' H ' ' HG2' ' A' ' 31' ' ' GLU . 6.2 mt -142.36 116.39 6.52 Favored Pre-proline 0 N--CA 1.452 -0.363 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -166.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.9 151.38 56.64 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.462 2.108 . . . . 0.0 109.867 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -69.75 24.13 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.383 2.273 . . . . 0.0 114.77 -169.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.8 -0.76 1.24 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.479 -1.179 . . . . 0.0 113.3 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.29 175.05 6.41 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.524 1.662 . . . . 0.0 113.053 -167.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -35.19 131.16 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 127.766 2.426 . . . . 0.0 109.045 162.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -117.08 141.83 29.03 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.338 0.655 . . . . 0.0 111.336 -171.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.65 161.84 14.44 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 123.628 2.885 . . . . 0.0 112.493 -162.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.26 167.58 17.49 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.668 2.245 . . . . 0.0 111.426 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.58 135.18 57.27 Favored 'General case' 0 N--CA 1.434 -1.238 0 O-C-N 121.304 -0.872 . . . . 0.0 109.641 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 64.13 32.48 12.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.71 2.404 . . . . 0.0 113.039 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -132.85 168.1 19.0 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.913 -1.117 . . . . 0.0 112.916 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -125.2 152.87 71.53 Favored Pre-proline 0 N--CA 1.466 0.326 0 C-N-CA 130.232 3.413 . . . . 0.0 110.206 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.44 102.03 1.57 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.99 3.126 . . . . 0.0 109.543 166.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -87.86 116.31 25.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.626 1.97 . . . . 0.0 107.623 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -83.83 99.61 10.43 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.801 2.041 . . . . 0.0 109.435 -172.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 3.3 m-85 -49.28 143.73 5.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.484 1.514 . . . . 0.0 113.141 -172.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.46 -58.26 2.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.175 1.369 . . . . 0.0 111.394 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -21.35 64.06 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.327 -1.102 . . . . 0.0 113.056 -175.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 m170 58.09 3.15 0.22 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.08 2.152 . . . . 0.0 114.398 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.82 164.63 11.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.297 1.046 . . . . 0.0 109.407 172.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.4 p -141.24 136.22 31.47 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -166.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.28 151.09 36.04 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 167.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -89.08 107.34 18.99 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 mt -128.79 150.77 50.17 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 169.13 21.43 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.87 1.224 . . . . 0.0 112.762 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -68.42 -23.65 37.6 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.331 2.687 . . . . 0.0 113.924 -162.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -57.25 -19.12 19.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.796 1.18 . . . . 0.0 113.31 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.0 7.05 23.54 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 109.507 -175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -114.3 166.22 11.89 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 126.389 1.875 . . . . 0.0 110.187 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -148.36 154.28 41.69 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.317 1.847 . . . . 0.0 106.847 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -69.97 127.4 14.38 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 123.135 2.557 . . . . 0.0 111.148 176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -55.35 -53.73 52.52 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.456 1.102 . . . . 0.0 111.271 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.01 -21.91 59.8 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.761 0.824 . . . . 0.0 111.881 -172.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -71.21 0.34 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.25 1.42 . . . . 0.0 109.031 167.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -81.26 15.78 1.83 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.379 1.472 . . . . 0.0 113.575 -166.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -52.93 -28.93 25.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.886 1.674 . . . . 0.0 112.019 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -34.86 6.9 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.123 0.874 . . . . 0.0 111.635 174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -60.87 -60.9 3.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.258 1.023 . . . . 0.0 109.011 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -85.19 -52.02 6.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.695 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.33 88.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 126.187 1.851 . . . . 0.0 111.856 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -151.48 158.83 44.16 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 126.418 1.887 . . . . 0.0 108.899 -174.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 m -60.0 150.89 27.75 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.886 1.327 . . . . 0.0 108.966 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.14 149.86 44.98 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.615 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -86.0 -14.1 45.54 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.171 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.5 mmt-85 -58.31 123.9 17.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 164.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -64.78 164.17 12.75 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.92 0.39 . . . . 0.0 110.082 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.73 -40.69 2.28 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 124.043 0.83 . . . . 0.0 111.719 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -52.43 -34.96 50.88 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.49 1.145 . . . . 0.0 112.168 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.46 -46.43 76.43 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 121.34 -0.85 . . . . 0.0 112.794 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.04 -43.76 86.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.771 1.229 . . . . 0.0 109.294 172.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.36 -36.45 93.1 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.421 -0.8 . . . . 0.0 113.02 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.04 -16.91 61.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.289 1.036 . . . . 0.0 112.661 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 28.6 t90 -77.97 -52.73 8.36 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.02 -46.09 92.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.755 0.822 . . . . 0.0 112.331 -173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.8 tt -63.58 -33.59 62.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 119.201 0.909 . . . . 0.0 111.806 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.49 -53.38 19.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.624 -0.672 . . . . 0.0 109.272 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -71.59 -21.94 61.79 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 123.803 0.689 . . . . 0.0 112.106 -170.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -55.63 -60.82 2.9 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.139 0.976 . . . . 0.0 110.219 163.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.82 -176.56 42.63 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 121.842 0.69 . . . . 0.0 113.631 -164.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.21 128.75 21.16 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.886 3.057 . . . . 0.0 109.829 -167.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 p -154.77 166.66 32.75 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 108.199 -165.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.57 22.95 13.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.974 0.91 . . . . 0.0 113.393 173.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.716 0 N-CA-C 107.579 -2.209 . . . . 0.0 107.579 178.247 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -131.44 161.65 31.99 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.645 0.778 . . . . 0.0 109.182 -172.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.2 125.35 2.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.91 -95.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.511 0 C-N-CA 125.208 1.385 . . . . 0.0 110.893 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.6 p -169.34 -62.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -49.7 128.48 18.0 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.922 1.289 . . . . 0.0 109.978 162.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.57 -157.68 2.25 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 159.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -143.83 156.93 44.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -78.34 169.51 18.14 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -136.97 169.95 16.91 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.527 1.531 . . . . 0.0 108.759 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 144.08 44.72 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.491 0.662 . . . . 0.0 110.863 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.18 5.9 59.85 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.418 -1.212 . . . . 0.0 113.328 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.84 140.98 51.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 120.28 2.04 . . . . 0.0 108.251 166.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.5 mt -88.42 136.38 33.01 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.05 162.38 13.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 123.478 0.711 . . . . 0.0 109.593 -178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -102.1 126.6 49.1 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 164.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.9 168.8 10.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 123.707 0.803 . . . . 0.0 109.507 173.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -133.44 150.2 51.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.472 0.709 . . . . 0.0 109.569 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 55.4 mtm -132.62 172.89 11.93 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.127 1.771 . . . . 0.0 109.463 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -80.55 71.23 7.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.143 1.377 . . . . 0.0 109.981 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.36 -41.38 1.2 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 125.414 1.483 . . . . 0.0 111.276 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -60.65 150.6 74.76 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.505 1.122 . . . . 0.0 110.946 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.52 165.44 29.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.549 3.499 . . . . 0.0 111.333 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -55.36 116.57 2.92 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -118.33 132.1 23.93 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.33 137.44 36.71 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.969 1.78 . . . . 0.0 110.751 -176.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.03 167.34 23.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.674 1.19 . . . . 0.0 110.249 -173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.41 139.5 53.6 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.69 112.5 3.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -73.97 171.04 14.19 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.582 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.2 154.31 37.66 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.43 1.109 . . . . 0.0 111.147 -172.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.5 mt -134.37 112.33 11.95 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 113.589 -1.641 . . . . 0.0 108.068 -161.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -64.69 166.02 19.1 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 124.477 3.452 . . . . 0.0 110.495 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -81.72 82.91 7.27 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.127 -0.983 . . . . 0.0 108.658 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.77 68.85 0.28 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.49 1.519 . . . . 0.0 110.525 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.94 -171.77 3.84 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.532 1.533 . . . . 0.0 107.621 160.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.58 140.48 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 119.096 0.862 . . . . 0.0 108.684 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -121.72 141.71 34.37 Favored Pre-proline 0 C--O 1.235 0.314 0 C-N-CA 123.5 0.72 . . . . 0.0 111.668 -168.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -70.79 156.61 60.32 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.702 2.268 . . . . 0.0 110.357 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -76.69 156.41 35.58 Favored 'Trans proline' 0 N--CA 1.435 -1.92 0 C-N-CA 120.823 1.015 . . . . 0.0 109.594 168.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.09 151.4 46.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 122.82 1.295 . . . . 0.0 110.142 -174.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.27 27.2 2.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.616 -2.084 . . . . 0.0 113.363 -169.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -128.19 166.7 18.02 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.349 1.06 . . . . 0.0 108.146 162.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -129.71 153.34 80.79 Favored Pre-proline 0 C--N 1.324 -0.532 0 C-N-CA 126.491 1.916 . . . . 0.0 107.283 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -70.12 115.68 4.25 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.397 2.065 . . . . 0.0 108.929 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.5 113.47 44.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -85.98 131.77 34.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -98.44 115.47 28.58 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -54.8 144.75 21.51 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.055 1.342 . . . . 0.0 110.718 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.86 -58.0 4.04 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.76 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.8 p -83.48 -24.64 31.68 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.849 2.324 . . . . 0.0 111.273 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.0 m170 70.01 17.43 7.4 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.349 1.459 . . . . 0.0 112.113 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.59 155.41 33.25 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.7 p -136.38 130.26 32.52 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.991 1.316 . . . . 0.0 108.0 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.02 159.02 42.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -89.79 121.63 32.11 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 81.7 mt -126.79 158.56 36.25 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.426 1.09 . . . . 0.0 109.062 169.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.47 168.86 16.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.701 1.143 . . . . 0.0 112.658 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -67.84 -15.73 44.5 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.33 2.687 . . . . 0.0 115.188 -160.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -63.53 -26.37 68.67 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.393 1.451 . . . . 0.0 111.664 174.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.1 10.66 33.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.485 1.514 . . . . 0.0 111.533 -173.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.3 mt -133.35 127.09 32.76 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.927 1.291 . . . . 0.0 109.408 -169.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -122.33 142.68 37.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.424 1.089 . . . . 0.0 110.745 -167.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.49 121.04 9.0 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.821 3.014 . . . . 0.0 111.411 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -56.28 -50.08 72.41 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 121.8 -0.562 . . . . 0.0 111.064 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -57.87 -31.97 67.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 112.267 -173.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -72.19 -68.06 0.5 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.013 0.925 . . . . 0.0 108.823 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -77.4 -2.57 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.374 1.07 . . . . 0.0 113.265 -160.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -50.49 -46.46 57.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.935 1.694 . . . . 0.0 110.713 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -79.67 -17.36 53.88 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -97.76 -62.48 1.24 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.683 1.593 . . . . 0.0 109.786 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -86.22 -30.82 22.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.822 1.649 . . . . 0.0 111.782 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.21 73.41 2.0 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -132.38 128.94 38.67 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 124.504 1.122 . . . . 0.0 108.556 -168.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.6 p -41.89 130.74 3.39 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 126.371 1.868 . . . . 0.0 109.208 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -138.85 134.72 33.7 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -78.1 72.21 4.62 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -120.09 133.96 55.38 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 165.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -68.32 147.74 51.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 -58.69 5.01 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -48.77 -61.1 2.22 Favored 'General case' 0 CA--C 1.522 -0.105 0 C-N-CA 124.83 1.252 . . . . 0.0 110.67 -171.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.1 -33.41 70.8 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 124.785 1.234 . . . . 0.0 114.073 -169.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.14 -39.97 68.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.645 0.778 . . . . 0.0 110.732 173.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.99 -34.69 80.14 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.567 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -68.94 -24.78 64.31 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.371 1.085 . . . . 0.0 111.832 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -70.69 -50.06 40.56 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 169.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -58.79 -46.51 87.4 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.308 1.043 . . . . 0.0 111.545 -172.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 tt -66.69 -42.36 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.409 0.284 . . . . 0.0 110.864 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -69.02 -20.32 64.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.013 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -109.53 28.99 7.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.77 2.028 . . . . 0.0 110.74 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 p -61.9 -17.82 57.99 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -146.12 -177.73 21.01 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.161 1.362 . . . . 0.0 109.926 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.7 154.73 67.61 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.478 2.785 . . . . 0.0 110.929 -173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 m -103.75 120.03 40.12 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.211 1.004 . . . . 0.0 110.044 -163.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m -137.85 -79.3 0.37 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.9 0.773 . . . . 0.0 111.69 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 104.488 -3.445 . . . . 0.0 104.488 -159.048 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 N-CA-C 111.236 -0.745 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.9 t -134.97 159.37 41.68 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.748 1.619 . . . . 0.0 107.902 168.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.99 50.68 0.25 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.748 1.219 . . . . 0.0 108.88 174.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.32 78.6 1.32 Allowed Glycine 0 C--N 1.338 0.64 0 C-N-CA 123.65 0.643 . . . . 0.0 112.448 166.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.5 m -116.85 175.66 5.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.948 1.699 . . . . 0.0 107.766 161.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.8 m -57.96 126.4 27.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 162.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.87 -91.4 0.17 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 107.616 -2.193 . . . . 0.0 107.616 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -138.02 96.49 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -62.48 135.17 57.29 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -128.94 158.67 38.17 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.089 0.859 . . . . 0.0 110.306 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.57 117.09 3.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 109.778 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.09 -37.75 2.23 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -169.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -69.8 160.7 31.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 122.716 1.246 . . . . 0.0 110.778 -174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -117.82 143.63 46.1 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.629 1.572 . . . . 0.0 107.846 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.31 167.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 123.554 0.742 . . . . 0.0 111.479 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.43 128.34 50.6 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 158.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.1 165.51 12.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 169.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HE2' ' CE1' ' A' ' 24' ' ' HIS . 6.8 tptp -143.92 106.32 4.41 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.9 mtm -78.28 161.7 27.05 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 166.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -63.02 139.34 58.76 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.61 -44.43 2.5 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.078 1.323 . . . . 0.0 113.796 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.67 160.03 78.97 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 118.61 1.205 . . . . 0.0 112.384 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 178.46 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.979 3.786 . . . . 0.0 111.482 169.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.455 ' CE1' ' HE2' ' A' ' 18' ' ' LYS . 55.1 m80 -71.28 89.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.495 1.118 . . . . 0.0 109.234 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -80.69 136.31 51.79 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.284 1.034 . . . . 0.0 110.161 -169.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.43 124.51 12.56 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.895 2.397 . . . . 0.0 110.506 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.82 166.66 24.6 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.717 -0.615 . . . . 0.0 110.28 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 2.8 ptm85 -125.89 159.62 32.08 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.512 -0.743 . . . . 0.0 109.882 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.5 mm -86.27 108.88 18.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 167.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -73.28 174.98 7.28 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' HG2' ' H ' ' A' ' 32' ' ' LEU . 13.8 tt0 -101.74 -163.91 1.05 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 164.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' H ' ' HG2' ' A' ' 31' ' ' GLU . 1.8 mp -132.12 144.18 52.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 168.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.04 161.87 3.11 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.205 2.603 . . . . 0.0 112.2 171.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -76.89 18.4 0.36 Allowed 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.299 -0.876 . . . . 0.0 112.019 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.05 92.82 0.09 OUTLIER Glycine 0 CA--C 1.524 0.606 0 C-N-CA 128.146 2.784 . . . . 0.0 108.025 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -157.64 -169.76 2.97 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.359 1.079 . . . . 0.0 110.184 -175.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.17 162.75 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 155.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -132.26 146.93 63.69 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 120.93 -1.107 . . . . 0.0 110.375 179.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' LYS . 32.2 Cg_exo -61.37 167.5 9.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 124.476 3.451 . . . . 0.0 115.719 -168.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -67.39 158.46 56.95 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 121.1 1.2 . . . . 0.0 111.647 160.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.97 131.07 46.54 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 63.04 16.39 9.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.23 2.612 . . . . 0.0 113.851 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -114.1 159.33 20.15 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.003 0.82 . . . . 0.0 110.2 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -122.84 153.11 63.5 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.282 1.833 . . . . 0.0 108.416 -177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.13 105.24 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.606 2.87 . . . . 0.0 110.487 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.7 mm -92.89 123.36 44.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 123.128 0.571 . . . . 0.0 109.527 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -101.87 115.99 31.74 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.668 1.587 . . . . 0.0 107.091 170.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -80.44 115.84 20.18 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.7 m-85 -65.86 149.04 50.83 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.402 0.62 . . . . 0.0 110.737 -176.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.49 -34.45 0.34 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.884 2.183 . . . . 0.0 114.059 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 p -85.68 -28.48 24.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.68 2.24 . . . . 0.0 110.88 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 66.36 13.83 9.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.31 2.244 . . . . 0.0 113.701 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -75.68 160.07 30.46 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.2 1.0 . . . . 0.0 109.288 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -122.65 149.55 43.86 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.817 0.847 . . . . 0.0 109.476 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.39 177.65 9.78 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.762 0.825 . . . . 0.0 109.287 167.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -117.33 122.82 44.94 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.83 156.94 32.18 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.73 0.3 . . . . 0.0 110.5 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.16 161.4 35.88 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 166.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.13 -20.97 63.22 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.957 2.438 . . . . 0.0 111.765 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -60.25 -23.73 64.33 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.87 0.868 . . . . 0.0 112.386 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.79 -9.94 50.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.489 1.04 . . . . 0.0 111.53 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.9 mt -116.48 160.58 20.39 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.23 1.412 . . . . 0.0 110.795 -162.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.55 146.95 47.14 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.066 0.946 . . . . 0.0 110.767 172.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -67.12 126.72 15.56 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.426 2.751 . . . . 0.0 110.508 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -52.8 -52.06 58.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.793 0.437 . . . . 0.0 110.841 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -66.66 -6.34 15.14 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -171.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -64.49 1.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.725 -0.609 . . . . 0.0 110.532 164.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -79.96 9.76 5.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.488 1.915 . . . . 0.0 113.525 -169.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -53.71 -20.45 5.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.748 2.019 . . . . 0.0 112.464 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -33.13 4.62 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 119.972 1.26 . . . . 0.0 113.229 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -61.26 -51.56 68.41 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.615 1.098 . . . . 0.0 109.024 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -92.4 -35.06 13.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.108 0.963 . . . . 0.0 110.112 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.97 80.25 0.59 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 118.64 -1.089 . . . . 0.0 110.993 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -141.86 142.59 33.11 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.095 1.758 . . . . 0.0 107.648 177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 m -54.4 103.54 0.09 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.853 2.461 . . . . 0.0 111.7 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -82.71 150.5 26.69 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.344 -0.848 . . . . 0.0 112.268 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -45.62 -49.39 14.29 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.8 1.64 . . . . 0.0 113.232 168.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -58.49 139.39 55.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.83 0.741 . . . . 0.0 110.598 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -71.27 172.5 9.22 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 162.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.34 -88.01 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 104.611 -3.396 . . . . 0.0 104.611 -143.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -32.24 -53.6 0.3 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.535 2.734 . . . . 0.0 115.547 -151.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -23.7 62.75 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.39 -57.29 4.98 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.633 2.373 . . . . 0.0 108.501 170.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.42 -27.75 61.19 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.332 -0.705 . . . . 0.0 112.563 -177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.48 -48.85 73.66 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.14 0.97 . . . . 0.0 111.384 170.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 77.0 t90 -60.89 -40.58 93.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.666 1.121 . . . . 0.0 110.178 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.58 -51.64 67.71 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.356 0.663 . . . . 0.0 111.678 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.2 tt -66.57 -29.4 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 118.892 0.769 . . . . 0.0 110.945 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -68.69 -30.99 69.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.214 -0.929 . . . . 0.0 110.905 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -96.04 39.18 1.15 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.208 -0.933 . . . . 0.0 110.282 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.3 m -142.67 125.31 15.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.628 2.771 . . . . 0.0 106.631 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 118.29 -124.17 5.97 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.433 1.968 . . . . 0.0 110.233 174.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -63.55 100.85 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.183 2.589 . . . . 0.0 109.233 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -77.54 100.39 6.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 169.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.4 m 56.21 30.84 17.3 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 N-CA-C 108.876 -1.69 . . . . 0.0 108.876 -176.644 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 m 55.0 -91.79 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.889 1.676 . . . . 0.0 112.295 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.6 171.56 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.264 1.393 . . . . 0.0 111.181 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.78 100.46 2.66 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.92 -44.58 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.445 1.498 . . . . 0.0 111.344 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 p -171.65 -174.57 1.39 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.535 1.934 . . . . 0.0 108.119 -166.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.13 163.31 29.71 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.048 1.308 . . . . 0.0 111.141 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 10.19 98.02 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 131.811 4.045 . . . . 0.0 115.183 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.73 136.32 57.95 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.188 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -134.5 167.95 19.84 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.974 1.31 . . . . 0.0 108.83 169.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -48.23 139.57 8.38 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 110.169 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.16 25.12 49.76 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.234 -1.314 . . . . 0.0 113.08 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -109.76 167.42 10.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.548 1.674 . . . . 0.0 109.693 164.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -109.45 138.25 46.1 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.766 2.026 . . . . 0.0 106.751 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 m -140.63 175.3 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.068 0.947 . . . . 0.0 108.901 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -109.38 151.9 26.03 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 157.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.13 147.09 49.37 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.461 1.505 . . . . 0.0 109.056 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -134.63 104.81 6.21 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -164.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.8 mtm -88.95 167.2 13.39 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.302 0.573 . . . . 0.0 110.349 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -51.06 113.32 0.9 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.892 1.677 . . . . 0.0 109.154 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.77 -36.13 3.16 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.781 1.658 . . . . 0.0 114.26 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -63.54 163.65 19.2 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.54 1.536 . . . . 0.0 112.515 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -85.55 -179.04 3.24 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 125.126 3.884 . . . . 0.0 110.68 168.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -67.18 92.66 0.27 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.269 1.028 . . . . 0.0 108.655 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -78.13 139.1 60.56 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.986 1.314 . . . . 0.0 108.089 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -66.4 137.22 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.352 2.034 . . . . 0.0 108.914 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.77 156.86 43.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -170.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 141.72 49.51 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 mm -78.12 105.37 7.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.27 170.87 6.5 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.655 0.782 . . . . 0.0 108.896 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -90.08 167.94 12.37 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.179 -0.951 . . . . 0.0 108.584 162.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.11 107.71 57.47 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 164.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -65.72 174.43 5.53 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.557 2.171 . . . . 0.0 109.872 171.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.1 163.07 6.44 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.576 -0.703 . . . . 0.0 110.138 169.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.72 -9.56 0.27 Allowed Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.919 1.247 . . . . 0.0 115.698 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.97 177.64 3.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.284 1.834 . . . . 0.0 111.008 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.89 147.97 11.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.766 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -108.03 105.39 56.3 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 125.007 1.323 . . . . 0.0 107.84 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.96 169.07 20.05 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.789 2.326 . . . . 0.0 111.187 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.95 160.08 51.31 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 N-CA-C 110.137 -0.755 . . . . 0.0 110.137 169.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.06 13.66 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.98 8.57 1.67 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.38 2.272 . . . . 0.0 111.278 -159.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -141.02 164.19 30.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 124.927 1.291 . . . . 0.0 108.187 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.67 152.67 59.03 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 124.412 1.085 . . . . 0.0 110.158 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.03 91.06 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.637 2.891 . . . . 0.0 109.476 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.6 mm -82.36 118.1 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -85.09 149.51 25.5 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 163.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -111.86 113.34 25.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -64.8 160.4 20.34 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.933 0.873 . . . . 0.0 110.455 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.49 -47.31 2.38 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.92 2.2 . . . . 0.0 113.201 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.6 p -96.77 -21.64 17.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.485 1.143 . . . . 0.0 112.093 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.0 m80 66.79 21.71 10.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.454 1.902 . . . . 0.0 112.065 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -71.66 163.37 27.9 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.219 1.009 . . . . 0.0 109.845 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -142.79 142.85 31.97 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 109.254 -176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.52 -175.81 5.53 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.986 2.514 . . . . 0.0 107.055 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -119.82 125.29 48.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 109.386 165.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.4 mt -130.48 150.89 51.49 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.518 1.927 . . . . 0.0 108.769 -177.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.81 165.54 28.34 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.34 0.971 . . . . 0.0 111.687 -178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.66 -22.33 50.63 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.937 3.091 . . . . 0.0 113.385 -173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmtp -60.96 -13.33 15.36 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 118.127 -0.939 . . . . 0.0 112.142 173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.44 -5.26 21.81 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.074 1.306 . . . . 0.0 113.734 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.2 mt -122.39 146.96 46.86 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.565 1.075 . . . . 0.0 109.911 -157.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -134.15 143.28 46.48 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.579 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -65.02 114.88 2.99 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.619 2.213 . . . . 0.0 108.664 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -46.98 -54.26 10.55 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 123.929 0.892 . . . . 0.0 109.471 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -60.11 -25.24 65.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.502 0.502 . . . . 0.0 112.299 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -57.03 4.18 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -83.42 17.06 2.27 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.186 2.194 . . . . 0.0 112.434 -173.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -66.65 -31.36 71.99 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.278 1.431 . . . . 0.0 108.968 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.62 -57.07 3.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 118.414 0.552 . . . . 0.0 111.253 162.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -57.92 -41.85 83.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.115 0.87 . . . . 0.0 110.843 -162.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 14.7 m-30 -102.73 -14.78 16.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.027 1.731 . . . . 0.0 112.541 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.64 75.17 2.14 Favored Glycine 0 C--N 1.337 0.625 0 CA-C-N 119.719 1.145 . . . . 0.0 110.268 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -133.3 132.67 41.64 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 118.252 -0.88 . . . . 0.0 109.251 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.2 p -61.62 79.79 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.833 2.053 . . . . 0.0 112.867 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -95.41 147.11 23.87 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 110.181 -168.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 tttm -91.97 41.96 1.09 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -149.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mmt85 -105.09 147.14 28.22 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -66.21 155.37 37.26 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.99 -28.2 1.64 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.973 1.273 . . . . 0.0 112.197 -171.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.28 -49.61 63.62 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 118.905 1.353 . . . . 0.0 112.932 -164.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -66.82 -22.64 66.0 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.625 0.77 . . . . 0.0 110.754 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -75.53 -47.52 26.55 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.136 0.975 . . . . 0.0 108.39 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -66.66 -26.79 72.99 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 120.11 -0.272 . . . . 0.0 113.366 175.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.0 mt -72.23 -29.72 64.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.65 1.225 . . . . 0.0 111.584 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 65.2 t90 -70.72 -42.59 70.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.33 -0.856 . . . . 0.0 109.161 171.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.84 -55.22 37.2 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.156 0.582 . . . . 0.0 110.409 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.8 tt -63.02 -34.12 64.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.989 0.813 . . . . 0.0 111.316 -173.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -71.38 -29.94 65.54 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.496 -0.752 . . . . 0.0 111.631 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -83.96 -7.86 59.31 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.071 1.348 . . . . 0.0 112.795 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -82.13 77.4 8.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.464 1.506 . . . . 0.0 109.616 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.09 -169.99 39.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.38 157.38 41.22 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.304 3.336 . . . . 0.0 110.421 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.4 m -110.31 112.73 24.86 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.013 0.925 . . . . 0.0 109.214 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.1 m -152.93 141.59 20.93 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.571 1.948 . . . . 0.0 106.453 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 106.071 -2.812 . . . . 0.0 106.071 -170.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m 50.08 82.22 0.05 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.4 1.48 . . . . 0.0 112.95 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 p -72.75 164.18 26.96 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 150.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.3 65.5 0.43 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -77.06 -83.2 0.08 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 163.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.2 p -82.76 170.37 15.14 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.533 0.733 . . . . 0.0 109.988 169.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.75 -83.71 0.31 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 165.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -141.76 135.02 29.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -85.07 155.6 21.45 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.73 156.52 46.74 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.794 -1.191 . . . . 0.0 110.058 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 141.8 50.44 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.63 40.41 10.95 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -136.55 173.08 12.1 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.248 1.024 . . . . 0.0 110.588 159.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -119.25 147.2 44.53 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.877 2.471 . . . . 0.0 106.801 176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.424 HG11 HD11 ' A' ' 29' ' ' ILE . 33.9 m -149.73 171.33 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.381 1.073 . . . . 0.0 108.759 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -108.76 125.56 52.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 164.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.03 151.55 20.81 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.041 0.936 . . . . 0.0 110.796 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -126.9 106.32 9.24 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.2 mtp -83.99 167.78 16.58 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 162.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -65.18 119.79 11.51 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -174.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.05 -16.53 2.0 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.038 -1.423 . . . . 0.0 116.374 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -67.16 159.19 78.35 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 119.741 1.77 . . . . 0.0 110.907 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.13 164.28 34.52 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.61 2.873 . . . . 0.0 110.037 168.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -65.47 103.15 0.79 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -95.28 138.44 21.93 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.389 -164.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -62.56 124.49 14.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.695 2.264 . . . . 0.0 110.345 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.83 164.16 30.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.047 0.539 . . . . 0.0 110.324 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -128.85 146.13 51.01 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.037 -0.414 . . . . 0.0 110.612 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.424 HD11 HG11 ' A' ' 15' ' ' VAL . 17.7 mm -85.24 98.63 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 103.414 -2.809 . . . . 0.0 103.414 172.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -85.68 -175.88 5.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.754 1.622 . . . . 0.0 109.252 174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -107.65 168.45 9.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.576 1.951 . . . . 0.0 108.907 167.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -81.08 151.62 70.31 Favored Pre-proline 0 N--CA 1.467 0.423 0 O-C-N 121.307 -0.871 . . . . 0.0 110.325 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -83.04 -167.49 0.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 124.721 3.614 . . . . 0.0 109.652 170.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -112.47 31.38 6.36 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.671 1.589 . . . . 0.0 112.163 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.23 46.45 0.17 Allowed Glycine 0 C--N 1.338 0.647 0 O-C-N 120.71 -1.244 . . . . 0.0 113.815 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.32 168.55 14.64 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.292 1.037 . . . . 0.0 110.998 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -66.11 119.2 10.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 143.04 96.0 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.931 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 73.3 Cg_endo -85.7 161.63 10.7 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.156 2.571 . . . . 0.0 114.591 -173.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.5 143.79 27.93 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.137 1.891 . . . . 0.0 111.11 172.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.81 75.32 3.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.091 -171.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -175.08 6.42 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.181 2.192 . . . . 0.0 110.622 177.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -136.9 -177.04 4.57 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.924 1.29 . . . . 0.0 109.679 -163.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -140.65 152.44 66.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.36 1.464 . . . . 0.0 109.084 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.81 92.01 0.62 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.424 3.416 . . . . 0.0 110.867 170.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.1 mm -87.84 141.15 14.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -118.59 133.02 56.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.018 1.727 . . . . 0.0 108.2 172.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -89.85 112.53 23.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.242 1.417 . . . . 0.0 108.357 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 17.1 m-85 -62.39 154.56 27.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 171.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.49 -21.53 0.9 Allowed Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.725 -1.597 . . . . 0.0 115.951 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.7 p -123.96 -14.05 7.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 121.079 2.439 . . . . 0.0 113.879 178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 61.65 16.3 7.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.569 2.348 . . . . 0.0 112.832 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -69.1 170.4 10.06 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.373 1.082 . . . . 0.0 109.954 170.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.2 p -141.79 147.73 37.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 108.198 -172.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.29 168.42 24.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 118.318 0.508 . . . . 0.0 109.695 167.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 39' ' ' PRO . 50.5 m-85 -110.28 112.34 24.24 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 163.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.5 mt -125.13 142.0 51.76 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.55 164.17 37.68 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -64.4 -32.61 60.27 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.27 2.647 . . . . 0.0 112.363 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -58.95 -32.95 70.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.856 0.862 . . . . 0.0 112.788 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -82.72 -10.36 58.94 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.236 0.925 . . . . 0.0 111.363 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.1 mt -108.15 154.7 21.35 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 126.614 1.965 . . . . 0.0 109.687 -171.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -134.01 140.89 37.66 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-O 118.152 -0.927 . . . . 0.0 109.797 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.76 126.12 20.26 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.442 2.761 . . . . 0.0 109.591 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.42 -48.77 80.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.706 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.56 -43.63 72.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.72 1.145 . . . . 0.0 112.731 -172.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.64 -54.11 36.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.403 0.681 . . . . 0.0 110.61 175.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -85.47 2.85 42.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -55.76 -49.87 71.96 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.144 1.777 . . . . 0.0 108.991 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.27 -16.99 44.18 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -82.17 -64.76 1.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.885 1.221 . . . . 0.0 112.085 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -88.68 -31.48 18.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.818 2.447 . . . . 0.0 113.712 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.62 63.87 1.14 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 125.463 1.506 . . . . 0.0 113.367 177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -128.99 142.6 50.87 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.7 p -56.75 150.13 16.71 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 122.382 1.087 . . . . 0.0 109.801 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.97 167.11 17.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 113.846 -1.525 . . . . 0.0 108.732 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -83.47 -16.83 44.17 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.155 0.889 . . . . 0.0 112.846 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -58.85 138.59 57.2 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.558 1.072 . . . . 0.0 109.768 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -67.29 154.69 40.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.356 0.663 . . . . 0.0 109.411 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.14 -31.97 1.11 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.389 0.995 . . . . 0.0 112.642 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.35 -26.23 66.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.922 1.861 . . . . 0.0 112.487 -174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.1 -49.9 21.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 121.135 -0.978 . . . . 0.0 109.742 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -55.45 -47.69 75.66 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.131 1.372 . . . . 0.0 108.572 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 49' ' ' PHE . . . -66.97 -34.75 88.02 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.425 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 mt -68.57 -20.38 64.52 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 119.581 1.691 . . . . 0.0 111.872 172.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 44.6 t90 -83.62 -42.69 16.43 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 120.765 1.621 . . . . 0.0 110.334 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -55.1 -49.93 70.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.045 0.538 . . . . 0.0 109.884 176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.6 tt -65.69 -31.79 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 121.527 -0.733 . . . . 0.0 111.94 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -67.66 -21.56 65.34 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.617 1.167 . . . . 0.0 111.769 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -117.09 -16.87 10.42 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.562 0.745 . . . . 0.0 112.058 -168.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -53.01 45.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.212 1.405 . . . . 0.0 111.402 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.73 41.71 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 117.95 0.341 . . . . 0.0 113.16 -164.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.19 81.63 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.433 3.422 . . . . 0.0 110.433 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.2 m -147.3 109.44 4.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.72 1.208 . . . . 0.0 108.437 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.0 t -50.61 111.06 0.48 Allowed 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.385 1.474 . . . . 0.0 108.842 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 C-N-CA 127.715 2.579 . . . . 0.0 107.353 -178.05 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.42 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.4 p -75.11 -161.75 0.15 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.697 0.799 . . . . 0.0 108.925 166.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -142.5 159.95 41.24 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.779 1.632 . . . . 0.0 107.767 171.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.89 143.84 13.1 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 174.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -71.95 -4.39 28.09 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.722 0.809 . . . . 0.0 111.496 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t -154.95 -164.78 1.87 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 121.466 -0.771 . . . . 0.0 109.112 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.02 38.69 14.74 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.208 175.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 109.48 141.32 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 1 C-N-CA 132.163 4.185 . . . . 0.0 108.041 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -93.78 157.78 15.98 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.705 0.802 . . . . 0.0 110.984 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -143.07 167.63 21.64 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.409 1.084 . . . . 0.0 110.214 171.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.21 132.37 23.97 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.065 0.946 . . . . 0.0 110.659 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.71 76.77 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.26 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.93 144.29 57.38 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 119.371 1.585 . . . . 0.0 107.926 165.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.6 mt -101.25 144.1 30.52 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 171.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.87 173.98 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.327 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -114.35 138.07 51.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 154.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.87 172.16 8.51 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.156 1.383 . . . . 0.0 107.92 165.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -141.89 106.32 4.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.78 172.8 12.88 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.297 1.046 . . . . 0.0 110.628 174.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -80.74 44.28 0.72 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.864 2.066 . . . . 0.0 112.956 -165.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 151.83 -43.11 0.68 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.536 1.541 . . . . 0.0 109.758 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -55.95 155.61 11.55 Favored Pre-proline 0 N--CA 1.468 0.44 0 CA-C-N 117.284 0.542 . . . . 0.0 110.41 170.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -68.57 -178.2 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 124.187 3.258 . . . . 0.0 109.894 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -74.54 79.29 1.96 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.738 0.815 . . . . 0.0 109.441 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -63.31 134.31 95.79 Favored Pre-proline 0 CA--C 1.539 0.549 0 O-C-N 120.855 -1.153 . . . . 0.0 111.27 -170.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.646 ' HG3' HD22 ' A' ' 85' ' ' LEU . 50.6 Cg_endo -67.95 131.38 23.78 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.587 2.191 . . . . 0.0 110.032 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.99 168.65 22.53 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.078 0.466 . . . . 0.0 109.843 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.47 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 7.5 ptm180 -134.67 160.29 38.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 O-C-N 121.692 -0.63 . . . . 0.0 110.878 -176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.2 mm -84.13 117.13 29.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -82.64 -179.4 7.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.382 1.473 . . . . 0.0 108.587 166.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -129.01 149.05 51.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 108.04 172.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 mt -80.89 120.71 79.63 Favored Pre-proline 0 C--O 1.239 0.509 0 CA-C-O 117.537 -1.221 . . . . 0.0 109.083 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.37 166.8 8.84 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.738 1.625 . . . . 0.0 109.632 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -76.23 -4.49 42.16 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -160.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.64 51.01 0.83 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 128.396 2.903 . . . . 0.0 109.782 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 -179.7 4.69 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 122.199 1.0 . . . . 0.0 112.198 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 t -92.66 74.32 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 122.136 0.97 . . . . 0.0 108.95 -172.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -28.22 108.94 0.23 Allowed Pre-proline 0 C--O 1.24 0.6 0 C-N-CA 128.169 2.588 . . . . 0.0 113.695 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.74 162.92 37.34 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.393 2.062 . . . . 0.0 112.012 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.34 138.74 39.91 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 N-CA-C 109.303 -1.076 . . . . 0.0 109.303 160.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.9 111.44 3.78 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 131.67 -4.48 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 131.428 3.891 . . . . 0.0 111.085 -170.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -115.26 143.96 44.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 120.725 1.602 . . . . 0.0 110.972 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -103.81 150.74 38.5 Favored Pre-proline 0 C--O 1.238 0.466 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.32 104.49 1.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.663 2.242 . . . . 0.0 108.555 159.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.55 140.83 16.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -112.97 121.16 43.81 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 127.563 2.345 . . . . 0.0 107.513 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -78.11 115.71 18.04 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.47 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 6.6 m-85 -67.79 155.77 38.54 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.906 0.384 . . . . 0.0 110.653 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.47 -58.8 4.1 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.979 0.8 . . . . 0.0 111.548 -175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -81.82 -21.16 37.8 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 112.152 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.4 m170 55.56 18.01 2.54 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.012 2.125 . . . . 0.0 112.619 -171.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -69.86 166.56 19.18 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 109.095 173.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 p -142.56 148.11 37.01 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.229 1.011 . . . . 0.0 108.523 -171.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.52 179.47 7.65 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.521 1.128 . . . . 0.0 109.002 173.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -123.01 107.39 11.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 165.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.4 146.54 47.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.454 1.901 . . . . 0.0 107.96 -176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.46 162.13 23.37 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.91 -24.07 61.22 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.846 3.031 . . . . 0.0 113.961 -165.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -67.06 -9.1 35.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.239 1.381 . . . . 0.0 112.457 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.62 4.86 36.06 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.782 1.174 . . . . 0.0 111.501 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.6 mt -132.51 153.93 50.44 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.298 1.439 . . . . 0.0 109.601 -166.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -143.13 143.93 26.7 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.901 0.88 . . . . 0.0 110.362 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.26 129.31 21.28 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.841 2.361 . . . . 0.0 110.568 -177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.54 -48.05 75.35 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 121.926 -0.484 . . . . 0.0 110.137 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.82 -24.74 66.08 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.75 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.0 -43.28 18.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.523 1.129 . . . . 0.0 110.203 174.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.428 ' CD1' ' CE2' ' A' ' 72' ' ' PHE . 54.3 m-85 -100.84 6.29 43.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.538 1.535 . . . . 0.0 114.047 -164.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -58.81 -33.72 70.7 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 127.249 2.219 . . . . 0.0 112.78 -167.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -98.85 -21.36 16.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.027 0.83 . . . . 0.0 110.346 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -76.13 -68.77 0.55 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.685 1.194 . . . . 0.0 108.576 -173.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.428 ' CE2' ' CD1' ' A' ' 68' ' ' TYR . 22.1 m-30 -81.0 -44.36 18.22 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.938 1.695 . . . . 0.0 108.975 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.36 96.0 0.05 OUTLIER Glycine 0 C--N 1.339 0.723 0 C-N-CA 125.862 1.696 . . . . 0.0 109.081 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -140.27 133.13 29.16 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 126.675 1.99 . . . . 0.0 106.245 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.88 122.57 21.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -145.06 171.76 14.02 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.256 1.823 . . . . 0.0 108.988 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -88.24 -60.05 2.07 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.083 0.856 . . . . 0.0 112.262 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.304 0.3 OUTLIER 44.5 -126.1 1.02 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.824 0.85 . . . . 0.0 109.876 -173.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -136.99 105.64 5.84 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 127.706 2.402 . . . . 0.0 105.975 173.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.1 89.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 119.927 1.239 . . . . 0.0 114.207 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 33.2 t80 -76.55 -52.91 8.84 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.243 1.522 . . . . 0.0 110.816 -170.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -40.97 69.22 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.882 1.219 . . . . 0.0 110.561 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -61.7 -52.0 66.08 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.059 1.344 . . . . 0.0 110.591 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.62 92.21 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 123.39 0.519 . . . . 0.0 112.676 -178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.646 HD22 ' HG3' ' A' ' 26' ' ' PRO . 4.4 mm? -63.53 -49.48 73.33 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -57.58 -35.86 70.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.469 0.577 . . . . 0.0 110.935 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.58 -47.63 69.18 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.924 0.784 . . . . 0.0 110.681 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -67.76 -34.65 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.867 0.758 . . . . 0.0 109.79 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -62.52 -17.83 60.65 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.789 1.235 . . . . 0.0 111.648 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -130.88 10.2 5.02 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 125.541 1.536 . . . . 0.0 112.658 -169.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -15.4 62.93 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -167.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 151.24 87.94 0.06 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-O 117.872 -1.515 . . . . 0.0 109.46 173.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.94 108.67 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.374 2.716 . . . . 0.0 110.783 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -60.01 156.06 15.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.062 0.545 . . . . 0.0 110.699 173.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 77.7 p -113.72 168.94 9.35 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.251 1.02 . . . . 0.0 110.164 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.255 -1.303 . . . . 0.0 112.39 171.799 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.1 p 54.14 34.57 20.4 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 120.608 -1.524 . . . . 0.0 112.453 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 m -54.2 114.46 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.842 0.857 . . . . 0.0 109.224 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.03 80.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 104.47 -3.452 . . . . 0.0 104.47 -168.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 m -138.57 95.54 3.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.206 1.002 . . . . 0.0 108.371 -154.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 m -133.15 100.11 4.76 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.985 1.714 . . . . 0.0 110.24 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.47 46.62 0.91 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-O 119.92 -0.378 . . . . 0.0 113.575 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -130.49 157.0 43.84 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 143.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -87.25 177.38 7.18 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 170.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -139.83 172.25 13.05 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 120.899 -1.125 . . . . 0.0 108.557 168.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.14 144.1 55.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.6 73.79 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.854 -0.97 . . . . 0.0 112.767 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -97.74 157.69 15.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.753 1.276 . . . . 0.0 108.697 161.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 61.0 mt -118.14 134.45 54.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.56 1.944 . . . . 0.0 106.328 -177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.98 171.73 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 118.942 0.792 . . . . 0.0 110.414 -167.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.36 142.11 34.78 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.499 -1.376 . . . . 0.0 107.791 162.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.58 161.47 15.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.433 1.493 . . . . 0.0 109.118 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -143.79 107.17 4.57 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.6 171.5 8.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.69 0.757 . . . . 0.0 109.816 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -53.08 119.13 4.33 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.025 1.73 . . . . 0.0 108.7 173.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.08 -48.36 3.54 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.397 0.999 . . . . 0.0 112.801 172.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -54.45 158.14 4.34 Favored Pre-proline 0 C--O 1.235 0.303 0 C-N-CA 125.908 1.683 . . . . 0.0 112.297 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.36 179.58 5.72 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.031 3.154 . . . . 0.0 110.698 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.86 94.12 0.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -85.62 134.91 38.95 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.809 1.243 . . . . 0.0 109.495 -170.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.81 126.18 17.6 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.052 2.501 . . . . 0.0 110.225 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.69 168.11 20.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.764 1.226 . . . . 0.0 109.493 -173.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.23 52.14 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 171.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -80.18 105.15 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 168.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -89.61 -172.39 3.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -126.04 157.33 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.987 0.899 . . . . 0.0 111.258 -173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.2 mt -78.7 134.3 61.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 109.336 -173.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -81.22 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 124.489 3.459 . . . . 0.0 111.262 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -66.78 -138.45 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.858 2.863 . . . . 0.0 112.197 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.8 21.39 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 129.144 3.259 . . . . 0.0 116.48 -171.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -179.83 0.18 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.389 1.876 . . . . 0.0 111.735 166.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.69 164.22 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.903 1.681 . . . . 0.0 109.509 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -112.07 136.78 21.28 Favored Pre-proline 0 C--O 1.242 0.708 0 O-C-N 120.545 -1.347 . . . . 0.0 109.736 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.4 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 69.0 Cg_endo -72.14 163.61 38.18 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.06 2.507 . . . . 0.0 112.052 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.01 151.36 73.37 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 N-CA-C 110.09 -0.773 . . . . 0.0 110.09 164.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.21 66.17 4.59 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.82 -8.8 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.582 1.953 . . . . 0.0 111.233 -171.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -136.01 153.58 51.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.387 1.075 . . . . 0.0 110.068 -171.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -106.11 148.18 36.15 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 125.121 1.368 . . . . 0.0 107.719 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.3 122.16 10.24 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.124 1.883 . . . . 0.0 107.625 155.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.3 mm -119.88 111.38 32.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.656 1.582 . . . . 0.0 107.589 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -85.47 129.14 34.88 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.121 0.969 . . . . 0.0 108.656 171.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -93.62 93.84 8.27 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 108.149 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.18 151.01 1.48 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.637 1.175 . . . . 0.0 110.572 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.57 -74.07 2.3 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -172.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -68.34 -20.89 64.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -172.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.2 m170 46.35 50.56 12.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.511 1.925 . . . . 0.0 111.001 -173.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -97.09 162.06 13.54 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 161.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.0 p -134.76 130.81 36.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.95 157.6 43.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.636 0.653 . . . . 0.0 111.189 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 39' ' ' PRO . 60.6 m-85 -94.98 108.44 20.5 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 31.8 mt -126.06 146.71 49.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.069 0.548 . . . . 0.0 110.305 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.4 161.9 23.35 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.09 0.852 . . . . 0.0 111.506 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.2 -20.81 42.94 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.734 2.956 . . . . 0.0 113.857 -164.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -70.54 -14.57 62.56 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.655 174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -98.64 0.39 44.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.005 1.322 . . . . 0.0 111.047 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -115.62 160.73 19.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.387 1.449 . . . . 0.0 110.482 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -144.8 145.63 28.61 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -65.14 130.91 26.88 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.767 2.311 . . . . 0.0 110.298 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -51.25 -58.05 7.21 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 124.183 0.993 . . . . 0.0 110.853 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -59.5 -34.26 72.37 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.964 1.305 . . . . 0.0 111.508 -168.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -56.38 6.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 176.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -86.16 6.38 29.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.831 1.253 . . . . 0.0 113.57 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -57.33 -40.83 78.8 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.271 1.828 . . . . 0.0 110.739 -172.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.58 -45.19 39.15 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 118.899 0.772 . . . . 0.0 111.475 172.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -66.24 -41.25 90.27 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.58 0.752 . . . . 0.0 111.767 -169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -114.83 -31.01 6.26 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.844 1.658 . . . . 0.0 110.969 -167.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.19 70.68 2.55 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -140.67 139.2 34.75 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.498 1.119 . . . . 0.0 108.256 -167.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.47 ' HA ' HD21 ' A' ' 82' ' ' ASN . 2.2 p -54.54 140.51 34.51 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.27 1.428 . . . . 0.0 109.993 -176.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -137.22 154.92 50.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.232 174.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -77.99 66.97 3.74 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.228 0.537 . . . . 0.0 109.739 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 42.2 mmt-85 -133.94 112.68 11.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.167 1.787 . . . . 0.0 106.529 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -57.93 150.13 21.25 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.36 -18.26 0.56 Allowed Glycine 0 CA--C 1.537 1.457 0 CA-C-O 118.477 -1.18 . . . . 0.0 115.031 -172.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -73.47 -55.93 5.71 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 121.426 2.613 . . . . 0.0 110.527 -174.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.47 HD21 ' HA ' ' A' ' 75' ' ' SER . 8.3 m120 -66.06 -27.92 68.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.703 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -65.25 -41.02 94.72 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.775 2.03 . . . . 0.0 110.594 171.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.37 -35.24 81.74 Favored Glycine 0 CA--C 1.523 0.543 0 O-C-N 121.399 -0.813 . . . . 0.0 111.697 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 mt -63.65 -32.82 74.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.081 -0.962 . . . . 0.0 110.901 172.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -59.77 -47.58 85.12 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.92 1.236 . . . . 0.0 110.435 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.39 -57.69 8.59 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.077 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.9 tt -59.24 -32.5 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 118.688 0.676 . . . . 0.0 111.732 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -64.98 -52.31 56.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.432 1.093 . . . . 0.0 109.799 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -73.91 -19.27 60.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.816 0.846 . . . . 0.0 112.807 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.0 m -85.35 2.29 44.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.705 2.002 . . . . 0.0 113.044 174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.2 -163.02 9.58 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.637 -1.29 . . . . 0.0 110.181 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.63 94.19 0.93 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.207 2.605 . . . . 0.0 108.784 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.0 t -65.68 -40.32 92.22 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m 53.25 -151.9 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.886 0.874 . . . . 0.0 110.558 -173.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.374 0 N-CA-C 106.456 -2.658 . . . . 0.0 106.456 -170.45 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.15 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 p -132.72 137.54 46.93 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.775 1.23 . . . . 0.0 109.364 -169.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -135.45 -37.57 0.76 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.114 1.365 . . . . 0.0 109.534 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.78 -179.37 51.28 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 124.683 1.135 . . . . 0.0 110.953 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.64 107.48 2.38 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -68.59 113.13 5.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.55 97.55 0.11 Allowed Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.52 159.26 0.07 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.472 2.709 . . . . 0.0 111.283 -167.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -117.5 148.43 41.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.945 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -135.43 157.89 45.76 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.962 1.705 . . . . 0.0 110.099 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.75 134.42 56.73 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.711 0.632 . . . . 0.0 109.981 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.98 47.33 5.33 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.54 174.59 10.45 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.021 0.529 . . . . 0.0 110.275 161.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 58.1 mt -125.08 140.31 53.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.805 2.042 . . . . 0.0 106.262 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.91 172.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -105.7 156.13 18.58 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 152.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.42 154.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.181 1.392 . . . . 0.0 108.216 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 tptp -128.92 106.32 8.82 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 60.8 mtm -86.21 167.59 14.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 167.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.26 125.43 20.66 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.719 1.207 . . . . 0.0 108.532 177.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.77 -33.58 1.22 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.371 1.462 . . . . 0.0 115.132 174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.13 158.69 62.22 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 118.887 1.344 . . . . 0.0 112.072 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.41 178.21 6.43 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.55 3.5 . . . . 0.0 110.247 168.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -66.7 96.31 0.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.565 0.746 . . . . 0.0 109.093 174.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -78.81 135.22 59.67 Favored Pre-proline 0 N--CA 1.449 -0.489 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.109 -173.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.04 122.5 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.537 2.158 . . . . 0.0 108.914 173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.15 165.91 25.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.206 0.527 . . . . 0.0 109.908 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -129.86 164.11 24.85 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.101 -1.0 . . . . 0.0 110.621 -178.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.2 mm -102.17 96.4 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -86.4 -169.12 2.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.69 2.396 . . . . 0.0 110.834 -166.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -131.16 170.26 14.79 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.23 -1.544 . . . . 0.0 112.281 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 75.4 mt -148.27 135.95 10.89 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 126.461 1.904 . . . . 0.0 106.31 -173.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.93 127.99 7.26 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.64 2.227 . . . . 0.0 110.2 164.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.4 125.81 24.88 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.256 0.622 . . . . 0.0 109.696 171.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.56 -38.78 2.45 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.341 1.448 . . . . 0.0 110.012 -172.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -167.5 0.62 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.65 1.18 . . . . 0.0 110.667 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.3 t -48.24 143.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.601 1.16 . . . . 0.0 110.802 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -129.01 115.16 18.85 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.814 1.246 . . . . 0.0 109.989 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.79 163.6 37.96 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.76 2.306 . . . . 0.0 111.704 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.22 153.58 74.24 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 C-N-CA 121.278 1.318 . . . . 0.0 110.137 171.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.84 52.19 1.44 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 124.192 0.932 . . . . 0.0 110.949 -172.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.47 7.52 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.748 2.419 . . . . 0.0 110.429 174.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -132.36 145.3 51.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.768 1.227 . . . . 0.0 108.972 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -107.75 148.6 37.64 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 124.002 0.921 . . . . 0.0 108.629 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.83 105.2 0.42 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.446 2.764 . . . . 0.0 109.19 162.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.64 156.77 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 170.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -133.13 124.96 28.48 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.338 1.855 . . . . 0.0 107.299 166.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -89.62 94.65 9.94 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.443 ' CE2' ' HB3' ' A' ' 28' ' ' ARG . 16.5 m-85 -46.68 148.13 1.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.493 1.117 . . . . 0.0 111.069 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.99 -35.87 1.06 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.093 0.854 . . . . 0.0 113.869 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.8 p -87.07 -26.81 23.51 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.586 1.693 . . . . 0.0 110.864 168.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 6.8 m80 62.01 24.46 14.56 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.496 2.318 . . . . 0.0 112.194 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -97.03 149.87 21.44 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.544 1.138 . . . . 0.0 108.994 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -123.74 147.42 47.51 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.247 1.019 . . . . 0.0 110.086 -172.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -147.96 165.27 31.2 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.681 1.193 . . . . 0.0 109.122 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.95 106.94 17.42 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 162.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.8 mt -109.19 156.58 19.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.02 161.25 22.54 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 166.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -63.32 -16.71 56.21 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.085 3.19 . . . . 0.0 115.076 -166.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -69.3 -17.79 63.76 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.446 1.476 . . . . 0.0 111.606 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -89.23 1.84 55.12 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.619 1.168 . . . . 0.0 110.905 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 20.7 mt -117.58 167.77 11.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.751 1.62 . . . . 0.0 111.463 -174.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -143.69 152.31 55.77 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.025 1.73 . . . . 0.0 109.169 162.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.58 118.27 5.4 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.269 2.646 . . . . 0.0 111.034 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -44.33 -62.27 1.23 Allowed 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 125.075 1.35 . . . . 0.0 112.324 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.79 -42.52 62.52 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.473 1.033 . . . . 0.0 112.055 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.41 -33.09 74.09 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.908 0.883 . . . . 0.0 111.426 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.31 8.82 18.16 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.198 -1.564 . . . . 0.0 112.787 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -56.77 -42.57 79.62 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.347 1.859 . . . . 0.0 111.144 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -74.54 -37.17 63.11 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.339 0.59 . . . . 0.0 110.877 176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -82.26 -49.37 10.15 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.895 1.278 . . . . 0.0 111.48 -162.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -94.75 -33.34 12.94 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.752 2.021 . . . . 0.0 110.363 -178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.29 61.76 3.47 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.278 1.418 . . . . 0.0 111.366 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.558 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 11.1 mmpt? -131.24 136.95 48.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.566 1.947 . . . . 0.0 107.799 -172.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.6 m -40.34 110.31 0.14 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.435 2.294 . . . . 0.0 110.824 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -86.65 176.6 7.69 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.046 0.45 . . . . 0.0 109.829 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -83.83 -38.8 20.75 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.537 -1.221 . . . . 0.0 110.047 164.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 125.81 16.63 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.669 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.23 163.65 8.01 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 0.0 109.675 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.08 -42.32 1.86 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -56.91 -44.74 82.68 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.455 1.102 . . . . 0.0 111.861 -168.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.52 -36.81 71.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.24 0.927 . . . . 0.0 110.445 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -63.11 -31.71 72.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.608 0.763 . . . . 0.0 110.39 172.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.19 -32.69 42.73 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.566 174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.6 -41.81 99.2 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.387 1.094 . . . . 0.0 110.137 172.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -54.87 -43.77 73.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.191 0.45 . . . . 0.0 111.101 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -63.62 -53.06 57.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.849 0.295 . . . . 0.0 111.357 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.4 tt -67.45 -33.97 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 117.785 0.266 . . . . 0.0 110.589 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -62.87 -38.06 89.37 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.7 0.8 . . . . 0.0 110.06 175.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -76.03 -74.28 0.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.538 -0.726 . . . . 0.0 110.473 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.9 p 48.36 73.2 0.22 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.203 2.201 . . . . 0.0 112.135 -167.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.07 100.87 0.17 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.905 -0.941 . . . . 0.0 111.54 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.38 156.0 28.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.213 1.942 . . . . 0.0 108.454 164.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 46.2 55.34 7.36 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.45 1.1 . . . . 0.0 112.011 -174.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 103.76 135.72 0.01 OUTLIER 'General case' 0 C--O 1.236 0.375 0 C-N-CA 131.545 3.938 . . . . 0.0 108.311 175.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.14 0 N-CA-C 103.92 -3.672 . . . . 0.0 103.92 -146.657 . . . . . . . . 0 0 . 1 stop_ save_